# EDGAR Filing Document

**Accession Number:** 0001610520
**File Stem:** 0001193125-26-047621
**Filing Date:** 2026-2
**Character Count:** 1038924
**Document Hash:** 8d1faa1c0845e219bcbdd87ab6cb31c8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-047621.hdr.sgml**: 20260212

**ACCESSION NUMBER**: 0001193125-26-047621

**CONFORMED SUBMISSION TYPE**: F-3

**PUBLIC DOCUMENT COUNT**: 46

**FILED AS OF DATE**: 20260212

**DATE AS OF CHANGE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UBS Group AG
- **CENTRAL INDEX KEY:** 0001610520
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** F-3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293403
- **FILM NUMBER:** 26623352

**BUSINESS ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 45
- **CITY:** ZURICH
- **STATE:** V8
- **ZIP:** CH-8001
- **BUSINESS PHONE:** 41-44-234-1111

**MAIL ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 45
- **CITY:** ZURICH
- **STATE:** V8
- **ZIP:** CH-8001
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UBS AG
- **CENTRAL INDEX KEY:** 0001114446
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** F-3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293403-02
- **FILM NUMBER:** 26623354

**BUSINESS ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 45
- **CITY:** ZURICH
- **STATE:** V8
- **ZIP:** CH 8001
- **BUSINESS PHONE:** 203-719-5241

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UBS AMERICAS INC
- **CENTRAL INDEX KEY:** 0001127918

**ORGANIZATION NAME:**
- **EIN:** 061595848
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** T2E64KWP8B9GCLM28W20

**FILING VALUES:**
- **FORM TYPE:** F-3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293403-01
- **FILM NUMBER:** 26623353

**BUSINESS ADDRESS:**
- **STREET 1:** 11 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010
- **BUSINESS PHONE:** 2037193000

**MAIL ADDRESS:**
- **STREET 1:** 11 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10010

##### [**Table of Contents**](#toc)
**As filed with the Securities and Exchange Commission on February 12, 2026** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM F-3** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

## UBS Group AG
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Canton of Zurich,<br>Switzerland** | **Bahnhofstrasse 45,<br>8001 Zurich, Switzerland<br>+41 44 234 11 11** | **Not Applicable** |
| (State or other jurisdiction of<br> incorporation or organization) | (Address and telephone number of<br> registrant's principal executive offices) | (IRS Employer<br> Identification Number) |

---

## UBS AG
(Exact name or registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Canton of Zurich,<br>Switzerland** | **Bahnhofstrasse 45,<br>8001 Zurich, Switzerland<br>Aeschenvorstadt 1,<br>4051 Basel, Switzerland<br>+41 44 234 11 11** | **Not Applicable** |
| (State or other jurisdiction of<br> incorporation or organization) | (Address and telephone number of<br> registrant's principal executive offices) | (IRS Employer<br> Identification Number) |

---

**Patrick T. Shilling** 

11 Madison Avenue

New York, NY 10010

Telephone: +1-212-713-3685

(Name, address and telephone number of agent for service)

------

##### [**Table of Contents**](#toc)

## UBS Americas Inc.
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **11 Madison Avenue**<br> **New York, NY 10010<br>+1-212-713-2000** | **06-1595848** |
| (State or other jurisdiction of<br> incorporation or organization) | (Address and telephone number of<br> registrant's principal executive offices) | (IRS Employer<br> Identification Number) |

---

***With a copy to:***

**John Horsfield-Bradbury** 

**Sullivan & Cromwell LLP** 

1 New Fetter Lane

London, EC4A 1AN

Tel: +44 20 7959 8900

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective time until the registrant shall file an amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to such Section 8(a), may determine.** 

† The term "new or revised financial accounting standard" refers to any update issued by the
Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

------

##### [**Table of Contents**](#toc)
**EXPLANATORY NOTE** 

This registration statement contains the following two prospectuses:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Prospectus relating to a rescission offer with respect to the notes described in the table below and market-making transactions that have occurred or may occur on a delayed or continuous basis in such notes which are outstanding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Title of Security** | **Issuer** | **CUSIP No.;<br>ISIN No.** | **Principal<br>Amount<br>Outstanding** | **Maturity Date** |
| 4.875% Senior Notes due 2045 | UBS Group AG (Credit Suisse Group AG until June 12, 2023) | 902613AY4;<br> US902613AY48 | $1924666000 | May 15, 2045 |
| 4.550% Senior Notes due 2026 | UBS Group AG (Credit Suisse Group AG until June 12, 2023) | 902613BB3;<br> US902613BB36 | $1982535000 | April 17, 2026 |
| 3.750% Senior Notes due 2025 | UBS Group AG (Credit Suisse Group AG until June 12, 2023) | 902613AX6;<br> US902613AX64 | N/A | March 26, 2025 |
| 3.800% Senior Notes due 2023 | Credit Suisse Group AG | 225433AT8;<br> US225433AT80 | N/A | June 9, 2023 |
| 3.800% Senior Notes due 2022 | Credit Suisse Group Funding (Guernsey) Limited (guaranteed by Credit Suisse Group AG) | 225433AH4;<br> US225433AH43 | N/A | September 15, 2022 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Prospectus relating to a rescission offer with respect to the 7<sup>1</sup>/<sub>8</sub>% Notes due July 15, 2032 of UBS Americas Inc. (Credit Suisse (USA) LLC until February 2, 2026) fully and unconditionally guaranteed by UBS Group AG and UBS AG (CUSIP No. 22541LAE39; ISIN No. US22541LAE39), and market-making transactions that have occurred or that may occur on a delayed or continuous basis in such notes which are outstanding.

------

##### [**Table of Contents**](#toc)
**The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission, in which this prospectus is included, is declared effective. This prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.** 

**SUBJECT TO COMPLETION, DATED FEBRUARY 12, 2026** 

## UBS Group AG
We, UBS Group AG (the "Issuer"), are offering, under the terms and conditions described in this prospectus, to rescind (the "Rescission Offer") the previous purchase of the securities listed in the table below (the "Subject Securities") by certain purchasers who acquired Subject Securities during the period from May 1, 2022 to the date of this prospectus (the "Relevant Period") (i) on or after June 12, 2023 (the "Merger Date"), from the Issuer or an affiliate of the Issuer or (ii) before the Merger Date, from Credit Suisse Group AG ("CSG") or an affiliate of CSG at such time (an "Applicable Transaction").

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Title of Security** | **Issuer** | **CUSIP No.;**<br>**ISIN No.** | **Principal**<br>**Amount<br>Outstanding\*\*** | **Maturity Date** |
|  4.875% Senior Notes due 2045 | UBS Group AG (CSG until<br> the Merger Date) | 902613AY4;<br> US902613AY48 | $1924666000 | May 15, 2045 |
|  4.550% Senior Notes due 2026 | UBS Group AG (CSG until<br> the Merger Date) | 902613BB3;<br> US902613BB36 | $1982535000 | April 17, 2026 |
|  3.750% Senior Notes due 2025\* | UBS Group AG (CSG until<br> the Merger Date) | 902613AX6;<br> US902613AX64 | N/A | March 26, 2025 |
|  3.800% Senior Notes due 2023\* | CSG | 225433AT8;<br> US225433AT80 | N/A | June 9, 2023 |
|  3.800% Senior Notes due 2022\* | Credit Suisse Group Funding (Guernsey) Limited<br> (guaranteed by CSG) | 225433AH4;<br> US225433AH43 | N/A | September 15, 2022 |

---

\* These securities have matured.

\*\* Only Eligible Investors may participate in the Rescission Offer.

For further information on the Subject Securities, see "*The Rescission Offer—Terms of the Rescission Offer—Subject Securities*."

The Subject Securities were originally issued by an affiliate of CSG pursuant to a registration statement under Section 5 of the Securities Act of 1933, as amended (the "Securities Act"). Affiliates of CSG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (the "Market-Making Transactions"), without an effective registration statement under the Securities Act. On the Merger Date, upon the merger between UBS Group and CSG, UBS Group AG was substituted as issuer with respect to the then outstanding Subject Securities, and affiliates of UBS Group AG continued the Market-Making Transactions without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction (the "Applicable Securities"). As a result, the Issuer has elected to make the Rescission Offer to those purchasers (each such purchaser, an "Eligible Investor"). The eligibility requirements for purchasers to take part in the Rescission Offer are described in this prospectus in the section entitled "*The Rescission Offer*" beginning on page 18.

If you are an Eligible Investor and accept the Rescission Offer, you will receive, upon satisfaction of the conditions set forth in this prospectus, the following:

• In the case of an Eligible Current Investor, an amount equal to the purchase price paid for the relevant
Applicable Security in the Applicable Transaction, *plus* interest on such purchase price from the settlement date of such Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the
Expiration Date (as defined below) and (y) the Settlement Date (as defined below) (the "Eligible Current Investor Applicable Period") *less* the amount of any interest, coupon payments, principal or other income received on
such Applicable Security. For the definition of Eligible Current Investors, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*."

------

##### [**Table of Contents**](#toc)
• In the case of an Eligible Former Investor, an amount equal to the excess, if any, of the purchase price paid for
the relevant Applicable Security over the proceeds from the Applicable Disposition (as defined below), *plus* interest (i) on the purchase price paid for such Applicable Security from the settlement date of the Applicable Transaction to,
and including, the date on which such Applicable Security either matured at a loss or the settlement date of the transaction in which such Applicable Security was sold at a loss (such maturity or transaction, the "Applicable Disposition"
and such period, the "Eligible Former Investor Holding Applicable Period") and (ii) on the loss realized from such Applicable Disposition from the date of such Applicable Disposition to, and including, the earlier to occur of
(x) the date that is five business days after the Expiration Date and (y) the Settlement Date (the "Eligible Former Investor Applicable Period"), *less* the amount of any interest, coupon payments, principal (except for
principal repaid at maturity) or other income received on such Applicable Security. For the definition of Eligible Former Investors, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*."

We refer to each of the Eligible Current Investor Applicable Period, Eligible Former Investor Holding Applicable Period and Eligible Former Investor Applicable Period as an "Applicable Period."

IF YOU ACCEPT THE RESCISSION OFFER, YOU WILL NOT BE PAID ANY OTHER AMOUNTS ON YOUR APPLICABLE SECURITIES OTHER THAN AS SET OUT ABOVE.

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

The Rescission Offer will expire at 5:00 p.m., Eastern Standard Time, on 2026 (the "Expiration Date"), which is 30 days from the date of this prospectus (including the date of this prospectus and the Expiration Date).

If you are an Eligible Current Investor, you may elect to accept the Rescission Offer by instructing your broker or bank through which your Applicable Securities are held to tender them for you as set forth in this prospectus. If you are an Eligible Former Investor, you may elect to accept the Rescission Offer by submitting an acceptance form to us on or before the Expiration Date as set forth in this prospectus. See "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer*." You do not need to take any action to reject the Rescission Offer. If you fail to validly accept the Rescission Offer by the Expiration Date, you will be deemed by us to have rejected the Rescission Offer. Acceptance or rejection of the Rescission Offer may prevent you from maintaining any action against us based on a claim that we failed to register the Market-Making Transactions. In any event, any such action may be barred by applicable statutes of limitations or repose*.* See "*Risk Factors—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer*."

If you have questions or require additional information about the Rescission Offer, you may contact the broker, bank or other institution where you purchased your Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer on-line portal, which can be accessed at https://deals.is.kroll.com/UBSgroupAG (the "Rescission Offer On-line Portal").

**Investing in the Subject Securities involves risks. See the [risk factors](#toc17238_6) beginning on page 15 of this prospectus and the other information incorporated by reference in this prospectus, for a discussion of the factors you should carefully consider before deciding whether to accept or reject the Rescission Offer or invest in Subject Securities.** 

------

##### [**Table of Contents**](#toc)
Neither the U.S. Securities and Exchange Commission (the "SEC") nor any U.S. state securities commission has approved or disapproved of the Subject Securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The Subject Securities are not deposit liabilities and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. The Subject Securities do not have the benefit of any agency or governmental guarantee.

We have not retained an underwriter in connection with the Rescission Offer.

In addition to the Rescission Offer, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may use this prospectus in market-making transactions involving outstanding Subject Securities. In a market-making transaction UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may resell a Subject Security it acquires from other holders, including in the Rescission Offer. Resales of this kind may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. The Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

**The date of this prospectus is , 2026** 

------

##### [**Table of Contents**](#toc)
**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
|  | **Page<br>Number** |
|  [About This Prospectus](#toc17238_1) | 1 |
|  [Limitations on Enforcement of U.S. Laws](#toc17238_2) | 2 |
|  [Cautionary Statement Regarding Forward-Looking Statements](#toc17238_3) | 3 |
|  [Where You Can Find More Information](#toc17238_4) | 6 |
|  [Questions and Answers About the Rescission Offer](#toc17238_5) | 8 |
|  [Risk Factors](#toc17238_6) | 15 |
|  [Use of Proceeds](#toc17238_7) | 17 |
|  [The Rescission Offer](#toc17238_8) | 18 |
|  [Description of the Subject Securities](#toc17238_9) | 35 |
|  [United States Tax Considerations](#toc17238_10) | 48 |
|  [Swiss Tax Considerations](#toc17238_11) | 52 |
|  [Benefit Plan Investor Considerations](#toc17238_12) | 55 |
|  [Plan of Distribution (Conflicts of Interest)](#toc17238_13) | 57 |
|  [Legal Matters](#toc17238_14) | 58 |
|  [Experts](#toc17238_15) | 59 |
|  [Expenses](#toc17238_20) | 60 |
|  [Appendix A—Former Investor Acceptance Form](#toc17238_16) | A-1 |
|  [Appendix B—Rescission Offer Withdrawal Form](#toc17238_17) | B-1 |
|  [Appendix C—Current Investor Acceptance Form](#toc17238_18) | C-1 |

---

WE ARE RESPONSIBLE FOR THE INFORMATION CONTAINED AND INCORPORATED BY REFERENCE IN THIS PROSPECTUS. AT THE DATE OF THIS PROSPECTUS, WE HAVE NOT AUTHORIZED ANYONE ELSE TO PROVIDE YOU WITH DIFFERENT INFORMATION, AND WE TAKE NO RESPONSIBILITY FOR ANY OTHER INFORMATION OTHERS MAY GIVE YOU. WE ARE NOT MAKING AN OFFER OF THE SUBJECT SECURITIES OR CONDUCTING MARKET-MAKING ACTIVITIES IN ANY JURISDICTION WHERE SUCH OFFER OR MARKET-MAKING ACTIVITIES ARE NOT PERMITTED. YOU SHOULD NOT ASSUME THAT THE INFORMATION IN THIS PROSPECTUS OR ANY PROSPECTUS SUPPLEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THE DATE ON THE FRONT OF THIS DOCUMENT.

------

##### [**Table of Contents**](#toc)
**ABOUT THIS PROSPECTUS** 

This prospectus is part of a registration statement on Form F-3 that we filed with the SEC using a "shelf" registration process. This prospectus describes the Subject Securities and the Rescission Offer. You should read both this prospectus and any prospectus supplement together with the additional information described under the headings "*Incorporation by Reference*" and "*Where You Can Find More Information*."

This prospectus may be used by the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer in connection with offers and sales of the outstanding Subject Securities in market-making transactions. A market-making transaction may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. The Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

Unless otherwise indicated or unless the context requires otherwise:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to the "Issuer," "we" or "us" we mean UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "UBS" or the "Group" we mean UBS Group AG and its consolidated
subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "CSG" we mean Credit Suisse Group AG; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "Credit Suisse" we mean CSG and its consolidated subsidiaries, before the
acquisition of CSG by UBS Group AG.

In this prospectus:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the term "affiliate" shall have the meaning given to such term in Rule 405 under the Securities Act;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• all references to prices at which the Subject Securities were acquired or sold exclude any accrued interest,
fees, selling concessions or other additional amounts.

------

##### [**Table of Contents**](#toc)
**LIMITATIONS ON ENFORCEMENT OF U.S. LAWS** 

UBS Group AG is a holding company for financial services companies that is domiciled in Switzerland. Many of its directors and executive officers, and certain experts named in this prospectus, are resident outside the United States, and all or a substantial portion of its assets and the assets of such persons are located outside the United States. As a result, it may be difficult for you to serve legal process on UBS Group AG or its directors and executive officers resident outside of the United States or have any of them appear in a U.S. court. We have been advised by Homburger AG, Swiss counsel to UBS Group AG that, due to the lack of reciprocal legislation between Switzerland and the United States, it may be difficult for you to enforce in Switzerland judgments obtained in U.S. courts against UBS Group AG (or any of its directors or executive officers resident in Switzerland). In addition, there is doubt as to enforceability in Switzerland, in original actions or in actions for enforcement of judgments of U.S. courts, of liabilities predicated solely upon the federal or state securities laws of the United States.

------

##### [**Table of Contents**](#toc)
**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS** 

This prospectus and certain documents incorporated by reference herein contain statements that constitute "forward-looking statements," as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as amended by the Private Securities Litigation Reform Act of 1995, including but not limited to management's outlook for UBS's financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS's business and future development and goals. Forward-looking statements can sometimes be identified by the use of forward-looking terms such as "believes," "expects," "may," "will," "shall," "should," "would," "could," "potential," "seeks," "aims," "projects," "predicts," "is optimistic," "intends," "plans," "estimates," "targets," "anticipates," "continues" or other comparable terms or negatives of these terms, but not all forward-looking statements include such identifying words.

While these forward-looking statements represent UBS's judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS's expectations. In particular, the global economy may suffer significant adverse effects from increasing political tensions between world powers, changes to international trade policies, including those related to tariffs and trade barriers, and evolving armed conflicts.

UBS's acquisition of Credit Suisse materially changed UBS's outlook and strategic direction and introduced new operational challenges. The integration of the Credit Suisse entities into the UBS structure is expected to continue through 2026 and presents significant operational and execution risk, including the risks that UBS may be unable to achieve the cost reductions and business benefits contemplated by the transaction, that it may incur higher costs to execute the integration of Credit Suisse and that the acquired business may have greater risks or liabilities, including those related to litigation, than expected.

Following the failure of Credit Suisse, Switzerland is considering significant changes to its capital, resolution and regulatory regime, which, if adopted, would significantly increase UBS's capital requirements or impose other costs on UBS. These factors create greater uncertainty about forward-looking statements.

Other factors that may affect UBS's performance and ability to achieve its plans, outlook and other objectives also include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which UBS is successful in the execution of its strategic plans, including its cost reduction and
efficiency initiatives and its ability to manage its levels of risk-weighted assets ("RWA") and leverage ratio denominator, liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising
from higher market volatility and the size of the combined Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which UBS is successful in implementing changes to its businesses to meet changing market,
regulatory and other conditions, including any potential changes to banking examination and oversight practices and standards as a result of executive branch orders or staff interpretations of law in the U.S.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inflation and interest rate volatility in major markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Developments in the macroeconomic climate and in the markets in which UBS operates or to which it is exposed,
including movements in securities prices or liquidity, credit spreads, currency exchange rates, residential and commercial real estate markets, general economic conditions and changes to national trade policies on the financial position or
creditworthiness of UBS's clients and counterparties, as well as on client sentiment and levels of activity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the availability of capital and funding, including any adverse changes in UBS's credit spreads
and credit ratings, as well as availability and cost of funding, including as affected by the

------

##### [**Table of Contents**](#toc)
marketability of a current additional tier one debt instrument, to meet requirements for debt eligible for total loss-absorbing capacity ("TLAC"); <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in and potential divergence between central bank policies or the implementation of financial legislation
and regulation in Switzerland, the U.S., the United Kingdom, the European Union and other financial centers that have imposed, or resulted in, or may do so in the future, more stringent or entity-specific capital, TLAC, leverage ratio, net stable
funding ratio, liquidity and funding requirements, heightened operational resilience requirements, incremental tax requirements, additional levies, limitations on permitted activities, constraints on remuneration, constraints on transfers of capital
and liquidity and sharing of operational costs across the Group or other measures and the effect these will or would have on UBS's business activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UBS's ability to successfully implement resolvability and related regulatory requirements and the potential
need to make further changes to the legal structure or booking model of UBS in response to legal and regulatory requirements including heightened requirements and expectations due to its acquisition of Credit Suisse;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UBS's ability to maintain and improve its systems and controls for complying with sanctions in a timely
manner and for the detection and prevention of money laundering to meet evolving regulatory requirements and expectations, in particular in the current geopolitical turmoil;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The uncertainty arising from domestic stresses in certain major economies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in UBS's competitive position, including whether differences in regulatory capital and other
requirements among the major financial centers adversely affect UBS's ability to compete in certain lines of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the standards of conduct applicable to its businesses that may result from new regulations or new
enforcement of existing standards, including measures to impose new and enhanced duties when interacting with customers and in the execution and handling of customer transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The liability to which UBS may be exposed, or possible constraints or sanctions that regulatory authorities might
impose on UBS, due to litigation, including litigation it has inherited by virtue of the acquisition of Credit Suisse, contractual claims and regulatory investigations, including the potential for disqualification from certain businesses,
potentially large fines or monetary penalties, or the loss of licenses or privileges as a result of regulatory or other governmental sanctions, as well as the effect that litigation, regulatory and similar matters have on the operational risk
component of its RWA;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UBS's ability to retain and attract the employees necessary to generate revenues and to manage, support and
control its businesses, which may be affected by competitive factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in accounting or tax standards or policies and determinations or interpretations affecting the
recognition of gain or loss, the valuation of goodwill, the recognition of deferred tax assets and other matters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UBS's ability to implement new technologies and business methods, including digital services, artificial
intelligence and other technologies and ability to successfully compete with both existing and new financial service providers, some of which may not be regulated to the same extent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Limitations on the effectiveness of UBS's internal processes for risk management, risk control, measurement
and modeling and of financial models generally;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The occurrence of operational failures, such as fraud, misconduct, unauthorized trading, financial crime,
cyberattacks, data leakage and systems failures, the risk of which is increased with persistently high levels of cyberattack threats;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Restrictions on the ability of UBS Group AG, UBS AG and regulated subsidiaries of UBS AG to make payments or
distributions, including due to restrictions on the ability of its subsidiaries to make loans

------

##### [**Table of Contents**](#toc)
or distributions, directly or indirectly, or, in the case of financial difficulties, due to the exercise by the Swiss Financial Market Supervisory Authority FINMA or the regulators of UBS's operations in other countries of their broad statutory powers in relation to protective measures, restructuring and liquidation proceedings; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which changes in regulation, capital or legal structure, financial results, or other factors may
affect UBS's ability to maintain its stated capital return objective;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Uncertainty over the scope of actions that may be required by UBS, governments and others for UBS to achieve
goals relating to climate, environmental and social matters, as well as the evolving nature of underlying science and industry and the increasing divergence among regulatory regimes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The ability of UBS to access capital markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The ability of UBS to successfully recover from a disaster or other business continuity problem due to a
hurricane, flood, earthquake, terrorist attack, war, conflict, pandemic, security breach, cyberattack, power loss, telecommunications failure, or other natural or man-made event; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect that these or other factors or unanticipated events, including media reports and speculations, may
have on its reputation and the additional consequences that this may have on its business and performance.

The sequence in which the factors above are presented is not indicative of their likelihood of occurrence or the potential magnitude of their consequences. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. We caution you not to place undue reliance on any forward-looking statements as they are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, our actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which we operate, may differ materially from those made in or suggested by the forward-looking statements contained or incorporated by reference herein. Except as required by law, we assume no obligation to update or revise the information contained or incorporated by reference herein, which speaks only as of the date hereof. For additional information about factors that could cause our results to differ materially from those described in the forward-looking statements, please read and consider the risk factors set out under "Risk Factors" in Part I, Item 3D of UBS Group AG's Annual Report on Form 20-F for the year ended 31 December 2024 (the "UBS Group AG 2024 20-F"), which is incorporated in this prospectus by reference, as well as in the other reports that UBS Group AG has filed with the SEC described in the section of this prospectus entitled "*Where You Can Find More Information.*"

------

##### [**Table of Contents**](#toc)
**WHERE YOU CAN FIND MORE INFORMATION** 

UBS Group AG files periodic reports and other information with the SEC. Copies of the documents filed by UBS Group AG with the SEC may be obtained either on the SEC's website at www.sec.gov, which contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, or on the website of UBS Group AG at https://www.ubs.com/investors. Information on our website is not incorporated by reference into this prospectus or our securities filings and is not part of this prospectus unless otherwise specifically incorporated by reference.

The SEC allows us to "incorporate by reference" into this prospectus the information that we file with the SEC, which means that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The incorporated documents are considered part of this prospectus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We can disclose important information to you by referring you to those documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information that we file with the SEC from time to time will automatically be considered to update and supersede
the information in this prospectus.

The information incorporated by reference is an important part of this prospectus. We incorporate by reference into this prospectus the following documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The UBS Group AG 2024 20-F (File No. 001-36764), filed by UBS Group AG with the SEC on [March 17, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1610520/000161052025000023/ubs-20241231.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Reports on Form 6-K furnished by UBS Group AG to the SEC on [April 17, 2025](http://www.sec.gov/Archives/edgar/data/1610520/000161052025000048/aoa6k20250417ubsgroup.htm) , [April 30, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000051/edgar1q25ubsgroup.htm) , [May 5, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000065/newsrelease6k20250505.htm) , [May 8, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000111444625001899/edgar1q25significan.htm) , [June 6, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000069/newsrelease6k20250606.htm) , [July 30, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1114446/000161052025000080/ubs-20250630.htm) , [August 5, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000111444625003777/edgar00significantreg.htm) , [October 29, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000105/edgar3q25ubsgroup.htm) , [October 29, 2025](http://www.sec.gov/Archives/edgar/data/1610520/000161052025000106/edgarq3q25kubsgroupagc.htm) and [February 4, 2026](http://www.sec.gov/Archives/edgar/data/1610520/000161052026000008/edgar4q25ubsgroup.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [The section titled "Risk Factors" of the Prospectus dated December 15, 2015, relating to the 3.750% Senior Notes due 2025, 4.875% Senior Notes due 2045 and 3.800% Senior Notes due 2022](http://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/a2226897z424b3.htm) ; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• [The section titled "Risk Factors" of the Prospectus dated October 18, 2016, relating to the 4.550% Senior Notes due 2026 and the 3.800% Senior Notes due 2023](http://www.sec.gov/Archives/edgar/data/1159510/000104746916016156/a2230018z424b3.htm) .

In addition we incorporate by reference into the registration statement of which this prospectus forms a part all documents that we file with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after (i) the date of the initial registration statement and prior to effectiveness of the registration statement and (ii) the date of this prospectus and before the date our subsidiaries and affiliates stop offering Subject Securities pursuant to this prospectus. Reports on Form 6-K furnished by us to the SEC (or portions thereof) are incorporated by reference only to the extent that the report expressly states that it is (or such portions are) incorporated by reference in the registration statement of which this prospectus is a part.

Any statement in this prospectus contained in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement in this prospectus or in any later filed document modifies or supersedes that statement. Any statement that is modified or superseded in this manner will no longer be a part of this prospectus, except as modified or superseded.

------

##### [**Table of Contents**](#toc)
You may request a copy, at no cost, of any or all of the documents that are incorporated by reference into this prospectus, excluding exhibits (other than those that we specifically incorporate by reference into the documents that you request) by contacting us, orally or in writing, at the following address:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Attention: Investor Relations

+41 44 234 11 11

Internet:

https://www.ubs.com/investor

Except for the documents specifically incorporated by reference into this prospectus, information contained on our website or that can be accessed through our website is not incorporated into and does not constitute a part of this prospectus. We have included our website address only as an inactive textual reference and do not intend it to be an active link to our website.

We have filed or incorporated by reference exhibits to the registration statement of which this prospectus forms a part. You should read the exhibits carefully for provisions that may be important to you. Statements in this prospectus concerning any document we have filed or will file as an exhibit to the registration statement of which this prospectus forms a part or that we have otherwise filed with the SEC are not intended to be comprehensive and are qualified in their entirety by reference to these filings. You should review the complete document to evaluate these statements.

------

##### [**Table of Contents**](#toc)
**QUESTIONS AND ANSWERS ABOUT THE RESCISSION OFFER** 

*The following questions and answers are intended to address briefly some commonly asked questions regarding the Rescission Offer. These questions and answers do not address all questions that may be important to you. Please refer to "The Rescission Offer" below and the more detailed information contained elsewhere in this prospectus, which you should read carefully, and the information we have incorporated by reference in this prospectus.* 

**What is a rescission offer?** 

A rescission offer is an offer to rescind a securities transaction in which a securities law violation occurred or may have occurred. To conduct a rescission offer, the issuer of the subject securities offers to repurchase the applicable securities from relevant purchasers who acquired such securities, at their purchase price plus interest, less the amount of any interest, coupon payments, principal or other income received pursuant to the terms of the securities, or to pay rescissory damages if such securities, after being purchased, were sold or matured at a loss.

**Why is UBS Group AG making the Rescission Offer?** 

The Subject Securities were originally issued by an affiliate of CSG, pursuant to a registration statement under Section 5 of the Securities Act. Affiliates of CSG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (i.e., the Market-Making Transactions), without an effective registration statement under the Securities Act. On the Merger Date, upon the merger between UBS Group AG and CSG, UBS Group AG was substituted as issuer with respect to the then outstanding Subject Securities, and affiliates of UBS Group AG continued the Market-Making Transactions without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction. The Issuer has therefore elected to make the Rescission Offer.

The Rescission Offer is not an admission that the Issuer or its affiliates did not comply with applicable federal securities law requirements as to specific securities or transactions, nor is it a waiver by the Issuer or its affiliates of any applicable statute of limitations or repose.

**Am I eligible to participate in the Rescission Offer?** 

You are eligible to participate in the Rescission Offer if you produce evidence satisfactory to the Issuer showing that, with respect to a given Subject Security, you meet the requirements to be deemed an Eligible Current Investor or an Eligible Former Investor, as described in this prospectus. For the definition of Eligible Current Investor and Eligible Former Investor, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*."

Eligible Current Investors will be required to produce evidence satisfactory to the Issuer that (1) they purchased the relevant Subject Security during the Relevant Period (i) on or after the Merger Date, from the Issuer or an affiliate of the Issuer or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time, and (2) they still hold such Applicable Security as of the date of this prospectus, and, subject to any tenders pursuant to the Rescission Offer, will continue to hold it on the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind.

Eligible Former Investors will be required to produce evidence satisfactory to the Issuer that (1) they purchased the relevant Subject Security during the Relevant Period (i) on or after the Merger Date, from the Issuer or an affiliate of the Issuer or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time, and (2) they no longer hold such Applicable Security as of the date of this prospectus and such Applicable Security has matured at a loss or been sold at a loss, in each case provided that they continuously held such Applicable Security until the time of maturity or sale, as applicable.

------

##### [**Table of Contents**](#toc)
All Eligible Investors, by accepting the Rescission Offer, will also be deemed to have provided certain representations and warranties, acknowledgements and agreements to the Issuer upon acceptance of the Rescission Offer. For further details, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*," "*The Rescission Offer—Terms of the Rescission Offer—Evidence of Eligibility*" and "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors.*"

For the avoidance of doubt, you should assess whether you meet the requirements to qualify as an Eligible Current Investor or an Eligible Former Investor in respect of each Subject Security. For example, you may be an Eligible Current Investor with respect to one Subject Security and an Eligible Former Investor with respect to another. You should make this assessment for each Subject Security in respect of which you wish to accept the Rescission Offer.

The following investors will <u>not</u> be considered Eligible Investors for purposes of the Rescission Offer: (i) holders who purchased Subject Securities through us or our affiliates (or, prior to the Merger Date, through CSG or its affiliates at the time) as agent and not as principal, in respect of Subject Securities acquired pursuant to such transactions; (ii) holders who, either to cover short positions or otherwise, borrowed Subject Securities from us or our affiliates (or, prior to the Merger Date, from CSG or its affiliates at the time), in respect of Subject Securities borrowed pursuant to such transactions; and (iii) holders of call options, put options or other types of options to purchase, sell or otherwise indirectly acquire or dispose of Subject Securities or an indirect interest therein, in respect of such options.

If you do not meet the requirements to be considered an Eligible Investor, you are not entitled to participate in the Rescission Offer. In particular, if you purchased Subject Securities from CSG or an affiliate of CSG at such time before May 1, 2022, you are not an Eligible Investor with respect to such Subject Securities.

**When does the Rescission Offer expire?** 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026.

**If I do not tender my Applicable Securities, will they be considered to have been offered and sold under an effective registration statement?** 

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus, your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

**Am I required to accept the Rescission Offer?** 

No. There is no requirement, legal or otherwise, that you accept the Rescission Offer. Your decision to accept or reject the Rescission Offer is completely voluntary and should be based on your assessment.

**What happens if I accept the Rescission Offer?** 

If you timely and validly accept the Rescission Offer, you will receive from us the Rescission Offer Proceeds (as defined below) and, if you are an Eligible Current Investor, you will cease to hold the Applicable Securities in respect of which you accepted the Rescission Offer once such Applicable Securities are tendered to us through ATOP (as defined below) as part of the Rescission Offer acceptance process as described in this prospectus.

------

##### [**Table of Contents**](#toc)
**Should I accept the Rescission Offer?** 

You must make your own decision whether to accept or reject the Rescission Offer. In making your decision, you should consider all relevant factors in light of your particular circumstances, including the potential tax consequences of accepting the rescission offer (see the section entitled "*United States Tax Considerations*"). Whether you are an Eligible Current Investor or an Eligible Former Investor, we encourage you to read and carefully consider this prospectus in its entirety, in particular the section headed "*Risk Factors*" in this prospectus and the other information incorporated by reference in this prospectus, for a discussion of certain factors you should carefully consider before deciding whether to accept or reject the Rescission Offer.

If you are an Eligible Current Investor, you should also consider your expected return on the Subject Securities should you continue to hold your Applicable Securities to maturity and the possibility that the value of the Subject Securities may increase or decrease after the Expiration Date. You should also consider whether the amount you will receive in the Rescission Offer is expected to be less or more than the amount you could receive if you currently decided to sell the Applicable Securities to a third party.

WE URGE YOU TO CAREFULLY REVIEW THIS PROSPECTUS BEFORE DECIDING WHETHER OR NOT TO ACCEPT THE RESCISSION OFFER.

**May I accept the Rescission Offer in part with respect to a given series of Subject Securities?** 

Yes, you may accept the Rescission Offer for some or all Applicable Securities of a given series, as long as such acceptance is for Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof.

**What will I receive if I accept the Rescission Offer?** 

If you submit the necessary documentation through the Rescission Offer On-line Portal, including evidence showing that you meet the requirements to be deemed an Eligible Investor and you validly accept the Rescission Offer, you will receive the Rescission Offer Proceeds, which will depend on whether you still hold the Applicable Securities or not:

• <u>If you are an Eligible Current Investor who has continued to hold an Applicable Security</u>: upon your tender
of such Applicable Security to us by accepting the Rescission Offer, we will pay you an amount equal to the purchase price you paid for such Applicable Security in the Applicable Transaction, *plus* interest on such purchase price from the
settlement date of the Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the Settlement Date, *less* the amount of any interest, coupon
payments, principal or other income received on such Applicable Security.

• <u>If you are an Eligible Former Investor having sold the Applicable Security at a loss or having had the Applicable Security mature at a loss</u>: we will pay you an amount equal to the excess, if any, of the purchase price you paid for such Applicable Security in the Applicable Transaction over the proceeds from the Applicable Disposition, *plus* interest (i) on the purchase price you paid for the Applicable Security in the Applicable Transaction from the settlement date of the Applicable Transaction to, and including, the date of the Applicable Disposition and (ii) on the loss
realized from the Applicable Disposition from the date of the Applicable Disposition to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the Settlement Date, *less* the
amount of any interest, coupon payments, principal (except for principal repaid at maturity) or other income received on such Applicable Security.

**Will indicative and final Rescission Offer Proceeds be published?** 

Eligible Investors that have validly accepted the Rescission Offer will be informed individually of the Rescission Offer Proceeds in respect of their Applicable Securities as soon as practicable following the

------

##### [**Table of Contents**](#toc)
Expiration Date and processing of the documents in support of their eligibility provided through the Rescission Offer On-line Portal.

We are unable to calculate indicative Rescission Offer Proceeds for Eligible Investors as the final amount of Rescission Offer Proceeds for each such investor will depend on various factors that may be unknown to us, including the prices paid in Applicable Transactions or received in Applicable Dispositions and the dates of Applicable Dispositions. Eligible Investors should make their own calculations of their Rescission Offer Proceeds.

We advise you to consult your financial, legal, and tax advisers, as you deem appropriate, before making any decision with respect to the Rescission Offer.

For further details, see "*The Rescission Offer—Terms of the Rescission Offer—Rescission Offer Proceeds.*"

**What interest rate will be used in calculating any amounts owed to me pursuant to the Rescission Offer?** 

The interest rate for a particular Applicable Security will be calculated on the basis of the yield-to-worst value for the Bloomberg Investment Grade: Banking Total Return Index Unhedged (the "Index") on (i) in the case of interest calculated for an Eligible Current Investor Applicable Period or an Eligible Former Investor Holding Applicable Period, the settlement date of the Applicable Transaction in which the applicable Eligible Investor purchased such Applicable Security (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), or (ii) in the case of interest calculated for an Eligible Former Investor Applicable Period, the settlement date of the Applicable Disposition in which such Applicable Security matured or was sold at a loss (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), plus, in each case, a 100 basis point margin (the "Index Rate"). The Index can be accessed at www.bloomberg.com/indices (I00408US Index Ticker).

**When and how will I receive payment if I validly accept the Rescission Offer?** 

If you are an Eligible Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms hereof, we will cause payment of the Rescission Offer Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date. Payment will be made through The Depository Trust Company ("DTC") or via bank transfer of immediately available funds to your bank account.

**What do I need to do if I want to accept the Rescission Offer?** 

If you are an Eligible Current Investor, in order to accept the Rescission Offer, you must (i) instruct your broker or bank through which your relevant Applicable Securities are held in time for such Applicable Securities to be tendered to us through ATOP on or before the Expiration Date and (ii) complete, sign and date the accompanying Current Investor Acceptance Form, included as Appendix C, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have rejected the Rescission Offer with respect to such Applicable Securities. Please note that DTC, its participants and the banks or brokers where you hold your Applicable Securities will establish their own cut-off dates and times for the tender of such Applicable Securities, which may be earlier than the Expiration Date. Please check with your broker or bank to determine the appropriate procedure.

If you are an Eligible Former Investor, in order to accept the Rescission Offer, you must complete, sign and date the accompanying Former Investor Acceptance Form, included as Appendix A, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have rejected the Rescission Offer.

------

##### [**Table of Contents**](#toc)
If you are both an Eligible Current Investor and an Eligible Former Investor, in order to accept the Rescission Offer in respect of both the Applicable Securities held by you as an Eligible Current Investor and those formerly held by you as an Eligible Former Investor, you must follow the process for accepting the Rescission Offer in each such capacity separately with respect to the relevant Applicable Securities.

You may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof.

For more details on the procedures for accepting the Rescission Offer, see "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer.*" For more details on the evidence required, see "*The Rescission Offer—Terms of the Rescission Offer—Evidence of Eligibility.*"

ALL DETERMINATIONS WITH RESPECT TO THE RESCISSION OFFER (INCLUDING ISSUES RELATING TO THE TIMELINESS OR EFFECTIVENESS OF ANY ELECTION, WITHDRAWAL OR TENDER OF SUBJECT SECURITIES OR EVIDENCE OF ELIGIBILITY) OR THE CALCULATION OF THE RESCISSION OFFER PROCEEDS WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION.

**What happens if I do not accept the Rescission Offer?** 

If you do not accept the Rescission Offer on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer and will continue to own any Applicable Securities still held by you, receive interest payments, coupon payments or other income on such Applicable Securities in accordance with their terms and be paid their principal amount upon maturity or early redemption as described and subject to the terms, conditions and risk factors set out under "*Description of the Subject Securities*" and in their respective issuance prospectuses. Furthermore, the Subject Securities not tendered in the Rescission Offer will be deemed to have been offered and sold under an effective registration statement of which this prospectus forms a part.

The rights remaining to the recipients of a rescission offer are not clearly delineated under federal or certain state securities laws. If you affirmatively reject or fail to accept the Rescission Offer, it is unclear whether your federal right of rescission, if any, will be preserved. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. See "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

**What do I need to do to reject the Rescission Offer?** 

You do not need to take any action to reject the Rescission Offer. If you do not tender your Applicable Securities or you do not submit the required information in either case so that it is received by us on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer.

**Can I change my mind after I have accepted the Rescission Offer?** 

Yes. You can change your decision about accepting the Rescission Offer at any time on or before the Expiration Date as described below.

<u>If you are an Eligible Current Investor</u>, you can do this by instructing your broker or bank, through which your relevant Applicable Securities are held, to withdraw your previously tendered Subject Securities in time for the transmission by your broker or bank of your instructions to be received by us on or before the Expiration

------

##### [**Table of Contents**](#toc)
Date. Otherwise, you will be deemed to have accepted the Rescission Offer and tendered such Subject Securities to us under the terms of any relevant previous instructions and acceptance form. Please note that DTC, its participants and the banks or brokers where you hold your Subject Securities will establish their own cut-off dates and times for withdrawal of any tender of the Subject Securities, which may be earlier than the Expiration Date. Please check with your broker or bank to determine the appropriate procedure. Withdrawals of tenders of Subject Securities by Eligible Current Investors may not be revoked, and any such Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer. Subject Securities properly withdrawn by Eligible Current Investors may, however, be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" and "*—Procedures for Brokers and Banks; DTC ATOP Account*" below, at any time on or before the Expiration Date.

<u>If you are an Eligible Former Investor</u>, in order to change a previous decision to accept the Rescission Offer and withdraw your acceptance of the Rescission Offer, you must complete, sign and date the accompanying Rescission Offer Withdrawal Form, included as Appendix B, and upload it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have accepted the Rescission Offer under the terms of your previously submitted acceptance form. Withdrawals of their acceptance of the Rescission Offer may not be revoked by Eligible Former Investors, and any such properly withdrawn acceptance will thereafter be deemed not a valid acceptance for purposes of the Rescission Offer. You may, however, re-accept the Rescission Offer by following the procedures described in "*—How to accept the Rescission Offer*" below, at any time on or before the Expiration Date.

In either case, the relevant withdrawal instruction or form, together with the supporting evidence required therein, if any, must be received by us on or before the Expiration Date. For more details on the appropriate procedures, see "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer.*"

ALL DETERMINATIONS WITH RESPECT TO THE RESCISSION OFFER (INCLUDING ISSUES RELATING TO THE TIMELINESS OR EFFECTIVENESS OF ANY ELECTION, TENDER OR WITHDRAWAL OF SUBJECT SECURITIES OR EVIDENCE OF ELIGIBILITY) OR THE CALCULATION OF THE RESCISSION OFFER PROCEEDS WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION.

**What is the effect of the Rescission Offer on my ability to assert claims?** 

The rights remaining to the recipients of a rescission offer are not clearly delineated under the federal or certain state securities laws. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. For a more detailed description of the effect of the Rescission Offer on any applicable federal and certain state securities law claims, please see the risk factors entitled "*Risk Factors—Risks Relating to the Rescission Offer—The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount*" and "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

**If I accept the Rescission Offer, will I experience any tax consequences?** 

For a more detailed description of the tax consequences of the Rescission Offer, see the section entitled "*United States Tax Considerations.*" You should consult your own tax adviser, as you deem appropriate, regarding the U.S. federal, state and local and other tax consequences of participating in the Rescission Offer.

------

##### [**Table of Contents**](#toc)
**Who can help answer my questions in relation to the Rescission Offer?** 

If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**RISK FACTORS** 

*An investment in the Subject Securities involves risks. You should carefully consider the risk factors and the other information contained in this prospectus and the UBS Group AG 2024 20-F, and the other information incorporated by reference in this prospectus, including the risk factors relating to Subject Securities as set out in their respective issuance prospectuses, before deciding to accept or reject the Rescission Offer or invest in Subject Securities.* 

**Risks Relating to the Rescission Offer** 

***The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount.***

It is not certain that the Rescission Offer will have the effect of barring claims relating to non-compliance with applicable federal securities laws in relation to the Subject Securities. If a person accepts the Rescission Offer, we believe our potential liability to that person will be eliminated. If a person rejects or fails to respond to the Rescission Offer, we may continue to be contingently liable for rescission or damages. In addition, the Rescission Offer will not prevent various other private claims from being asserted against us and/or our affiliates, including claims under applicable U.S. federal securities laws. Further, the Rescission Offer will not bar the SEC or other authorities from pursuing enforcement actions against us and/or our affiliates, which could result in fines, penalties and/or other sanctions. Any such private claims or enforcement actions could result in an adverse effect on our results of operations and financial condition.

***Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.***

The rights remaining to the recipients of a rescission offer are not clearly delineated under federal or certain state securities laws. If you affirmatively reject or fail to accept the Rescission Offer, it is unclear whether your federal right of rescission, if any, will be preserved. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief.

The Rescission Offer may also affect your right of rescission and your right to damages, if any, under state law. We believe that the sale of Subject Securities in Market-Making Transactions was exempt from registration under state laws. Furthermore, we believe that the Rescission Offer is exempt from registration under the laws of such states. However, we do not make any representation as to the compliance of the Rescission Offer with applicable state law. Under most state laws, acceptance or rejection of rescission offers may preclude offerees from initiating an action against the rescission offeror in connection with the registration of securities that are the subject of the rescission offer. We may assert, among other defenses, in any litigation initiated by a person eligible to participate in the Rescission Offer who accepts or rejects (or is deemed to reject) the Rescission Offer, that such person is legally barred from asserting such claims as a result of the Rescission Offer.

Generally, the statute of limitations for enforcement of federal statutory rights of rescission or rescissory damages by a security holder is one year commencing on the date the security was sold in violation of the federal registration requirements. Pursuant to Section 13 of the Securities Act, the statute of repose is three years after the security was *bona fide* offered to the public. Statutes of limitations under state laws vary by state, with the limitation time period under many state statutes not typically beginning until the facts giving rise to a violation are known. The Rescission Offer is not an admission that we or our affiliates did not comply with any federal and state registration or disclosure requirements as to specific securities or transactions, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose or any other potential defense we may have. However, we have decided to make the Rescission Offer to certain otherwise Eligible Investors that purchased Subject Securities during the Relevant Period even if now outside the applicable period of limitations or repose.

------

##### [**Table of Contents**](#toc)
Determining when a statute of limitations or repose expires under federal or state law can be a difficult issue and you should consult with an attorney if you have any questions regarding how federal or state statutes of limitations or repose may apply to any claims you may have.

***We cannot predict, if you are an Eligible Current Investor, whether the amounts you would receive in the Rescission Offer as a result of tendering your Subject Securities would be greater than the amounts you may receive for the Subject Securities from a third-party buyer. Nor can we predict whether the amounts that a third-party buyer might pay for the Subject Securities will be affected by the Rescission Offer.***

If you are an Eligible Current Investor, the amount you would receive in the Rescission Offer as a result of tendering the Subject Securities is determined by a set formula which is not tied to the market value of the Subject Securities at the time the Rescission Offer closes on the Expiration Date. The amount you would receive in the Rescission Offer will be reduced by the amount of any interest, coupon payments, principal or other income received on such Applicable Securities pursuant to their terms. In addition, when you accept the Rescission Offer, you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you. As a result, if you are an Eligible Current Investor and accept the Rescission Offer, you may receive or retain less than the market value of the Subject Securities that you would be tendering to us. Further, we cannot anticipate subsequent market developments, whether at the time or after payment is made, or the future market value of the Subject Securities, nor can we predict whether such market value will be affected by the Rescission Offer.

***You may be subject to certain tax consequences if you accept or reject the Rescission Offer.***

Your decision to accept or reject the Rescission Offer may subject you to certain U.S. federal income tax consequences. See "*United States Tax Considerations*" below.

------

##### [**Table of Contents**](#toc)
**USE OF PROCEEDS** 

We will receive no proceeds from the Rescission Offer. We do not expect to receive any proceeds from resales of outstanding Subject Securities by UBS Securities LLC, UBS Financial Services Inc. or any of our other affiliates in market-making transactions. We expect our affiliates to retain the proceeds of their market-making resales and not to pay the proceeds to us.

------

##### [**Table of Contents**](#toc)
**THE RESCISSION OFFER** 

**Background and Reasons for the Rescission Offer** 

The Subject Securities were originally issued by an affiliate of CSG, pursuant to a registration statement under Section 5 of the Securities Act. Affiliates of CSG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (i.e., the Market-Making Transactions), without an effective registration statement under the Securities Act. On the Merger Date, upon the merger between UBS Group AG and CSG, UBS Group AG was substituted as issuer with respect to the then outstanding Subject Securities, and affiliates of the Issuer continued the Market-Making Transactions without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction. The Issuer has therefore elected to make the Rescission Offer to those purchasers.

On February 12, 2026, we filed a registration statement on Form F-3 of which this prospectus forms a part. The outstanding Subject Securities have been registered by means of this registration statement.

The Rescission Offer is not an admission that we or our affiliates did not comply with applicable federal securities law requirements as to specific securities or transactions, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose.

**Effect of the Rescission Offer** 

If you reject, or fail to accept, the Rescission Offer on or before the Expiration Date, or if you accept the Rescission Offer but we determine that you are not eligible to accept the Rescission Offer under the terms set forth in this prospectus, you will retain ownership of any Subject Securities you still hold and will not receive any payment for such Subject Securities. In addition, any Subject Securities that you still hold, for purposes of applicable federal securities law, will have been registered as of the date of this prospectus.

We believe that the applicable statute of limitations for potential claims for rescission or rescissory damages under the Securities Act is one year from the date of sale of such security in violation of the federal registration requirements, and the statute of repose is three years after such sale. Determining when a statute of limitations or repose expires under federal or state law can be a difficult issue, and you should consult with an attorney if you have any questions regarding how federal or state statutes of limitations or repose may apply to any claims you have or regarding any of your legal rights and remedies before deciding whether or not to accept the Rescission Offer.

Your acceptance of the Rescission Offer may preclude you from later seeking similar relief, if any is available. We may assert, among other defenses, in any litigation initiated by a person eligible to participate in the Rescission Offer who accepts or rejects (or is deemed to reject) the Rescission Offer, that such person is legally barred from asserting such claims as a result of the Rescission Offer. For federal securities law purposes, it is unclear what the effect of a rejection of or the failure to accept a rescission offer may be on an offeree's right to bring a civil action against the rescission offeror for failure to register a securities transaction under the Securities Act before expiration of the applicable statute of limitations or repose. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. Each person is urged to consider this possibility with respect to the Rescission Offer. The Rescission Offer is not an admission that we or our affiliates did not comply with applicable federal requirements as to specific securities, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose. However, we have decided to make the Rescission Offer to certain otherwise Eligible Investors that purchased Subject Securities during the Relevant Period even if now outside the period of limitations or repose.

------

##### [**Table of Contents**](#toc)
The above discussion relates primarily to your potential rescission rights and does not address other provisions of federal securities laws or rights under state securities laws, common law or equity. We believe that the Market-Making Transactions were exempt from registration under state laws. Furthermore, we believe that the Rescission Offer is exempt from registration under state laws. See "*Risk Factors—Risks Relating to the Rescission Offer—The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount*" and "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus, your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

**Terms of the Rescission Offer** 

If you are an Eligible Investor and validly accept the Rescission Offer on or before the Expiration Date, you will have the right to receive from us the Rescission Offer Proceeds, subject to the terms below.

***Subject Securities***

The Subject Securities were originally issued by an affiliate of CSG and guaranteed by CSG. In November 2020, the original issuer was substituted with CSG with respect to four of the series of Subject Securities then outstanding, and on the Merger Date, upon the merger between UBS Group AG and CSG, UBS Group AG was substituted as issuer with respect to the then outstanding Subject Securities, as indicated below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Title of<br>Security** | **Issuer** | **CUSIP No.;<br>ISIN No.** | **Principal<br>Amount<br>Outstanding\*\*** | **Maturity Date** | **Issuance Prospectus** |
| 4.875%<br> Senior Notes due 2045 | UBS Group AG (CSG until the Merger Date) | 902613AY4;<br> US902613AY48 | $1924666000 | May 15, 2045 | [https://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/<br>a2226897z424b3.htm](http://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/a2226897z424b3.htm) |
| 4.550%<br> Senior Notes due 2026 | UBS Group AG (CSG until the Merger Date) | 902613BB3;<br> US902613BB36 | $1982535000 | April 17, 2026 | [https://www.sec.gov/Archives/edgar/data/1159510/000104746916016156/<br>a2230018z424b3.htm](http://www.sec.gov/Archives/edgar/data/1159510/000104746916016156/a2230018z424b3.htm) |
| 3.750%<br> Senior Notes due 2025\* | UBS Group AG (CSG until the Merger Date) | 902613AX6;<br> US902613AX64 | N/A | March 26, 2025 | [https://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/<br>a2226897z424b3.htm](http://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/a2226897z424b3.htm) |
| 3.800%<br> Senior Notes due 2023\* | CSG | 225433AT8;<br> US225433AT80 | N/A | June 9, 2023 | [https://www.sec.gov/Archives/edgar/data/1159510/000104746916016156/<br>a2230018z424b3.htm](http://www.sec.gov/Archives/edgar/data/1159510/000104746916016156/a2230018z424b3.htm) |
| 3.800%<br> Senior Notes due 2022\* | Credit Suisse Group Funding (Guernsey) Limited (guaranteed by CSG) | 225433AH4;<br> US225433AH43 | N/A | September 15, 2022 | [https://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/<br>a2226897z424b3.htm](http://www.sec.gov/Archives/edgar/data/1159510/000104746915009228/a2226897z424b3.htm) |

---

\* These securities have matured.

\*\* Only Eligible Investors may participate in the Rescission Offer.

------

##### [**Table of Contents**](#toc)
The Subject Securities are not deposit liabilities and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. The Subject Securities do not have the benefit of any agency or governmental guarantee.

***Eligibility Requirements***

To be eligible to participate in the Rescission Offer with respect to a given Subject Security, you must make representations and warranties and provide us with evidence to the following effects:

1. To be deemed an "Eligible Current Investor":

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. You purchased the relevant Subject Security during the Relevant Period either (i) on or after the Merger
Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time (for the avoidance of doubt, if you purchased the relevant Subject Securities from UBS Group AG or an affiliate
of UBS Group AG before the Merger Date, you will not be considered an Eligible Current Investor with respect to such Subject Security); <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. You still hold such Applicable Security as of the date of this prospectus, and will continue to hold (unless
and until tendered through ATOP pursuant to the Rescission Offer) until the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind.

2. To be deemed an "Eligible Former Investor":

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1. You purchased the relevant Subject Security during the Relevant Period either (i) on or after the Merger
Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time (for the avoidance of doubt, if you purchased the relevant Subject Securities from UBS Group AG or an affiliate
of UBS Group AG before the Merger Date, you will not be considered an Eligible Former Investor with respect to such Subject Security); <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2. You no longer hold such Applicable Security as of the date of this prospectus and such Applicable Security has
either (i) matured at a loss or (ii) been sold at a loss, in each case provided that you continuously held such Applicable Security until the time of maturity or sale, as applicable.

Eligible Current Investors and Eligible Former Investors are collectively referred to as "Eligible Investors."

For the avoidance of doubt, you should assess whether you meet the requirements to qualify as an Eligible Current Investor or an Eligible Former Investor in respect of each Subject Security. For example, you may be an Eligible Current Investor with respect to one Subject Security and an Eligible Former Investor with respect to another. You should make this assessment for each Subject Security in respect of which you wish to accept the Rescission Offer.

The following investors will <u>not</u> be considered Eligible Investors for purposes of the Rescission Offer: (i) holders who purchased Subject Securities through us or our affiliates (or, prior to the Merger Date, through CSG or its affiliates at the time) as agent and not as principal, in respect of Subject Securities acquired pursuant to such transactions; (ii) holders who, either to cover short positions or otherwise, borrowed Subject Securities from us or our affiliates (or, prior to the Merger Date, from CSG or its affiliates at the time), in respect of Subject Securities borrowed pursuant to such transactions; and (iii) holders of call options, put options or other types of options to purchase, sell or otherwise indirectly acquire or dispose of the Subject Securities or an indirect interest therein, in respect of such options.

If you do not meet the requirements to be considered an Eligible Investor, you are not entitled to participate in the Rescission Offer. In particular, if you purchased Subject Securities from CSG or an affiliate of CSG at such time before May 1, 2022, you are not an Eligible Investor with respect to such Subject Securities.

------

##### [**Table of Contents**](#toc)
***Evidence of Eligibility***

<u>If you are an Eligible Current Investor</u>:

To demonstrate your eligibility to participate in the Rescission Offer with respect to a Subject Security, you will be required to provide the following documentation when accepting the Rescission Offer pursuant to the terms of this prospectus:

1. A signed acceptance agreement a form of which is included in Appendix C (Current Investor Acceptance Form), by
which the Eligible Current Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements described under "*—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors* "; <u>and</u> 

2. Satisfactory evidence that you purchased the Subject Security in an Applicable Transaction (i.e., the Subject
Security is an Applicable Security) and that you continue to hold such Applicable Security as of the date of this prospectus, and will continue to hold it (through ATOP pursuant to the Rescission Offer) until the Expiration Date. For such purposes,
the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Account statement(s) reflecting (i) the purchase of such Applicable Security from the Issuer or an
affiliate of the Issuer (for an Applicable Transaction during the Relevant Period on or after the Merger Date) or from CSG or an affiliate of CSG at such time (for an Applicable Transaction during the Relevant Period prior to the Merger Date) and
(ii) purchase price information of such Applicable Security, and demonstrating the continued holding of such Applicable Security until at least the date of this prospectus; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Receipt, transaction or trade confirmation statement reflecting (i) for an Applicable Transaction during
the Relevant Period on or after the Merger Date, the Issuer or an affiliate of the Issuer or (ii) for an Applicable Transaction during the Relevant Period prior to the Merger Date, CSG or an affiliate of CSG at such time, as a principal seller
of such Applicable Security in such Applicable Transaction.

<u>If you are an Eligible Former Investor</u>:

To demonstrate your eligibility to participate in the Rescission Offer with respect to a Subject Security, you will be required to provide the following documentation when accepting the Rescission Offer pursuant to the terms of this prospectus:

1. A signed acceptance agreement a form of which is included in Appendix A (Former Investor Acceptance Form), by
which the Eligible Former Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements described under "*—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors* "; <u>and</u> 

2. Satisfactory evidence that you purchased the Subject Security in an Applicable Transaction (i.e., the Subject
Security is an Applicable Security) and that such Applicable Security subsequently was sold in a *bona fide* transaction or matured, in each case at a loss. For such purposes, the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Account statement(s) reflecting (i) the purchase of such Applicable Security from the Issuer or an
affiliate of the Issuer (for an Applicable Transaction during the Relevant Period on or after the Merger Date) or from CSG or an affiliate of CSG at such time (for an Applicable Transaction during the Relevant Period prior to the Merger Date), (ii)
purchase price information of such Applicable Security and (iii) the subsequent Applicable Disposition (and sale or maturity price information, as applicable) of such Applicable Security before the date of this prospectus, and demonstrating the
continued holding of such Applicable Security until the time of the Applicable Disposition; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) With respect to an Applicable Transaction: receipt, transaction or trade confirmation statement reflecting
(i) for an Applicable Transaction during the Relevant Period on or after the Merger Date, the

------

##### [**Table of Contents**](#toc)
Issuer or an affiliate of the Issuer or (ii) for an Applicable Transaction during the Relevant Period prior to the Merger Date, CSG or an affiliate of CSG at such time, as a principal seller of such Applicable Security in such Applicable Transaction; <u>and/or</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) With respect to an Applicable Disposition: receipt, transaction or trade confirmation statement reflecting such
Applicable Security being sold or matured, including the date, price and other relevant details of the sale; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) With respect to the loss as a result of an Applicable Disposition: tax documents, such as IRS Form 1099-B, evidencing the losses incurred on the Applicable Disposition of such Applicable Security prior to the date of this prospectus.

If you are both an Eligible Current Investor and an Eligible Former Investor in the same series of Subject Securities you must provide evidence as shown above in your capacity as Eligible Current Investor and Eligible Former Investor, as applicable.

ALL DETERMINATIONS WITH RESPECT TO THE EVIDENCE SUBMITTED FOR PURPOSES OF MEETING THE ELIGIBILITY REQUIREMENTS TO ACCEPT THE RESCISSION OFFER WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION. WE RESERVE THE RIGHT TO, AT ANY TIME, REQUEST ANY ADDITIONAL INFORMATION OR EVIDENCE THAT WE MAY DEEM REASONABLY APPROPRIATE TO DEMONSTRATE THAT YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE INVESTOR.

Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

We and others will rely upon the truth and accuracy of the foregoing evidence for purposes of the Rescission Offer and we and our affiliates reserve the right to take all actions available at law to recover any losses incurred as a result of such reliance in case any of such evidence proves to be inaccurate, incorrect, false or misleading.

***Rescission Offer Proceeds***

*Description of Rescission Offer Proceeds* 

If you are an Eligible Investor and you validly accept the Rescission Offer, the price you will receive for a particular Applicable Security (such price in respect of such Applicable Security, the "Rescission Offer Proceeds") will depend on whether you are an Eligible Current Investor or an Eligible Former Investor with respect to such Applicable Security and be determined as follows:

• If you are an Eligible Current Investor with respect to such Applicable Security, if you accept the Rescission
Offer in respect of such Applicable Security in accordance with the terms hereof, we will pay you an amount equal to the purchase price you paid for such Applicable Security in the Applicable Transaction, *plus* interest on such purchase price
from the settlement date of the Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the

------

##### [**Table of Contents**](#toc)
Settlement Date, *less* the amount of any interest, coupon payments, principal or other income received on such Applicable Security, as represented in the following formula: <br>

*A =* *P + I* – *R* 

*where:* 

*A* = Rescission Offer Proceeds

*P* = purchase price

---

| | |
|:---|:---|
| *I* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the purchase price and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Current Investor Applicable Period  |

---

---

| | |
|:---|:---|
| *R* = | total amount of any interest, coupon payments, principal or other income received by the Eligible Current Investor on the Applicable Security  |

---

• If you are an Eligible Former Investor with respect to such Applicable Security, if you accept the Rescission
Offer in respect of such Applicable Security in accordance with the terms hereof, we will pay you an amount equal to the excess, if any, of the purchase price you paid for such Applicable Security in the Applicable Transaction over the proceeds from
the Applicable Disposition of such Subject Security, *plus* interest (i) on the purchase price you paid for the Applicable Security in the Applicable Transaction from the settlement date of the Applicable Transaction to, and including, the
date of the Applicable Disposition and (ii) on the loss realized from the Applicable Disposition from the date of the Applicable Disposition to, and including, the earlier to occur of (x) the date that is five business days after the
Expiration Date and (y) the Settlement Date, *less* the amount of any interest, coupon payments, principal (except for principal repaid at maturity) or other income received on such Applicable Security, as represented in the following
formula:

*A =* *(P–D)+ I1 + I2 – R* 

*where:* 

*A* = Rescission Offer Proceeds

*P* = purchase price

*D* = proceeds from the Applicable Disposition

---

| | |
|:---|:---|
| *I1* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the purchase price and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Former Investor Holding Applicable Period  |

---

---

| | |
|:---|:---|
| *I2* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the loss realized from the Applicable Disposition (i.e., *P-D*) and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Former Investor Applicable Period  |

---

---

| | |
|:---|:---|
| *R* = | total amount of any interest, coupon payments, principal (except for principal repaid at maturity), or other income received by the Eligible Former Investor on the Applicable Security  |

---

All references to the purchase price or proceeds from an Applicable Disposition exclude any accrued interest, fees, selling concessions or other additional amounts.

All Rescission Offer Proceeds will be rounded to the nearest cent.

------

##### [**Table of Contents**](#toc)
*Interest Component of the Rescission Offer Proceeds* 

In calculating the Rescission Offer Proceeds we will use an interest rate calculated for a particular Applicable Security on the basis of the yield-to-worst value for the Bloomberg Investment Grade: Banking Total Return Index Unhedged (the "Index") on (i) in the case of interest calculated for an Eligible Current Investor Applicable Period or an Eligible Former Investor Holding Applicable Period, the settlement date of the Applicable Transaction in which the applicable Eligible Investor purchased such Applicable Security (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), or (ii) in the case of interest calculated for an Eligible Former Investor Applicable Period, the settlement date of the Applicable Disposition in which such Applicable Security matured or was sold at a loss (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), plus, in each case, a 100 basis point margin (the "Index Rate"). The Index can be accessed at www.bloomberg.com/indices (I00408US Index Ticker).

For purposes of determining the amount of interest included in the Rescission Offer Proceeds in respect of a particular Applicable Security, the day-count fraction for any calendar year within an Applicable Period shall be equal to the actual number of days in such calendar year that occur during such Applicable Period divided by the actual number of days in such calendar year (i.e., Actual/Actual) (the "Day-Count Fraction").

Although this prospectus uses the term "interest" when describing the calculation of the Rescission Offer Proceeds, the term is only intended to describe the method used to calculate the payment amount, and the payment is not considered interest for federal income tax purposes, but rather is included in the amount realized from the sale of the Subject Securities.

*Deduction of any interest, coupon payments, principal or other income due on Subject Securities* 

If you are an Eligible Current Investor, you will continue to receive any interest, coupon payments, principal or other income due on your Subject Security pursuant to its terms until you tender such Subject Security to us through ATOP; provided, however, that (i) any such amounts received by you prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus. and (ii) you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

If you are an Eligible Former Investor, any interest, coupon payments, principal (except for principal repaid at maturity) or other income received on such Subject Security prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

As a result, if you accept the Rescission Offer in respect of any Subject Security, (1) the amount equal to the purchase price you paid for such Subject Security, plus interest on such purchase price (as described in the calculation of the Rescission Offer Proceeds), in case you are an Eligible Current Investor or (2) the amount equal to the excess, if any, of the purchase price you paid for such Subject Security over the proceeds from the subsequent sale or maturity of such Subject Security, plus interest (as described in the calculation of the Rescission Offer Proceeds) in case you are an Eligible Former Investor, will be offset in part or in full by deductions made by us or reimbursements you owe to us to account for any interest, coupon payments, principal (except for principal repaid at maturity) or other income due on such Subject Security pursuant to its terms.

Therefore, you may not receive any amount as a result of accepting the Rescission Offer. You must make your own decision whether to accept or reject the Rescission Offer. We are not making any determinations as to

------

##### [**Table of Contents**](#toc)
whether it is in your economic interest to do so. We urge you to carefully review this prospectus before deciding whether or not to accept or reject the Rescission Offer.

*Publication of Rescission Offer Proceeds* 

We will endeavor to publish in a press release with available information regarding the results of the Rescission Offer as soon as practicable following the Expiration Date. Eligible Investors that have validly accepted the Rescission Offer will be informed individually of the Rescission Offer Proceeds in respect of their Applicable Securities as soon as practicable following the Expiration Date and processing of the documents in support of their eligibility provided through the Rescission Offer On-line Portal. ****

We are unable to calculate indicative Rescission Offer Proceeds for Eligible Investors as the final amount of Rescission Offer Proceeds for each such investor will depend on various factors that may be unknown to us, including the prices paid in Applicable Transactions or received in Applicable Disposition and the dates of Applicable Dispositions. Eligible Investors should make their own calculations of the Rescission Offer Proceeds.

We advise you to consult your financial, legal, and tax advisers, as you deem appropriate, before making any decision with respect to the Rescission Offer.

*Payment of the Rescission Offer Proceeds* 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026.

If you are an Eligible Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms hereof, we will cause payment of the Rescission Offer Proceeds to be made to you on the Settlement Date, which is expected to be no later than ten business days following the Expiration Date. Payment will be made through DTC or via bank transfer of immediately available funds to your bank account.

None of us, our affiliates or any of our or our affiliates' executive officers or directors makes any recommendations to any person with respect to the Rescission Offer. We urge you to read this prospectus carefully and to make an independent evaluation with respect to the Rescission Offer. We also urge you to consult with your advisers, as you deem appropriate, before accepting or rejecting the Rescission Offer.

BY ACCEPTING THE RESCISSION OFFER YOU WILL NOT BE ENTITLED TO ANY OTHER PAYMENTS ON YOUR APPLICABLE SECURITIES OTHER THAN PAYMENT OF THE RESCISSION OFFER PROCEEDS AS DETAILED ABOVE.

The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service (the "IRS"). You may also be subject to backup withholding on payments in respect of your Subject Securities unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

**Acceptance or Rejection of the Rescission Offer** 

YOU ARE NOT LEGALLY REQUIRED TO ACCEPT THE RESCISSION OFFER.

------

##### [**Table of Contents**](#toc)
All acceptances of the Rescission Offer will be deemed to be effective on the Expiration Date, at which time your right to accept the Rescission Offer will terminate. You can withdraw any previous acceptance of the Rescission Offer prior to the Expiration Date. While withdrawals may not be revoked, and any Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer, such Subject Securities may be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" at any time on or before the Expiration Date. Whether or not you accept the Rescission Offer, as of the date of this prospectus, the Subject Securities will be deemed to have been offered and sold under an effective registration statement.

IT IS UNCLEAR WHAT THE EFFECT OF ACCEPTANCE OR REJECTION OF THE RESCISSION OFFER WILL BE ON YOUR RIGHT TO BRING A CIVIL ACTION AGAINST US ALLEGING A FAILURE TO REGISTER THE MARKET-MAKING TRANSACTIONS UNDER FEDERAL SECURITIES LAWS. HOWEVER, FEDERAL LAW DOES PROVIDE THAT YOU MAY LOSE ANY RESCISSION RIGHTS UNDER FEDERAL SECURITIES LAWS ONE YEAR FROM THE DATE OF PURCHASE OF THE APPLICABLE SECURITIES AND THREE YEARS FROM THE DATE SUCH SECURITIES WERE BONA FIDE OFFERED TO THE PUBLIC.

***How to accept the Rescission Offer***

You may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof.

<u>If you are an Eligible Current Investor</u>: Because the outstanding Subject Securities are represented by global book-entry notes, DTC or its nominee is treated as the registered holder of such Subject Securities and will be the only entity that can tender such Subject Securities for repurchase by us. Therefore, to tender your Applicable Securities in order to obtain the Rescission Offer Proceeds for them, you must instruct the institution where you hold your Applicable Securities to tender your Applicable Securities on your behalf so that they are received on or before the Expiration Date.

YOU SHOULD CONSULT YOUR BROKER OR BANK WHERE YOU HOLD YOUR APPLICABLE SECURITIES TO DETERMINE THE PREFERRED PROCEDURE FOR TENDERING YOUR APPLICABLE SECURITIES.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER, PLEASE INSTRUCT YOUR BROKER OR BANK WHERE YOU HOLD YOUR APPLICABLE SECURITIES IN TIME FOR YOUR APPLICABLE SECURITIES TO BE TENDERED TO US ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR TENDER OF SUBJECT SECURITIES HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE CURRENT INVESTOR TO ACCEPT THE RESCISSION OFFER.

PLEASE NOTE THAT DTC, ITS PARTICIPANTS AND THE BANKS OR BROKERS WHERE YOU HOLD YOUR SUBJECT SECURITIES WILL ESTABLISH THEIR OWN CUT-OFF DATES AND TIMES FOR THE TENDER OF THE SUBJECT SECURITIES, WHICH MAY BE EARLIER THAN THE EXPIRATION DATE.

In addition, you must complete, sign and date the accompanying Current Investor Acceptance Form, included as Appendix C, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date.

------

##### [**Table of Contents**](#toc)
The Current Investor Acceptance Form must be legible. If you choose to accept the Rescission Offer, we recommend that you return the Current Investor Acceptance Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

If you choose to accept the Rescission Offer, you will be deemed to have made to us the representations and warranties, acknowledgements and agreements set forth under "*—Representations of Eligible Investors*" below.

If you tender your Subject Security to us through ATOP, you will cease to receive any interest, coupon payments, principal or other income due on such Subject Security pursuant to its terms upon such tender; provided, however, that (i) any such amounts due to you prior to or during the Rescission Offer, or following the Expiration Date, that remain unpaid because of your tender of such Subject Security through ATOP will not be deducted from the Rescission Offer Proceeds pursuant to this prospectus (and, conversely, any such amounts that are received by you prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus) and (ii) you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you. See "*—Terms of the Rescission Offer—Rescission Offer Proceeds.*" You will resume receipt of interest, coupons payments, principal and other income due on such Subject Security pursuant to its terms upon a valid withdrawal of such previously tendered Subject Security. See "*—Terms of the Rescission Offer—How to Reject the Rescission Offer.*" 

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or the tender of the Subject Securities or evidence of eligibility) or the calculation of the Rescission Offer Proceeds will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

<u>If you are an Eligible Former Investor</u>: In the event you elect to accept the Rescission Offer, you must complete, sign and date the accompanying Former Investor Acceptance Form, included as Appendix A to this prospectus, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us (together with the supporting evidence required therein) on or before the Expiration Date.

The Former Investor Acceptance Form must be legible. If you choose to accept the Rescission Offer, we recommend that you return the Former Investor Acceptance Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

If you choose to accept the Rescission Offer, any interest, coupon payments, principal (except for principal repaid at maturity) or other income received on such Subject Security prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

WE MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED FORMER INVESTOR ACCEPTANCE FORM (TOGETHER WITH APPROPRIATE SUPPORTING EVIDENCE) ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR FORMER INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE FORMER INVESTOR TO ACCEPT THE RESCISSION OFFER.

------

##### [**Table of Contents**](#toc)
All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the Former Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

If you are both an Eligible Current Investor and an Eligible Former Investor, in order to accept the Rescission Offer in respect of both the Applicable Securities held by you as an Eligible Current Investor and those formerly held as an Eligible Former Investor, you must follow the process for accepting the Rescission Offer in each such capacity separately with respect to the relevant Applicable Securities.

***Representations of Eligible Investors***

By accepting the Rescission Offer, each Eligible Investor will be deemed to have represented and warranted, acknowledged to, and agreed with, us that such Eligible Investor:

1. has received and reviewed the information contained in this prospectus;

2. elects to accept the Rescission Offer with respect to the specified Subject Securities, and understands that
he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

3. meets the requirements to be considered an Eligible Investor, as set out under "*—Terms of the Rescission Offer—Eligibility Requirements*" above, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. if an Eligible Current Investor, such investor (1) purchased the Subject Securities in respect of which
the Rescission Offer is accepted during the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time; and (2) has
continued to hold the Subject Securities in respect of which the Rescission Offer is accepted until the date of this prospectus, and will continue to hold such Subject Securities (unless and until tendered through ATOP pursuant to the Rescission
Offer) until the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind, and UBS Group AG will acquire good, indefeasible and unencumbered title to such Subject Securities, free and clear
of all liens, charges, claims, encumbrances, interests and restrictions of any kind, when the tender of the same is accepted by UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. if an Eligible Former Investor, such investor (1) purchased the Subject Securities in respect of which the
Rescission Offer is accepted during the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time; and (2) no longer
holds the Subject Securities in respect of which the Rescission Offer is accepted as at the date of this prospectus, and such Subject Securities matured at a loss or were sold at a loss (provided, in each case, that such investor continuously held
such relevant Subject Security until the time of maturity or sale, as applicable);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3. if an Eligible Current Investor, is the beneficial owner or the authorized representative of the beneficial
owner of the Subject Securities in respect of which he, she or it is accepting the Rescission Offer, or, if an Eligible Former Investor, was the beneficial owner or is the authorized representative of the former beneficial owner of those Subject
Securities when acquired during the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time, and has full power and
authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4. if an Eligible Current Investor, will not sell, pledge, hypothecate or otherwise encumber or transfer any
Subject Securities in respect of which he, she or it is accepting the Rescission Offer, from the date of acceptance of the Rescission Offer, and agrees that any purported sale, pledge, hypothecation or other encumbrance or transfer will be void and
of no effect;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5. in evaluating the Rescission Offer and in making the decision whether to participate therein, has made his, her
or its own independent appraisal of the matters referred to in this prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to him, her or it by us other than those
contained in this prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6. is not a Sanctioned Person (as defined below) and none of its subsidiaries is a Sanctioned Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7. will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make
available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as
defined below), or (y) in any other manner; in each case that would result in a violation of Sanctions (as defined below), constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the
Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8. acknowledges and agrees that any violation of clauses 3.6 or 3.7 above constitutes a material change in the
commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9. (i) acknowledges and agrees that any interest, coupon payments, principal or other income due on the specified
Subject Securities pursuant to their terms received by such Eligible Investor prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and
(ii) will repay to UBS Group AG any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the Eligible Investor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10. understands that UBS Group AG, its affiliates and others will rely upon the truth and accuracy of the foregoing
acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made by his, her or its acceptance of the Rescission Offer are at any time prior to the consummation of the Rescission
Offer no longer accurate, he, she or it shall promptly notify us and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the
Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11. if delivering the Subject Securities as a fiduciary or agent for one or more investor accounts, has sole
investment discretion with respect to each such account and full power to make the foregoing acknowledgements, representations and warranties on behalf of such account;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12. any documentation provided to UBS Group AG evidencing the foregoing acknowledgements, representations and
warranties is true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13. his, hers or its participation in the Rescission Offer will not constitute or result in a violation of any
provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14. will execute any further documents and give any further assurances that may be required in connection with any
of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

For purposes of the above:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Person" means any natural person, corporation, limited partnership, general partnership, limited
liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign
government or agency, instrumentality, or political subdivision, territory, or similar entity or organization;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctionable Activity" means any condition or activity specifically identified under any Sanctions
as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described by such condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctioned Territory" means any country or territory with which dealings are broadly and
comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, the Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctioned Person" means any Person with whom dealings are restricted or prohibited under any
Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory,
or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctions" means all national and supranational laws, regulations, decrees, orders, or other acts
with force of law of the United States, Switzerland, the United Kingdom or the European Union, or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking of assets of
targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any laws threatening to impose such trade and economic sanctions on any Person for
engaging in proscribed or targeted behavior.

We and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and we and our affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

***Eligible Current Investors: Procedures for Brokers and Banks; DTC ATOP Account***

If you are an Eligible Current Investor, in order to accept the Rescission Offer on your behalf, your broker or bank must submit, or cause the DTC participant who holds the Applicable Securities on your behalf to submit, an Agent's Message (as defined below).

Kroll Issuer Services US (the "Rescission Agent"), on our behalf, will seek to establish an Automated Tender Offer Program ("ATOP") account with respect to the outstanding Subject Securities at DTC promptly after the delivery of this prospectus. Any financial institution that is a DTC participant, including your broker or bank, may make book-entry tender of outstanding Subject Securities by causing the book-entry transfer of such Subject Securities to our ATOP account in accordance with DTC's procedures for such transfers. Concurrently with the delivery of the Subject Securities, an Agent's Message in connection with such book-entry transfer must be transmitted by DTC to, and received by, the Rescission Agent on or prior to the Expiration Date. The confirmation of a book-entry transfer into the ATOP account as described above is referred to herein as a "Book-Entry Confirmation."

The term "Agent's Message" means a message transmitted by the DTC participants to DTC, and thereafter transmitted by DTC to the Rescission Agent, forming a part of the Book-Entry Confirmation which states that DTC has received an express acknowledgment from the DTC participant described in such Agent's Message stating that such DTC participant and beneficial owner agree to be bound by the terms of the Rescission Offer.

Each Agent's Message must include the following information:

1. the name of the relevant DTC participant;

------

##### [**Table of Contents**](#toc)
2. the phone number of the relevant DTC participant; and

3. any additional information deemed necessary by the DTC participant, subject to the applicable character limit.

BY SENDING AN AGENT'S MESSAGE, THE DTC PARTICIPANT IS DEEMED TO HAVE CERTIFIED THAT THE BENEFICIAL OWNER FOR WHOM THE SUBJECT SECURITIES ARE BEING TENDERED MEETS THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE CURRENT INVESTOR, STILL HOLDS SUCH SUBJECT SECURITIES AND HAS BEEN PROVIDED WITH A COPY OF THIS PROSPECTUS. WE MAY REQUIRE FURTHER DOCUMENTATION VERIFYING THIS INFORMATION.

The delivery of the Subject Securities through DTC, and any transmission of an Agent's Message through ATOP, is at the election and risk of the person tendering the Subject Securities. We will ask the Rescission Agent to instruct DTC to return those Subject Securities, if any, that were tendered through ATOP but were not accepted by us, to the DTC participant that tendered such Subject Securities on behalf of the holders of such Subject Securities. Neither we nor the Rescission Agent is responsible or liable for the return of such Subject Securities to the tendering DTC participants or to the beneficial owners, nor as to the time by which such return is completed.

We reserve the absolute right to reject any or all tenders of outstanding Subject Securities that are not in proper form, including, without limitation, lack of satisfactory records that the tendering holder is an Eligible Current Investor with respect to the Subject Securities tendered, or the acceptance of which, in our opinion, would be unlawful. We also reserve the right to waive any defects, irregularities or conditions of tender as to particular outstanding Subject Securities.

Our interpretation of the terms and conditions of the Rescission Offer, including, without limitation, the instructions in any Agent's Message, will be final and binding; however, an Eligible Current Investor may, in his, her, or its discretion, challenge the rejection of a tender of outstanding Applicable Securities and/or an interpretation of the terms and conditions of the Rescission Offer in a court of competent jurisdiction.

We encourage tenders of outstanding Applicable Securities to be submitted early. Any defect or irregularity in connection with tenders of outstanding Subject Securities must be cured on or before the Expiration Date, unless waived by us. Tenders of outstanding Subject Securities will not be deemed to have been made until all defects and irregularities have been waived by us or cured. Neither we, nor any other person, will be under any duty to give notice of any defects or irregularities in tenders of outstanding Subject Securities, or will incur any liability to Eligible Current Investors for failure to give any such notice.

***How to reject the Rescission Offer***

Regardless of whether you are an Eligible Current Investor or an Eligible Former Investor, you do not need to take any action to reject the Rescission Offer. If you do not accept the Rescission Offer on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer and, if you are a Eligible Current Investor, and continue to hold any Subject Securities, you will receive interest payments on such Subject Securities at their stated rate and will be paid their principal amount in accordance with their terms, conditions and risk factors, each as described under "*Description of the Subject Securities*" and in their respective issuance prospectuses. Furthermore, the Subject Securities not repurchased in the Rescission Offer will be deemed to have been offered and sold under an effective registration statement of which this prospectus forms a part.

If you had previously accepted the Rescission Offer but you change your decision and want to reject the Rescission Offer, you may withdraw your acceptance of the Rescission Offer at any time on or before the Expiration Date, pursuant to the instructions below. If you validly withdraw your acceptance of the Rescission Offer, you will be deemed to have rejected the Rescission Offer. While withdrawals may not be revoked, Subject Securities properly withdrawn may be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" above at any time prior to the Expiration Date.

------

##### [**Table of Contents**](#toc)
<u>If you are an Eligible Current Investor</u>: For a withdrawal of tendered Subject Securities to be effective, you should contact your bank or broker where your Subject Securities are held and have them submit a properly transmitted "Requested Message" through ATOP, which must be received by the Rescission Agent through ATOP.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, YOU MUST INSTRUCT YOUR ACCOUNT REPRESENTATIVE AT THE BROKER OR BANK WHERE YOU HOLD YOUR SUBJECT SECURITIES IN TIME FOR YOUR TENDER OF SUBJECT SECURITIES TO BE WITHDRAWN ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

PLEASE NOTE THAT DTC, ITS PARTICIPANTS AND THE BANKS OR BROKERS WHERE YOU HOLD YOUR SUBJECT SECURITIES WILL ESTABLISH THEIR OWN CUT-OFF DATES AND TIMES FOR THE WITHDRAWAL OF ANY TENDER OF THE SUBJECT SECURITIES, WHICH MAY BE EARLIER THAN THE EXPIRATION DATE.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or the tender of the Subject Securities or evidence of eligibility) or the calculation of the Rescission Offer Proceeds will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

Withdrawals of tenders of the Subject Securities by Eligible Current Investors may not be revoked, and any Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer. Properly withdrawn Subject Securities may, however, be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" and "*—Procedures for Brokers and Banks; DTC ATOP Account*" above, at any time prior to the Expiration Date.

<u>If you are an Eligible Former Investor</u>: If you change your decision and want to reject the Rescission Offer after having submitted a Former Investor Acceptance Form, you must complete, sign and date the accompanying Rescission Offer Withdrawal Form, included as Appendix B to this prospectus, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us on or before the Expiration Date.

The Rescission Offer Withdrawal Form must be legible. If you choose to withdraw and revoke your previous acceptance of the Rescission Offer, we recommend that you return the Rescission Offer Withdrawal Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, WE MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED RESCISSION OFFER WITHDRAWAL FORM ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER PURSUANT TO YOUR ELECTION ON THE LAST EFFECTIVE FORMER INVESTOR ACCEPTANCE FORM YOU SUBMITTED. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

Withdrawals of their acceptance of the Rescission Offer may not be revoked by Eligible Former Investors, and any such properly withdrawn acceptance will thereafter be deemed not a valid acceptance for purposes of the

------

##### [**Table of Contents**](#toc)
Rescission Offer. You may, however, re-accept the Rescission Offer by following the procedures described in "*—How to accept the Rescission Offer*" above, at any time prior to the Expiration Date.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election or tender of Subject Securities or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the withdrawal instructions or the Rescission Offer Withdrawal Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

**Other Terms and Conditions** 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026, i.e., 30 days from the date of this prospectus (including the date of this prospectus and the Expiration Date), unless extended by us. We expressly reserve the right to extend the term of the Rescission Offer. During any extension of the term of the Rescission Offer, all outstanding Subject Securities previously tendered, not validly withdrawn and not yet accepted for rescission will remain subject to the Rescission Offer and may be accepted for rescission by us. To the extent we are legally permitted to do so, we expressly reserve the absolute right, in our sole discretion, to waive any condition to the Rescission Offer.

ALTHOUGH WE HAVE NO PRESENT PLANS OR ARRANGEMENTS TO DO SO, WE RESERVE THE RIGHT TO AMEND, AT ANY TIME, THE TERMS OF THE RESCISSION OFFER. WE WILL GIVE HOLDERS NOTICE OF ANY AMENDMENTS IF REQUIRED BY APPLICABLE LAW.

The conditions to the Rescission Offer are for our sole benefit and may be asserted by us in our sole discretion or may be waived by us, in whole or in part, in our sole discretion, whether or not any other condition of the Rescission Offer also is waived. We have not made a decision as to what circumstances would lead us to waive any condition, and any waiver would depend on circumstances prevailing at the time of that waiver. Any determination by us concerning the conditions described in this section shall be final and binding upon all persons, subject to the provision in the penultimate paragraph of the subsection entitled "—*Procedures for Brokers and Banks; DTC ATOP Account*."

Any waiver or amendment to the Rescission Offer will be made on a series by series basis, per series of Subject Security, and will apply to all the Subject Securities of such series that were tendered and to all acceptances of the Rescission Offer with respect to such series by Eligible Former Investors. If we make a material change in the terms of the Rescission Offer or if we waive a material condition of the Rescission Offer, we will disseminate additional Rescission Offer materials. If the amendment or waiver is made less than ten business days before the expiration of the Rescission Offer, we will extend the Rescission Offer so that holders have at least ten business days to accept, or withdraw acceptances to, the Rescission Offer.

We expressly reserve the right, in our sole discretion, to terminate the Rescission Offer if any of the conditions set forth in this prospectus have not been satisfied by the Eligible Investors or waived by us. In the event we terminate the Rescission Offer, we will notify you of the termination, and all outstanding Subject Securities previously tendered and not yet accepted for rescission will be returned promptly to the tendering holders.

If any outstanding Subject Securities tendered by Eligible Current Investors are not accepted for rescission for any reason, such Subject Securities will be returned, at our expense, to the tendering holder via book-entry transfer to the account maintained by the holder's broker or bank at DTC, promptly following the Expiration Date or the termination or withdrawal of the Rescission Offer. The holder's broker or bank will be responsible for crediting the transfer into the holder's individual account.

We have engaged the Rescission Agent to facilitate and assist us with the acceptance procedures of the Rescission Offer for Eligible Investors. We have not retained, nor do we intend to retain, any person to make solicitations or recommendations to you in connection with the Rescission Offer.

------

##### [**Table of Contents**](#toc)
None of us, our affiliates or the Rescission Agent, nor any of our, our affiliates' or the Rescission Agent's officers or directors may make or shall be deemed to have made any recommendations to you with respect to the Rescission Offer. We urge you to read this prospectus carefully and to make an independent evaluation with respect to the Rescission Offer.

**Funding the Rescission Offer** 

We will fund any payments required under the Rescission Offer from available cash.

**Questions about the Rescission Offer** 

If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**DESCRIPTION OF THE SUBJECT SECURITIES** 

*The following description is only a summary of certain terms of the outstanding Subject Securities and the Indentures (as defined below) governing each series of outstanding Subject Securities. We urge you to read the Notes (as defined below) and the Indentures in their entirety because the Notes and the Indentures, which are filed as exhibits to the registration statement of which this prospectus forms a part, and not this summary, define the rights of holders of the outstanding Subject Securities. You may also request a copy of the Notes and the Indentures from us. See "Where You Can Find More Information." The following summary does not purport to be complete and is subject to, and is qualified in its entirety by reference to, all of the provisions of the Indentures and those terms made a part of the Indentures by reference to the Trust Indenture Act of 1939, as amended (the "Trust Indenture Act"). We provide our definitions for the capitalized terms in this section that we otherwise do not define at the end of the relevant subsection.* 

**General** 

The $1,982,535,000 4.550% Senior Notes due 2026 (CUSIP 902613BB3; ISIN US902613BB36) (the "Notes due 2026") were originally issued by Credit Suisse Group Funding (Guernsey) Limited (the "Original Issuer") and guaranteed by CSG and authenticated and delivered by the Trustee under the indenture (as amended and supplemented, the "2026 Indenture") entered into on April 18, 2016 among the Original Issuer, CSG and U.S. Bank National Association, as trustee (the "Original Trustee"). On November 3, 2020, the Original Issuer, CSG and the Original Trustee entered into a supplemental indenture with respect to the Notes due 2026, pursuant to which CSG was substituted as, and assumed all of the obligations of the Original Issuer as, principal obligor under the Notes due 2026, and its guarantees of the Notes due 2026 ceased to exist. On June 9, 2023, UBS Group AG, CSG and U.S. Bank Trust Company, National Association, as successor in interest to the Original Trustee (the "Trustee") entered into a second supplemental indenture with respect to the Notes due 2026, pursuant to which, in connection with the merger of CSG with UBS Group AG on the Merger Date, UBS Group AG expressly assumed all of CSG's obligations as issuer and obligor under the 2026 Indenture and on the Notes due 2026. The $1,924,666,000 4.875% Senior Notes due 2045 (CUSIP 902613AY4; ISIN US902613AY48) (the "Notes due 2045") were originally issued by the Original Issuer and guaranteed by CSG and authenticated and delivered by the Trustee under the indenture (as amended and supplemented, the "2045 Indenture") entered into on May 21, 2015 among the Original Issuer, CSG and the Original Trustee. On November 3, 2020, the Original Issuer, CSG and the Original Trustee entered into a supplemental indenture with respect to the Notes due 2045, pursuant to which CSG was substituted as, and assumed all of the obligations of the Original Issuer as, principal obligor under the Notes due 2045, and its guarantees of the Notes due 2045 ceased to exist. On June 9, 2023, UBS Group AG, CSG and the Trustee entered into a second supplemental indenture with respect to the Notes due 2045, pursuant to which, in connection with the merger of CSG with UBS Group AG on the Merger Date, UBS Group AG expressly assumed all of CSG's obligations as issuer and obligor under the 2045 Indenture and on the Notes due 2045. As used in this prospectus, the "Notes" means, collectively, the Notes due 2026 and the Notes due 2045. As used in this prospectus, "Indentures" means, collectively, the 2026 Indenture and the 2045 Indenture. Although the Notes due 2026 and the Notes due 2045 were issued under separate indentures, for purposes of this "Description of the Subject Securities," each is referred to herein as a "series" of Notes, and references herein to the Notes refer to each series of Notes, as applicable.

The Notes due 2026 will mature on April 17, 2026 and the Notes due 2045 will mature on May 15, 2045, each of which we refer to as a "Maturity Date." The Notes of each series were issued in the form of fully registered Global Notes in denominations of $250,000 and integral multiples of $1,000 in excess thereof. The Issuer will pay interest on the Notes due 2026 at a rate of 4.550% per annum on April 18 and October 18 of each year and on the applicable Maturity Date or redemption date, if any. The Issuer will pay interest on the Notes due 2045 at a rate of 4.875% per annum on May 15 and November 15 of each year and on the applicable Maturity Date or redemption date, if any. Each fixed date on which interest on any series of Notes is payable is an "Interest Payment Date." Except as otherwise specified, the Notes will mature at their par value.

------

##### [**Table of Contents**](#toc)
Interest payments will equal the amount of interest accrued from and including the immediately preceding Interest Payment Date in respect of which interest has been paid or duly made available for payment to but excluding the relevant Interest Payment Date, applicable Maturity Date or redemption date, if any, as the case may be.

If an Interest Payment Date or the applicable Maturity Date or any redemption date for the Notes of any series would fall on a day that is not a Business Day (as defined below), principal and interest otherwise payable on such date will be paid on the next succeeding Business Day with the same effect as if that following Business Day were the date on which the payment were due. The Issuer will not pay any additional interest as a result of the delay in payment. The term "Business Day" with respect to the Notes means (a) any day that is not a Saturday or Sunday and that is not a day on which banking institutions are generally authorized or obligated by law, regulation or executive order to close in the City of New York or in the City of Zurich or in Guernsey and (b) any day that is not a Saturday or Sunday and that is not a day on which banking institutions are generally authorized or obligated by law, regulation or executive order to close in any other place of payment with respect to the Notes.

Interest will be payable to the person in whose name a Note is registered at the close of business on the regular Record Date (as defined below) next preceding the related Interest Payment Date, except that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) if the Issuer fails to pay the interest due on an Interest Payment Date, the defaulted interest will be paid to
the person in whose name the Note is registered at the close of business on the Record Date the Issuer will establish for the payment of defaulted interest; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) interest payable at maturity, redemption or repayment will be payable to the person to whom principal shall be
payable.

The "Record Date" for the Notes will be, for so long as the Notes are in the form of Global Notes, three Business Days prior to the relevant Interest Payment Date and, in the event that any Notes are not represented by one or more Global Notes, the fifteenth day (whether or not a Business Day) prior to the relevant Interest Payment Date. Interest on the Notes will be calculated on the basis of a 360-day year comprised of twelve 30-day months.

Should the Swiss Resolution Authority order any Restructuring Protective Measures that result in the deferment of any payments of interest or principal when otherwise due and payable, such payments shall be deferred for the period for which the Swiss Resolution Authority requires any such deferment. If and to the extent that any such payments have not been subsequently written down and cancelled or converted into equity of the Issuer, following any such period, the Issuer will be required to pay any such principal and/or interest on the later of (i) the next Interest Payment Date and (ii) the date that is 15 Business Days after the date on which such period ends. Any such payments of deferred interest or deferred principal shall be made to holders in whose names the Notes are registered at the close of business on a special record date for the payment of such deferred interest and/or deferred principal.

The Notes have been listed on the SIX Swiss Exchange.

The Notes constitute direct, unsecured and senior obligations of the Issuer and rank pari passu with all other unsecured and unsubordinated obligations of the Issuer and without any preference among themselves.

There is no sinking fund for the Notes.

**Further Issues** 

The Issuer may from time to time, without notice to or the consent of the holders of the Notes of the relevant series, create and issue further notes having the same terms and ranking *pari passu* with any of the outstanding

------

##### [**Table of Contents**](#toc)
Notes due 2026 or the Notes due 2045 in all respects (or the same terms in all respects except for issue dates, public offering prices, initial Interest Payment Dates and initial interest accrual dates). Such further notes will be consolidated and form a single issue with the outstanding Notes due 2026 or the Notes due 2045, as applicable, and will, except as aforesaid, have the same terms as to status, redemption or otherwise as the outstanding Notes due 2026 or the Notes due 2045, as applicable, and payments on such further notes in liquidation will be made on a *pro rata* basis.

**Agreement with Respect to the Exercise of Swiss Resolution Power and the Ordering of Restructuring Protective Measures** 

By its acquisition of the Notes, each holder of the Notes (including each beneficial owner) acknowledges, agrees to be bound by, and consents to the exercise of, any Swiss Resolution Power with respect to the Issuer that results in the write-down and cancellation and/or conversion into equity of the Issuer of the entire, or a portion of the, principal amount of, and/or accrued interest on, the Notes, irrespective of whether such amounts have already become due and payable prior to such action. By its acquisition of the Notes, each such holder (including each beneficial owner) further acknowledges, agrees to be bound by, and consents to the ordering of any Restructuring Protective Measures that result in the deferment of payment of principal and/or interest under the Notes. By its acquisition of the Notes, each holder of Notes (including each beneficial owner) further acknowledges, agrees and consents that its rights are subject to, and, if necessary, will be altered without such holder's or owner's consent, including by means of an amendment or modification to the terms of the relevant Indenture or of the Notes so as to give effect to any such exercise of the Swiss Resolution Power or any such ordering of Restructuring Protective Measures. For the avoidance of doubt, this acknowledgement, agreement and consent does not qualify as a waiver of the rights, procedural or otherwise, existing for creditors generally, and the holder of Notes specifically, under the applicable banking regulation pursuant to which any Swiss Resolution Power is exercised.

As used in this "Description of the Subject Securities":

A "Swiss Resolution Power" means any statutory power of the Swiss Resolution Authority that it may exercise during Restructuring Proceedings as set forth in article 28 et seq. of the Swiss Federal Act of November 8, 1934, on Banks and Savings Banks, as may be amended from time to time (referred to herein as the "Swiss Banking Act") and article 40 et seq. of the Ordinance of August 30, 2012 of the Swiss Financial Market Supervisory Authority FINMA on the Insolvency of Banks and Securities Dealers, as may be amended from time to time (referred to herein as the "Swiss Banking Insolvency Ordinance"), or in any successor Swiss law or regulation or analogous Swiss law or regulation applicable to bank holding companies in Switzerland such as the Issuer, including, without limitation, the power to (a) transfer the assets of the entity subject to such Restructuring Proceedings, or portions thereof, together with such entity's debt and other liabilities, or portions thereof, and contracts, to another entity, (b) stay (for a maximum of two business days in the case of the Notes due 2026 or 48 hours in the case of the Notes due 2045) the termination of, and the exercise of rights to (i) terminate, netting rights, right to enforce or dispose of certain types of collateral or rights to transfer claims, liabilities or certain collateral under contracts (in the case of the Notes due 2026), or (ii) terminate relating to, financial contracts (in the case of the Notes due 2045), to which the entity subject to such Restructuring Proceedings is a party, (c) convert the debt of the entity subject to such Restructuring Proceedings into equity, and/or (d) partially or fully write-down the obligations of the entity subject to such Restructuring Proceedings. A "Protective Measure" means any protective measure that the Swiss Resolution Authority may order pursuant to any statutory power set forth in article 26 of the Swiss Banking Act, or in any successor Swiss law or regulation or analogous Swiss law or regulation applicable to bank holding companies in Switzerland such as the Issuer, including, without limitation, (a) giving instructions to the governing bodies, (b) appointing an investigator of the respective entity, (c) stripping governing bodies of their power to legally represent the respective entity or remove them from office, (d) removing the regulatory or company-law audit firm from office, (e) limiting the respective entity's business activities, (f) forbidding the respective entity to make or accept payments or undertake security trades, (g) closing down the respective entity, or (h) except for with respect to mortgage-secured receivables of central mortgage bond institutions, ordering a moratorium or deferral of payments.

------

##### [**Table of Contents**](#toc)
"Restructuring Protective Measures" means any Protective Measures ordered by the Swiss Resolution Authority with respect to the Issuer that are ordered or confirmed upon the opening of Restructuring Proceedings by the Swiss Resolution Authority with respect to the Issuer or during any such Restructuring Proceedings.

"Non-Restructuring Protective Measures" means any Protective Measures ordered by the Swiss Resolution Authority with respect to the Issuer that are ordered outside of and independently of any Restructuring Proceedings that have been opened by the Swiss Resolution Authority with respect to the Issuer.

"Swiss Resolution Authority" means FINMA or other authority in Switzerland that is competent under Swiss law to exercise a Swiss Resolution Power or to order Protective Measures at the relevant time.

"FINMA" means the Swiss Financial Market Supervisory Authority FINMA and any successor thereto.

"Restructuring Proceedings" means restructuring proceedings within the meaning of article 28 et seq. of the Swiss Banking Act, and article 40 et seq. of the Swiss Banking Insolvency Ordinance, or any successor Swiss law or regulation or analogous Swiss law or regulation applicable to banks or bank holding companies in Switzerland such as the Issuer.

By its acquisition of Notes, each holder of Notes (including each beneficial owner) waives any and all claims, in law and/or in equity, against the Trustee for, agrees not to initiate a suit against the Trustee in respect of, and agrees that the Trustee shall not be liable for, any action that the Trustee takes, or abstains from taking, in either case in accordance with (i) the opening of Restructuring Proceedings by the Swiss Resolution Authority with respect to the Issuer, (ii) the exercise of any Swiss Resolution Power with respect to the Issuer that requires or results in any write-down and cancellation and/or conversion into equity of the Issuer of the entire, or a portion of, the principal of, and/or accrued interest on, the Notes, (iii) the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of principal and/or interest under the Notes or (iv) any consequences resulting from any of the foregoing. Additionally, by its acquisition of the Notes, each holder of the Notes (including each beneficial owner) will acknowledge, agree and consent that (a) upon the exercise of any Swiss Resolution Power with respect to the Issuer or the ordering of any Restructuring Protective Measures, (i) the Trustee will not take any further directions from the holders under Section 7.05 (Control by Majority) of the Indentures, which section authorizes holders of a majority in aggregate outstanding principal amount of the Notes to direct certain actions relating to the Notes, and that any such direction given prior to the exercise of any Swiss Resolution Power with respect to the Issuer or the ordering of any Restructuring Protective Measures shall thereafter be deemed null and void, and (ii) the Indentures and the Notes issued thereunder will not impose any duties, liability, cost or expense upon the Trustee whatsoever with respect to the exercise of any such Swiss Resolution Power or the ordering of any Restructuring Protective Measures and (b) neither the opening of Restructuring Proceedings by the Swiss Resolution Authority with respect to the Issuer, nor the exercise of any Swiss Resolution Power with respect to the Issuer that requires or results in any write-down and cancellation and/or conversion into equity of the Issuer of the entire, or a portion of, the principal amount of, and/or accrued interest on, the Notes, nor the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of principal and/or interest under the Notes nor any consequences resulting from any of the foregoing shall give rise to a Default or Event of Default under the Indentures, including, without limitation, for purposes of Section 315(b) and Section 315(c) under the Trust Indenture Act. By its acquisition of the Notes, each holder or beneficial owner of Notes that acquires its Notes in the secondary market shall be deemed to acknowledge, agree to be bound by and consent to the same matters specified herein as the holders and beneficial owners of the Notes that acquired the Notes upon initial issuance, including, without limitation, with respect to the acknowledgment and agreement to be bound by and consent to the terms of the Notes relating to the Swiss Resolution Power and any Restructuring Protective Measures. By its purchase of the Notes, each holder and beneficial owner of Notes shall be deemed to have (i) consented to the exercise of any Swiss Resolution Power with respect to the Issuer that requires or results in any write-down and cancellation and/or conversion into equity of the Issuer of the entire, or a portion of, the principal amount of, and/or accrued interest on, the Notes and the ordering of any Restructuring Protective Measures that require or result in the deferment of

------

##### [**Table of Contents**](#toc)
payment of principal and/or interest under the Notes as such Swiss Resolution Power or Restructuring Protective Measure as it may be imposed without any prior notice by the Swiss Resolution Authority of its decision to exercise such power or order such Restructuring Protective Measure and (ii) authorized, directed and requested DTC and any direct participant in DTC or other intermediary through which it holds such Notes to take any and all necessary action, if required, to implement any such exercise of Swiss Resolution Power or ordering of any Restructuring Protective Measures, without any further action or direction on the part of such holder or beneficial owner. No repayment of the principal of the Notes or payment of interest on the Notes shall become due and payable after the exercise of any Swiss Resolution Power with respect to the Issuer that results in the write-down and cancellation and/or conversion into the equity of the Issuer of the entire, or a portion of, the principal and/or accrued but unpaid interest on, the Notes, or the ordering of any Restructuring Protective Measures that required or result in the deferment of payment of principal and/or interest under the Notes, unless, at the time that such repayment or payment, respectively, is scheduled to become due, such repayment or payment would be permitted to be made by the Issuer under the Swiss laws, regulations and orders applicable to the Issuer; provided that the Trustee shall not be liable for any payments it makes until a Responsible Officer of the Trustee has actual knowledge of any such exercise of any Swiss Resolution Power or any such ordering of any Restructuring Protective Measures.

Notwithstanding anything herein to the contrary, so long as any Notes remain outstanding (including, for example, if the exercise of the Swiss Resolution Power results in only a partial write-down and/or conversion of the principal of the Notes), then the Trustee's duties and rights under the relevant Indenture will remain applicable with respect to such Notes.

The Issuer's obligation to indemnify the Trustee in accordance with Section 8.07 of the Indentures will survive the exercise of the Swiss Resolution Power with respect to the Notes. However, if and to the extent such obligation has already accrued as a liability of the Issuer, it may be written down and cancelled and/or converted into equity of the Issuer as a result of an exercise of the Swiss Resolution Power or its payment deferred as a result of the ordering of any Restructuring Protective Measures.

Upon the occurrence of (i) the opening of Restructuring Proceedings by the Swiss Resolution Authority with respect to the Issuer, (ii) the exercise of Swiss Resolution Power that affects, or may affect, the Notes or (iii) the ordering of any Restructuring Protective Measures that affects, or may affect, the Notes, the Issuer shall provide a written notice to the holders of the relevant series through DTC as soon as practicable regarding the occurrence of such an event for purposes of notifying holders of such occurrence. The Issuer shall also deliver a copy of such notice to the Trustee for information purposes.

**Waiver of Set-Off** 

By its acquisition of Notes, each holder of Notes (including each beneficial owner) will be deemed to have waived any right of set-off, compensation or retention, or in respect of such other netting arrangement in respect of any amount with respect to such Notes or the applicable Indenture that they might otherwise have against the Issuer, whether before or during Restructuring Proceedings with respect to or winding up of the Issuer.

**Repurchases** 

Holders of the Notes may not require the Issuer to repurchase the Notes prior to maturity.

Subject to the prior approval of FINMA, if then required under Swiss laws and regulations applicable to the Issuer from time to time, each of the Issuer or any subsidiary of the Issuer, may at any time purchase or procure others to purchase beneficially for its account Notes in any manner and at any price. Notes so purchased may, at the Issuer's or any such subsidiary's discretion, be held, resold or surrendered for cancellation.

------

##### [**Table of Contents**](#toc)
**Tax Redemption** 

Subject to the prior approval of FINMA, if then required under Swiss laws applicable to the Issuer from time to time, as evidenced by an officers' certificate from the Issuer certifying the same, the Issuer may at its option redeem the Notes of any series, in whole but not in part, at any time on giving not less than 30 nor more than 60 days' notice to the holders and the Trustee, at the principal amount of the Notes being redeemed, together with accrued interest to, but excluding the date of redemption, if it or the Issuer has or will become obligated to pay Additional Amounts in respect of the Notes of such series as described under "—Payment of Additional Amounts" below as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of Switzerland or Guernsey, as applicable, or any political subdivision or taxing authority thereof or therein, or any change in the application or official interpretation of such laws, regulations or rulings, which change or amendment becomes effective on or after the date of the applicable Indenture, and such obligation cannot be avoided by the Issuer taking reasonable measures available to it, provided that no such notice of redemption will be given earlier than 90 days prior to the earliest date on which it would be obliged to pay such Additional Amounts were a payment in respect of the Notes of such series then due; provided, however, that if the Issuer has given such notice and Restructuring Proceedings are opened by the Swiss Resolution Authority with respect to the Issuer thereafter, but prior to the tax redemption date, such tax redemption will be canceled. Prior to the giving of any notice of redemption pursuant to this paragraph, the Issuer will deliver to the Trustee a certificate stating that it is entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to its right to redeem have occurred, and an opinion of independent counsel of recognized standing to the effect that the Issuer has or will become obligated to pay such Additional Amounts as a result of such change or amendment.

**Payment of Additional Amounts** 

The Issuer will, subject to the exceptions and limitations set forth below, pay such Additional Amounts to the holder of Notes as may be necessary so that every net payment on the Notes, after deduction or withholding for or on account of any present or future tax, assessment or other governmental charge imposed upon or as a result of such payment by Switzerland or Guernsey, as applicable, or any political subdivision or taxing authority thereof or therein, will not be less than the amount provided in the Notes to be then due and payable, subject to the discussion below, such amounts referred to herein as "Additional Amounts."

The Issuer will not be required to make any payments of Additional Amounts described above in respect of any present or future tax, assessment or other governmental charge imposed by Switzerland, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the holder having some connection with Switzerland other than the mere holding of the Note; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date (as defined below) except to the extent that the holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including, but not
limited to, the agreement between the European Union and Switzerland of October 26, 2004, or any law or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) where such withholding or deduction is imposed on a payment and is required to be made pursuant to any
agreements between Switzerland and other countries on final withholding taxes (*internationale* 

------

##### [**Table of Contents**](#toc)
 *Quellensteuern*) in respect of persons resident in the other country on income of such person on Notes booked or deposited with a Swiss paying agent, or any law or the other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) in respect of the Notes due 2026, any such taxes, duties, assessments or other governmental charges imposed on
a payment in respect of the Notes required to be made pursuant to laws enacted by Switzerland providing for the taxation of payments according to principles similar to those laid down in the draft legislation of the Swiss Federal Council of
December 17, 2014, or otherwise changing the Swiss federal withholding tax system from an issuer-based system to a paying-agent-based system pursuant to which a person other than the issuer is required to withhold tax on any interest payments;
or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) where such withholding or deduction is imposed on any payment by reason of FATCA (as defined below); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) any combination of two or more items (i) through (vii) above.

"Relevant Date" as used herein means whichever is the later of (x) the date on which such payment first becomes due and (y) if the full amount payable has not been received by the Trustee on or prior to such date, the date on which the full amount having been so received, notice to that effect shall have been given to the holders.

The Issuer will not be required to make any payments of Additional Amounts described above in respect of any present or future tax, assessment or other governmental charge imposed by Guernsey, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the holder having some connection with Guernsey other than the mere holding of the Note; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to the extent the withholding or deduction is imposed or levied because the holder (or beneficial owner) of the
Note has not made a declaration of non residence or other claim for exemption, if such holder is able to avoid such deduction or withholding by making such a declaration or claim; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date (as defined below) except to the extent that the holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including any law
or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) where such withholding or deduction is imposed on any payment by reason of FATCA; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) any combination of two or more items (i) through (vi) above.

------

##### [**Table of Contents**](#toc)
**U.S. Foreign Account Tax Compliance Act** 

Payments on the Notes will be subject in all cases to any withholding or deduction required pursuant to an agreement described in Section 1471(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), or described in any agreement between any jurisdiction and the United States relating to the foreign account provisions of the U.S. Hiring Incentives to Restore Employment Act of 2010, or otherwise imposed pursuant to Sections 1471 through 1474 of the Code, any regulations or agreements thereunder, official interpretations thereof, or any agreements, law, regulation or other official guidance implementing an intergovernmental agreement or other intergovernmental approach thereto (collectively, "FATCA").

**Consolidation, Merger or Sale** 

The Issuer has agreed in each Indenture not to consolidate with or merge with or into any other person or convey or transfer all or substantially all of its properties and assets to any person (other than with or into any subsidiary of the Issuer) unless:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the Issuer is the continuing person; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the successor expressly assumes by supplemental indenture the obligations of the Issuer under such Indenture.

In either case, the Issuer will also have to deliver a certificate to the Trustee stating that after giving effect to the merger, conveyance or transfer there will not be any Defaults under the Indentures and an opinion of counsel stating that the merger, conveyance or transfer and the supplemental indenture, if required, comply with these provisions and that the supplemental indenture is a legal, valid and binding obligation of the successor corporation enforceable against it.

**Subsequent Holders' Agreement** 

Holders of the Notes that acquire the Notes in the secondary market shall be deemed to acknowledge, agree to be bound by and consent to the provisions specified in the Indentures to the same extent as the holders of the Notes that acquired the Notes upon their initial issuance, including, without limitation, with respect to the acknowledgement and agreement to be bound by and consent to the terms of the Notes, including in relation to any Swiss Resolution Power, any Restructuring Protective Measures and any Issuer Substitution.

**Modification of the Indentures** 

In general, rights and obligations of the Issuer and the holders under each Indenture may be modified if the holders of a majority in aggregate principal amount of the outstanding Notes of the relevant series affected by the modification consent to such modification, except as provided herein. However, unless each affected holder of the relevant series agrees, an amendment cannot:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) impair the right of any holder to receive payment of the principal of and interest on Notes of the relevant
series on or after the respective due dates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) impair the right of any holder of the relevant series to institute suit for the enforcement of any such payment
on or after such respective dates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) make any adverse change to any payment term of the Notes of the relevant series such as extending the
applicable Maturity Date, extending the date on which the Issuer has to pay interest, reducing the applicable interest rate, reducing the amount of principal the Issuer has to repay or the amount thereof provable in bankruptcy, insolvency or similar
proceeding, changing the currency or place in which the Issuer has to make any payment of principal, premium or interest, modifying any redemption right to the detriment of the holder, and impairing any right of a holder to bring suit for payment;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) reduce the percentage of the aggregate principal amount of Notes of the relevant series needed to make any
amendment to the applicable Indenture or to waive any covenant or Default;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) waive any payment Default with respect to the relevant series; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) make any change to the amendment provisions of the applicable Indenture;

provided that any amendments made pursuant to the agreement with respect to the exercise of Swiss Resolution Power and/or the ordering of Restructuring Protective Measures provided for in the Indentures and herein shall not be subject to the foregoing.

However, other than in the circumstances mentioned above, if the Issuer and the Trustee agree, the applicable Indenture may be amended without notifying any holders or seeking their consent if the amendment does not materially and adversely affect the rights of any holder of the relevant series.

In particular, if the Issuer and the Trustee agree, the applicable Indenture may be amended without notifying any holders or seeking their consent to add a guarantee from a third party on the outstanding and any future Notes to be issued under the applicable Indenture.

The Indentures do not contain any covenants or other provisions designed to protect holders of the Notes against a reduction in the creditworthiness of the Issuer in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the Notes, including a change in control of the Issuer.

**Events of Default** 

With respect to each series of Notes, an Event of Default occurs upon:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) a Default in payment of the principal or any premium on any Note of such series when due and payable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) a Default in payment of the interest on any Note of such series for 30 Business Days after such interest
becomes due and payable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) a Default in performing any other covenant in the applicable Indenture for 60 Business Days after written
notice from the Trustee or from the holders of 25% (with a copy to the Trustee) in principal amount of the outstanding Notes of such series; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) certain events of bankruptcy, insolvency or insolvent reorganization of the Issuer;

provided, however, that neither (i) the opening of Restructuring Proceedings by the Swiss Resolution Authority with respect to the Issuer, nor (ii) the exercise of any Swiss Resolution Power with respect to the Issuer that requires or results in any write-down and cancellation and/or conversion into equity of the Issuer of the entire, or a portion of, the principal amount of, and/or accrued interest on, the Notes, nor (iii) the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of principal and/or interest under the Notes nor (iv) any consequences resulting from any of the foregoing shall constitute a Default or an Event of Default under the applicable Indenture. For the avoidance of doubt, any consequences resulting from any Non-Restructuring Protective Measures that would otherwise constitute a Default or an Event of Default will constitute a Default or an Event of Default, as applicable.

The Trustee may withhold notice to the holders of Notes of any Default with respect to the applicable series (except in the payment of principal, premium or interest) if it considers such withholding of notice to be in the best interests of the holders of such series. A "Default" is any event which is, or after notice or the passage of time or both would be, an Event of Default.

------

##### [**Table of Contents**](#toc)
If an Event of Default with respect to a series of Notes occurs and continues, the Trustee or the holders of the aggregate principal amount of the Notes of such series as specified below may require the Issuer to repay immediately, or accelerate, the entire principal of the Notes of such series.

If the Event of Default with respect to a series of Notes occurs because of a Default in a payment of principal or interest on the Notes of such series, then the Trustee or the holders of at least 25% of the aggregate principal amount of Notes of such series can accelerate the Notes of such series. If the Event of Default with respect to a series of Notes occurs because of a failure to perform any other covenant in the applicable Indenture, then the Trustee or the holders of at least 25% of the aggregate principal amount of the Notes of such series can accelerate the Notes of such series. If the Event of Default occurs because of bankruptcy proceedings, then all of the Notes under the applicable Indenture will be accelerated automatically. Therefore, except in the case of a Default due to bankruptcy or insolvency of the Issuer, it is possible that you may not be able to accelerate a series of Notes because of the failure of holders of other Notes in such series issued under the applicable Indenture to take action.

The holders of a majority of the aggregate principal amount of the Notes of any series can rescind this accelerated payment requirement with respect to such series or waive any past Default or Event of Default with respect to such series or allow noncompliance with any provision of the applicable Indenture. However, they cannot waive a Default in payment of principal of, premium, if any, or interest on, any of the Notes of such series.

After an Event of Default, the Trustee must exercise the same degree of care a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the Trustee is not obligated to exercise any of its rights or powers under the applicable Indenture at the request, order or direction of any holders, unless the holders offer the Trustee satisfactory indemnity. If they provide this satisfactory indemnity, the holders of a majority in principal amount of the Notes of the relevant series, may direct the time, method and place of conducting any proceeding or any remedy available to the Trustee, or exercising any power conferred upon the Trustee, with respect to the Notes of such series.

**Defeasance** 

The term defeasance means discharge from some or all of the obligations under an Indenture. Subject to certain tax conditions, if the Issuer deposits with the Trustee sufficient cash or government securities, in the opinion of a nationally recognized investment bank, appraisal firm or firm of independent public accountants, to pay the principal, interest, any premium and any other sums due to the stated applicable Maturity Date or a redemption date of the Notes of any series, the Issuer will be discharged from its obligations with respect to the Notes of such series.

In the case of defeasance pursuant to the above, the holders of the Notes of the relevant series will not be entitled to the benefits of the applicable Indenture except for registration of transfer and exchange of Notes of such series and replacement of lost, stolen or mutilated Notes of such series. Instead, the holders of Notes of such series will only be able to rely on the deposited funds or obligations for payment.

The Issuer must deliver to the Trustee an officers' certificate and an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the Notes of the relevant series to recognize income, gain or loss for U.S. federal income tax purposes and that those holders would be subject to U.S. federal income tax on the same amount and in the same manner and at the same time as would have been the case if such deposit and defeasance had not occurred. The Issuer may, in lieu of an opinion of counsel, deliver a ruling to such effect directed to the Trustee received from or published by the IRS.

**Currency Indemnity** 

Payment on the Notes and amounts due under the Indentures are due to be made in U.S. dollars, which we refer to as the "Required Currency." Any amount received or recovered in a currency other than the Required

------

##### [**Table of Contents**](#toc)
Currency by the Trustee, any holder in respect of any sum expressed to be due to it from the Issuer, as applicable, shall only constitute a discharge to the Issuer, as applicable, to the extent of the Required Currency amount which the recipient is able to purchase with the amount so received or recovered in that other currency on the date of that receipt or recovery (or, if it is not practicable to make that purchase on that date, on the first date on which it is practicable to do so). If that Required Currency amount is less than the Required Currency amount expressed to be due to the recipient under any such Note, the Issuer shall indemnify it against any resulting loss sustained by the recipient. In any event, the Issuer shall indemnify the recipient against the cost of making any such purchase. For the purposes of this condition, it will be sufficient for the Trustee or a holder, as the case may be, to demonstrate that it would have suffered a loss had an actual purchase been made. These indemnities constitute a separate and independent obligation from the Issuer's other obligations, shall give rise to a separate and independent cause of action, shall apply irrespective of any waiver granted by any holder of the Notes and shall continue in full force and effect despite any other judgment, order, claim or proof for a liquidated amount in respect of any sum due under the Notes or any other judgment or order.

**Provisions Relating to the Notes in Global Form and Book-Entry Clearance Systems** 

The Notes of each series are represented by one or more Global Notes in definitive, fully registered form without interest coupons, which we refer to collectively as the "Global Notes." The Global Notes have been deposited with the Trustee as custodian for DTC and registered in the name of Cede & Co. as DTC's nominee in New York, New York for the accounts of institutions that have accounts with DTC, which we refer to as "participants." DTC is the depositary for the Global Notes.

Except as set forth below, the Notes of each series will be issued in registered, global form in minimum denominations of $250,000 and integral multiples of $1,000 in excess thereof.

Investors in the Global Notes who are participants in DTC's system may hold their interests directly through DTC. Investors in the Global Notes who are not participants may hold their interests therein indirectly through organizations that are DTC participants, including Euroclear Bank, S.A./N.V as operator of the Euroclear System, which we refer to as "Euroclear," and Clearstream Banking, société anonyme, which we refer to as "Clearstream, Luxembourg," (as indirect participants in DTC). Except in the limited circumstances described below, holders of Notes represented by interests in a Global Note will not be entitled to receive their Notes in fully certificated, non-global definitive form, which Notes we refer to as "Definitive Notes."

So long as the depositary or its nominee is the registered owner of a global security, the Issuer and the Trustee will treat the depositary as the sole holder of the Notes for purposes of the Indentures. Therefore, except as set forth below, you will not be entitled to have the Notes registered in your name or to receive physical delivery of certificates representing the Notes. Accordingly, you will have to rely on the procedures of the depositary and the participant in the depositary through whom you hold your beneficial interest in order to exercise any rights of a holder under the Indentures. We understand that under existing practices, the depositary would act upon the instructions of a participant or authorize that participant to take any action that a holder is entitled to take.

As long as the Notes are represented by Global Notes, the Issuer will pay principal of and interest and premium on those Notes to, or as directed by, DTC as the registered holder of the Global Notes. Payments to DTC will be in immediately available funds by wire transfer. DTC, Clearstream, Luxembourg or Euroclear, as applicable, will credit the relevant accounts of their participants on the applicable date. Neither the Issuer nor the Trustee will be responsible for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of participants and their customers, and you will have to rely on the procedures of the depositary and its participants.

DTC has advised us that it is a limited-purpose trust company organized under the New York Banking Law, a "banking organization" within the meaning of the New York Banking Law, a member of the Federal Reserve

------

##### [**Table of Contents**](#toc)
System, a "clearing corporation" within the meaning of the New York Uniform Commercial Code, and a "clearing agency" registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds securities deposited with it by its participants and facilitates the settlement of transactions among its participants in such securities through electronic computerized book-entry changes in accounts of the participants, thereby eliminating the need for physical movement of securities certificates. DTC's participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and/or their representatives) own DTC. Access to DTC's book-entry system is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly.

According to DTC, the foregoing information with respect to DTC has been provided to the financial community for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.

Global Notes generally are not transferable. Physical certificates will be issued to beneficial owners of a global security if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the depositary notifies the Issuer that it is unwilling or unable to continue as depositary and the Issuer does
not appoint a successor within 90 days after its receipt of such notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the depositary ceases to be a clearing agency registered under the Exchange Act and the Issuer does not appoint a
successor within 90 days after it becomes aware of such cessation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Issuer decides in its sole discretion (subject to the procedures of the depositary) that it does not want to
have the Notes of the relevant series represented by Global Notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an Event of Default has occurred with regard to the Notes of the relevant series and has not been cured or waived
and DTC, on behalf of the beneficial owners, has requested the issuance of physical certificates.

If any of the events described in the preceding paragraph occurs, the Issuer will issue Definitive Notes in certificated form in an amount equal to a holder's beneficial interest in the Notes of the relevant series. Definitive Notes will be issued in minimum denominations of $250,000 and integral multiples of $1,000 in excess thereof, and will be registered in the name of the person DTC specifies in a written instruction to the registrar of the Notes.

In the event Definitive Notes are issued:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• holders of Definitive Notes will be able to receive payments of principal and interest on their Notes at the
office of the Issuer's paying agent maintained in the Borough of Manhattan, subject to surrender of the Notes in the case of payments of principal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• upon provision of certifications, if any, to the Trustee, as may be required by the Indentures and the Notes,
holders of Definitive Notes will be able to transfer their Notes in whole or in part, by surrendering the Notes for registration of transfer at the office of the Trustee under the Indentures. The Issuer will not charge any fee for the registration
or transfer or exchange, except that it may require the payment of a sum sufficient to cover any applicable tax or other governmental charge payable in connection with the registration, transfer or exchange; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any moneys the Issuer pays to its paying agents for the payment of principal and interest on the Notes which
remain unclaimed at the second anniversary of the date such payment was due will be returned to the Issuer, and thereafter holders of Definitive Notes may look only to the Issuer, as general unsecured creditors, for payment, provided, however, that
the paying agents must first publish notice in an authorized newspaper that such money remains unclaimed.

Each of the persons shown in the records of Euroclear, Clearstream, Luxembourg, DTC, or any other clearing system (any such other clearing system, an "alternative clearing system") as the holder of a Note

------

##### [**Table of Contents**](#toc)
represented by the Global Notes must look solely to Euroclear, Clearstream, Luxembourg, DTC or any such alternative clearing system (as the case may be) for his share of each payment made by the Issuer to the holder of the Global Notes and in relation to all other rights arising under the Global Notes, subject to and in accordance with the respective rules and procedures of Euroclear, Clearstream, Luxembourg, DTC or such alternative clearing system (as the case may be). Such persons shall have no claim directly against the Issuer in respect of payments due on the Notes for so long as the Notes are represented by the Global Notes and such obligations of the Issuer will be discharged by payment to the holder of the Global Notes in respect of each amount so paid.

**Information Concerning the Trustee for the Notes** 

U.S. Bank Trust Company, National Association, a national association, is the Trustee for the Notes. The Trustee will be required to perform only those duties that are specifically set forth in the Indentures, except when certain defaults have occurred and are continuing with respect to the Notes. After certain defaults, the Trustee must exercise the same degree of care that a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the Trustee will be under no obligation to exercise any of the powers vested in it by the Indentures at the request of any holder of Notes unless the holder offers the Trustee satisfactory indemnity against the costs, expenses and liabilities that might be incurred by exercising those powers. The Trustee may conclusively rely and shall be fully protected in acting or refraining from acting upon any officers' certificate, opinion of counsel (or both), resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper person or persons. The Issuer is obliged to furnish to the Trustee annually, or upon request of the Trustee, a list of the names and addresses of the holders of registered Notes.

U.S. Bank Trust Company, National Association has loaned money to the Issuer and certain of its subsidiaries and affiliates and provided other services to it and has acted as trustee or fiscal agent under certain of its and its subsidiaries' and affiliates' indentures or fiscal agency agreements in the past and may do so in the future as a part of its regular business.

**Governing Law** 

The Notes and the Indentures are governed by and will be construed in accordance with the laws of the State of New York.

**Jurisdiction** 

Any suit, action or proceeding against the Issuer arising out of or based upon the Notes or the Indentures may be instituted in any state or federal court in the borough of Manhattan, The City of New York.

------

##### [**Table of Contents**](#toc)
**UNITED STATES TAX CONSIDERATIONS** 

This section describes certain U.S. federal income tax consequences of the Rescission Offer and ownership of the Subject Securities to beneficial owners of Subject Securities that are U.S. holders (as defined below). It applies to you only if you hold or have held your Subject Securities as capital assets for U.S. federal income tax purposes.

This section does not discuss all of the tax consequences applicable to you if you are a member of a class of holders subject to special rules, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a dealer in securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a tax-exempt organization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an insurance company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a person that holds or has held the Subject Securities as part of a straddle or a hedging or conversion
transaction for tax purposes or as part of a "synthetic security" or other integrated financial transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a person that purchases or sells the Subject Securities as part of a wash sale for tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a person whose functional currency for tax purposes is not the U.S. dollar;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a bank;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an entity taxed as a partnership or the partners therein; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a regulated investment company.

This summary does not address state, local or foreign taxes, the U.S. federal estate and gift taxes, the alternative minimum tax or the Medicare contribution tax applicable to net investment income of certain non-corporate U.S. holders.

This section is based on the Internal Revenue Code of 1986, as amended (the "Code"), its legislative history, existing and proposed regulations, published rulings and court decisions. These laws are subject to change, possibly on a retroactive basis.

You should consult your own tax adviser, as you deem appropriate, regarding the U.S. federal, state and local and other tax consequences of participating in the Rescission Offer and owning the Subject Securities.

You are a U.S. holder if you are a beneficial owner of the Subject Securities and you are, for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a citizen or resident of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a domestic corporation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• otherwise subject to U.S. federal income taxation on a net income basis in respect of the Subject Securities.

**U.S. Federal Income Tax Consequences of the Rescission Offer** 

This discussion assumes that each issuer's position that the Subject Securities should be treated as debt for U.S. federal income tax purposes will be respected. See the issuance prospectus for each of the Subject Securities for a discussion of the tax treatment of the Subject Securities and possible alternative tax treatment of the Subject Securities.

------

##### [**Table of Contents**](#toc)
*Tender of Subject Securities Pursuant to the Rescission Offer* 

This subsection addresses the tax treatment of a holder that disposes of its Subject Securities pursuant to the Rescission Offer.

Upon the tender of a Subject Security pursuant to the Rescission Offer, you generally will recognize taxable income or loss equal to the difference between the amount realized and your adjusted tax basis in the Subject Security. Although this prospectus uses the term "interest" when describing the calculation of the Rescission Offer Proceeds, the term is only intended to describe the method used to calculate the payment amount, and the payment is not considered interest for federal income tax purposes, but rather is included in the amount realized from the sale of the Subject Securities.

Your adjusted tax basis in a Subject Security should generally equal the amount that you paid for the Subject Security, increased by the amount of any market discount you previously included in gross income with respect to the Subject Security and reduced by the amount of any bond premium that you previously amortized with respect to the Subject Security. Your amount realized should equal the amount received in the Rescission Offer, except that a portion of such amount should be treated as a payment of interest for tax purposes to the extent of the accrued but unpaid interest on the Subject Securities at the time of the Rescission Offer. Such amount should be treated as foreign source ordinary income to the extent that you did not previously include such amount in income.

Except to the extent that any gain is recharacterized as ordinary income pursuant to the market discount rules discussed below, any gain or loss that you recognize upon a disposition of the Subject Securities pursuant to the Rescission Offer generally will be capital gain or loss, and will be long-term capital gain or loss if you held the Subject Security for more than one year upon the disposition of the Subject Security. Certain non-corporate U.S. holders (including individuals) generally are eligible for preferential rates of U.S. federal income taxation in respect of long-term capital gains. The deductibility of capital losses is limited under the Code. Any gain or loss recognized by a U.S. holder pursuant to the Rescission Offer generally should be treated as U.S.-source gain or loss.

If you acquired your Subject Securities with market discount, any gain realized upon the disposition of the Subject Securities pursuant to the Rescission Offer will be treated as ordinary income to the extent of the portion of the market discount that has accrued while you held such Subject Securities, unless you elected to include market discount in income currently as it accrues. You generally will be treated as having acquired the Subject Securities with market discount if the principal amount of the Subject Securities exceeds your purchase price for the Subject Securities by more than a statutory de minimis amount. Market discount will be considered to accrue ratably during the period from the date of that you acquired the Subject Securities to the maturity date of the Subject Securities, unless you elect to accrue market discount on a constant yield basis.

*Holders Who Disposed of their Subject Securities or Whose Subject Securities Matured Prior to the Rescission Offer* 

If your Subject Securities have matured or were sold prior to the Rescission Offer, although not entirely clear, it is likely that the amount that you receive, if any, pursuant to the Rescission Offer should first be treated as capital gain to the extent of any capital loss you recognized in respect of the Subject Securities upon their sale or maturity. Any such capital gain should be long-term or short-term capital gain based on whether you recognized a long-term or short-term capital loss on the Subject Securities upon their maturity or disposition.

If the amount that you receive pursuant to the Rescission Offer exceeds the capital gain amount described above, it is likely that such excess amount should first be treated as ordinary interest income to the extent of the interest that accrued on such loss under the formula for purposes of determining the amount received under the Rescission Offer, and thereafter as ordinary income. However, other characterizations are possible. For example,

------

##### [**Table of Contents**](#toc)
it is possible that the IRS could assert that all or a portion of the capital gain amount described above should instead be treated as ordinary income. Accordingly, you should consult with your tax adviser regarding the tax treatment of amounts received pursuant to the Rescission Offer.

*Information Reporting and Backup Withholding* 

You may be subject to information reporting with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules.

**U.S. Federal Income Tax Consequences of Ownership of Subject Securities** 

This section describes certain U.S. federal income tax consequences of ownership of the Subject Securities to beneficial owners of Subject Securities that are U.S. holders that purchase Subject Securities on or after the date hereof.

*Payments or Accruals of Interest* 

Interest payments on the Subject Securities will be taxable to you as ordinary interest income at the time that you receive or accrue such amounts in accordance with your regular method of tax accounting (except that the portion of an interest payment that is allocable to the portion of your purchase price that relates to interest that accrued prior to your purchase of the Subject Securities, which this discussion refers to as "pre-purchase accrued interest," will not be included in income and will rather be treated as a non-taxable return of the pre-purchase accrued interest).

*Purchase, Sale and Retirement of Subject Securities* 

Your tax basis in the Subject Securities generally will equal the cost of the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest). Your basis will increase by any amounts that you are required to include in income under the rules described below governing market discount, and will decrease by the amount of any bond premium that you previously amortized with respect to the Subject Securities under the rules described below.

Upon the sale or maturity of the Subject Securities, you generally will recognize gain or loss equal to the difference between the amount you realize on the transaction (less any accrued interest, which will be treated in the manner described above under "— Payments or Accruals of Interest") and your tax basis in the Subject Securities.

Except as discussed below with respect to market discount, any gain or loss that you recognize upon the sale or maturity of the Subject Securities generally will be capital gain or loss and will be long-term capital gain or loss if you have held the Subject Securities for more than one year on the date of disposition. Net long-term capital gain recognized by an individual U.S. holder generally will be subject to tax at the lower rate than net short-term capital gain or ordinary income. The ability of U.S. holders to offset capital losses against ordinary income is limited.

*Premium* 

If you purchase the Subject Securities at a cost greater than the principal amount of the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest), you will be considered to have purchased the Subject Securities at a premium, and you may elect to amortize the premium as an offset to interest income, using a constant yield method, over the remaining term of the Subject Securities. If you make this

------

##### [**Table of Contents**](#toc)
election, it generally will apply to all debt instruments that you hold at the time of the election, as well as any debt instruments that you subsequently acquire. In addition, you may not revoke the election without the consent of the IRS. If you elect to amortize the premium, you will be required to reduce your tax basis in the Subject Securities by the amount of the premium amortized during your holding period. If you do not elect to amortize premium, the amount of premium will be included in your tax basis in the Subject Securities. Therefore, if you do not elect to amortize premium and you hold the Subject Securities to maturity, you generally will be required to treat the premium as capital loss when the Subject Securities mature.

*Market Discount* 

If the principal amount of the Subject Securities exceeds your purchase price for the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest) by an amount at least equal to the product of (i) 0.25%, (ii) the principal amount of the Subject Securities and (iii) the remaining whole years to the maturity of the Subject Securities, the Subject Securities will be considered to bear "market discount." In this case, any gain that you realize on the sale or maturity of the Subject Securities generally will be treated as ordinary interest income to the extent of the market discount that accrued on the Subject Securities during your holding period. In addition, you may be required to defer the deduction of a portion of the interest paid on any indebtedness that you incurred or maintained to purchase or carry the Subject Securities. In general, market discount will be treated as accruing ratably over the term of the Subject Securities, or, at your election, under a constant yield method.

You may elect to include market discount in gross income currently as it accrues (on either a ratable or constant yield basis), in lieu of treating a portion of any gain realized on a sale of the Subject Securities as ordinary income. If you elect to include market discount on a current basis, the interest deduction deferral rule described above will not apply. If you do make such an election, it will apply to all market discount debt instruments that you acquire on or after the first day of the first taxable year to which the election applies. The election may not be revoked without the consent of the IRS.

*Information Reporting and Backup Withholding* 

Information returns will be required to be filed with the IRS in connection with payments on the Subject Securities made to certain U.S. holders. If you are a U.S. holder, you generally will not be subject to a United States backup withholding tax (currently at a rate of 24%) on such payments if you provide your taxpayer identification number to the applicable withholding agent. You may also be subject to information reporting and backup withholding tax requirements with respect to the proceeds from a sale of the Subject Securities. Any amounts withheld under the backup withholding rules may be allowed as a credit against the holder's U.S. federal income tax liability and may entitle the holder to a refund, provided that the required information is timely furnished to the IRS.

------

##### [**Table of Contents**](#toc)
**SWISS TAX CONSIDERATIONS** 

**Rescission Offer** 

The following is a summary of the principal tax consequences of accepting the Rescission Offer for Eligible Investors who are not residents of Switzerland for tax purposes and have no Swiss permanent establishment and do not conduct a Swiss-based trade or business. It does not address the tax treatment of Eligible Investors who are residents of Switzerland for tax purposes or who are subject to Swiss taxes for other reasons. This summary is based on legislation as of the date of this prospectus and does not aim to be a comprehensive description of all the Swiss tax considerations that may be relevant to a decision to accept the Rescission Offer.

*Withholding Tax* 

Whether you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, or an Eligible Former Investor who accepts the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer will not be subject to Swiss withholding tax.

*Securities Turnover Tax* 

If you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer may be subject to Swiss securities turnover tax at a rate of up to 0.15%, if a Swiss domestic (or Principality of Liechtenstein) securities dealer (as defined in the Swiss Federal Act on Stamp Duties of June 27, 1973, as amended) is a party to, or acts as an intermediary for, the transaction and no exemption applies in respect of one of the parties to the transaction.

*Income Taxation* 

Whether you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, or an Eligible Former Investor who accepts the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer will not be subject to any Swiss federal, cantonal or communal income tax if (i) you are not a resident of Switzerland, (ii) if you are an Eligible Current Investor, during the relevant taxation year have not engaged in a trade or business through a permanent establishment or a fixed place of business in Switzerland to which the tendered Subject Securities are attributable, and (iii) are not subject to income taxation in Switzerland for any other reason, will not be subject to any Swiss federal, cantonal or communal income tax.

**Outstanding Subject Securities** 

The following is a summary of the principal tax consequences of holding Notes due 2026 or Notes due 2045 (collectively, for purposes of this summary, the "Outstanding Subject Securities") for investors who are not residents of Switzerland for tax purposes and have no Swiss permanent establishment and do not conduct a Swiss-based trade or business. It does not address the tax treatment of holders of Outstanding Subject Securities who are residents of Switzerland for tax purposes or who are subject to Swiss taxes for other reasons. This summary is based on legislation as of the date of this prospectus and does not aim to be a comprehensive description of all the Swiss tax considerations that may be relevant to a decision to invest in Outstanding Subject Securities.

*Withholding Tax* 

Neither payments of interest on, nor the repayment of principal of, the Outstanding Subject Securities by the Issuer will be subject to Swiss federal withholding tax.

On April 3, 2020, the Swiss Federal Council published draft legislation and opened a consultation procedure regarding the reform of the Swiss withholding tax system applicable to interest on bonds. This draft legislation

------

##### [**Table of Contents**](#toc)
provided for, among other things, the replacement of the current debtor-based regime applicable to interest payments on bonds with a paying agent-based regime for Swiss withholding tax. Generally speaking, this proposed paying agent-based regime would have (i) subjected all interest payments on bonds made through paying agents in Switzerland to individuals resident in Switzerland to Swiss withholding tax, and (ii) exempted from Swiss withholding tax interest payments on bonds to all other persons, including to Swiss-domiciled legal entities and foreign investors (other than indirect interest payments through foreign and Swiss domestic collective investments vehicles). However, the results of the consultation, which ended on July 10, 2020, were controversial. Consequently, on April 15, 2021, the Swiss Federal Council submitted new draft legislation on the reform of the Swiss withholding tax system providing for the abolition of Swiss withholding tax on interest payments on bonds for submission to the Swiss Parliament, which legislation was accepted by the Swiss Parliament on December 17, 2021. The proposed legislation was rejected in a referendum held on September 25, 2022. In view of the rejection of this legislation, the Swiss Federal Council could again propose a paying agent-based regime as contemplated by the draft legislation published on April 3, 2020.

*Securities Turnover Tax* 

Neither the issue nor the redemption of Outstanding Subject Securities by the Issuer is subject to Swiss securities turnover tax.

The trading of the Outstanding Subject Securities in the secondary market is subject to Swiss securities turnover tax at a rate of 0.15% of the consideration paid for the Outstanding Subject Securities traded, if a Swiss domestic (or Principality of Liechtenstein) securities dealer (as defined in the Swiss Federal Act on Stamp Duties of June 27, 1973, as amended) is a party to, or acts as an intermediary for, the transaction and no exemption applies in respect of one of the parties to the transaction. In such case and subject to applicable statutory exemptions, typically half of the Swiss securities turnover tax is charged to one party to the transaction and the other half to the other party.

*Income Taxation* 

Payments by the Issuer of interest on and repayment of principal of Outstanding Subject Securities to, and the gain realized on the sale or redemption of Outstanding Subject Securities by, a holder of Outstanding Subject Securities who (i) is not a resident of Switzerland, (ii) during the relevant taxation year has not engaged in a trade or business through a permanent establishment or a fixed place of business in Switzerland to which the Outstanding Subject Securities are attributable, and (iii) is not subject to income taxation in Switzerland for any other reason, will not be subject to any Swiss federal, cantonal or communal income tax.

*Automatic Exchange of Information in Tax Matters* 

Switzerland has concluded a multilateral agreement with the European Union (the "EU") on the international exchange of information ("AEOI") in tax matters, which applies to all EU member states and some other jurisdictions. In addition, Switzerland has signed the multilateral competent authority agreement on the automatic exchange of financial account information (the "MCAA"), and based on the MCAA, a number of bilateral AEOI agreements with other countries. Based on such agreements and the implementing laws of Switzerland, depending on the date of effectiveness of the applicable agreement, Switzerland collects and exchanges data in respect of financial assets (including any Outstanding Subject Securities) held in, and income derived thereon and credited to, accounts or deposits with a paying agent in Switzerland for the benefit of individuals, entities and controlling persons (as applicable) resident in an EU member state or in another treaty state.

*Swiss Facilitation of the Implementation of U.S. Foreign Account Tax Compliance Act* 

The United States and Switzerland entered into an intergovernmental agreement (the "current U.S.-Switzerland IGA") to facilitate the implementation of the U.S. Foreign Account Tax Compliance Act

------

##### [**Table of Contents**](#toc)
("FATCA"). Under the current U.S.-Switzerland IGA, financial institutions acting out of Switzerland generally are directed to become participating foreign financial institutions. The current U.S.-Switzerland IGA ensures that accounts held by U.S. persons with Swiss financial institutions (including any such account in which an Outstanding Subject Security is held) are disclosed to the U.S. tax authorities either with the consent of the account holder or by means of group requests within the scope of administrative assistance, on the basis of the Convention between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation (the "Double Taxation Treaty"). Since it was amended in 2019, the Double Taxation Treaty includes a mechanism for the exchange of information in tax matters upon request between Switzerland and the United States, which is in line with international standards, and allows the United States to make group requests under FATCA concerning non-consenting non-participating foreign financial institutions for periods from June 30, 2014.

On June 27, 2024, Switzerland and the United States signed a new intergovernmental agreement to facilitate the implementation of FATCA (the "new U.S.-Switzerland IGA") that will change the current direct notification-based regime that is in place under the current U.S.-Switzerland IGA to a regime where the relevant information is sent to the Swiss Federal Tax Administration, which in turn provides the information to the U.S. tax authorities. In Switzerland, the implementation of the new U.S.-Switzerland IGA requires an amendment to national law, which will be decided by the Swiss Federal Assembly. According to communication from the State Secretariat for International Finance SIF, such amendment is currently expected to enter into force in Switzerland on January 1, 2027. However, it is not possible to predict whether and when such amendment will be enacted.

------

##### [**Table of Contents**](#toc)
**BENEFIT PLAN INVESTOR CONSIDERATIONS** 

A fiduciary of a pension, profit-sharing or other employee benefit plan subject to the U.S. Employee Retirement Income Security Act of 1974, as amended ("ERISA") or any entity or account deemed to hold "plan assets" of the foregoing (each, a "Plan"), should consider the fiduciary standards of ERISA in the context of the Plan's particular circumstances before determining whether to accept or reject the Rescission Offer. Among other factors, the fiduciary should consider whether the acceptance or rejection of the Rescission Offer would satisfy the prudence and diversification requirements of ERISA and would be consistent with the documents and instruments governing the Plan, and whether such acceptance or rejection would involve a prohibited transaction under ERISA or the Code.

Section 406 of ERISA and Section 4975 of the Code prohibit Plans, as well as individual retirement accounts, Keogh plans, any other plans that are subject to Section 4975 of the Code and any entities or accounts deemed to hold "plan assets" of the foregoing (also "Plans"), from engaging in certain transactions involving "plan assets" with persons who are "parties in interest" under ERISA or "disqualified persons" under the Code with respect to the Plan. A violation of these prohibited transaction rules may result in excise tax or other liabilities under ERISA or the Code for those persons, unless exemptive relief is available under an applicable statutory, regulatory or administrative exemption. Employee benefit plans that are governmental plans (as defined in Section 3(32) of ERISA), certain church plans (as defined in Section 3(33) of ERISA) and non-U.S. plans (as described in Section 4(b)(4) of ERISA) ("Non-ERISA Arrangements") are not subject to the requirements of Section 406 of ERISA or Section 4975 of the Code but may be subject to similar provisions under applicable federal, state, local, non-U.S. or other laws ("Similar Laws").

UBS Group AG and/or any of its respective affiliates may be considered a party in interest or disqualified person with respect to a Plan or entity whose underlying assets include "plan assets" by reason of any Plan's investment in the entity (a "Plan Asset Entity"). The continued holding or tender in the Rescission Offer of the Subject Securities by a Plan or a Plan Asset Entity with respect to which UBS Group AG and/or any of its respective affiliates is or becomes a party in interest or disqualified person may result in a prohibited transaction under ERISA or Section 4975 of the Code, unless the continued holding or tender in the Rescission Offer of the Subject Securities is done pursuant to an applicable exemption.

The U.S. Department of Labor has issued five prohibited transaction class exemptions, or "PTCEs," that may provide exemptive relief if required for direct or indirect prohibited transactions that may arise from the continued holding or tender in the Rescission Offer of the Subject Securities. These exemptions are PTCE 84-14 (for certain transactions determined by independent qualified professional asset managers), PTCE 90-1 (for certain transactions involving insurance company pooled separate accounts), PTCE 91-38 (for certain transactions involving bank collective investment funds), PTCE 95-60 (for transactions involving certain insurance company general accounts), and PTCE 96-23 (for transactions managed by in-house asset managers).

In addition, ERISA Section 408(b)(17) and Section 4975(d)(20) of the Code provide an exemption for the purchase and sale of the Subject Securities, provided that neither UBS Group AG nor any of their affiliates has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Plan involved in the transaction, and provided further that the Plan pays no more and receives no less than "adequate consideration" in connection with the transaction (the "service provider exemption"). There can be no assurance that all of the conditions of any such exemptions will be satisfied.

Any holder of the Subject Securities or any interest therein or investor that accepts or rejects the Rescission Offer will be deemed to have represented by its holding of the Subject Securities or any interest therein or its acceptance or rejection of the Rescission Offer that either (1) it is not a Plan, Plan Asset Entity or Non-ERISA Arrangement and is not accepting or rejecting the Rescission Offer on behalf of, or in respect of the assets of, any Plan, Plan Asset Entity or Non-ERISA Arrangement or (2)(i) the holding of the Subject Securities or acceptance or rejection of the Rescission Offer will not constitute a non-exempt prohibited

------

##### [**Table of Contents**](#toc)
transaction under ERISA or the Code or a similar violation under any applicable Similar Laws and (ii) none of UBS Group AG or any of its affiliates directly or indirectly exercises any discretionary authority or control or renders investment advice or otherwise acts in a fiduciary capacity with respect to the assets of the Plan or Plan Asset Entity within the meaning of ERISA.

Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is important that fiduciaries or other persons considering whether to accept or reject the Rescission Offer on behalf of or with the assets of any Plan, Plan Asset Entity or Non-ERISA Arrangement consult with their counsel regarding the availability of exemptive relief under any of the PTCEs listed above, the service provider exemption or the potential consequences of any holding or tender in the Rescission Offer of the Subject Securities under Similar Laws, as applicable.

Persons holding the Subject Securities have exclusive responsibility for ensuring that their continued holding and disposition (including through the Rescission Offer) of the Subject Securities do not violate the fiduciary or prohibited transaction rules of ERISA or the Code or any similar provisions of Similar Laws. The repurchase of any Subject Security from a Plan, Plan Asset Entity or Non-ERISA Arrangement pursuant to the Rescission Offer is in no respect a representation by UBS Group AG or any of its affiliates or representatives that the rescission meets all relevant legal requirements applicable to any such Plans, Plan Asset Entities or Non-ERISA Arrangements generally or any particular Plan, Plan Asset Entity or Non-ERISA Arrangement, or that the rescission is appropriate for such Plans, Plan Asset Entities or Non-ERISA Arrangements generally or any particular Plan, Plan Asset Entity or Non-ERISA Arrangement.

------

##### [**Table of Contents**](#toc)
**PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)** 

This prospectus may be used by UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer in connection with offers and sales of the Subject Securities in market-making transactions, including following the tender of Subject Securities pursuant to the Rescission Offer. Market-making transactions may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

**Conflicts of Interest** 

UBS Securities LLC and UBS Financial Services Inc. are indirect subsidiaries of UBS Group AG. Financial Industry Regulatory Authority ("FINRA") Rule 5121 imposes certain requirements when a member of FINRA, such as UBS Securities LLC and UBS Financial Services Inc., distributes an affiliated company's securities. If UBS Securities LLC, UBS Financial Services Inc. or any of our other U.S.-registered broker-dealer affiliates participate in the distribution of the outstanding Subject Securities, they will conduct the offers and sales of the outstanding Subject Securities in accordance with the applicable provisions of FINRA Rule 5121. In any offerings subject to FINRA Rule 5121, no underwriter will confirm initial sales to accounts over which it exercises discretionary authority without the prior written approval of the customer.

------

##### [**Table of Contents**](#toc)
**LEGAL MATTERS** 

Certain legal matters with respect to U.S. law relating to the Subject Securities will be passed upon for UBS Group AG by its U.S. counsel, Sullivan & Cromwell LLP, London, England. Certain legal matters with respect to Swiss law relating to the Subject Securities will be passed upon for UBS Group AG by its Swiss counsel, Homburger AG, Zurich, Switzerland.

------

##### [**Table of Contents**](#toc)
**EXPERTS** 

The consolidated financial statements of UBS Group AG appearing in its Annual Report on Form 20-F for the year ended December 31, 2024, and the effectiveness of UBS Group AG's internal control over financial reporting as of December 31, 2024, have been audited by Ernst & Young Ltd, independent registered public accounting firm, as set forth in their reports thereon and included therein and incorporated herein by reference. Such consolidated financial statements and UBS Group AG management's assessments of the effectiveness of internal control over financial reporting as of December 31, 2024 have been so incorporated in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

------

##### [**Table of Contents**](#toc)
**EXPENSES** 

The following table sets forth the main costs and expenses in connection with this offering, all of which are estimated.

---

| | |
|:---|:---|
|  Securities and Exchange Commission registration fee | $150510.0 |
|  Printing expenses | $49807.0 |
|  Legal fees and expenses | $465194.0 |
|  Accountants' fees and expenses | $59768.0 |
|  Miscellaneous | $6973.0 |
|  Total | $732251.0 |

---

------

##### [**Table of Contents**](#toc)
**APPENDIX A** 

**FORMER INVESTOR ACCEPTANCE FORM** 

**Note: This Former Investor Acceptance Form is to be completed only if you are an Eligible Former Investor and you wish to accept the Rescission Offer.** 

**Please confirm the following:** In regard to the Subject Securities in respect of which this Rescission Offer is hereby accepted:

• I am an Eligible Former Investor: **Yes No** 

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE FORMER INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS GROUP AG (THE "ISSUER"). ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER AND YOU MEET THE REQUIREMENTS TO BE AN ELIGIBLE FORMER INVESTOR, PLEASE COMPLETE ANDSIGN THIS FORM AND UPLOAD YOUR SUPPORTING EVIDENCE PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Accepting the Rescission Offer**: In order to accept the Rescission Offer, you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Former Investor Acceptance Form and the accompanying acceptance agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Former Investor Acceptance Form on the On-Line Portal; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Complete this Former Investor Acceptance Form, together with the supporting evidence required herein, so that
it is received by UBS on or before 5:00 p.m., Eastern Standard Time, on    , 2026. The Former Investor Acceptance Form must be completed and submitted on the Rescission Offer On-line Portal, which can be found at
https://deals.is.kroll.com/UBSgroupAG.

To access the Rescission Offer On-line Portal you will need to go to the Rescission Agent's website at https://deals.is.kroll.com/UBSgroupAG.The Rescission Offer On-line Portal will be operated by the Rescission Agent. By completing the registration process for the Rescission Offer On-line Portal, you are authorizing the Rescission Agent to communicate with you on behalf of UBS. If you have technical difficulties, you may contact the Rescission Agent at UBSRescission@is.kroll.com

This Former Investor Acceptance Form and the supporting evidence that you submit through the Rescission Offer On-line Portal must be legible. If you choose to accept the Rescission Offer, UBS recommends that you complete this Former Investor Acceptance Form and your supporting evidence sufficiently in advance of the Expiration Date to ensure its receipt by UBS by the deadline specified above. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
Supporting evidence must be uploaded into the Rescission Offer On-line Portal in PDF, Doc, Docx, JPEG, JPG or PNG file formats. You may upload up to one file per upload field with a maximum size of 100 MB per file. If you have multiple documents, you will need to upload into one upload field.You may also combine the documents into one before uploading. If you have technical difficulties submitting your Former Investor Acceptance Form or your supporting evidence, you may submit your claim through the Rescission Offer On-line Portal and email any necessary supporting material to UBSRescission@is.kroll.com within 48 hours of when your claim is submitted for processing but in no event later than the Expiration Date. When you email the supporting evidence for your claim, you must include the confirmation number you receive after submitting the Former Investor Acceptance Form through the Rescission Offer On-line Portal in the subject line of your email. If you do not submit your supporting evidence within 48 hours or do not include the confirmation number you receive after submitting the Former Investor Acceptance Form in the subject line of your email, your claim may be automatically rejected and you will be required to file a new claim if you wish to accept the Rescission Offer.

UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED FORMER INVESTOR ACCEPTANCE FORM AND APPROPRIATE SUPPORTING EVIDENCE ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR FORMER INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE FORMER INVESTOR TO ACCEPT THE RESCISSION OFFER.

You may be subject to information reporting requirements of the Internal Revenue Service (the "IRS") with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or this Former Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion. We reserve the right to, at any time, request any additional information or evidence that we may deem reasonably appropriate to demonstrate that you meet the eligibility requirements to be considered an Eligible Former Investor.

Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date, or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Former Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

If you are an Eligible Former Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms set forth in the Prospectus, we will cause payment of the Rescission Offer Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date.

------

##### [**Table of Contents**](#toc)
***Questions:*** If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**CLAIM DETAILS** 

*Please complete a separate version of this form for each Applicable Transaction pursuant to which you purchased Subject Securities and the Applicable Disposition pursuant to which you sold such Subject Securities for a loss, in each case, in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. If you sold in an Applicable Disposition part of a lot of Subject Securities that you purchased in an Applicable Transaction and still hold part of that lot and wish to accept the Rescission Offer with respect to the entire lot, please complete the Current Investor Acceptance Form with respect to the part of the lot that you still hold and this Former Investor Acceptance Form with respect to the part of the lot that you sold in an Applicable Disposition.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETED THROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Pursuant to the Prospectus, please note that you may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof.* 

*Further, please note that you must complete one version of this table online through the portal and complete one copy of your signed Former Investor Acceptance Form with respect to each Applicable Transaction pursuant to which you purchased Subject Securities and the Applicable Disposition pursuant to which you sold such Subject Securities for a loss, in each case, in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. Thus, if you bought 1,000 of Subject Security X on two different days, and sold all 2,000 at the same time in an Applicable Disposition, you must file two claims through the portal, one for each Applicable Transaction. If you purchased 2,000 of Subject Security X at the same time in a single Applicable Transaction, and sold 1,000 of Subject Security X for a loss on two different days in two separate Applicable Dispositions (or if you sold 1,000 of Subject Security X for a loss in an Applicable Disposition and subsequently 1,000 of Subject Security X matured at a loss), you must file two claims through the portal, one for each Applicable Disposition. For the avoidance of doubt, you must submit one form for each Applicable Transaction and Applicable Disposition. Multiple transactions should not be included in one Acceptance Form Submission.* 

PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL (1) EVIDENCE OF PURCHASE OF THE SUBJECT SECURITIES IN AN APPLICABLE TRANSACTION; (2) EVIDENCE OF THE SALE OR MATURITY OF SUCH SUBJECT SECURITIES AT A LOSS IN AN APPLICABLE DISPOSITION; AND (3) IF APPLICABLE, EVIDENCE OF YOUR AUTHORITY TO ACCEPT THIS RESCISSION OFFER ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (E.G., CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.).

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Claimant's Identifying Information<sup>(1)</sup>** | **Claimant's Identifying Information<sup>(1)</sup>** |
| Full Name\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Company (If Filing for an Entity) | *Please provide this information through the Rescission Offer On-line Portal* |
| Phone Number\*<sup>(2)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 1\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| City\* | *Please provide this information through the Rescission Offer On-line Portal* |
| State/Province/Region\* | *Please provide this information through the Rescission Offer On-line Portal* |
| ZIP/Postal Code\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Country\* | *Please provide this information through the Rescission Offer On-line Portal* |
| **Purchase in an Applicable Transaction Information** | **Purchase in an Applicable Transaction Information** |
| CUSIP\*<sup>(3)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Subject Securities\*<sup>(4)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Purchased \*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Trade Date\*<sup>(6)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Settlement Date\*<sup>(7)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Purchase Price\*<sup>(8)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| **Sale or Maturity in an Applicable Disposition Information** | **Sale or Maturity in an Applicable Disposition Information** |
| Date of Sale, Redemption or Maturity\*<sup>(11)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Sale, Redemption or Maturity Price\*<sup>(12)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Sold, Redeemed or<br>Matured\*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Loss on Sale or Maturity of the Subject Securities\*<sup>(13)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Total Interest, Coupon Payments, Principal, or other<br>Income Received\*<sup>(14)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)
**<u>Notes:</u>** 

\* Fields marked with \* are mandatory.

(1) If you are filing a claim on behalf of yourself, then please provide your details. If you are filing a claim on
behalf of a corporate entity, provide a business address and phone number. If you are filing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are filing.

(3) Provide the CUSIP of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "CUSIP No.; ISIN No." under "*The Rescission Offer—Terms of the Rescission Offer* — *Subject Securities*" in the Prospectus.

(4) Provide the name of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "*Title of Security*" under "*The Rescission Offer—Terms of the Rescission Offer—Subject Securities*" in the Prospectus.

(5) Include the quantity of purchased Subject Securities in respect of which the Rescission Offer is accepted. As
an example, an Eligible Former Investor accepting the Rescission Offer in respect of $10,000,000 in a series of Subject Securities with a minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof, would disclose a quantity
of 10,000.

(6) Provide the date you agreed to purchase the Subject Securities in respect of which the Rescission Offer is
accepted.

(7) Provide the date you received the Subject Securities in respect of which the Rescission Offer is accepted.

(8) Include the price in U.S. dollars at which you purchased the Subject Securities in an Applicable Transaction
for the acquisition of the quantity of Subject Securities described in the third line above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Former Investor accepting the Rescission Offer in respect of 100 Subject
Securities purchased at a price of $1,000 per Subject Security, would disclose a purchase price of $1,000. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(9) Include the reference number or other identification number, if any, assigned to the relevant Applicable
Transaction to help us identify the transaction in the evidence that you submit in support of your claim. If you do not have a Transaction Reference Number, please put "N/A" in this field.

(10) Provide the name of the party with whom you transacted with respect to your relevant purchase and, if
applicable, sale of Subject Securities in respect of which the Rescission Offer is accepted.

(11) Provide the date of maturity or the date of settlement of the Applicable Disposition of Subject Securities with
respect to which you are accepting the Rescission Offer and filing a claim.

(12) Include the price in U.S. dollars that you received for the sale or maturity of the quantity of Subject
Securities described in the line immediately above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Former Investor accepting the Rescission Offer in respect of 100 Subject Securities sold at a price of $900 per
Subject Security, would disclose a sale price of $900. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(13) Include the amount of loss you are claiming that you incurred as a result of the sale or maturity of the
Subject Securities in respect of which the Rescission Offer is accepted. For the avoidance of doubt, the loss should reflect only the sale or maturity of the Subject Security on this submission. Holders will need to submit one form for each
Applicable Transaction and Applicable Disposition.

(14) Include the total amount of any interest, coupon payments, principal or other income received by the Eligible
Former Investor on the Applicable Security.

------

##### [**Table of Contents**](#toc)
**RESCISSION OFFER ACCEPTANCE AGREEMENT** 

The undersigned acknowledges receipt of the Prospectus of UBS Group AG in respect of the Rescission Offer, pursuant to which UBS Group AG offers to rescind the previous purchase of the Subject Securities listed and described under "*The Rescission Offer—Terms of the Rescission Offer—Subject Securities*" in the Prospectus that were acquired by the undersigned in an Applicable Transaction and that matured or were sold by the undersigned in an Applicable Disposition.

**Effective as of the Expiration Date, the undersigned hereby accepts the Rescission Offer for the Subject Securities indicated in this Former Investor Acceptance Form upon the terms and subject to the conditions set forth in the Prospectus, and directs UBS to credit all proceeds to which it is entitled pursuant to the Rescission Offer to the undersigned's bank account, details of which have been provided by the undersigned to UBS.** 

**1. <u>Representations and Warranties, Acknowledgements and Agreements</u>:** By accepting the Rescission Offer, the undersigned hereby represents and warrants, acknowledges to, and agrees with, UBS that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the undersigned has received and reviewed the information contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the undersigned elects to accept the Rescission Offer with respect to the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal), and understands that he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. the undersigned meets the eligibility requirements to be considered an Eligible Former Investor, as set out under "The *Rescission Offer—Terms of the Rescission Offer*—*Eligibility Requirements*" in the Prospectus, including that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned purchased the Subject Securities in respect of which the Rescission Offer is accepted during
the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. the undersigned no longer held the Subject Securities in respect of which the Rescission Offer is accepted as
at the date of the Prospectus, and such Subject Securities matured at a loss or were sold at a loss (provided, in either case, that the undersigned continuously held such relevant Subject Security until the time of maturity or sale, as applicable);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. the undersigned was the beneficial owner or is the authorized representative of the former beneficial owner of those Subject Securities in respect of which the Rescission Offer is accepted when acquired during the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time, and has full power and authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. in evaluating the Rescission Offer and in making the decision whether to participate therein, the undersigned has made his, her or its own independent appraisal of the matters referred to in the Prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to the undersigned by UBS other than those contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. the undersigned is not a Sanctioned Person (as defined below) and none of its Subsidiaries (as defined below) is a Sanctioned Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. the undersigned will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other Person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as defined below), or (y) in any other manner; in each case that would result

------

##### [**Table of Contents**](#toc)
in a violation of Sanctions (as defined below) or constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. the undersigned acknowledges and agrees that any violation of items (1.f) or (1.g) above constitutes a material change in the commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned acknowledges and agrees that (i) any interest, coupon payments, principal or other income received on the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal) pursuant to their terms received by the undersigned prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to the Prospectus and (ii) the undersigned will repay to UBS Group AG any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. the undersigned understands that UBS and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made herein are at any time prior to the consummation of the Rescission Offer no longer accurate, the undersigned shall promptly notify UBS and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. any documentation provided to us evidencing the foregoing acknowledgements, representations and warranties is true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. the undersigned's participation in the Rescission Offer will not constitute or result in a violation of any provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. the undersigned will execute any further documents and give any further assurances that may be required in connection with any of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

The undersigned acknowledges and agrees that the Company and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and the Company and its affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

For purposes of this document, the term: (i) "**Person**" means any natural person, corporation, limited partnership, general partnership, limited liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign government or agency, instrumentality, or political subdivision, territory, or similar entity or organization; (ii) "**Sanctionable Activity**" means any condition or activity specifically identified under any Sanctions as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described by such condition; (iii) "**Sanctioned Territory**" means any country or territory with which dealings are broadly and comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria); (iv) "**Sanctioned Person**" means any Person with whom dealings are restricted or prohibited under any Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory, or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); (v) "**Sanctions**" means all national and supranational laws, regulations, decrees, orders, or other acts with force of law of the United States, Switzerland, the United Kingdom, or the European Union, or United Nations Security Council resolutions, concerning trade

------

##### [**Table of Contents**](#toc)
and economic sanctions including embargoes; the freezing or blocking of assets of targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any Laws threatening to impose such trade and economic sanctions on any person for engaging in proscribed or targeted behavior; and (vi) "**undersigned**" means you, if filing on behalf of yourself, or the Eligible Former Investor that is the claimant, if filing on behalf of another person or entity.

**2.**  **<u>Release of Liability</u>** . The undersigned, in consideration of the payment of the Rescission
Offer Proceeds under the Rescission Offer in respect of the loss incurred upon the disposition of the Subject Securities specified herein in an Applicable Disposition, and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, hereby, acting on his or her own behalf and, if it is not the beneficial owner of the Subject Securities specified in this Former Investor Acceptance Form, on behalf of such beneficial owner, irrevocably releases, discharges
and acquits forever UBS Group AG, each of its subsidiaries and other affiliates, and each of its past and present officers, directors, stockholders, employees, agents, attorneys, successors and assigns from any and all claims, demands, rights,
causes of action, liabilities and damages whatsoever, whether in law or equity, that the undersigned and the undersigned's successors and assigns ever had, or now has, based in any way upon, related in any way to, or arising in any way from,
out of or in connection with, the offer and sale of the Subject Securities during the Relevant Period by UBS Group AG or an affiliate of UBS Group AG or by CSG or an affiliate of CSG at such time, including but not limited to, any violation of
federal, state or territorial securities laws or regulations.

------

##### [**Table of Contents**](#toc)
**Bank Account Details to Receive Wire Transfer:** 

---

| | |
|:---|:---|
| **Domestic Wire Transfer** | **Domestic Wire Transfer** |
| Bank Account Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Account Number | *Please provide this information through the Rescission Offer On-line Portal* |
| ABA/Routing Number | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Address | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 3 | *Please provide this information through the Rescission Offer On-line Portal* |
| **International Wire Transfer** | **International Wire Transfer** |
| Intermediary Bank Name (Bank 1): | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank State: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank SWIFT code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank Name (End Bank): | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank SWIFT Code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| IBAN/Acct #: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2: | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| <br> Signature(s) of Eligible Former Investor(s) or Authorized Representatives | <br> Signature(s) of Eligible Former Investor(s) or Authorized Representatives |
| Dated<u> </u>, 2026 | Dated<u> </u>, 2026 |
| Name(s) of Eligible Former Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Former Investor): |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**<u>INSTRUCTIONS</u>**:

**1. *Evidence.***

To accept the Rescission Offer, an Eligible Former Investor must provide evidence to the following effects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. A signed acceptance agreement, a form of which is included in this Appendix A, by which the Eligible Former
Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements set forth in the Prospectus; <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. Satisfactory evidence that the Eligible Former Investor purchased the Subject Security in an Applicable
Transaction (i.e., the Subject Security is an Applicable Security) and that such Applicable Security subsequently was sold in a *bona fide* transaction or matured, in each case at a loss. For such purposes, the Issuer is prepared to accept the
following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG (for an Applicable Transaction during the Relevant Period on or after the Merger Date) or from CSG or an affiliate of CSG at such time (for an Applicable Transaction during the Relevant Period prior to the Merger Date),
(ii) purchase price information of such Applicable Security and (iii) the subsequent Applicable Disposition (and sale or maturity price information, as applicable) of such Applicable Security before the date of the Prospectus, and demonstrating
the continued holding of such Applicable Security until the time of the Applicable Disposition; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) With respect to an Applicable Transaction: receipt, transaction or trade confirmation statement reflecting
(i) for an Applicable Transaction during the Relevant Period on or after the Merger Date, UBS Group AG or an affiliate of UBS Group AG or (ii) for an Applicable Transaction during the Relevant Period prior to the Merger Date, CSG or an
affiliate of CSG at such time, as a principal seller of such Applicable Security in such Applicable Transaction; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) With respect to an Applicable Disposition: receipt, transaction or trade confirmation statement reflecting such
Applicable Security being sold or matured, including the date, price and other relevant details of the sale; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) With respect to the loss as a result of an Applicable Disposition: tax documents, such as IRS Form 1099 B,
evidencing the losses incurred on the Applicable Disposition of such Applicable Security prior to the date of the Prospectus.

**2. *Signatures***.

*Exact Signatures.* The signature(s) on this Former Investor Acceptance Form must correspond with the name(s) as indicated elsewhere in this Former Investor Acceptance Form.

*Joint Holders*. If any of the Subject Securities that are the subject of this Former Investor Acceptance Form are owned of record by two or more joint owners, all such owners must sign this Former Investor Acceptance Form.

*Signature of Fiduciaries*. If this Former Investor Acceptance Form is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and provide proper evidence satisfactory to UBS of such person's authority so to act.

------

##### [**Table of Contents**](#toc)
**3. *Backup Withholding and Information Reporting.***

The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service ("IRS"). To avoid the imposition of backup withholding, an Eligible Former Investor should complete the applicable IRS withholding form (W-9 or W-8) which can be obtained at the website of the Internal Revenue Service at www.irs.gov. Certain offerees (including, among others, corporations and certain foreign persons) are exempt from these backup withholding and information reporting requirements, but may be required to establish their entitlement to an exception. If UBS is not provided with the correct TIN or an adequate basis for exemption, an Eligible Former Investor may be subject to a backup withholding tax on the gross proceeds received in the Rescission Offer. If backup withholding results in an overpayment of taxes, a refund or credit may be obtained, provided that the required information is provided to the IRS.

------

##### [**Table of Contents**](#toc)
**APPENDIX B** 

**RESCISSION OFFER WITHDRAWAL FORM** 

**Note: This Rescission Offer Withdrawal Form is to be completed only if you have previously completed and returned a Former Investor Acceptance Form, but no longer wish to participate in the Rescission Offer. If you have previously completed and returned a Current Investor Acceptance Form and tendered the relevant Subject Securities, you should contact your bank or broker where your Subject Securities are held and have them submit a properly transmitted "Requested Message" through ATOP, which must be received by the Rescission Agent through ATOP.** YOU MUST INSTRUCT YOUR ACCOUNT REPRESENTATIVE AT THE BROKER OR BANK WHERE YOU HOLD YOUR SUBJECT SECURITIES IN TIME FOR YOUR TENDER OF SUBJECT SECURITIES TO BE WITHDRAWN ON OR BEFORE THE EXPIRATION DATE (AS DEFINED BELOW).

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS GROUP AG (THE "ISSUER"). ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER AND HAVE NOT COMPLETED AND RETURNED A RESCISSION OFFER ACCEPTANCE FORM, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER UNLESS YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER BY COMPLETING AND RETURNING A RESCISSION OFFER ACCEPTANCE FORM.

IF YOU HAVE PREVIOUSLY COMPLETED AND RETURNED A RESCISSION OFFER ACCEPTANCE FORM, BUT NO LONGER WISH TO ACCEPT THE RESCISSION OFFER, YOU MAY REVOKE YOUR ACCEPTANCE. IN ORDER TO REVOKE YOUR ACCEPTANCE, YOU MUST COMPLETE, SIGN AND RETURN THIS RESCISSION OFFER WITHDRAWAL FORM PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Revoking your previous acceptance of the Rescission Offer*:*** If you have previously completed and returned a Former Investor Acceptance Form but no longer wish to participate in the Rescission Offer, in order to revoke your acceptance you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Rescission Offer Withdrawal Form;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Rescission Offer Withdrawal Form, including the "Details of Claim Being
Withdrawn" below; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Return this Rescission Offer Withdrawal Form by completing it on the Rescission Offer On-line Portal which may be accessed at https://deals.is.kroll.com/UBSgroupAG, so that it is received by UBS on or before the Expiration Date.

This Rescission Offer Withdrawal Form must be legible. If you choose to revoke your previous acceptance of the Rescission Offer, UBS recommends that you complete this Rescission Offer Withdrawal Form sufficiently in

------

##### [**Table of Contents**](#toc)
advance of the Expiration Date to ensure its receipt by UBS by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED RESCISSION OFFER WITHDRAWAL FORM ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER PURSUANT TO YOUR ELECTION ON THE LAST EFFECTIVE FORMER INVESTOR ACCEPTANCE FORM YOU SUBMITTED. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election or tender of Subject Securities or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the withdrawal instructions or this Rescission Offer Withdrawal Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

***Questions***: If you have questions or require additional information about the Rescission Offer acceptance or withdrawal procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer Withdrawal Form will be available through the Rescission Offer On-line Portal.

**Effective as of the Expiration Date, the undersigned hereby revokes acceptance of the Rescission Offer for the following Subject Securities described under "Details of Claim Being Withdrawn" below. All of the instructions and covenants set forth in the Former Investor Acceptance Form that were previously completed by the undersigned are hereby revoked.** 

For purposes of this document, the term "undersigned" means you, if filing on behalf of yourself, or the Eligible Former Investor that was the claimant, if filing on behalf of another person or entity.

------

##### [**Table of Contents**](#toc)
**DETAILS OF CLAIM BEING WITHDRAWN** 

*Please complete a separate version of this form for each claim that you previously submitted and now wish to withdraw.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETED THROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Please note that, in order to withdraw your claim, you must provide, on the Rescission Offer On-line Portal (1) the Kroll Confirmation Number that you previously received when submitting your claim.* 

IF APPLICABLE, PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL EVIDENCE OF YOUR AUTHORITY TO SUBMIT THIS RESCISSION OFFER WITHDRAWAL FORM ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (e.g. CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.), IF SUCH EVIDENCE HAS NOT ALREADY BEEN SUBMITTED.

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;**Claimant's Identifying Information<sup>(1)</sup>** |
| &nbsp;&nbsp;&nbsp;Full Name\* |
| &nbsp;&nbsp;&nbsp;Company (If Filing for an Entity) |
| &nbsp;&nbsp;&nbsp;Phone Number\*<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;Address Line 1\* |
| &nbsp;&nbsp;&nbsp;Address Line 2 |
| &nbsp;&nbsp;&nbsp;City\* |
| &nbsp;&nbsp;&nbsp;State/Province/Region\* |
| &nbsp;&nbsp;&nbsp;ZIP/Postal Code\* |
| &nbsp;&nbsp;&nbsp;Country\* |
| &nbsp;&nbsp;&nbsp;Kroll Confirmation Number\*<sup>(3)</sup> |

---

**<u>Notes</u>:** 

\* Fields marked with \* are mandatory.

(1) If you are withdrawing a claim on behalf of yourself, then please provide your details below. If you are
withdrawing a claim on behalf of a corporate entity, provide a business address and phone number. If you are withdrawing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are withdrawing. This phone
number may be different than the phone number provided for receipt of text messages in connection with the account registration process.

(3) Provide the confirmation number provided to you by Kroll, upon submitting your Former Investor Acceptance Form,
corresponding to the rescission offer acceptance you are seeking to withdraw.

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| <br> Signature(s) of Eligible Former Investor(s) or Authorized Representatives | <br> Signature(s) of Eligible Former Investor(s) or Authorized Representatives |
| Dated<u> </u>, 2026 | Dated<u> </u>, 2026 |
| Name(s) of Eligible Former Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Former Investor): |  |
|  | <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**APPENDIX C** 

**CURRENT INVESTOR ACCEPTANCE FORM** 

**Note: This Current Investor Acceptance Form is to be completed only if you are an Eligible Current Investor and you wish to accept the Rescission Offer.** 

**Please confirm the following:** In regard to the Subject Securities in respect of which this Rescission Offer is hereby accepted:

• I am an Eligible Current Investor: **Yes No** 

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE CURRENT INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS GROUP AG (THE "ISSUER"). ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER AND YOU MEET THE REQUIREMENTS TO BE AN ELIGIBLE CURRENT INVESTOR, PLEASE COMPLETE AND SIGN THIS FORM AND UPLOAD YOUR SUPPORTING EVIDENCE PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Accepting the Rescission Offer**: In order to accept the Rescission Offer, you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Current Investor Acceptance Form and the accompanying acceptance agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Current Investor Acceptance Form on the On-Line Portal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Complete this Current Investor Acceptance Form, together with the supporting evidence required herein, so that
it is received by UBS on or before 5:00 p.m., Eastern Standard Time, on      , 2026. The Current Investor Acceptance Form must be completed and submitted on the Rescission Offer On-line Portal, which can be found at https://deals.is.kroll.com/UBSgroupAG.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Instruct your broker or bank through which your relevant Applicable Securities are held in time for such
Applicable Securities to be tendered to us through ATOP on or before the Expiration Date.

To access the Rescission Offer On-line Portal, you will need to go to the Rescission Agent's website at https://deals.is.kroll.com/UBSgroupAG. The Rescission Offer On-line Portal will be operated by the Rescission Agent. By completing the registration process for the Rescission Offer On-line Portal, you are authorizing the Rescission Agent to communicate with you on behalf of UBS. If you have technical difficulties, you may contact the Rescission Agent at UBSRescission@is.kroll.com.

This Current Investor Acceptance Form and the supporting evidence that you submit through the Rescission Offer On-line Portal must be legible. If you choose to accept the Rescission Offer, UBS recommends that you complete this Current Investor Acceptance Form and your supporting evidence sufficiently in advance of the

------

##### [**Table of Contents**](#toc)
Expiration Date to ensure its receipt by UBS by the deadline specified above. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

Supporting evidence must be uploaded into the Rescission Offer On-line Portal in PDF, Doc, Docx, JPEG, JPG or PNG file formats. You may upload up one file per upload field with a maximum size of 100 MB per file. If you have multiple documents, you will need to upload into one upload field. You may also combine the documents into one before uploading. If you have technical difficulties submitting your Current Investor Acceptance Form or your supporting evidence, you may submit your claim through the Rescission Offer On-line Portal and email any necessary supporting material to UBSRescission@is.kroll.com within 48 hours of when your claim is submitted for processing but in no event later than the Expiration Date. When you email the supporting evidence for your claim, you must include the confirmation number you receive after submitting the Current Investor Acceptance Form through the Rescission Offer On-line Portal in the subject line of your email. If you do not submit your supporting evidence within 48 hours or do not include the confirmation number you receive after submitting the Current Investor Acceptance subject line of your email, your claim may be automatically rejected and you will be required to file a new claim if you wish to accept the Rescission Offer.

UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED CURRENT INVESTOR ACCEPTANCE FORM AND APPROPRIATE SUPPORTING EVIDENCE ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR CURRENT INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE CURRENT INVESTOR TO ACCEPT THE RESCISSION OFFER.

**Your valid acceptance of the Rescission Offer will be conditioned upon the tender of your Subject Security to us. If you are an Eligible Current Investor, in order to accept the Rescission Offer on your behalf, your broker or bank must submit, or cause The Depository Trust Company ("DTC") participant who holds your Subject Security on your behalf to submit, an Agent's Message in accordance with the procedures described in the Prospectus under "The Recission Offer—Acceptance or Rejection of the Rescission Offer—*Eligible Current Investors: Procedures for Brokers and Banks; DTC ATOP Account*". Please note, all positions will be blocked from trading once tendered in accordance with the procedures described in the Prospectus.** 

You may be subject to information reporting requirements of the Internal Revenue Service (the "IRS") with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or this Current Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion. We reserve the right to, at any time, request any additional information or evidence that we may deem reasonably appropriate to demonstrate that you meet the eligibility requirements to be considered an Eligible Current Investor.

Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency

------

##### [**Table of Contents**](#toc)
identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date, or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Current Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

If you are an Eligible Current Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms set forth in the Prospectus, we will cause payment of the Rescission Offer Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date.

***Questions:*** If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**CLAIM DETAILS** 

*Please complete a separate version of this form for each Applicable Transaction pursuant to which you purchased Subject Securities in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. If you sold in an Applicable Disposition part of a lot of Subject Securities that you purchased in an Applicable Transaction and still hold part of that lot and wish to accept the Rescission Offer with respect to the entire lot, please complete this Current Investor Acceptance Form with respect to the part of the lot that you still hold and the Former Investor Acceptance Form with respect to the part of the lot that you sold in an Applicable Disposition.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETEDTHROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Pursuant to the Prospectus, please note that you may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof.* 

*Further, please note that you must complete one version of this table online through the portal and complete one copy of your signed Current Investor Acceptance Form with respect to each Applicable Transaction pursuant to which you purchased Subject Securities in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. Thus, if you bought 1,000 of Subject Security X on two different days, you must file two claims through the portal, one for each Applicable Transaction. For the avoidance of doubt, you must submit one form for each Applicable Transaction. Multiple transactions should not be included in one Acceptance Form Submission.* 

PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL (1) EVIDENCE OF PURCHASE OF THE SUBJECT SECURITIES IN AN APPLICABLE TRANSACTION AND (2) IF APPLICABLE, EVIDENCE OF YOUR AUTHORITY TO ACCEPT THIS RESCISSION OFFER ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (E.G., CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.).

---

| | |
|:---|:---|
| **Claimant's Identifying Information<sup>(1)</sup>** | **Claimant's Identifying Information<sup>(1)</sup>** |
| Full Name\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Company (If Filing for an Entity) | *Please provide this information through the Rescission Offer On-line Portal* |
| Phone Number\*<sup>(2)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 1\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| City\* | *Please provide this information through the Rescission Offer On-line Portal* |
| State/Province/Region\* | *Please provide this information through the Rescission Offer On-line Portal* |
| ZIP/Postal Code\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Country\* | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Purchase in an Applicable Transaction Information** | **Purchase in an Applicable Transaction Information** |
| CUSIP\*<sup>(3)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Subject Securities\*<sup>(4)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Purchased\*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Trade Date\*<sup>(6)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Settlement Date\*<sup>(7)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Purchase Price\*<sup>(8)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Total Interest, Coupon Payments, Principal, or other Income Received\*<sup>(11)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| **Tender of Securities<sup>(12)</sup>** | **Tender of Securities<sup>(12)</sup>** |
| Quantity Tendered\*<sup>(13)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| VOI (ATOP Confirmation Number) or Euroclear/Clearstream Reference Number\*<sup>(14)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| DTC Participant Number\*<sup>(15)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| DTC Participant Name\*<sup>(16)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |

---

**<u>Notes:</u>** 

\* Fields marked with \* are mandatory.

(1) If you are filing a claim on behalf of yourself, then please provide your details. If you are filing a claim on
behalf of a corporate entity, provide a business address and phone number. If you are filing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are filing.

(3) Provide the CUSIP of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "CUSIP No.; ISIN No." under "The Rescission Offer—Terms of the Rescission Offer— *Subject Securities*" in the Prospectus.

(4) Provide the name of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "Title of Security" under "The Rescission Offer—Terms of the Rescission Offer— *Subject Securities*" in the Prospectus.

(5) Include the quantity of purchased Subject Securities in respect of which the Rescission Offer is accepted. As
an example, an Eligible Current Investor accepting the Rescission Offer in respect of $10,000,000 in a series of Subject Securities with a minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof, would disclose a
quantity of 10,000.

(6) Provide the date you agreed to purchase the Subject Securities in respect of which the Rescission Offer is
accepted.

------

##### [**Table of Contents**](#toc)
(7) Provide the date you received the Subject Securities in respect of which the Rescission Offer is accepted.

(8) Include the price in U.S. dollars at which you purchased the Subject Securities in an Applicable Transaction
for the acquisition of the quantity of Subject Securities described in the third line above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Current Investor accepting the Rescission Offer in respect of 100
Subject Securities purchased at a price of $1,000 per Subject Security, would disclose a purchase price of $1,000. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(9) Include the reference number or other identification number, if any, assigned to the relevant Applicable
Transaction to help us identify the transaction in the evidence that you submit in support of your claim. If you do not have a Transaction Reference Number, please put "N/A" in this field.

(10) Provide the name of the party with whom you transacted with respect to your relevant purchase of Subject
Securities in respect of which the Rescission Offer is accepted.

(11) Include the total amount of any interest, coupon payments, principal or other income received by the Eligible
Current Investor on the Applicable Security.

(12) You may accept the Rescission Offer for any number of Subject Securities, as long as such acceptance is for
Subject Securities in the minimum denomination of $250,000, and integral multiples of $1,000 in excess thereof. THIS FIELD SHOULD ONLY BE USED TO ACCEPT THE RESCISSION OFFER IN RESPECT OF SUBJECT SECURITIES HELD BY YOU AS AN ELIGIBLE CURRENT
INVESTOR.

(13) Provide the quantity of Subject Securities for which you are accepting the Rescission Offer and filing a claim
and have coordinated to have your bank or broker tender into DTC's ATOP platform.

(14) Provide the VOI or ATOP Confirmation Number provided to your bank or broker after they tendered your securities
though DTC's ATOP platform. This is a 14 unique character ID that is generated by DTC once your broker or bank tenders your position. If you hold through Euroclear or Clearstream you will need to provide the unique reference number provided to
them once they tender your position. Please work with your bank or broker to obtain this information.

(15) Provide the DTC participant number associated with your bank or broker. Please work with your bank or broker to
obtain this information.

(16) Provide the DTC participant name associated with your bank or broker. Please work with your bank or broker to
obtain this information.

------

##### [**Table of Contents**](#toc)
**RESCISSION OFFER ACCEPTANCE AGREEMENT** 

The undersigned acknowledges receipt of the Prospectus of UBS Group AG in respect of the Rescission Offer, pursuant to which UBS Group AG offers to rescind the previous purchase of the Subject Securities listed and described under "The Rescission Offer—Terms of the Rescission Offer—*Subject Securities*" in the Prospectus that were acquired by the undersigned in an Applicable Transaction.

**Effective as of the Expiration Date, the undersigned hereby accepts the Rescission Offer for the Subject Securities indicated in this Current Investor Acceptance Form upon the terms and subject to the conditions set forth in the Prospectus, and directs UBS to credit all proceeds to which it is entitled pursuant to the Rescission Offer to the undersigned's bank or broker through DTC or the undersigned's bank account, details of which have been provided by the undersigned to UBS. If the proceeds are delivered through DTC, they will be sent to the undersigned's bank or broker, and it will be up to the applicable bank or broker to distribute the proceeds to their applicable clients.** 

**1. <u>Representations and Warranties, Acknowledgements and Agreements</u>:** By accepting the Rescission Offer, the undersigned hereby represents and warrants, acknowledges to, and agrees with, UBS that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the undersigned has received and reviewed the information contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the undersigned elects to accept the Rescission Offer with respect to the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal), and understands that he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. the undersigned meets the eligibility requirements to be considered an Eligible Current Investor, as set out under "The Rescission Offer—Terms of the Rescission Offer—*Eligibility Requirements*" in the Prospectus, including that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned purchased the Subject Securities in respect of which the Rescission Offer is accepted during
the Relevant Period (i) on or after the Merger Date, from UBS Group AG or an affiliate of UBS Group AG or (ii) before the Merger Date, from CSG or an affiliate of CSG at such time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. the undersigned has continued to hold the Subject Securities in respect of which the Rescission Offer is
accepted until the date of the Prospectus, and will continue to hold such Subject Securities (unless and until tendered through ATOP pursuant to the Rescission Offer) until the Expiration Date, free and clear of any liens, charges, claims,
encumbrances, interests and restrictions of any kind, and UBS Group AG will acquire good, indefeasible and unencumbered title to such Subject Securities, free and clear of all liens, charges, claims, encumbrances, interests and restrictions of any
kind, when the tender of the same is accepted by UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. the undersigned is the beneficial owner or is the authorized representative of the beneficial owner of those Subject Securities in respect of which the Rescission Offer is accepted, and has full power and authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. the undersigned will not sell, pledge, hypothecate or otherwise encumber or transfer any Subject Securities in respect of which he, she or it is accepting the Rescission Offer, from the date of acceptance of the Rescission Offer, and agrees that any purported sale, pledge, hypothecation or other encumbrance or transfer will be void and of no effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. in evaluating the Rescission Offer and in making the decision whether to participate therein, the undersigned has made his, her or its own independent appraisal of the matters referred to in the Prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to the undersigned by UBS other than those contained in the Prospectus;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. the undersigned is not a Sanctioned Person (as defined below) and none of its Subsidiaries (as defined below) is a Sanctioned Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. the undersigned will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other Person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as defined below), or (y) in any other manner; in each case that would result in a violation of Sanctions (as defined below) or constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned acknowledges and agrees that any violation of items (1.g) or (1.h) above constitutes a material change in the commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. the undersigned acknowledges and agrees that (i) any interest, coupon payments, principal or other income due on the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal) pursuant to their terms received by the undersigned prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to the Prospectus and (ii) the undersigned will repay to UBS Group AG any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. the undersigned understands that UBS and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made herein are at any time prior to the consummation of the Rescission Offer no longer accurate, the undersigned shall promptly notify UBS and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. if delivering the Subject Securities as a fiduciary or agent for one or more investor accounts, the undersigned has sole investment discretion with respect to each such account and full power to make the foregoing acknowledgements, representations and warranties on behalf of such account;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. any documentation provided to us evidencing the foregoing acknowledgements, representations and warranties is true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n. the undersigned's participation in the Rescission Offer will not constitute or result in a violation of any provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o. the undersigned will execute any further documents and give any further assurances that may be required in connection with any of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

The undersigned acknowledges and agrees that the Company and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and the Company and its affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

For purposes of this document, the term: (i) "**Person**" means any natural person, corporation, limited partnership, general partnership, limited liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign government or agency, instrumentality, or political subdivision, territory, or similar entity or organization; (ii) "**Sanctionable Activity**" means any condition or activity specifically identified under any Sanctions as constituting a basis for the imposition of Sanctions against a person engaged in such

------

##### [**Table of Contents**](#toc)
activity or described by such condition; (iii) "**Sanctioned Territory**" means any country or territory with which dealings are broadly and comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria); (iv) "**Sanctioned Person**" means any Person with whom dealings are restricted or prohibited under any Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory, or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); (v) "**Sanctions**" means all national and supranational laws, regulations, decrees, orders, or other acts with force of law of the United States, Switzerland, the United Kingdom, or the European Union, or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking of assets of targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any Laws threatening to impose such trade and economic sanctions on any person for engaging in proscribed or targeted behavior; and (vi) "**undersigned**" means you, if filing on behalf of yourself, or the Eligible Current Investor that is the claimant, if filing on behalf of another person or entity.

**2. <u>Release of Liability</u>**. The undersigned, in consideration of the payment of the Rescission Offer Proceeds under the Rescission Offer in respect of the tendered Subject Securities specified herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, hereby, acting on his or her own behalf and, if it is not the beneficial owner of the Subject Securities specified in this Current Investor Acceptance Form, on behalf of such beneficial owner, irrevocably releases, discharges and acquits forever UBS Group AG, each of its subsidiaries and other affiliates, and each of its past and present officers, directors, stockholders, employees, agents, attorneys, successors and assigns from any and all claims, demands, rights, causes of action, liabilities and damages whatsoever, whether in law or equity, that the undersigned and the undersigned's successors and assigns ever had, or now has, based in any way upon, related in any way to, or arising in any way from, out of or in connection with, the offer and sale of the Subject Securities during the Relevant Period by UBS Group AG or an affiliate of UBS Group AG or by CSG or an affiliate of CSG at such time, including but not limited to, any violation of federal, state or territorial securities laws or regulations.

------

##### [**Table of Contents**](#toc)
**Bank Account Details to Receive Wire Transfer:** 

---

| | |
|:---|:---|
| **Domestic Wire Transfer** | **Domestic Wire Transfer** |
| Bank Account Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Account Number | *Please provide this information through the Rescission Offer On-line Portal* |
| ABA/Routing Number | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Address | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 3 | *Please provide this information through the Rescission Offer On-line Portal* |
| **International Wire Transfer** | **International Wire Transfer** |
| Intermediary Bank Name (Bank 1): | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank State: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank SWIFT code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank Name (End Bank): | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank SWIFT Code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| IBAN/Acct #: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2: | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| <br> Signature(s) of Eligible Current Investor(s) or Authorized Representatives | <br> Signature(s) of Eligible Current Investor(s) or Authorized Representatives |
| Dated , 2026 | Dated , 2026 |
| Name(s) of Eligible Current Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Current Investor): |  |
|  | <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Current Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Current Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**<u>INSTRUCTIONS</u>**:

**1. *Evidence.***

To accept the Rescission Offer, an Eligible Current Investor must provide evidence to the following effects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. A signed acceptance agreement, a form of which is included in this Appendix C, by which the Eligible Current
Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements set forth in the Prospectus; <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. Satisfactory evidence that the Eligible Current Investor purchased the Subject Security in an Applicable
Transaction (i.e., the Subject Security is an Applicable Security) and that such Eligible Current Investor continues to hold such Applicable Security as of the date of the Prospectus, and will continue to hold it (unless and until tendered through
ATOP pursuant to the Rescission Offer) until the Expiration Date. For such purposes, the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG (for an Applicable Transaction during the Relevant Period on or after the Merger Date) or from CSG or an affiliate of CSG at such time (for an Applicable Transaction during the Relevant Period prior to the Merger Date) and
(ii) purchase price information of such Applicable Security, and demonstrating the continued holding of such Applicable Security until at least the date of the Prospectus; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Receipt, transaction or trade confirmation statement reflecting (i) for an Applicable Transaction during
the Relevant Period on or after the Merger Date, UBS Group AG or an affiliate of UBS Group AG or (ii) for an Applicable Transaction during the Relevant Period prior to the Merger Date, CSG or an affiliate of CSG at such time, as a principal
seller of such Applicable Security in such Applicable Transaction.

**2. *Signatures***.

*Exact Signatures.* The signature(s) on this Current Investor Acceptance Form must correspond with the name(s) as indicated elsewhere in this Current Investor Acceptance Form.

*Joint Holders*. If any of the Subject Securities that are the subject of this Current Investor Acceptance Form are owned of record by two or more joint owners, all such owners must sign this Current Investor Acceptance Form.

*Signature of Fiduciaries*. If this Current Investor Acceptance Form is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and provide proper evidence satisfactory to UBS of such person's authority so to act.

**3. *Backup Withholding and Information Reporting.***

The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service ("IRS"). To avoid the imposition of backup withholding, an Eligible Current Investor should complete the applicable IRS withholding form (W-9 or W-8) which can be obtained at the website of the Internal Revenue Service at www.irs.gov. Certain offerees (including, among others, corporations and certain foreign persons) are exempt from these backup withholding and information reporting requirements, but may be required to establish their entitlement to an exception. If UBS is not provided with the correct TIN or an adequate basis for exemption, an Eligible Current Investor may be subject to a backup withholding tax on the gross proceeds received in the Rescission Offer. If backup withholding results in an overpayment of taxes, a refund or credit may be obtained, provided that the required information is provided to the IRS.

------

##### [**Table of Contents**](#toc)
**The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission, in which this prospectus is included, is declared effective. This prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.** 

**SUBJECT TO COMPLETION, DATED FEBRUARY 12, 2026** 

**UBS Americas Inc.** 

**7<sup>1</sup>∕<sub>8</sub>% Notes due July 15, 2032** 

**fully and unconditionally guaranteed by** 

**UBS Group AG** 

**and** 

**UBS AG** 

UBS Americas Inc. (the "Issuer" or "UBS Americas"), is offering, under the terms and conditions described in this prospectus, to rescind (the "Rescission Offer") the previous purchase of the 7<sup>1</sup>∕<sub>8</sub>% Notes due July 15, 2032 (CUSIP 22541LAE3; ISIN US22541LAE39) (the "Subject Securities") by certain purchasers who acquired Subject Securities during the period from October 1, 2023 to the date of this prospectus (the "Relevant Period") from UBS Group AG or an affiliate of UBS Group AG (an "Applicable Transaction").

The Subject Securities were issued pursuant to a senior indenture dated as of June 1, 2001 (the "Base Indenture"), between Credit Suisse (USA) LLC (formerly known as Credit Suisse (USA), Inc. and Credit Suisse First Boston (USA), Inc.) ("CS USA") and The Bank of New York Mellon (formerly known as The Bank of New York, as successor to The Chase Manhattan Bank), as trustee (the "Trustee"), as supplemented by (i) the first supplemental indenture dated as of March 26, 2007 (the "First Supplemental Indenture"), among Credit Suisse Group AG ("CSG"), CS USA, Credit Suisse AG ("CS AG") and the Trustee, (ii) the second supplemental indenture, dated as of June 9, 2023 (the "Second Supplemental Indenture"), among UBS Group AG, CSG, CS AG, CS USA and the Trustee, (iii) the third supplemental indenture dated as of May 30, 2024 (the "Third Supplemental Indenture"), among UBS Group AG, CS AG, CS USA, UBS AG and the Trustee and (iv) the fourth supplemental indenture dated as of February 2, 2026 (the "Fourth Supplemental Indenture"), among CS USA, UBS Americas, UBS Group AG, UBS AG and the Trustee. The Base Indenture as supplemented is referred to as the "Indenture." Pursuant to the Second Supplemental Indenture, effective upon completion of the merger of CSG with UBS Group AG on June 12, 2023 (the "Group Merger" and such date, the "Group Merger Date"), UBS Group AG expressly assumed all of CSG's obligations as guarantor under the Indenture. Pursuant to the Third Supplemental Indenture, effective upon completion of the merger of CS AG with UBS AG on May 31, 2024 (the "Parent Bank Merger" and such date, the "Parent Bank Merger Date"), UBS AG expressly assumed all of CS AG's obligations as guarantor under the Indenture. Pursuant to the Fourth Supplemental Indenture, effective upon completion of the merger of CS USA with UBS Americas on February 2, 2026 (the "UBS Americas Merger" and such date, the "UBS Americas Merger Date"), UBS Americas expressly assumed all of CS USA's obligations as issuer under the Indenture and the Subject Securities. For further information on the Subject Securities, see "*Description of the Subject Securities*."

The Subject Securities were issued pursuant to a registration statement under Section 5 of the Securities Act of 1933, as amended (the "Securities Act"). Following the Group Merger, affiliates of UBS Group AG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (the "Market-Making Transactions"). The Market-Making Transactions were made pursuant to an effective registration statement under Section 5 of the Securities Act until October 2023, when UBS Group AG determined to cease using such registration statement. Certain affiliates of UBS Group AG continued to conduct Market-Making Transactions, without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction (the "Applicable Securities"). As a result, the Issuer has elected to make the Rescission Offer to those purchasers (each such purchaser, an "Eligible Investor"). The eligibility requirements for purchasers to take part in the Rescission Offer are described in this prospectus in the section entitled "*The Rescission Offer*" beginning on page 17.

If you are an Eligible Investor and accept the Rescission Offer, you will receive, upon satisfaction of the of the conditions set forth in this prospectus, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the case of an Eligible Current Investor, an amount equal to the purchase price paid for the Applicable
Security in the Applicable Transaction, *plus* interest on such purchase price from the Settlement date of

------

##### [**Table of Contents**](#toc)
such Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date (as defined below) and (y) the Settlement Date (as defined below) (the "Eligible Current Investor Applicable Period"), *less* the amount of any interest, coupon payments, principal or other income received on such Applicable Security. For the definition of Eligible Current Investors, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*." <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the case of an Eligible Former Investor, an amount equal to the excess, if any, of the purchase price paid for
the Applicable Security over the proceeds from the Applicable Disposition (as defined below), *plus* interest (i) on the purchase price paid for such Applicable Security from the settlement date of the Applicable Transaction to, and
including, the settlement date of the transaction in which such Applicable Security was sold at a loss (such transaction, the "Applicable Disposition" and such period, the "Eligible Former Investor Holding Applicable Period")
and (ii) on the loss realized from such Applicable Disposition from the date of such Applicable Disposition to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the
Settlement Date (the "Eligible Form Investor Applicable Period"), *less* the amount of any interest, coupon payments, principal or other income received on such Applicable Security. For the definition of Eligible Former Investors,
see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*."

We refer to each of the Eligible Current Investor Applicable Period, Eligible Former Investor Holding Applicable Period and Eligible Former Investor Applicable Period as an "Applicable Period."

IF YOU ACCEPT THE RESCISSION OFFER, YOU WILL NOT BE PAID ANY OTHER AMOUNTS ON YOUR APPLICABLE SECURITIES OTHER THAN AS SET OUT ABOVE.

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

The Rescission Offer will expire at 5:00 p.m., Eastern Standard Time, on , 2026 (the "Expiration Date"), which is 30 days from the date of this prospectus (including the date of this prospectus and the Expiration Date).

If you are an Eligible Current Investor, you may elect to accept the Rescission Offer by instructing your broker or bank through which your Applicable Securities are held to tender them for you as set forth in this prospectus. If you are an Eligible Former Investor, you may elect to accept the Rescission Offer by submitting an acceptance form to the Issuer on or before the Expiration Date as set forth in this prospectus. See "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer*." You do not need to take any action to reject the Rescission Offer. If you fail to validly accept the Rescission Offer by the Expiration Date, you will be deemed by us to have rejected the Rescission Offer. Acceptance or rejection of the Rescission Offer may prevent you from maintaining any action against us based on a claim that we failed to register the Market-Making Transactions. In any event, any such action may be barred by applicable statutes of limitations or repose*.* See "*Risk Factors—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer*."

If you have questions or require additional information about the Rescission Offer, you may contact the broker, bank or other institution where you purchased your Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer on-line portal, which can be accessed at https://deals.is.kroll.com/UBSgroupAG (the "Rescission Offer On-line Portal").

**Investing in the Subject Securities involves risks. See the [risk factors](#toca17238_6) beginning on page 14 of this prospectus and the other information incorporated by reference in this prospectus, for a discussion of the factors you should carefully consider before deciding whether to accept or reject the Rescission Offer or invest in Subject Securities.** 

------

##### [**Table of Contents**](#toc)
Neither the U.S. Securities and Exchange Commission (the "SEC") nor any U.S. state securities commission has approved or disapproved of the Subject Securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The Subject Securities are not deposit liabilities and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. The Subject Securities do not have the benefit of any agency or governmental guarantee.

We have not retained an underwriter in connection with the Rescission Offer.

In addition to the Rescission Offer, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may use this prospectus in market-making transactions involving Subject Securities. In a market-making transaction, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of the Issuer may resell a Subject Security it acquires from other holders, including in the Rescission Offer. Resales of this kind may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. The Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

**The date of this prospectus is , 2026** 

------

##### [**Table of Contents**](#toc)
**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
|  | **Page<br>Number** |
|  [About This Prospectus](#toca17238_1) | 1 |
|  [Limitations on Enforcement of U.S. Laws](#toca17238_2) | 2 |
|  [Cautionary Statement Regarding Forward-Looking Statements](#toca17238_3) | 3 |
|  [Where You Can Find More Information](#toca17238_4) | 6 |
|  [Questions and Answers About the Rescission Offer](#toca17238_5) | 8 |
|  [Risk Factors](#toca17238_6) | 14 |
|  [Use of Proceeds](#toca17238_7) | 16 |
|  [The Rescission Offer](#toca17238_8) | 17 |
|  [Description of the Subject Securities](#toca17238_9) | 33 |
|  [United States Tax Considerations](#toca17238_10) | 36 |
|  [Swiss Tax Considerations](#toca17238_11) | 41 |
|  [Benefit Plan Investor Considerations](#toca17238_12) | 44 |
|  [Plan of Distribution (Conflicts of Interest)](#toca17238_13) | 46 |
|  [Legal Matters](#toca17238_14) | 47 |
|  [Experts](#toca17238_15) | 48 |
|  [Expenses](#toca17238_15a) | 49 |
|  [Appendix A—Former Investor Acceptance Form](#toca17238_16) | A-1 |
|  [Appendix B—Rescission Offer Withdrawal Form](#toca17238_17) | B-1 |
|  [Appendix C—Current Investor Acceptance Form](#toca17238_18) | C-1 |

---

WE ARE RESPONSIBLE FOR THE INFORMATION CONTAINED AND INCORPORATED BY REFERENCE IN THIS PROSPECTUS. AT THE DATE OF THIS PROSPECTUS, WE HAVE NOT AUTHORIZED ANYONE ELSE TO PROVIDE YOU WITH DIFFERENT INFORMATION, AND WE TAKE NO RESPONSIBILITY FOR ANY OTHER INFORMATION OTHERS MAY GIVE YOU. WE ARE NOT MAKING AN OFFER OF THE SUBJECT SECURITIES OR CONDUCTING MARKET-MAKING ACTIVITIES IN ANY JURISDICTION WHERE SUCH OFFER OR MARKET-MAKING ACTIVITIES ARE NOT PERMITTED. YOU SHOULD NOT ASSUME THAT THE INFORMATION IN THIS PROSPECTUS OR ANY PROSPECTUS SUPPLEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THE DATE ON THE FRONT OF THIS DOCUMENT.

------

##### [**Table of Contents**](#toc)
**ABOUT THIS PROSPECTUS** 

This prospectus is part of a registration statement on Form F-3 that the Issuer, UBS Group AG and UBS AG filed with the SEC using a "shelf" registration process. This prospectus describes the Subject Securities and the Rescission Offer. You should read both this prospectus and any prospectus supplement together with the additional information described under the headings "*Incorporation by Reference*" and "*Where You Can Find More Information*."

This prospectus may be used by the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG in connection with offers and sales of the Subject Securities in market-making transactions. A market-making transaction may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, the Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. The Issuer, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

Unless otherwise indicated or unless the context requires otherwise:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "UBS," the "Group," "we" or "us" we mean UBS
Group AG and its consolidated subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "CSG" we mean Credit Suisse Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "Credit Suisse" we mean CSG and its consolidated subsidiaries, before the
acquisition of CSG by UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "CS AG" we mean Credit Suisse AG before its merger with UBS AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "CS USA" we mean Credit Suisse (USA) LLC before its merger with UBS Americas;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to "UBS Americas" or the "Issuer" we mean UBS Americas Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to the "Group Merger" we mean the merger of CSG with UBS Group AG on June 12,
2023;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to the "Parent Bank Merger" we mean the merger of CS AG with UBS AG on May 31,
2024; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when we refer to the "UBS Americas Merger" we mean the merger of CS USA with UBS Americas on February
2, 2026.

In this prospectus:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the term "affiliate" shall have the meaning given to such term in Rule 405 under the Securities Act;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• all references to prices at which the Subject Securities were acquired or sold exclude any accrued interest,
fees, selling concessions or other additional amounts.

------

##### [**Table of Contents**](#toc)
**LIMITATIONS ON ENFORCEMENT OF U.S. LAWS** 

UBS Group AG is a holding company for financial services companies that is domiciled in Switzerland and UBS AG is a bank domiciled in Switzerland. Many of their respective directors and executive officers, and certain experts named in this prospectus, are resident outside the United States, and all or a substantial portion of their respective assets and the assets of such persons are located outside the United States. As a result, it may be difficult for you to serve legal process on UBS Group AG, UBS AG or their respective directors and executive officers resident outside of the United States or have any of them appear in a U.S. court. The registrants have been advised by Homburger AG, Swiss counsel to UBS Group AG and UBS AG that, due to the lack of reciprocal legislation between Switzerland and the United States, it may be difficult for you to enforce in Switzerland judgments obtained in U.S. courts against UBS Group AG or UBS AG (or any of their respective directors or executive officers resident in Switzerland). In addition, there is doubt as to the enforceability in Switzerland, in original actions or in actions for enforcement of judgments of U.S. courts, of liabilities predicated solely upon the federal or state securities laws of the United States.

------

##### [**Table of Contents**](#toc)
**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS** 

This prospectus and certain documents incorporated by reference herein contain statements that constitute "forward-looking statements," as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as amended by the Private Securities Litigation Reform Act of 1995, including but not limited to management's outlook for our financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on our business and future development and goals. Forward-looking statements can sometimes be identified by the use of forward-looking terms such as "believes," "expects," "may," "will," "shall," "should," "would," "could," "potential," "seeks," "aims," "projects," "predicts," "is optimistic," "intends," "plans," "estimates," "targets," "anticipates," "continues" or other comparable terms or negatives of these terms, but not all forward-looking statements include such identifying words.

While these forward-looking statements represent our judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. In particular, the global economy may suffer significant adverse effects from increasing political tensions between world powers, changes to international trade policies, including those related to tariffs and trade barriers, and evolving armed conflicts.

Our acquisition of Credit Suisse materially changed our outlook and strategic direction and introduced new operational challenges. The integration of the Credit Suisse entities into our structure is expected to continue through 2026 and presents significant operational and execution risk, including the risks that we may be unable to achieve the cost reductions and business benefits contemplated by the transaction, that it may incur higher costs to execute the integration of Credit Suisse and that the acquired business may have greater risks or liabilities, including those related to litigation, than expected.

Following the failure of Credit Suisse, Switzerland is considering significant changes to its capital, resolution and regulatory regime, which, if adopted, would significantly increase our capital requirements or impose other costs on us. These factors create greater uncertainty about forward-looking statements.

Other factors that may affect our performance and ability to achieve our plans, outlook and other objectives also include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which we are successful in the execution of our strategic plans, including our cost reduction and
efficiency initiatives and our ability to manage our levels of risk-weighted assets ("RWA") and leverage ratio denominator, liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising
from higher market volatility and the size of the combined Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which UBS is successful in implementing changes to our businesses to meet changing market,
regulatory and other conditions, including any potential changes to banking examination and oversight practices and standards as a result of executive branch orders or staff interpretations of law in the U.S.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inflation and interest rate volatility in major markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Developments in the macroeconomic climate and in the markets in which we operate or to which we are exposed,
including movements in securities prices or liquidity, credit spreads, currency exchange rates, residential and commercial real estate markets, general economic conditions and changes to national trade policies on the financial position or
creditworthiness of our clients and counterparties, as well as on client sentiment and levels of activity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the availability of capital and funding, including any adverse changes in our credit spreads and
credit ratings, as well as availability and cost of funding, including as affected by the marketability

------

##### [**Table of Contents**](#toc)
of a current additional tier one debt instrument, to meet requirements for debt eligible for total loss-absorbing capacity ("TLAC"); <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in and potential divergence between central bank policies or the implementation of financial legislation
and regulation in Switzerland, the U.S., the United Kingdom, the European Union and other financial centers that have imposed, or resulted in, or may do so in the future, more stringent or entity-specific capital, TLAC, leverage ratio, net stable
funding ratio, liquidity and funding requirements, heightened operational resilience requirements, incremental tax requirements, additional levies, limitations on permitted activities, constraints on remuneration, constraints on transfers of capital
and liquidity and sharing of operational costs across the Group or other measures and the effect these will or would have on our business activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to successfully implement resolvability and related regulatory requirements and the potential need to
make further changes to our legal structure or booking model in response to legal and regulatory requirements including heightened requirements and expectations due to our acquisition of Credit Suisse;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to maintain and improve our systems and controls for complying with sanctions in a timely manner and
for the detection and prevention of money laundering to meet evolving regulatory requirements and expectations, in particular in the current geopolitical turmoil;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The uncertainty arising from domestic stresses in certain major economies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in our competitive position, including whether differences in regulatory capital and other requirements
among the major financial centers adversely affect our ability to compete in certain lines of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the standards of conduct applicable to its businesses that may result from new regulations or new
enforcement of existing standards, including measures to impose new and enhanced duties when interacting with customers and in the execution and handling of customer transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The liability to which we may be exposed, or possible constraints or sanctions that regulatory authorities might
impose on us, due to litigation, including litigation inherited by virtue of the acquisition of Credit Suisse, contractual claims and regulatory investigations, including the potential for disqualification from certain businesses, potentially large
fines or monetary penalties, or the loss of licenses or privileges as a result of regulatory or other governmental sanctions, as well as the effect that litigation, regulatory and similar matters have on the operational risk component of our RWA;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to retain and attract the employees necessary to generate revenues and to manage, support and control
our businesses, which may be affected by competitive factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in accounting or tax standards or policies and determinations or interpretations affecting the
recognition of gain or loss, the valuation of goodwill, the recognition of deferred tax assets and other matters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to implement new technologies and business methods, including digital services, artificial
intelligence and other technologies and ability to successfully compete with both existing and new financial service providers, some of which may not be regulated to the same extent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Limitations on the effectiveness of our internal processes for risk management, risk control, measurement and
modeling and of financial models generally;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The occurrence of operational failures, such as fraud, misconduct, unauthorized trading, financial crime,
cyberattacks, data leakage and systems failures, the risk of which is increased with persistently high levels of cyberattack threats;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Restrictions on the ability of UBS Group AG, UBS AG and regulated subsidiaries of UBS AG to make payments or
distributions, including due to restrictions on the ability of its subsidiaries to make loans or distributions, directly or indirectly, or, in the case of financial difficulties, due to the exercise by the

------

##### [**Table of Contents**](#toc)
Swiss Financial Market Supervisory Authority FINMA or the regulators of our operations in other countries of their broad statutory powers in relation to protective measures, restructuring and liquidation proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The degree to which changes in regulation, capital or legal structure, financial results, or other factors may
affect our ability to maintain our stated capital return objective;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Uncertainty over the scope of actions that may be required by us, governments and others for us to achieve goals
relating to climate, environmental and social matters, as well as the evolving nature of underlying science and industry and the increasing divergence among regulatory regimes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to access capital markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to successfully recover from a disaster or other business continuity problem due to a hurricane,
flood, earthquake, terrorist attack, war, conflict, pandemic, security breach, cyberattack, power loss, telecommunications failure, or other natural or man-made event; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect that these or other factors or unanticipated events, including media reports and speculations, may
have on our reputation and the additional consequences that this may have on our business and performance.

The sequence in which the factors above are presented is not indicative of their likelihood of occurrence or the potential magnitude of their consequences. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. We caution you not to place undue reliance on any forward-looking statements as they are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, our actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which we operate, may differ materially from those made in or suggested by the forward-looking statements contained or incorporated by reference herein. Except as required by law, we assume no obligation to update or revise the information contained or incorporated by reference herein, which speaks only as of the date hereof. For additional information about factors that could cause our results to differ materially from those described in the forward-looking statements, please read and consider the risk factors set out under "Risk Factors" in Part I, Item 3D of UBS Group AG's Annual Report on Form 20-F for the year ended 31 December 2024 (the "UBS Group AG 2024 20-F") and UBS AG's Annual Reports on Form 20-F for the year ended 31 December 2024 (the "UBS AG 2024 20-F"), which are incorporated in this prospectus by reference, as well as in the other reports that UBS Group AG and UBS AG have filed with the SEC described in the section of this prospectus entitled "*Where You Can Find More Information.*"

------

##### [**Table of Contents**](#toc)
**WHERE YOU CAN FIND MORE INFORMATION** 

UBS Group AG and UBS AG file periodic reports and other information with the SEC. Copies of the documents filed by UBS Group AG or UBS AG with the SEC may be obtained either on the SEC's website at www.sec.gov, which contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, or on the website of UBS at https://www.ubs.com/investors. Information on our website is not incorporated by reference into this prospectus or our securities filings and is not part of this prospectus unless otherwise specifically incorporated by reference.

The SEC allows us to "incorporate by reference" into this prospectus the information that we file with the SEC, which means that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The incorporated documents are considered part of this prospectus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We can disclose important information to you by referring you to those documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Information that we file with the SEC from time to time will automatically be considered to update and supersede
the information in this prospectus.

The information incorporated by reference is an important part of this prospectus. We incorporate by reference into this prospectus the following documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The UBS Group AG 2024 20-F (File No. 001-36764), filed by UBS Group
AG with the SEC on [March 17, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1610520/000161052025000023/ubs-20241231.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The UBS AG 2024 20-F (File No. 001-15060), filed by UBS AG with the
SEC on [March 17, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1114446/000161052025000027/ubs-20241231.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Reports on Form 6-K furnished to the SEC by UBS Group AG and UBS AG on [April 30, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000051/edgar1q25ubsgroup.htm) , [May 5, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000065/newsrelease6k20250505.htm) , [May 8, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000111444625001899/edgar1q25significan.htm) , [June 6, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000069/newsrelease6k20250606.htm) , [July 30, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1114446/000161052025000080/ubs-20250630.htm) , [August 5, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000111444625003777/edgar00significantreg.htm) , [October 29, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000105/edgar3q25ubsgroup.htm) and [February 4, 2026](http://www.sec.gov/Archives/edgar/data/1114446/000161052026000008/edgar4q25ubsgroup.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Reports on Form 6-K furnished to the SEC by UBS Group AG on [April 17, 2025](http://www.sec.gov/Archives/edgar/data/1610520/000161052025000048/aoa6k20250417ubsgroup.htm) and [October 29, 2025](http://www.sec.gov/Archives/edgar/data/1610520/000161052025000106/edgarq3q25kubsgroupagc.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Reports on Form 6-K furnished to the SEC by UBS AG, [March 17, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000031/exhibit991.htm) , [March 17, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000032/edgarubsagstandalo.htm) , [May 8, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000111444625001896/edgar1q25ubsag.htm) , [August 5, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1114446/000111444625003774/ubsag-20250630.htm) , [November 4, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000119/edgar3q25ubsag.htm) and [November 4, 2025](http://www.sec.gov/Archives/edgar/data/1114446/000161052025000120/edgar3q256kubsagctr.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exhibit 99.1 to the Report on Form 6-K furnished to the SEC by UBS AG on [March 28, 2024](http://www.sec.gov/Archives/edgar/data/1114446/000161052024000051/ubsagproforma20240328.htm) (as amended by the additional Form 6-K/A filed on [May 7, 2024](http://www.sec.gov/Archives/edgar/data/1114446/000111444624002302/ubsagproforma6ka20240507.htm)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Prospectus Supplement dated [July 12, 2002](http://www.sec.gov/Archives/edgar/data/29646/000091205702027543/a2084500z424b2.txt) to the Prospectus dated April 29, 2002, relating to the 71∕8% Notes due July 
15, 2032 filed by CS USA with the SEC, except for any portion of such document that incorporates by reference CS USA's prior and future filings made with the SEC under Section 13(a), 13(c), 
14 or 15(d) of the Exchange Act (the "Issuance Prospectus").

In addition UBS Group AG and UBS AG incorporate by reference into the registration statement of which this prospectus forms a part all documents that UBS Group AG and/or UBS AG file with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after (i) the date of the initial registration statement and prior to effectiveness of the registration statement and (ii) the date of this prospectus and before the date the subsidiaries and affiliates of UBS Group AG and UBS AG stop offering Subject Securities pursuant to this prospectus. Reports on Form 6-K furnished by UBS Group AG and/or UBS AG to the SEC (or portions thereof) are incorporated by reference only to the extent that the report expressly states that it is (or such portions are) incorporated by reference in the registration statement of which this prospectus is a part.

Any statement in this prospectus contained in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement in this prospectus or in any later filed document modifies or supersedes that statement. Any statement that is modified or superseded in this manner will no longer be a part of this prospectus, except as modified or superseded.

------

##### [**Table of Contents**](#toc)
You may request a copy, at no cost, of any or all of the documents that are incorporated by reference into this prospectus, excluding exhibits (other than those that we specifically incorporate by reference into the documents that you request) by contacting us, orally or in writing, at the following address:

UBS Group AG Bahnhofstrasse 45 8001 Zurich, Switzerland Attention: Investor Relations +41 44 234 11 11 Internet: https://www.ubs.com/investor UBS AG Investor Relations Bahnhofstrasse 45 P.O. Box 8098 Zurich, Switzerland +41 44 234 41 00 Internet: https://www.ubs.com/investor

Except for the documents specifically incorporated by reference into this prospectus, information contained on our website or that can be accessed through our website is not incorporated into and does not constitute a part of this prospectus. We have included our website address only as an inactive textual reference and do not intend it to be an active link to our website.

We have filed or incorporated by reference exhibits to the registration statement of which this prospectus forms a part. You should read the exhibits carefully for provisions that may be important to you. Statements in this prospectus concerning any document we have filed or will file as an exhibit to the registration statement of which this prospectus forms a part or that we have otherwise filed with the SEC are not intended to be comprehensive and are qualified in their entirety by reference to these filings. You should review the complete document to evaluate these statements.

------

##### [**Table of Contents**](#toc)
**QUESTIONS AND ANSWERS ABOUT THE RESCISSION OFFER** 

*The following questions and answers are intended to address briefly some commonly asked questions regarding the Rescission Offer. These questions and answers do not address all questions that may be important to you. Please refer to "The Rescission Offer" below and the more detailed information contained elsewhere in this prospectus, which you should read carefully, and the information we have incorporated by reference in this prospectus.* 

**What is a rescission offer?** 

A rescission offer is an offer to rescind a securities transaction in which a securities law violation occurred or may have occurred. To conduct a rescission offer, the issuer of the subject securities offers to repurchase the applicable securities from relevant purchasers who acquired such securities, at their purchase price plus interest, less the amount of any interest, coupon payments, principal or other income received pursuant to the terms of the securities, or to pay rescissory damages if such securities, after being purchased, were sold or matured at a loss.

**Why is the Issuer making the Rescission Offer?** 

The Subject Securities were issued pursuant to a registration statement under Section 5 of the Securities Act. Following the Group Merger, affiliates of UBS Group AG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (i.e., the Market-Making Transactions). The Market-Making Transactions were made pursuant to an effective registration statement under Section 5 of the Securities Act until October 2023, when UBS Group AG determined to cease using such registration statement. Certain affiliates of UBS Group AG continued to conduct Market-Making Transactions, without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction. The Issuer has therefore elected to make the Rescission Offer.

The Rescission Offer is not an admission that the Issuer, UBS Group AG or UBS Group AG's affiliates did not comply with applicable federal securities law requirements as to specific securities or transactions, nor is it a waiver by the Issuer, UBS Group AG or UBS Group AG's affiliates of any applicable statute of limitations or repose.

**Am I eligible to participate in the Rescission Offer?** 

You are eligible to participate in the Rescission Offer if you produce evidence satisfactory to the Issuer showing that, with respect to a given Subject Security, you meet the requirements to be deemed an Eligible Current Investor or an Eligible Former Investor, as described in this prospectus. For the definition of Eligible Current Investor and Eligible Former Investor, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*."

Eligible Current Investors will be required to produce evidence satisfactory to the Issuer that (1) they purchased the relevant Subject Security during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG and (2) they still hold such Applicable Security as of the date of this prospectus, and, subject to any tenders pursuant to the Rescission Offer, will continue to hold it on the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind.

Eligible Former Investors will be required to produce evidence satisfactory to the Issuer that (1) they purchased the relevant Subject Security during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG and (2) they no longer hold such Applicable Security as of the date of this prospectus and such Applicable Security has been sold at a loss, provided that they continuously held such Applicable Security until the time of sale.

------

##### [**Table of Contents**](#toc)
All Eligible Investors, by accepting the Rescission Offer, will also be deemed to have provided certain representations and warranties, acknowledgements and agreements to the Issuer upon acceptance of the Rescission Offer. For further details, see "*The Rescission Offer—Terms of the Rescission Offer—Eligibility Requirements*," "*The Rescission Offer—Terms of the Rescission Offer—Evidence of Eligibility*" and "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors.*"

For the avoidance of doubt, you should assess whether you meet the requirements to qualify as an Eligible Current Investor or an Eligible Former Investor in respect of each Subject Security. For example, you may be an Eligible Current Investor with respect to one Subject Security and an Eligible Former Investor with respect to another. You should make this assessment for each Subject Security in respect of which you wish to accept the Rescission Offer.

The following investors will <u>not</u> be considered Eligible Investors for purposes of the Rescission Offer: (i) holders who purchased Subject Securities through us or our affiliates as agent and not as principal, in respect of Subject Securities acquired pursuant to such transactions; (ii) holders who, either to cover short positions or otherwise, borrowed Subject Securities from us or our affiliates, in respect of Subject Securities borrowed pursuant to such transactions; and (iii) holders of call options, put options or other types of options to purchase, sell or otherwise indirectly acquire or dispose of Subject Securities or an indirect interest therein, in respect of such options.

If you do not meet the requirements to be considered an Eligible Investor, you are not entitled to participate in the Rescission Offer. In particular, if you purchased Subject Securities from UBS Group AG or an affiliate of UBS Group AG (or, prior to the Merger Date, through CSG or its affiliates at the time) before October 1, 2023, you are not an Eligible Investor with respect to such Subject Securities.

**When does the Rescission Offer expire?** 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026.

**If I do not tender my Applicable Securities, will they be considered to have been offered and sold under an effective registration statement?** 

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus, your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

**Am I required to accept the Rescission Offer?** 

No. There is no requirement, legal or otherwise, that you accept the Rescission Offer. Your decision to accept or reject the Rescission Offer is completely voluntary and should be based on your assessment.

**What happens if I accept the Rescission Offer?** 

If you timely and validly accept the Rescission Offer, you will receive from the Issuer the Rescission Offer Proceeds (as defined below) and, if you are an Eligible Current Investor, you will cease to hold the Applicable Securities in respect of which you accepted the Rescission Offer once such Applicable Securities are tendered to the Issuer through ATOP (as defined below) as part of the Rescission Offer acceptance process as described in this prospectus.

------

##### [**Table of Contents**](#toc)
**Should I accept the Rescission Offer?** 

You must make your own decision whether to accept or reject the Rescission Offer. In making your decision, you should consider all relevant factors in light of your particular circumstances, including the potential tax consequences of accepting the rescission offer (see the section entitled "*United States Tax Considerations*"). Whether you are an Eligible Current Investor or an Eligible Former Investor, we encourage you to read and carefully consider this prospectus in its entirety, in particular the section headed "*Risk Factors*" and the other information incorporated by reference in this prospectus, for a discussion of certain factors you should carefully consider before deciding whether to accept or reject the Rescission Offer.

If you are an Eligible Current Investor, you should also consider your expected return on the Subject Securities should you continue to hold your Applicable Securities to maturity and the possibility that the value of the Subject Securities may increase or decrease after the Expiration Date. You should also consider whether the amount you will receive in the Rescission Offer is expected to be less or more than the amount you could receive if you currently decided to sell the Applicable Securities to a third party.

WE URGE YOU TO CAREFULLY REVIEW THIS PROSPECTUS BEFORE DECIDING WHETHER OR NOT TO ACCEPT THE RESCISSION OFFER.

**May I accept the Rescission Offer in part with respect to a given series of Subject Securities?** 

Yes, you may accept the Rescission Offer for some or all of your Applicable Securities, as long as such acceptance is for Applicable Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof.

**What will I receive if I accept the Rescission Offer?** 

If you submit the necessary documentation through the Rescission Offer On-line Portal, including evidence showing that you meet the requirements to be deemed an Eligible Investor and you validly accept the Rescission Offer, you will receive the Rescission Offer Proceeds, which will depend on whether you still hold the Applicable Securities or not:

• <u>If you are an Eligible Current Investor who has continued to hold an Applicable Security</u>: upon your tender
of such Applicable Security to the Issuer by accepting the Rescission Offer, the Issuer will pay you an amount equal to the purchase price you paid for such Applicable Security in the Applicable Transaction, *plus* interest on such purchase
price from the settlement date of the Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the Settlement Date, *less* the amount of any interest,
coupon payments, principal or other income received on such Applicable Security.

• <u>If you are an Eligible Former Investor having sold the Applicable Security at a loss</u>: the Issuer will pay
you an amount equal to the excess, if any, of the purchase price you paid for such Applicable Security in the Applicable Transaction over the proceeds from the Applicable Disposition, *plus* interest (i) on the purchase price you paid for
the Applicable Security in the Applicable Transaction from the settlement date of the Applicable Transaction to, and including, the date of the Applicable Disposition and (ii) on the loss realized from the Applicable Disposition from the date
of the Applicable Disposition to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the Settlement Date, *less* the amount of any interest, coupon payments, principal or
other income received on such Applicable Security.

**Will indicative and final Rescission Offer Proceeds be published?** 

Eligible Investors that have validly accepted the Rescission Offer will be informed individually of the Rescission Offer Proceeds in respect of their Applicable Securities as soon as practicable following the

------

##### [**Table of Contents**](#toc)
Expiration Date and processing of the documents in support of their eligibility provided through the Rescission Offer On-line Portal.

We are unable to calculate indicative Rescission Offer Proceeds for Eligible Investors as the final amount of Rescission Offer Proceeds for each such investor will depend on various factors that may be unknown to us, including the prices paid in Applicable Transactions or received in Applicable Dispositions and the dates of Applicable Dispositions. Eligible Investors should make their own calculations of their Rescission Offer Proceeds.

We advise you to consult your financial, legal, and tax advisers, as you deem appropriate, before making any decision with respect to the Rescission Offer.

For further details, see "*The Rescission Offer—Terms of the Rescission Offer—Rescission Offer Proceeds.*"

**What interest rate will be used in calculating any amounts owed to me pursuant to the Rescission Offer?** 

The interest rate for a particular Applicable Security will be calculated on the basis of the yield-to-worst value for the Bloomberg Investment Grade: Banking Total Return Index Unhedged (the "Index") on (i) in the case of interest calculated for an Eligible Current Investor Applicable Period or an Eligible Former Investor Holding Applicable Period, the settlement date of the Applicable Transaction in which the applicable Eligible Investor purchased such Applicable Security (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), or (ii) in the case of interest calculated for an Eligible Former Investor Applicable Period, the settlement date of the Applicable Disposition in which such Applicable Security matured or was sold at a loss (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), plus, in each case, a 100 basis point margin (the "Index Rate"). The Index can be accessed at www.bloomberg.com/indices (I00408US Index Ticker).

**When and how will I receive payment if I validly accept the Rescission Offer?** 

If you are an Eligible Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms hereof, we will cause payment of the Rescission Offer Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date. Payment will be made through The Depository Trust Company ("DTC") or via bank transfer of immediately available funds to your bank account.

**What do I need to do if I want to accept the Rescission Offer?** 

If you are an Eligible Current Investor, in order to accept the Rescission Offer, you must (i) instruct your broker or bank through which your relevant Applicable Securities are held in time for such Applicable Securities to be tendered to the Issuer through ATOP on or before the Expiration Date and (ii) complete, sign and date the accompanying Current Investor Acceptance Form, included as Appendix C, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have rejected the Rescission Offer with respect to such Applicable Securities. Please note that DTC, its participants and the banks or brokers where you hold your Applicable Securities will establish their own cut-off dates and times for the tender of such Applicable Securities, which may be earlier than the Expiration Date. Please check with your broker or bank to determine the appropriate procedure.

If you are an Eligible Former Investor, in order to accept the Rescission Offer, you must complete, sign and date the accompanying Former Investor Acceptance Form, included as Appendix A, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have rejected the Rescission Offer.

If you are both an Eligible Current Investor and an Eligible Former Investor, in order to accept the Rescission Offer in respect of both the Applicable Securities held by you as an Eligible Current Investor and

------

##### [**Table of Contents**](#toc)
those formerly held by you as an Eligible Former Investor, you must follow the process for accepting the Rescission Offer in each such capacity separately with respect to the relevant Applicable Securities.

You may accept the Rescission Offer for any number of your Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof.

For more details on the procedures for accepting the Rescission Offer, see "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer.*" For more details on the evidence required, see "*The Rescission Offer—Terms of the Rescission Offer—Evidence of Eligibility.*"

ALL DETERMINATIONS WITH RESPECT TO THE RESCISSION OFFER (INCLUDING ISSUES RELATING TO THE TIMELINESS OR EFFECTIVENESS OF ANY ELECTION, WITHDRAWAL OR TENDER OF SUBJECT SECURITIES OR EVIDENCE OF ELIGIBILITY), OR THE CALCULATION OF THE RESCISSION OFFER PROCEEDS WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION.

**What happens if I do not accept the Rescission Offer?** 

If you do not accept the Rescission Offer on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer and will continue to own any Applicable Securities still held by you, receive interest payments, coupon payments or other income on such Applicable Securities in accordance with their terms and be paid their principal amount upon maturity or early redemption as described and subject to the terms, conditions and risk factors set out under "*Description of the Subject Securities*" and in the Issuance Prospectus. Furthermore, the Subject Securities not tendered in the Rescission Offer will be deemed to have been offered and sold under an effective registration statement of which this prospectus forms a part.

The rights remaining to the recipients of a rescission offer are not clearly delineated under federal or certain state securities laws. If you affirmatively reject or fail to accept the Rescission Offer, it is unclear whether your federal right of rescission, if any, will be preserved. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. See "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

**What do I need to do to reject the Rescission Offer?** 

You do not need to take any action to reject the Rescission Offer. If you do not tender your Applicable Securities or you do not submit the required information in either case so that it is received by us on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer.

**Can I change my mind after I have accepted the Rescission Offer?** 

Yes. You can change your decision about accepting the Rescission Offer at any time on or before the Expiration Date as described below.

<u>If you are an Eligible Current Investor</u>, you can do this by instructing your broker or bank, through which your relevant Applicable Securities are held, to withdraw your previously tendered Subject Securities in time for the transmission by your broker or bank of your instructions to be received by us on or before the Expiration Date. Otherwise, you will be deemed to have accepted the Rescission Offer and tendered such Subject Securities to the Issuer under the terms of any relevant previous instructions and acceptance form. Please note that DTC, its participants and the banks or brokers where you hold your Subject Securities will establish their own cut-off dates and times for withdrawal of any tender of the Subject Securities, which may be earlier than the Expiration

------

##### [**Table of Contents**](#toc)
Date. Please check with your broker or bank to determine the appropriate procedure. Withdrawals of tenders of Subject Securities by Eligible Current Investors may not be revoked, and any such Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer. Subject Securities properly withdrawn by Eligible Current Investors may, however, be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" and "*—Procedures for Brokers and Banks; DTC ATOP Account*" below, at any time on or before the Expiration Date.

<u>If you are an Eligible Former Investor</u>, in order to change a previous decision to accept the Rescission Offer and withdraw your acceptance of the Rescission Offer, you must complete, sign and date the accompanying Rescission Offer Withdrawal Form, included as Appendix B, and upload it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us on or before the Expiration Date. Otherwise, you will be deemed to have accepted the Rescission Offer under the terms of your previously submitted acceptance form. Withdrawals of their acceptance of the Rescission Offer may not be revoked by Eligible Former Investors, and any such properly withdrawn acceptance will thereafter be deemed not a valid acceptance for purposes of the Rescission Offer. You may, however, re-accept the Rescission Offer by following the procedures described in "*—How to accept the Rescission Offer*" below, at any time on or before the Expiration Date.

In either case, the relevant withdrawal instruction or form, together with the supporting evidence required therein, if any, must be received by us on or before the Expiration Date. For more details on the appropriate procedures, see "*The Rescission Offer—Acceptance or Rejection of the Rescission Offer—How to accept the Rescission Offer.*"

ALL DETERMINATIONS WITH RESPECT TO THE RESCISSION OFFER (INCLUDING ISSUES RELATING TO THE TIMELINESS OR EFFECTIVENESS OF ANY ELECTION, TENDER OR WITHDRAWAL OF SUBJECT SECURITIES OR EVIDENCE OF ELIGIBILITY), THE CALCULATION OF THE RESCISSION OFFER PROCEEDS OR THE RESCISSION OFFER WITHDRAWAL FORM WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION.

**What is the effect of the Rescission Offer on my ability to assert claims?** 

The rights remaining to the recipients of a rescission offer are not clearly delineated under the federal or certain state securities laws. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. For a more detailed description of the effect of the Rescission Offer on any applicable federal and certain state securities law claims, please see the risk factors entitled "*Risk Factors—Risks Relating to the Rescission Offer—The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount*" and "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

**If I accept the Rescission Offer, will I experience any tax consequences?** 

For a more detailed description of the tax consequences of the Rescission Offer, see the section entitled "*United States Tax Considerations.*" You should consult your own tax adviser, as you deem appropriate, regarding the U.S. federal, state and local and other tax consequences of participating in the Rescission Offer.

**Who can help answer my questions in relation to the Rescission Offer?** 

If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**RISK FACTORS** 

*An investment in the Subject Securities involves risks. You should carefully consider the risk factors and the other information contained in this prospectus and the UBS Group AG 2024 20-F and the UBS AG 2024 20-F, and the other information incorporated by reference in this prospectus, before deciding to accept or reject the Rescission Offer or invest in Subject Securities.* 

**Risks Relating to the Rescission Offer** 

***The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount.***

It is not certain that the Rescission Offer will have the effect of barring claims relating to non-compliance with applicable federal securities laws in relation to the Subject Securities. If a person accepts the Rescission Offer, we believe our potential liability to that person will be eliminated. If a person rejects or fails to respond to the Rescission Offer, we may continue to be contingently liable for rescission or damages. In addition, the Rescission Offer will not prevent various other private claims from being asserted against us and/or our affiliates, including claims under applicable U.S. federal securities laws. Further, the Rescission Offer will not bar the SEC or other authorities from pursuing enforcement actions against us and/or our affiliates, which could result in fines, penalties and/or other sanctions. Any such private claims or enforcement actions could result in an adverse effect on our results of operations and financial condition.

***Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.***

The rights remaining to the recipients of a rescission offer are not clearly delineated under federal or certain state securities laws. If you affirmatively reject or fail to accept the Rescission Offer, it is unclear whether your federal right of rescission, if any, will be preserved. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief.

The Rescission Offer may also affect your right of rescission and your right to damages, if any, under state law. We believe that the sale of Subject Securities in Market-Making Transactions was exempt from registration under state laws. Furthermore, we believe that the Rescission Offer is exempt from registration under the laws of such states. However, we do not make any representation as to the compliance of the Rescission Offer with applicable state law. Under most state laws, acceptance or rejection of rescission offers may preclude offerees from initiating an action against the rescission offeror in connection with the registration of securities that are the subject of the rescission offer. We may assert, among other defenses, in any litigation initiated by a person eligible to participate in the Rescission Offer who accepts or rejects (or is deemed to reject) the Rescission Offer, that such person is legally barred from asserting such claims as a result of the Rescission Offer.

Generally, the statute of limitations for enforcement of federal statutory rights of rescission or rescissory damages by a security holder is one year commencing on the date the security was sold in violation of the federal registration requirements. Pursuant to Section 13 of the Securities Act, the statute of repose is three years after the security was *bona fide* offered to the public. Statutes of limitations under state laws vary by state, with the limitation time period under many state statutes not typically beginning until the facts giving rise to a violation are known. The Rescission Offer is not an admission that we or our affiliates did not comply with any federal and state registration or disclosure requirements as to specific securities or transactions, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose or any other potential defense we may have. However, we have decided to make the Rescission Offer to certain otherwise Eligible Investors that purchased Subject Securities during the Relevant Period even if now outside the applicable period of limitations or repose. Determining when a statute of limitations or repose expires under federal or state law can be a difficult issue and you should consult with an attorney if you have any questions regarding how federal or state statutes of limitations or repose may apply to any claims you may have.

------

##### [**Table of Contents**](#toc)
***We cannot predict, if you are an Eligible Current Investor, whether the amounts you would receive in the Rescission Offer as a result of tendering your Subject Securities would be greater than the amounts you may receive for the Subject Securities from a third-party buyer. Nor can we predict whether the amounts that a third-party buyer might pay for the Subject Securities will be affected by the Rescission Offer.***

If you are an Eligible Current Investor, the amount you would receive in the Rescission Offer as a result of tendering your Subject Securities is determined by a set formula which is not tied to the market value of the Subject Securities at the time the Rescission Offer closes on the Expiration Date. The amount you would receive in the Rescission Offer will be reduced by the amount of any interest, coupon payments, principal or other income due on such Applicable Securities pursuant to their terms. In addition, when you accept the Rescission Offer, you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to us any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you. As a result, if you are an Eligible Current Investor and accept the Rescission Offer, you may receive or retain less than the market value of the Subject Securities that you would be tendering to us. Further, we cannot anticipate subsequent market developments, whether at the time or after payment is made, or the future market value of the Subject Securities, nor can we predict whether such market value will be affected by the Rescission Offer.

***You may be subject to certain tax consequences if you accept or reject the Rescission Offer.***

Your decision to accept or reject the Rescission Offer may subject you to certain U.S. federal income tax consequences. See "*United States Tax Considerations*" below.

------

##### [**Table of Contents**](#toc)
**USE OF PROCEEDS** 

We will receive no proceeds from the Rescission Offer. We do not expect to receive any proceeds from resales of Subject Securities by UBS Securities LLC, UBS Financial Services Inc. or any of our other affiliates in market-making transactions. We expect our affiliates to retain the proceeds of their market-making resales and not to pay the proceeds to us.

------

##### [**Table of Contents**](#toc)
**THE RESCISSION OFFER** 

**Background and Reasons for the Rescission Offer** 

The Subject Securities were issued pursuant to a registration statement under Section 5 of the Securities Act. Following the Group Merger, affiliates of UBS Group AG made a market in the Subject Securities, including by conducting secondary resales of the Subject Securities to unaffiliated investors (i.e., the Market-Making Transactions). The Market-Making Transactions were made pursuant to an effective registration statement under Section 5 of the Securities Act until October 2023, when UBS Group AG determined to cease using such registration statement. Certain affiliates of UBS Group AG continued to conduct Market-Making Transactions, without an effective registration statement under the Securities Act. As such, certain offers and sales of the Subject Securities were not made in full compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the Subject Securities in an Applicable Transaction. The Issuer has therefore elected to make the Rescission Offer to those purchasers.

On February 12, 2026, the Issuer, UBS Group AG and UBS AG filed a registration statement on Form F-3 of which this prospectus forms a part. The Subject Securities have been registered by means of this registration statement.

The Rescission Offer is not an admission that we or our affiliates did not comply with applicable federal securities law requirements as to specific securities or transactions, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose.

**Effect of the Rescission Offer** 

If you reject, or fail to accept, the Rescission Offer on or before the Expiration Date, or if you accept the Rescission Offer but we determine that you are not eligible to accept the Rescission Offer under the terms set forth in this prospectus, you will retain ownership of any Subject Securities you still hold and will not receive any payment for such Subject Securities. In addition, any Subject Securities that you still hold, for purposes of applicable federal securities law, will have been registered as of the date of this prospectus.

We believe that the applicable statute of limitations for potential claims for rescission or rescissory damages under the Securities Act is one year from the date of sale of such security in violation of the federal registration requirements, and the statute of repose is three years after such sale. Determining when a statute of limitations or repose expires under federal or state law can be a difficult issue, and you should consult with an attorney if you have any questions regarding how federal or state statutes of limitations or repose may apply to any claims you have or regarding any of your legal rights and remedies before deciding whether or not to accept the Rescission Offer.

Your acceptance of the Rescission Offer may preclude you from later seeking similar relief, if any is available. We may assert, among other defenses, in any litigation initiated by a person eligible to participate in the Rescission Offer who accepts or rejects (or is deemed to reject) the Rescission Offer, that such person is legally barred from asserting such claims as a result of the Rescission Offer. For federal securities law purposes, it is unclear what the effect of a rejection of or the failure to accept a rescission offer may be on an offeree's right to bring a civil action against the rescission offeror for failure to register a securities transaction under the Securities Act before expiration of the applicable statute of limitations or repose. The few federal courts that have addressed this issue in the past have suggested that, at least in certain circumstances, a person who rejects or fails to accept a rescission offer may be precluded from later seeking similar relief. Each person is urged to consider this possibility with respect to the Rescission Offer. The Rescission Offer is not an admission that we or our affiliates did not comply with applicable federal requirements as to specific securities, nor is it a waiver by us or our affiliates of any applicable statute of limitations or repose. However, we have decided to make the Rescission Offer to certain otherwise Eligible Investors that purchased Subject Securities during the Relevant Period even if now outside the period of limitations or repose.

------

##### [**Table of Contents**](#toc)
The above discussion relates primarily to your potential rescission rights and does not address other provisions of federal securities laws or rights under state securities laws, common law or equity. We believe that the Market-Making Transactions were exempt from registration under state laws. Furthermore, we believe that the Rescission Offer is exempt from registration under state laws. See "*Risk Factors—Risks Relating to the Rescission Offer—The Rescission Offer may not bar claims relating to non-compliance with securities laws, and we may continue to be contingently liable for rescission or damages in an indeterminate amount*" and "*Risk Factors—Risks Relating to the Rescission Offer—Your right of rescission under federal and state law may not survive if you affirmatively reject or fail to accept the Rescission Offer.*"

The Subject Securities have now been registered by means of the registration statement on Form F-3 of which this prospectus forms a part. Accordingly, whether or not you accept the Rescission Offer, as of the date of this prospectus, your Subject Securities will be deemed to have been offered and sold under an effective registration statement. The Subject Securities currently are unrestricted securities, meaning that they are not "restricted securities" within the meaning of Rule 144 under the Securities Act, and are freely tradeable (other than by us or any of our affiliates).

**Terms of the Rescission Offer** 

If you are an Eligible Investor and validly accept the Rescission Offer on or before the Expiration Date, you will have the right to receive from us the Rescission Offer Proceeds, subject to the terms below.

***Subject Securities***

The Subject Securities were issued pursuant to the Indenture. Pursuant to the Second Supplemental Indenture, effective upon completion of the Group Merger, UBS Group AG expressly assumed all of CSG's obligations as guarantor under the Indenture. Pursuant to the Third Supplemental Indenture, effective upon completion of the Parent Bank Merger, UBS AG expressly assumed all of CS AG's obligations as guarantor under the Indenture. Pursuant to the Fourth Supplemental Indenture, effective upon completion of the UBS Americas Merger, UBS Americas expressly assumed all of CS USA's obligations as issuer under the Indenture and the Subject Securities.

On the date of this prospectus the outstanding principal amount of the Subject Securities was $742,344,000, as indicated below.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Title of<br>Security** | **Issuer** | **Guarantors** | **CUSIP No.;<br>ISIN No.** | **Principal<br>Amount<br>Outstanding\*\*** | **Maturity<br>Date** | **Issuance Prospectus** |
| 71/8% Notes due July 15, 2032 | UBS Americas (CS USA until the UBS Americas Merger Date) | UBS Group AG (CSG until the Merger Date) and UBS AG (CS AG until the Parent Bank Merger Date) | 22541LAE3;<br> US22541LAE39 | $742344000 | July 15, 2032 | [https://www.sec.gov/<br>Archives/edgar/data/<br>29646/000091205702027543/<br>a2084500z424b2.txt](http://www.sec.gov/Archives/edgar/data/29646/000091205702027543/a2084500z424b2.txt) |

---

The Subject Securities are not deposit liabilities and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. The Subject Securities do not have the benefit of any agency or governmental guarantee.

***Eligibility Requirements***

To be eligible to participate in the Rescission Offer with respect to a given Subject Security, you must make representations and warranties and provide us with evidence to the following effects:

1. To be deemed an "Eligible Current Investor":

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. You purchased the relevant Subject Security during the Relevant Period from UBS Group AG or an affiliate of UBS
Group AG; and

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. You still hold such Applicable Security as of the date of this prospectus, and will continue to hold (unless
and until tendered through ATOP pursuant to the Rescission Offer) until the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind.

2. To be deemed an "Eligible Former Investor":

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1. You purchased the relevant Subject Security during the Relevant Period from UBS Group AG or an affiliate of UBS
Group AG; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2. You no longer hold such Applicable Security as of the date of this prospectus and such Applicable Security has
been sold at a loss, provided that you continuously held such Applicable Security until the time of sale.

Eligible Current Investors and Eligible Former Investors are collectively referred to as "Eligible Investors."

For the avoidance of doubt, you should assess whether you meet the requirements to qualify as an Eligible Current Investor or an Eligible Former Investor in respect of each Subject Security. For example, you may be an Eligible Current Investor with respect to one Subject Security and an Eligible Former Investor with respect to another. You should make this assessment for each Subject Security in respect of which you wish to accept the Rescission Offer.

The following investors will <u>not</u> be considered Eligible Investors for purposes of the Rescission Offer: (i) holders who purchased Subject Securities through us or our affiliates as agent and not as principal, in respect of Subject Securities acquired pursuant to such transactions; (ii) holders who, either to cover short positions or otherwise, borrowed Subject Securities from us or our affiliates, in respect of Subject Securities borrowed pursuant to such transactions; and (iii) holders of call options, put options or other types of options to purchase, sell or otherwise indirectly acquire or dispose of the Subject Securities or an indirect interest therein, in respect of such options.

If you do not meet the requirements to be considered an Eligible Investor, you are not entitled to participate in the Rescission Offer. In particular, if you purchased Subject Securities from UBS Group AG or an affiliate of UBS Group AG (or, prior to the Group Merger Date, through CSG or its affiliates at the time) before October 1, 2023, you are not an Eligible Investor with respect to such Subject Securities.

***Evidence of Eligibility***

<u>If you are an Eligible Current Investor</u>:

To demonstrate your eligibility to participate in the Rescission Offer with respect to a Subject Security, you will be required to provide the following documentation when accepting the Rescission Offer pursuant to the terms of this prospectus:

1. A signed acceptance agreement a form of which is included in Appendix C (Current Investor Acceptance Form), by
which the Eligible Current Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements described under "*—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors* "; <u>and</u> 

2. Satisfactory evidence that you purchased the Subject Security in an Applicable Transaction (i.e., the Subject
Security is an Applicable Security) and that you continue to hold such Applicable Security as of the date of this prospectus, and will continue to hold it (through ATOP pursuant to the Rescission Offer) until the Expiration Date. For such purposes,
the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG during the Relevant Period and (ii) purchase price information of such Applicable Security, and demonstrating the continued holding of such Applicable Security until at least the date of this prospectus; <u>and/or</u> 

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Receipt, transaction or trade confirmation statement reflecting UBS Group AG or an affiliate of UBS Group AG as
a principal seller of such Applicable Security in such Applicable Transaction.

<u>If you are an Eligible Former Investor</u>:

To demonstrate your eligibility to participate in the Rescission Offer with respect to a Subject Security, you will be required to provide the following documentation when accepting the Rescission Offer pursuant to the terms of this prospectus:

1. A signed acceptance agreement a form of which is included in Appendix A (Former Investor Acceptance Form), by
which the Eligible Former Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements described under "*—Acceptance or Rejection of the Rescission Offer—Representations of Eligible Investors* "; <u>and</u> 

2. Satisfactory evidence that you purchased the Subject Security in an Applicable Transaction (i.e., the Subject
Security is an Applicable Security) and that such Applicable Security subsequently was sold in a *bona fide* transaction at a loss. For such purposes, the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG during the Relevant Period, (ii) purchase price information of such Applicable Security and (iii) the subsequent Applicable Disposition (and sale price information, as applicable) of such Applicable Security
before the date of this prospectus, and demonstrating the continued holding of such Applicable Security until the time of the Applicable Disposition; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) With respect to an Applicable Transaction: receipt, transaction or trade confirmation statement reflecting UBS
Group AG or an affiliate of UBS Group AG as a principal seller of such Applicable Security in such Applicable Transaction; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) With respect to an Applicable Disposition: receipt, transaction or trade confirmation statement reflecting such
Applicable Security being sold, including the date, price and other relevant details of the sale; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) With respect to the loss as a result of an Applicable Disposition: tax documents, such as IRS Form 1099-B, evidencing the losses incurred on the Applicable Disposition of such Applicable Security prior to the date of this prospectus.

If you are both an Eligible Current Investor and an Eligible Former Investor in the same series of Subject Securities you must provide evidence as shown above in your capacity as Eligible Current Investor and Eligible Former Investor, as applicable.

ALL DETERMINATIONS WITH RESPECT TO THE EVIDENCE SUBMITTED FOR PURPOSES OF MEETING THE ELIGIBILITY REQUIREMENTS TO ACCEPT THE RESCISSION OFFER WILL BE MADE BY US, IN OUR SOLE DISCRETION, WHICH DETERMINATIONS SHALL BE FINAL AND BINDING, ABSENT MANIFEST ERROR DETERMINED BY US IN OUR SOLE DISCRETION. WE RESERVE THE RIGHT TO, AT ANY TIME, REQUEST ANY ADDITIONAL INFORMATION OR EVIDENCE THAT WE MAY DEEM REASONABLY APPROPRIATE TO DEMONSTRATE THAT YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE INVESTOR.

Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

------

##### [**Table of Contents**](#toc)
We and others will rely upon the truth and accuracy of the foregoing evidence for purposes of the Rescission Offer and we and our affiliates reserve the right to take all actions available at law to recover any losses incurred as a result of such reliance in case any of such evidence proves to be inaccurate, incorrect, false or misleading.

***Rescission Offer Proceeds***

*Description of Rescission Offer Proceeds* 

If you are an Eligible Investor and you validly accept the Rescission Offer, the price you will receive for a particular Applicable Security (such price in respect of such Applicable Security, the "Rescission Offer Proceeds") will depend on whether you are an Eligible Current Investor or an Eligible Former Investor with respect to such Applicable Security and be determined as follows:

• If you are an Eligible Current Investor with respect to such Applicable Security, if you accept the Rescission
Offer in respect of such Applicable Security in accordance with the terms hereof, the Issuer will pay you an amount equal to the purchase price you paid for such Applicable Security in the Applicable Transaction, *plus* interest on such
purchase price from the settlement date of the Applicable Transaction to, and including, the earlier to occur of (x) the date that is five business days after the Expiration Date and (y) the Settlement Date, *less* the amount of any
interest, coupon payments, principal or other income received on such Applicable Security, as represented in the following formula:

*A =* *P + I – R*

*where:*

*A* = Rescission Offer Proceeds

*P* = purchase price

---

| | |
|:---|:---|
| *I* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the purchase price and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Current Investor Applicable Period  |

---

---

| | |
|:---|:---|
| *R* = | total amount of any interest, coupon payments, principal or other income received by the Eligible Current Investor on the Applicable Security  |

---

• If you are an Eligible Former Investor with respect to such Applicable Security, if you accept the Rescission
Offer in respect of such Applicable Security in accordance with the terms hereof, the Issuer will pay you an amount equal to the excess, if any, of the purchase price you paid for such Applicable Security in the Applicable Transaction over the
proceeds from the Applicable Disposition, *plus* interest (i) on the purchase price you paid for the Applicable Security in the Applicable Transaction from the settlement date of the Applicable Transaction to, and including, the date of
the Applicable Disposition and (ii) on the loss realized from the Applicable Disposition from the date of the Applicable Disposition to, and including, the earlier to occur of (x) the date that is five business days after the Expiration
Date and (y) the Settlement Date, *less* the amount of any interest, coupon payments, principal or other income received on such Applicable Security, as represented in the following formula:

*A =* *(P–D)+ I1 + I2 – R*

*where:*

*A* = Rescission Offer Proceeds

*P* = purchase price

*D* = proceeds from the Applicable Disposition

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| *I1* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the purchase price and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Former Investor Holding Applicable Period  |

---

---

| | |
|:---|:---|
| *I2* = | interest equal to the Index Rate (as defined below) for such Applicable Security multiplied by the loss realized from the Applicable Disposition (i.e., *P-D*) and multiplied by the aggregate of the Day-Count Fraction (as defined below) for each calendar year within the Eligible Former Investor Applicable Period  |

---

---

| | |
|:---|:---|
| *R* = | total amount of any interest, coupon payments, principal, or other income received by the Eligible Former Investor on the Applicable Security  |

---

All references to the purchase price or proceeds from an Applicable Disposition exclude any accrued interest, fees, selling concessions or other additional amounts.

All Rescission Offer Proceeds will be rounded to the nearest cent.

*Interest Component of the Rescission Offer Proceeds* 

In calculating the Rescission Offer Proceeds, we will use an interest rate calculated for a particular Applicable Security on the basis of the yield-to-worst value for the Bloomberg Investment Grade: Banking Total Return Index Unhedged (the "Index") on (i) in the case of interest calculated for an Eligible Current Investor Applicable Period or an Eligible Former Investor Holding Applicable Period, the settlement date of the Applicable Transaction in which the applicable Eligible Investor purchased such Applicable Security (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), or (ii) in the case of interest calculated for an Eligible Former Investor Applicable Period, the settlement date of the Applicable Disposition in which such Applicable Security matured or was sold at a loss (or, if the Index was not published on such date, on the next succeeding date on which the Index was published), plus, in each case, a 100 basis point margin (the "Index Rate"). The Index can be accessed at www.bloomberg.com/indices (I00408US Index Ticker).

For purposes of determining the amount of interest included in the Rescission Offer Proceeds in respect of a particular Applicable Security, the day-count fraction for any calendar year within an Applicable Period shall be equal to the actual number of days in such calendar year that occur during such Applicable Period divided by the actual number of days in such calendar year (i.e., Actual/Actual) (the "Day-Count Fraction").

Although this prospectus uses the term "interest" when describing the calculation of the Rescission Offer Proceeds, the term is only intended to describe the method used to calculate the payment amount, and the payment is not considered interest for federal income tax purposes, but rather is included in the amount realized from the sale of the Subject Securities.

*Deduction of any interest, coupon payments, principal or other income due on Subject Securities* 

If you are an Eligible Current Investor, you will continue to receive any interest, coupon payments, principal or other income due on your Subject Security pursuant to its terms until you tender such Subject Security to the Issuer through ATOP; provided, however, that (i) any such amounts received by you prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and (ii) you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to the Issuer any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

If you are an Eligible Former Investor, any interest, coupon payments, principal or other income received on your Subject Security prior to or during the Rescission Offer, or following the Expiration Date, will be deducted

------

##### [**Table of Contents**](#toc)
from the Rescission Offer Proceeds pursuant to this prospectus and you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to the Issuer any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

As a result, if you accept the Rescission Offer in respect of any Subject Security, (1) the amount equal to the purchase price you paid for such Subject Security, plus interest on such purchase price (as described in the calculation of the Rescission Offer Proceeds), in case you are an Eligible Current Investor or (2) the amount equal to the excess, if any, of the purchase price you paid for such Subject Security over the proceeds from the subsequent sale of such Subject Security, plus interest (as described in the calculation of the Rescission Offer Proceeds) in case you are an Eligible Former Investor, will be offset in part or in full by deductions made by us or reimbursements you owe to the Issuer to account for any interest, coupon payments, principal or other income due on such Subject Security pursuant to its terms.

Therefore, you may not receive any amount as a result of accepting the Rescission Offer. You must make your own decision whether to accept or reject the Rescission Offer. We are not making any determinations as to whether it is in your economic interest to do so. We urge you to carefully review this prospectus before deciding whether or not to accept or reject the Rescission Offer.

*Publication of Rescission Offer Proceeds* 

We will endeavor to publish in a press release with available information regarding the results of the Rescission Offer as soon as practicable following the Expiration Date. Eligible Investors that have validly accepted the Rescission Offer will be informed individually of the Rescission Offer Proceeds in respect of their Applicable Securities as soon as practicable following the Expiration Date and processing of the documents in support of their eligibility provided through the Rescission Offer On-line Portal.

We are unable to calculate indicative Rescission Offer Proceeds for Eligible Investors as the final amount of Rescission Offer Proceeds for each such investor will depend on various factors that may be unknown to us, including the prices paid in Applicable Transactions or received in Applicable Disposition and the dates of Applicable Dispositions. Eligible Investors should make their own calculations of the Rescission Offer Proceeds.

We advise you to consult your financial, legal, and tax advisers, as you deem appropriate, before making any decision with respect to the Rescission Offer.

*Payment of the Rescission Offer Proceeds* 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026.

If you are an Eligible Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms hereof, we will cause payment of the Rescission Offer Proceeds to be made to you on the Settlement Date, which is expected to be no later than ten business days following the Expiration Date. Payment will be made through DTC or via bank transfer of immediately available funds to your bank account.

None of us, our affiliates or any of our or our affiliates' executive officers or directors makes any recommendations to any person with respect to the Rescission Offer. We urge you to read this prospectus carefully and to make an independent evaluation with respect to the Rescission Offer. We also urge you to consult with your advisers, as you deem appropriate, before accepting or rejecting the Rescission Offer.

BY ACCEPTING THE RESCISSION OFFER YOU WILL NOT BE ENTITLED TO ANY OTHER PAYMENTS ON YOUR APPLICABLE SECURITIES OTHER THAN PAYMENT OF THE RESCISSION OFFER PROCEEDS AS DETAILED ABOVE.

------

##### [**Table of Contents**](#toc)
The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service (the "IRS"). You may also be subject to backup withholding on payments in respect of your Subject Securities unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

**Acceptance or Rejection of the Rescission Offer** 

YOU ARE NOT LEGALLY REQUIRED TO ACCEPT THE RESCISSION OFFER.

All acceptances of the Rescission Offer will be deemed to be effective on the Expiration Date, at which time your right to accept the Rescission Offer will terminate. You can withdraw any previous acceptance of the Rescission Offer prior to the Expiration Date. While withdrawals may not be revoked, and any Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer, such Subject Securities may be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" at any time on or before the Expiration Date. Whether or not you accept the Rescission Offer, as of the date of this prospectus, the Subject Securities will be deemed to have been offered and sold under an effective registration statement.

IT IS UNCLEAR WHAT THE EFFECT OF ACCEPTANCE OR REJECTION OF THE RESCISSION OFFER WILL BE ON YOUR RIGHT TO BRING A CIVIL ACTION AGAINST US ALLEGING A FAILURE TO REGISTER THE MARKET-MAKING TRANSACTIONS UNDER FEDERAL SECURITIES LAWS. HOWEVER, FEDERAL LAW DOES PROVIDE THAT YOU MAY LOSE ANY RESCISSION RIGHTS UNDER FEDERAL SECURITIES LAWS ONE YEAR FROM THE DATE OF PURCHASE OF THE APPLICABLE SECURITIES AND THREE YEARS FROM THE DATE SUCH SECURITIES WERE BONA FIDE OFFERED TO THE PUBLIC.

***How to accept the Rescission Offer***

You may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof.

<u>If you are an Eligible Current Investor</u>: Because the Subject Securities are represented by global book-entry notes, DTC or its nominee is treated as the registered holder of such Subject Securities and will be the only entity that can tender the Subject Securities for repurchase by the Issuer. Therefore, to tender your Applicable Securities in order to obtain the Rescission Offer Proceeds for them, you must instruct the institution where you hold your Applicable Securities to tender your Applicable Securities on your behalf so that they are received on or before the Expiration Date.

YOU SHOULD CONSULT YOUR BROKER OR BANK WHERE YOU HOLD YOUR APPLICABLE SECURITIES TO DETERMINE THE PREFERRED PROCEDURE FOR TENDERING YOUR APPLICABLE SECURITIES.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER, PLEASE INSTRUCT YOUR BROKER OR BANK WHERE YOU HOLD YOUR APPLICABLE SECURITIES IN TIME FOR YOUR APPLICABLE

------

##### [**Table of Contents**](#toc)
SECURITIES TO BE TENDERED TO THE ISSUER ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR TENDER OF SUBJECT SECURITIES HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE INVESTOR TO ACCEPT THE RESCISSION OFFER.

PLEASE NOTE THAT DTC, ITS PARTICIPANTS AND THE BANKS OR BROKERS WHERE YOU HOLD YOUR SUBJECT SECURITIES WILL ESTABLISH THEIR OWN CUT-OFF DATES AND TIMES FOR THE TENDER OF THE SUBJECT SECURITIES, WHICH MAY BE EARLIER THAN THE EXPIRATION DATE.

In addition, you must complete, sign and date the accompanying Current Investor Acceptance Form, included as Appendix C, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), together with the supporting evidence required therein, so that it is received by us on or before the Expiration Date.

The Current Investor Acceptance Form must be legible. If you choose to accept the Rescission Offer, we recommend that you return the Current Investor Acceptance Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

If you choose to accept the Rescission Offer, you will be deemed to have made to us the representations and warranties, acknowledgements and agreements set forth under "*—Representations of Eligible Investors*" below.

If you tender your Subject Security to the Issuer through ATOP, you will cease to receive any interest, coupon payments, principal or other income due on such Subject Security pursuant to its terms upon such tender; provided, however, that (i) any such amounts due to you prior to or during the Rescission Offer, or following the Expiration Date, that remain unpaid because of your tender of such Subject Security through ATOP will not be deducted from the Rescission Offer Proceeds pursuant to this prospectus (and, conversely, any such amounts that are received by you prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus) and (ii) you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to the Issuer any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you. See "*—Terms of the Rescission Offer—Rescission Offer Proceeds.*" You will resume receipt of interest, coupons payments, principal and other income due on such Subject Security pursuant to its terms upon a valid withdrawal of such previously tendered Subject Security. See "*—Terms of the Rescission Offer—How to Reject the Rescission Offer.*" 

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or the tender of the Subject Securities or evidence of eligibility) or the calculation of the Rescission Offer Proceeds will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

<u>If you are an Eligible Former Investor</u>: In the event you elect to accept the Rescission Offer, you must complete, sign and date the accompanying Former Investor Acceptance Form, included as Appendix A to this prospectus, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us (together with the supporting evidence required therein) on or before the Expiration Date.

The Former Investor Acceptance Form must be legible. If you choose to accept the Rescission Offer, we recommend that you return the Former Investor Acceptance Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
If you choose to accept the Rescission Offer, any interest, coupon payments, principal or other income received on such Subject Security prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and you will be deemed to have represented and warranted, acknowledged and agreed, as part of the terms of the acceptance of the Rescission Offer, that you will repay to the Issuer any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to you.

WE MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED FORMER INVESTOR ACCEPTANCE FORM (TOGETHER WITH APPROPRIATE SUPPORTING EVIDENCE) ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR FORMER INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE FORMER INVESTOR TO ACCEPT THE RESCISSION OFFER.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the Former Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

If you are both an Eligible Current Investor and an Eligible Former Investor, in order to accept the Rescission Offer in respect of both the Applicable Securities held by you as an Eligible Current Investor and those formerly held as an Eligible Former Investor, you must follow the process for accepting the Rescission Offer in each such capacity separately with respect to the relevant Applicable Securities.

***Representations of Eligible Investors***

By accepting the Rescission Offer, each Eligible Investor will be deemed to have represented and warranted, acknowledged to, and agreed with, us that such Eligible Investor:

1. has received and reviewed the information contained in this prospectus;

2. elects to accept the Rescission Offer with respect to the specified Subject Securities, and understands that
he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

3. meets the requirements to be considered an Eligible Investor, as set out under "*—Terms of the Rescission Offer—Eligibility Requirements*" above, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. if an Eligible Current Investor, such investor (1) purchased the Subject Securities in respect of which
the Rescission Offer is accepted during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG; and (2) has continued to hold the Subject Securities in respect of which the Rescission Offer is accepted until the date of this
prospectus, and will continue to hold such Subject Securities (unless and until tendered through ATOP pursuant to the Rescission Offer) until the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions
of any kind, and UBS Americas Inc. will acquire good, indefeasible and unencumbered title to such Subject Securities, free and clear of all liens, charges, claims, encumbrances, interests and restrictions of any kind, when the tender of the same is
accepted by UBS Americas Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. if an Eligible Former Investor, such investor (1) purchased the Subject Securities in respect of which the
Rescission Offer is accepted during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG; and (2) no longer holds the Subject Securities in respect of which the Rescission Offer is accepted as at the date of this prospectus,
and such Subject Securities were sold at a loss (provided, that such investor continuously held such relevant Subject Security until the time of sale);

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3. if an Eligible Current Investor, is the beneficial owner or the authorized representative of the beneficial
owner of the Subject Securities in respect of which he, she or it is accepting the Rescission Offer, or, if an Eligible Former Investor, was the beneficial owner or is the authorized representative of the former beneficial owner of those Subject
Securities when acquired during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG and has full power and authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4. if an Eligible Current Investor, will not sell, pledge, hypothecate or otherwise encumber or transfer any
Subject Securities in respect of which he, she or it is accepting the Rescission Offer, from the date of acceptance of the Rescission Offer, and agrees that any purported sale, pledge, hypothecation or other encumbrance or transfer will be void and
of no effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5. in evaluating the Rescission Offer and in making the decision whether to participate therein, has made his, her
or its own independent appraisal of the matters referred to in this prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to him, her or it by us other than those
contained in this prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6. is not a Sanctioned Person (as defined below) and none of its subsidiaries is a Sanctioned Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7. will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make
available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as
defined below), or (y) in any other manner; in each case that would result in a violation of Sanctions (as defined below), constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the
Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8. acknowledges and agrees that any violation of clauses 3.6 or 3.7 above constitutes a material change in the
commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9. (i) acknowledges and agrees that any interest, coupon payments, principal or other income due on the specified
Subject Securities pursuant to their terms received by such Eligible Investor prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to this prospectus and
(ii) will repay to UBS any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the Eligible Investor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10. understands that UBS, its affiliates and others will rely upon the truth and accuracy of the foregoing
acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made by his, her or its acceptance of the Rescission Offer are at any time prior to the consummation of the Rescission
Offer no longer accurate, he, she or it shall promptly notify us and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the
Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11. if delivering the Subject Securities as a fiduciary or agent for one or more investor accounts, has sole
investment discretion with respect to each such account and full power to make the foregoing acknowledgements, representations and warranties on behalf of such account;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12. any documentation provided to UBS evidencing the foregoing acknowledgements, representations and warranties is
true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13. his, hers or its participation in the Rescission Offer will not constitute or result in a violation of any
provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14. will execute any further documents and give any further assurances that may be required in connection with any
of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

------

##### [**Table of Contents**](#toc)
For purposes of the above:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Person" means any natural person, corporation, limited partnership, general partnership, limited
liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign
government or agency, instrumentality, or political subdivision, territory, or similar entity or organization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctionable Activity" means any condition or activity specifically identified under any Sanctions
as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described by such condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctioned Territory" means any country or territory with which dealings are broadly and
comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, the Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctioned Person" means any Person with whom dealings are restricted or prohibited under any
Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory,
or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sanctions" means all national and supranational laws, regulations, decrees, orders, or other acts
with force of law of the United States, Switzerland, the United Kingdom or the European Union, or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking of assets of
targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any laws threatening to impose such trade and economic sanctions on any Person for
engaging in proscribed or targeted behavior.

We and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and we and our affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

***Eligible Current Investors: Procedures for Brokers and Banks; DTC ATOP Account***

If you are an Eligible Current Investor, in order to accept the Rescission Offer on your behalf, your broker or bank must submit, or cause the DTC participant who holds the Applicable Securities on your behalf to submit, an Agent's Message (as defined below).

Kroll Issuer Services US (the "Rescission Agent"), on our behalf, will seek to establish an Automated Tender Offer Program ("ATOP") account with respect to the Subject Securities at DTC promptly after the delivery of this prospectus. Any financial institution that is a DTC participant, including your broker or bank, may make book-entry tender of Subject Securities by causing the book-entry transfer of such Subject Securities to our ATOP account in accordance with DTC's procedures for such transfers. Concurrently with the delivery of the Subject Securities, an Agent's Message in connection with such book-entry transfer must be transmitted by DTC to, and received by, the Rescission Agent on or prior to the Expiration Date. The confirmation of a book-entry transfer into the ATOP account as described above is referred to herein as a "Book-Entry Confirmation."

The term "Agent's Message" means a message transmitted by the DTC participants to DTC, and thereafter transmitted by DTC to the Rescission Agent, forming a part of the Book-Entry Confirmation which states that DTC has received an express acknowledgment from the DTC participant described in such Agent's Message stating that such DTC participant and beneficial owner agree to be bound by the terms of the Rescission Offer.

------

##### [**Table of Contents**](#toc)
Each Agent's Message must include the following information:

1. the name of the relevant DTC participant;

2. the phone number of the relevant DTC participant; and

3. any additional information deemed necessary by the DTC participant, subject to the applicable character limit.

BY SENDING AN AGENT'S MESSAGE, THE DTC PARTICIPANT IS DEEMED TO HAVE CERTIFIED THAT THE BENEFICIAL OWNER FOR WHOM THE SUBJECT SECURITIES ARE BEING TENDERED MEETS THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE CURRENT INVESTOR, STILL HOLDS SUCH SUBJECT SECURITIES AND HAS BEEN PROVIDED WITH A COPY OF THIS PROSPECTUS. WE MAY REQUIRE FURTHER DOCUMENTATION VERIFYING THIS INFORMATION.

The delivery of the Subject Securities through DTC, and any transmission of an Agent's Message through ATOP, is at the election and risk of the person tendering the Subject Securities. We will ask the Rescission Agent to instruct DTC to return those Subject Securities, if any, that were tendered through ATOP but were not accepted by the Issuer, to the DTC participant that tendered such Subject Securities on behalf of the holders of such Subject Securities. Neither we nor the Rescission Agent is responsible or liable for the return of such Subject Securities to the tendering DTC participants or to the beneficial owners, nor as to the time by which such return is completed.

We reserve the absolute right to reject any or all tenders of Subject Securities that are not in proper form, including, without limitation, lack of satisfactory records that the tendering holder is an Eligible Current Investor with respect to the Subject Securities tendered, or the acceptance of which, in our opinion, would be unlawful. We also reserve the right to waive any defects, irregularities or conditions of tender as to particular Subject Securities.

Our interpretation of the terms and conditions of the Rescission Offer, including, without limitation, the instructions in any Agent's Message, will be final and binding; however, an Eligible Current Investor may, in his, her, or its discretion, challenge the rejection of a tender of Applicable Securities and/or an interpretation of the terms and conditions of the Rescission Offer in a court of competent jurisdiction.

We encourage tenders of Applicable Securities to be submitted early. Any defect or irregularity in connection with tenders of Subject Securities must be cured on or before the Expiration Date, unless waived by us. Tenders of Subject Securities will not be deemed to have been made until all defects and irregularities have been waived by us or cured. Neither we, nor any other person, will be under any duty to give notice of any defects or irregularities in tenders of Subject Securities, or will incur any liability to Eligible Current Investors for failure to give any such notice.

***How to reject the Rescission Offer***

Regardless of whether you are an Eligible Current Investor or an Eligible Former Investor, you do not need to take any action to reject the Rescission Offer. If you do not accept the Rescission Offer on or before the Expiration Date, you will be deemed to have rejected the Rescission Offer and, if you are a Eligible Current Investor, and continue to hold any Subject Securities, you will receive interest payments on such Subject Securities at their stated rate and will be paid their principal amount in accordance with their terms, conditions and risk factors, each as described under "*Description of the Subject Securities*" and in the Issuance Prospectus. Furthermore, the Subject Securities not repurchased in the Rescission Offer will be deemed to have been offered and sold under an effective registration statement of which this prospectus forms a part.

If you had previously accepted the Rescission Offer but you change your decision and want to reject the Rescission Offer, you may withdraw your acceptance of the Rescission Offer at any time on or before the Expiration Date, pursuant to the instructions below. If you validly withdraw your acceptance of the Rescission

------

##### [**Table of Contents**](#toc)
Offer, you will be deemed to have rejected the Rescission Offer. While withdrawals may not be revoked, Subject Securities properly withdrawn may be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" above at any time on or before the Expiration Date.

<u>If you are an Eligible Current Investor</u>: For a withdrawal of tendered Subject Securities to be effective, you should contact your bank or broker where your Subject Securities are held and have them submit a properly transmitted "Requested Message" through ATOP, which must be received by the Rescission Agent through ATOP.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, YOU MUST INSTRUCT YOUR ACCOUNT REPRESENTATIVE AT THE BROKER OR BANK WHERE YOU HOLD YOUR SUBJECT SECURITIES IN TIME FOR YOUR TENDER OF SUBJECT SECURITIES TO BE WITHDRAWN ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER. WE WILL, IN OUR SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

PLEASE NOTE THAT DTC, ITS PARTICIPANTS AND THE BANKS OR BROKERS WHERE YOU HOLD YOUR SUBJECT SECURITIES WILL ESTABLISH THEIR OWN CUT-OFF DATES AND TIMES FOR THE WITHDRAWAL OF ANY TENDER OF THE SUBJECT SECURITIES, WHICH MAY BE EARLIER THAN THE EXPIRATION DATE.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or the tender of the Subject Securities or evidence of eligibility) or the calculation of the Rescission Offer Proceeds will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

Withdrawals of tenders of the Subject Securities by Eligible Current Investors may not be revoked, and any Subject Securities properly withdrawn will thereafter be deemed not validly tendered for purposes of the Rescission Offer. Properly withdrawn Subject Securities may, however, be re-tendered by following the procedures described in "*—How to accept the Rescission Offer*" and "*—Procedures for Brokers and Banks; DTC ATOP Account*" above, at any time prior to the Expiration Date.

<u>If you are an Eligible Former Investor</u>: If you change your decision and want to reject the Rescission Offer after having submitted a Former Investor Acceptance Form, you must complete, sign and date the accompanying Rescission Offer Withdrawal Form, included as Appendix B to this prospectus, and return it by uploading it to the Rescission Offer On-line Portal (which can be accessed at https://deals.is.kroll.com/UBSgroupAG), so that it is received by us on or before the Expiration Date.

The Rescission Offer Withdrawal Form must be legible. If you choose to withdraw and revoke your previous acceptance of the Rescission Offer, we recommend that you return the Rescission Offer Withdrawal Form sufficiently in advance of the Expiration Date to ensure its receipt by us by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, WE MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED RESCISSION OFFER WITHDRAWAL FORM ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER PURSUANT TO YOUR ELECTION ON THE LAST EFFECTIVE FORMER INVESTOR ACCEPTANCE FORM YOU SUBMITTED. WE WILL, IN OUR

------

##### [**Table of Contents**](#toc)
SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

Withdrawals of their acceptance of the Rescission Offer may not be revoked by Eligible Former Investors, and any such properly withdrawn acceptance will thereafter be deemed not a valid acceptance for purposes of the Rescission Offer. You may, however, re-accept the Rescission Offer by following the procedures described in "*—How to accept the Rescission Offer*" above, at any time prior to the Expiration Date.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election or tender of Subject Securities or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the withdrawal instructions or the Rescission Offer Withdrawal Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

**Other Terms and Conditions** 

The Rescission Offer will expire on the Expiration Date, which is 5:00 p.m., Eastern Standard Time, on , 2026, i.e., 30 days from the date of this prospectus (including the date of this prospectus and the Expiration Date), unless extended by us. We expressly reserve the right to extend the term of the Rescission Offer. During any extension of the term of the Rescission Offer, all Subject Securities previously tendered, not validly withdrawn and not yet accepted for rescission will remain subject to the Rescission Offer and may be accepted for rescission by us. To the extent we are legally permitted to do so, we expressly reserve the absolute right, in our sole discretion, to waive any condition to the Rescission Offer.

ALTHOUGH WE HAVE NO PRESENT PLANS OR ARRANGEMENTS TO DO SO, WE RESERVE THE RIGHT TO AMEND, AT ANY TIME, THE TERMS OF THE RESCISSION OFFER. WE WILL GIVE HOLDERS NOTICE OF ANY AMENDMENTS IF REQUIRED BY APPLICABLE LAW.

The conditions to the Rescission Offer are for our sole benefit and may be asserted by us in our sole discretion or may be waived by us, in whole or in part, in our sole discretion, whether or not any other condition of the Rescission Offer also is waived. We have not made a decision as to what circumstances would lead us to waive any condition, and any waiver would depend on circumstances prevailing at the time of that waiver. Any determination by us concerning the conditions described in this section shall be final and binding upon all persons, subject to the provision in the penultimate paragraph of the subsection entitled "—*Procedures for Brokers and Banks; DTC ATOP Account*."

Any waiver or amendment to the Rescission Offer will apply to all the Subject Securities that were tendered and to all acceptances of the Rescission Offer by Eligible Former Investors. If we make a material change in the terms of the Rescission Offer or if we waive a material condition of the Rescission Offer, we will disseminate additional Rescission Offer materials. If the amendment or waiver is made less than ten business days before the expiration of the Rescission Offer, we will extend the Rescission Offer so that holders have at least ten business days to accept, or withdraw acceptances to, the Rescission Offer.

We expressly reserve the right, in our sole discretion, to terminate the Rescission Offer if any of the conditions set forth in this prospectus have not been satisfied by the Eligible Investors or waived by us. In the event we terminate the Rescission Offer, we will notify you of the termination, and all Subject Securities previously tendered and not yet accepted for rescission will be returned promptly to the tendering holders.

If any Subject Securities tendered by Eligible Current Investors are not accepted for rescission for any reason, such Subject Securities will be returned, at our expense, to the tendering holder via book-entry transfer to the account maintained by the holder's broker or bank at DTC, promptly following the Expiration Date or the termination or withdrawal of the Rescission Offer. The holder's broker or bank will be responsible for crediting the transfer into the holder's individual account.

------

##### [**Table of Contents**](#toc)
We have engaged the Rescission Agent to facilitate and assist us with the acceptance procedures of the Rescission Offer for Eligible Investors. We have not retained, nor do we intend to retain, any person to make solicitations or recommendations to you in connection with the Rescission Offer.

None of us, our affiliates or the Rescission Agent, nor any of our, our affiliates' or the Rescission Agent's officers or directors may make or shall be deemed to have made any recommendations to you with respect to the Rescission Offer. We urge you to read this prospectus carefully and to make an independent evaluation with respect to the Rescission Offer.

**Funding the Rescission Offer** 

We will fund any payments required under the Rescission Offer from available cash.

**Questions about the Rescission Offer** 

If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, if you are an Eligible Former Investor, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance or withdrawal form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**DESCRIPTION OF THE SUBJECT SECURITIES** 

*The following description is only a summary of certain terms of the Subject Securities and the Indenture governing the Subject Securities. We urge you to read the form of note representing the Subject Securities and the Indenture in their entirety because these documents, which are filed as exhibits to the registration statement of which this prospectus forms a part, and not this summary, define the rights of holders of the Subject Securities. You may also request a copy of these documents from us. See "Where You Can Find More Information." The following summary does not purport to be complete and is subject to, and is qualified in its entirety by reference to, all of the provisions of the Indenture and those terms made a part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (the "Trust Indenture Act").* 

**Description of the Subject Securities** 

The description of the Subject Securities is incorporated in the registration statement of which this prospectus forms a part by reference to the section entitled "*Description of Debt Securities*" in the prospectus dated April 29, 2002 and the section entitled "*Description of Notes*" in the prospectus supplement filed by CS USA with the SEC on July 16, 2002 (film no. 02703849) in connection with the initial issuance of the Subject Securities under registration statement number 333-86720, as amended by Post-Effective Amendment No. 1 filed with the SEC on March 29, 2007, except for any portion of each such document that incorporates by reference CS USA's prior and future filings made with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act.

**Description of the Indenture** 

The Subject Securities were issued pursuant to the senior indenture dated as of June 1, 2001 (the "Base Indenture"), between CS USA and the Trustee, as supplemented by (i) the first supplemental indenture dated as of March 26, 2007 (the "First Supplemental Indenture"), among CSG, CS AG, CS USA and the Trustee, (ii) the second supplemental indenture dated as of June 9, 2023 (the "Second Supplemental Indenture"), among UBS Group AG, CSG, CS AG, CS USA and the Trustee; (iii) the third supplemental indenture dated as of May 30, 2024 (the "Third Supplemental Indenture"), among CS USA, UBS Group AG, CS AG, UBS AG and the Trustee and (iv) the fourth supplemental indenture dated as of February 2, 2026 (the "Fourth Supplemental Indenture"), among CS USA, UBS Americas, UBS Group AG, UBS AG and the Trustee. The Base Indenture as supplemented is referred to as the "Indenture."

The Indenture has been qualified under the Trust Indenture Act.

The description of the Base Indenture is incorporated in the registration statement by reference to the prospectus and prospectus supplement filed by CS USA in connection with the initial issuance of the Subject Securities. See the "*Description of the Guarantees*" and "*Subordination of the UBS Group AG Guarantee*" below for a description of the First Supplemental Indenture.

The Second Supplemental Indenture provides that, in accordance with the Indenture and by operation of Swiss law, effective upon completion of the Group Merger, UBS Group AG succeeded to, and was substituted for, and may exercise every right and power of, CSG under the CSG guarantee of the Subject Securities with the same effect as if UBS Group AG had been named as the "Group Guarantor" under the Indenture, the CSG guarantee of the Subject Securities and the Subject Securities. In addition, pursuant to the Second Supplemental Indenture, effective upon completion of the Group Merger, UBS Group AG (i) expressly assumed all of CSG's obligations under the CSG guarantee of the Subject Securities and the Indenture, on the terms and subject to the conditions set forth in the Indenture, and (ii) undertook in favor of each holder of Subject Securities to be bound by the terms and conditions of the CSG guarantee of the Subject Securities and the provisions of the Indenture, with the same effect as if UBS Group AG had been named as the "Group Guarantor" under the Indenture, the CSG guarantee of the Subject Securities and the Subject Securities.

The Third Supplemental Indenture provides that, in accordance with the Indenture and by operation of Swiss law, effective upon completion of the Parent Bank Merger, UBS AG succeeded to, and was substituted for,

------

##### [**Table of Contents**](#toc)
and may exercise every right and power of, CS AG under the CS AG guarantee of the Subject Securities with the same effect as if UBS AG had been named as the "Bank Guarantor" under the Indenture, the CS AG guarantee of the Subject Securities and the Subject Securities. In addition, pursuant to the Third Supplemental Indenture, effective upon completion of the Parent Bank Merger, UBS AG (i) expressly assumed all of CS AG's obligations under the CS AG guarantee of the Subject Securities and the Indenture, on the terms and subject to the conditions set forth in the Indenture, and (ii) undertook in favor of each holder of Subject Securities to be bound by the terms and conditions of the CS AG guarantee of the Subject Securities and the provisions of the Indenture, with the same effect as if UBS AG had been named as the "Bank Guarantor" under the Indenture, the CS AG guarantee of the Subject Securities and the Subject Securities.

The Fourth Supplemental Indenture provides that, in accordance with the Indenture, effective upon completion of the UBS Americas Merger, UBS Americas succeeded to, and was substituted for, and may exercise every right and power of, CS USA under the Subject Securities and the Indenture with the same effect as if UBS Americas had been named as the "Company" under the Indenture and the Subject Securities. In addition, pursuant to the Fourth Supplemental Indenture, effective upon completion of the UBS Americas Merger, UBS Americas (i) expressly assumed all of CS USA's obligations under the Subject Securities and the Indenture, on the terms and subject to the conditions set forth in the Indenture, and (ii) undertook in favor of each holder of Subject Securities to be bound by the terms and conditions of the Subject Securities and the provisions of the Indenture, with the same effect as if UBS Americas had been named as the "Company" under the Indenture and the Subject Securities.

**Description of the Guarantees** 

The Securities have been fully and unconditionally guaranteed by UBS Group AG and UBS AG on a several basis. If UBS Americas, for any reason, does not make a required payment in respect of the Subject Securities when due, whether on the normal due date, on acceleration, redemption or otherwise, either or both of UBS Group AG and UBS AG will cause the payment to be made to or to the order of the Trustee. The UBS Group AG guarantee is on a subordinated basis as described below. The holder of a Subject Security will be entitled to payment under the guarantees of UBS Group AG and UBS AG without taking any action whatsoever against UBS Americas.

The terms of the guarantees are set forth in the First Supplemental Indenture. CSG's obligations under its guarantee of the Subject Securities and under the Indenture were assumed by UBS Group AG pursuant to the Second Supplemental Indenture. CS AG's obligations under its guarantee of the Subject Securities and under the Indenture were assumed by UBS AG pursuant to the Third Supplemental Indenture.

**Subordination of the UBS Group AG Guarantee** 

The discussion of subordination in this section applies only to the guarantee by UBS Group AG of the Subject Securities.

When the term "senior indebtedness" is used in the context of this guarantee, it means:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any money UBS Group AG has borrowed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any money borrowed by someone else where UBS Group AG has assumed or guaranteed the obligations, directly or
indirectly;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any letters of credit and acceptances made by banks on UBS Group AG's behalf;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• indebtedness that UBS Group AG has incurred or assumed in connection with the acquisition of any property; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• all deferrals, renewals, extensions and refundings of, and amendments, modifications and supplements to, any of
the above.

------

##### [**Table of Contents**](#toc)
Senior indebtedness does not include any indebtedness that is expressed to be subordinated to or on par with the UBS Group AG guarantee of the Subject Securities or any money owed to UBS Group AG's subsidiaries.

The Indenture provides that UBS Group AG cannot:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• make any payments of principal or interest on the Subject Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• redeem any Subject Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• acquire any Subject Securities; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• defease any Subject Securities;

if

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any senior indebtedness in an aggregate principal amount of more than $100 million has become due either on
maturity or as a result of acceleration or otherwise and the principal, premium and interest on that senior indebtedness has not yet been paid in full by UBS Group AG; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UBS Group AG has defaulted in the payment of any principal, premium or interest on any senior indebtedness in an
aggregate principal amount of more than $100 million at the time the payment was due, unless and until the payment default is cured by UBS Group AG or waived by the holders of the senior indebtedness.

If UBS Group AG is liquidated, the holders of senior indebtedness will be entitled to receive payment in full in cash or cash equivalents for principal, premium and interest on the senior indebtedness before the holders of Subject Securities receive any of UBS Group AG's assets. As a result, holders of Subject Securities may receive a smaller proportion of UBS Group AG's assets in liquidation than holders of senior indebtedness.

Even if the subordination provisions prevent UBS Group AG from making any payment when due on the Subject Securities or its guarantee thereof, UBS Group AG will be in default on its obligations under the Indenture, if it does not make the payment when due. This means that the Trustee and the holders of the Subject Securities can take action against UBS Group AG, but they would not receive any money until the claims of the senior indebtedness have been fully satisfied.

The Indenture allows the holders of senior indebtedness to obtain specific performance of the subordination provisions from UBS Group AG.

------

##### [**Table of Contents**](#toc)
**UNITED STATES TAX CONSIDERATIONS** 

This section describes certain U.S. federal income tax consequences of the Rescission Offer and ownership of the Subject Securities to beneficial owners of Subject Securities. It applies to you only if you hold or have held your Subject Securities as capital assets for U.S. federal income tax purposes.

This section does not discuss all of the tax consequences applicable to you if you are a member of a class of holders subject to special rules, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a dealer in securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a tax-exempt organization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an insurance company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a person that holds or has held the Subject Securities as part of a straddle or a hedging or conversion
transaction for tax purposes or as part of a "synthetic security" or other integrated financial transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a person that purchases or sells the Subject Securities as part of a wash sale for tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a U.S. holder (as defined below) whose functional currency for tax purposes is not the U.S. dollar;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a bank;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an entity taxed as a partnership or the partners therein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• regulated investment company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a nonresident alien individual present in the United States for more than 182 days in a taxable year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a U.S. expatriate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a controlled foreign corporation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a non-U.S. holder (as defined below) that actually or constructively owns
10% or more of the combined voting power of the Issuer's voting stock or that is an individual present in the U.S. for 183 days or more in the year that it receives a payment in respect of the Subject Securities.

This summary does not address state, local or foreign taxes, the U.S. federal estate and gift taxes, the alternative minimum tax, taxes imposed pursuant to the Foreign Account Tax Compliance Act or the Medicare contribution tax applicable to net investment income of certain non-corporate U.S. holders.

This section is based on the Internal Revenue Code of 1986, as amended (the "Code"), its legislative history, existing and proposed regulations, published rulings and court decisions. These laws are subject to change, possibly on a retroactive basis.

You should consult your own tax adviser, as you deem appropriate, regarding the U.S. federal, state and local and other tax consequences of participating in the Rescission Offer and ownership of the Subject Securities.

You are a U.S. holder if you are a beneficial owner of the Subject Securities and you are, for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a citizen or resident of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a domestic corporation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• otherwise subject to U.S. federal income taxation on a net income basis in respect of the Subject Securities.

------

##### [**Table of Contents**](#toc)
You are a non-U.S. holder if you are a beneficial owner of the Subject Securities and you are, for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a nonresident alien individual,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a foreign corporation or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an estate or trust that in either case is not subject to U.S. federal income tax on a net income basis on income
or gain from the Subject Securities.

**U.S. Federal Income Tax Consequences of the Rescission Offer** 

This discussion assumes that the Issuer's position that the Subject Securities should be treated as debt for U.S. federal income tax purposes will be respected. See the Issuance Prospectus for a discussion of the tax treatment of the Subject Securities and possible alternative tax treatment of the Subject Securities.

*<u>U.S. Holders</u>*

*Tender of Subject Securities Pursuant to the Rescission Offer* 

This subsection addresses the tax treatment of a U.S. holder that disposes of its Subject Securities pursuant to the Rescission Offer.

Upon the tender of a Subject Security pursuant to the Rescission Offer, you generally will recognize taxable income or loss equal to the difference between the amount realized and your adjusted tax basis in the Subject Security. Although this prospectus uses the term "interest" when describing the calculation of the Rescission Offer Proceeds, the term is only intended to describe the method used to calculate the payment amount, and the payment is not considered interest for federal income tax purposes, but rather is included in the amount realized from the sale of the Subject Securities.

Your adjusted tax basis in a Subject Security will generally equal the amount that you paid for the Subject Security, increased by the amount of any market discount you previously included in gross income with respect to the Subject Security and reduced by the amount of any bond premium that you previously amortized with respect to the Subject Security. Your amount realized should equal the amount received in the Rescission Offer, except that a portion of such amount should be treated as a payment of interest for tax purposes to the extent of the accrued but unpaid interest on the Subject Securities at the time of the Rescission Offer. Such amount should be treated as U.S. source ordinary income to the extent that you did not previously include such amount in income.

Except to the extent that any gain is recharacterized as ordinary income pursuant to the market discount rules discussed below, any gain or loss that you recognize upon a disposition of the Subject Securities pursuant to the Rescission Offer generally will be capital gain or loss, and will be long-term capital gain or loss if you held the Subject Security for more than one year upon the disposition of the Subject Security. Certain non-corporate U.S. holders (including individuals) generally are eligible for preferential rates of U.S. federal income taxation in respect of long-term capital gains. The deductibility of capital losses is limited under the Code. Any gain or loss recognized by a U.S. holder pursuant to the Rescission Offer generally should be treated as U.S. source gain or loss.

If you acquired your Subject Securities with market discount, any gain realized upon the disposition of the Subject Securities pursuant to the Rescission Offer will be treated as ordinary income to the extent of the portion of the market discount that has accrued while you held such Subject Securities, unless you elected to include market discount in income currently as it accrues. You generally will be treated as having acquired the Subject Securities with market discount if the principal amount of the Subject Securities exceeds your purchase price for the Subject Securities by more than a statutory de minimis amount. Market discount will be considered to accrue

------

##### [**Table of Contents**](#toc)
ratably during the period from the date of that you acquired the Subject Securities to the maturity date of the Subject Securities, unless you elect to accrue market discount on a constant yield basis.

*Holders Who Disposed of their Subject Securities Prior to the Rescission Offer* 

If your Subject Securities were sold prior to the Rescission Offer, although not entirely clear, it is likely that the amount that you receive, if any, pursuant to the Rescission Offer should first be treated as capital gain to the extent of any capital loss you recognized in respect of the Subject Securities upon their sale or maturity. Any such capital gain should be long-term or short-term capital gain based on whether you recognized a long-term or short-term capital loss on the Subject Securities upon their maturity or disposition.

If the amount that you receive pursuant to the Rescission Offer exceeds the capital gain amount described above, it is likely that such excess amount should first be treated as ordinary interest income to the extent of the interest that accrued on such loss for purposes of determining the amount received under the Rescission Offer, and thereafter as ordinary income. However, other characterizations are possible. For example, it is possible that the IRS could assert that all or a portion of the capital gain amount described above should instead be treated as ordinary income. Accordingly, you should consult with your tax adviser regarding the tax treatment of amounts received pursuant to the Rescission Offer.

*<u>Non-U.S. Holders</u>*

This subsection addresses the tax treatment of a non-U.S. holder that disposes of its Subject Securities pursuant to the Rescission Offer.

If you are a non-U.S. holder, you should generally not subject to U.S. federal income of withholding tax on any income or gain recognized in respect of amounts received pursuant to the Rescission Offer, unless such income or gain is effectively connected with your conduct of a trade or business in the U.S. or, in case of interest income, you have you failed to properly provide the applicable withholding agent an IRS Form W-8BEN or W-8BEN-E (or other applicable form), signed under penalties of perjury, that includes your name and address and that certifies your non-U.S. status in compliance with applicable law and regulations.

You will generally be subject to U.S. federal income tax on income and gain recognized pursuant to the Rescission Offer that is effectively connected with your conduct of a trade or business in the U.S. in the same manner as a U.S. holder, unless an applicable income tax treaty provides otherwise. If you are treated as a foreign corporation for United States federal income tax purposes, you may also be subject to a branch profits tax at a 30% rate (or lower applicable treaty rate). If you fail to properly provide an IRS Form W-8BEN or W-8BEN-E (or other applicable form), you will generally be subject to withholding tax on interest income at a 30% rate, unless an applicable income tax treaty provides otherwise.

*<u>Information Reporting and Backup Withholding</u>*

You may be subject to information reporting with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules.

**U.S. Federal Income Tax Consequences of Ownership of Subject Securities** 

This section describes certain U.S. federal income tax consequences of ownership of the Subject Securities to beneficial owners of Subject Securities that purchase Subject Securities on or after the date hereof.

------

##### [**Table of Contents**](#toc)
*<u>U.S. Holders</u>*

*Payments or Accruals of Interest* 

Interest payments on the Subject Securities will be taxable to you as ordinary interest income at the time that you receive or accrue such amounts in accordance with your regular method of tax accounting (except that the portion of an interest payment that is allocable to the portion of your purchase price that relates to interest that accrued prior to your purchase of the Subject Securities, which this discussion refers to as "pre-purchase accrued interest," will not be included in income and will rather be treated as a non-taxable return of the pre-purchase accrued interest).

*Purchase, Sale and Retirement of Subject Securities* 

Your tax basis in the Subject Securities generally will equal the cost of the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest). Your basis will increase by any amounts that you are required to include in income under the rules described below governing market discount, and will decrease by the amount of any bond premium that you previously amortized with respect to the Subject Securities under the rules described below.

Upon the sale or maturity of the Subject Securities, you generally will recognize gain or loss equal to the difference between the amount you realize on the transaction (less any accrued interest, which will be treated in the manner described above under "—Payments or Accruals of Interest") and your tax basis in the Subject Securities.

Except as discussed below with respect to market discount, any gain or loss that you recognize upon the sale or maturity of the Subject Securities generally will be capital gain or loss and will be long-term capital gain or loss if you have held the Subject Securities for more than one year on the date of disposition. Net long-term capital gain recognized by an individual U.S. holder generally will be subject to tax at the lower rate than net short-term capital gain or ordinary income. The ability of U.S. holders to offset capital losses against ordinary income is limited.

*Premium* 

If you purchase the Subject Securities at a cost greater than the principal amount of the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest), you will be considered to have purchased the Subject Securities at a premium, and you may elect to amortize the premium as an offset to interest income, using a constant yield method, over the remaining term of the Subject Securities. If you make this election, it generally will apply to all debt instruments that you hold at the time of the election, as well as any debt instruments that you subsequently acquire. In addition, you may not revoke the election without the consent of the IRS. If you elect to amortize the premium, you will be required to reduce your tax basis in the Subject Securities by the amount of the premium amortized during your holding period. If you do not elect to amortize premium, the amount of premium will be included in your tax basis in the Subject Securities. Therefore, if you do not elect to amortize premium and you hold the Subject Securities to maturity, you generally will be required to treat the premium as capital loss when the Subject Securities mature.

*Market Discount* 

If the principal amount of the Subject Securities exceeds your purchase price for the Subject Securities (excluding the portion of the price allocable to pre-purchase accrued interest) by an amount at least equal to the product of (i) 0.25%, (ii) the principal amount of the Subject Securities and (iii) the remaining whole years to the maturity of the Subject Securities, the Subject Securities will be considered to bear "market discount." In this case, any gain that you realize on the sale or maturity of the Subject Securities generally will be treated as ordinary interest income to the extent of the market discount that accrued on the Subject Securities during your

------

##### [**Table of Contents**](#toc)
holding period. In addition, you may be required to defer the deduction of a portion of the interest paid on any indebtedness that you incurred or maintained to purchase or carry the Subject Securities. In general, market discount will be treated as accruing ratably over the term of the Subject Securities, or, at your election, under a constant yield method.

You may elect to include market discount in gross income currently as it accrues (on either a ratable or constant yield basis), in lieu of treating a portion of any gain realized on a sale of the Subject Securities as ordinary income. If you elect to include market discount on a current basis, the interest deduction deferral rule described above will not apply. If you do make such an election, it will apply to all market discount debt instruments that you acquire on or after the first day of the first taxable year to which the election applies. The election may not be revoked without the consent of the IRS.

*<u>Non-U.S. Holders</u>*

If you are a non-U.S. holder, you should generally not subject to U.S. federal income or withholding tax on any income or gain recognized in respect of the Subject Securities, unless such income or gain is effectively connected with your conduct of a trade or business in the U.S. or, in case of interest income, you have you failed to properly provide the applicable withholding an IRS Form W-8BEN or W-8BEN-E (or other applicable form), signed under penalties of perjury, that includes your name and address and that certifies your non-U.S. status in compliance with applicable law and regulations.

You will generally be subject to U.S. federal income tax on income and gain that is effectively connected with your conduct of a trade or business in the U.S. in the same manner as a U.S. holder, unless an applicable income tax treaty provides otherwise. If you are treated as a foreign corporation for United States federal income tax purposes, you may also be subject to a branch profits tax at a 30% rate (or lower applicable treaty rate). If you fail to properly provide an IRS Form W-8BEN or W-8BEN-E (or other applicable form), you will generally be subject to withholding tax on interest income at a 30% rate, unless an applicable income tax treaty provides otherwise.

*<u>Information Reporting and Backup Withholding</u>*

Information returns will be required to be filed with the IRS in connection with payments on the Subject Securities made to certain U.S. holders. If you are a U.S. holder, you generally will not be subject to a U.S. backup withholding tax (currently at a rate of 24%) on such payments if you provide your taxpayer identification number to the applicable withholding agent. You may also be subject to information reporting and backup withholding tax requirements with respect to the proceeds from a sale of the Subject Securities.

If you are a non-U.S. holder, payments of interest on the Subject Securities will generally be reportable on IRS Form 1042-S. Payments in respect of the Subject Securities would otherwise not be subject to information reporting and backup withholding, provided that the certification requirements described above under "— Non-U.S. Holders" are satisfied or you otherwise establish an exemption.

Any amounts withheld under the backup withholding rules may be allowed as a credit against the holder's U.S. federal income tax liability and may entitle the holder to a refund, provided that the required information is timely furnished to the IRS.

------

##### [**Table of Contents**](#toc)
**SWISS TAX CONSIDERATIONS** 

**Rescission Offer** 

The following is a summary of the principal tax consequences of accepting the Rescission Offer for Eligible Investors who are not residents of Switzerland for tax purposes and have no Swiss permanent establishment and do not conduct a Swiss-based trade or business. It does not address the tax treatment of Eligible Investors who are residents of Switzerland for tax purposes or who are subject to Swiss taxes for other reasons. This summary is based on legislation as of the date of this prospectus and does not aim to be a comprehensive description of all the Swiss tax considerations that may be relevant to a decision to accept the Rescission Offer.

*Withholding Tax* 

Whether you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, or an Eligible Former Investor who accepts the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer will not be subject to Swiss withholding tax.

*Securities Turnover Tax* 

If you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer may be subject to Swiss securities turnover tax at a rate of up to 0.15%, if a Swiss domestic (or Principality of Liechtenstein) securities dealer (as defined in the Swiss Federal Act on Stamp Duties of June 27, 1973, as amended) is a party to, or acts as an intermediary for, the transaction and no exemption applies in respect of one of the parties to the transaction.

*Income Taxation* 

Whether you are an Eligible Current Investor who tenders your Subject Securities pursuant to the Rescission Offer, or an Eligible Former Investor who accepts the Rescission Offer, the cash amount that you receive, if any, pursuant to the Recission Offer will not be subject to any Swiss federal, cantonal or communal income tax if (i) you are not a resident of Switzerland, (ii) if you are an Eligible Current Investor, during the relevant taxation year have not engaged in a trade or business through a permanent establishment or a fixed place of business in Switzerland to which the tendered Subject Securities are attributable, and (iii) are not subject to income taxation in Switzerland for any other reason, will not be subject to any Swiss federal, cantonal or communal income tax.

**Subject Securities** 

The following is a summary of the principal tax consequences of holding Subject Securities for investors who are not residents of Switzerland for tax purposes and have no Swiss permanent establishment and do not conduct a Swiss-based trade or business. It does not address the tax treatment of holders of Subject Securities who are residents of Switzerland for tax purposes or who are subject to Swiss taxes for other reasons. This summary is based on legislation as of the date of this prospectus and does not aim to be a comprehensive description of all the Swiss tax considerations that may be relevant to a decision to invest in Subject Securities.

*Withholding Tax* 

Neither payments of interest on, nor the repayment of principal of, the Subject Securities will be subject to Swiss federal withholding tax, even though they are guaranteed by UBS Group AG and UBS AG, provided that the net proceeds from the issue of the Subject Securities are used outside of Switzerland (except to the extent use in Switzerland is permitted under the Swiss taxation laws in force from time to time without payments in respect of the Subject Securities becoming subject to withholding or deduction for Swiss withholding tax as a consequence of such use of proceeds in Switzerland) and that UBS Americas is at all times resident and managed outside Switzerland for Swiss tax purposes.

------

##### [**Table of Contents**](#toc)
On April 3, 2020, the Swiss Federal Council published draft legislation and opened a consultation procedure regarding the reform of the Swiss withholding tax system applicable to interest on bonds. This draft legislation provided for, among other things, the replacement of the current debtor-based regime applicable to interest payments on bonds with a paying agent-based regime for Swiss withholding tax. Generally speaking, this proposed paying agent-based regime would have (i) subjected all interest payments on bonds made through paying agents in Switzerland to individuals resident in Switzerland to Swiss withholding tax, including any such interest payments made on bonds issued by entities organized in a jurisdiction outside Switzerland (such as UBS Americas), and (ii) exempted from Swiss withholding tax interest payments on bonds to all other persons, including to Swiss-domiciled legal entities and foreign investors (other than indirect interest payments through foreign and Swiss domestic collective investments vehicles). However, the results of the consultation, which ended on July 10, 2020, were controversial. Consequently, on April 15, 2021, the Swiss Federal Council submitted new draft legislation on the reform of the Swiss withholding tax system providing for the abolition of Swiss withholding tax on interest payments on bonds for submission to the Swiss Parliament, which legislation was accepted by the Swiss Parliament on December 17, 2021. The proposed legislation was rejected in a referendum held on September 25, 2022. In view of the rejection of this legislation, the Swiss Federal Council could again propose a paying agent-based regime as contemplated by the draft legislation published on April 3, 2020.

*Securities Turnover Tax* 

Neither the issue nor the redemption of the Subject Securities by the Issuer is subject to Swiss securities turnover tax.

The trading of the Subject Securities in the secondary market is subject to Swiss securities turnover tax at a rate of 0.3% of the consideration paid for the Subject Securities traded, if a Swiss domestic (or Principality of Liechtenstein) securities dealer (as defined in the Swiss Federal Act on Stamp Duties of June 27, 1973, as amended) is a party to, or acts as an intermediary for, the transaction and no exemption applies in respect of one of the parties to the transaction. In such case and subject to applicable statutory exemptions, typically half of the Swiss securities turnover tax is charged to one party to the transaction and the other half to the other party.

*Income Taxation* 

Payments by the Issuer of interest on and repayment of principal of the Subject Securities to, and the gain realized on the sale or redemption of Outstanding Subject Securities by, a holder of Subject Securities who (i) is not a resident of Switzerland, (ii) during the relevant taxation year has not engaged in a trade or business through a permanent establishment or a fixed place of business in Switzerland to which the Outstanding Subject Securities are attributable, and (iii) is not subject to income taxation in Switzerland for any other reason, will not be subject to any Swiss federal, cantonal or communal income tax.

*Automatic Exchange of Information in Tax Matters* 

Switzerland has concluded a multilateral agreement with the European Union (the "EU") on the international exchange of information ("AEOI") in tax matters, which applies to all EU member states and some other jurisdictions. In addition, Switzerland has signed the multilateral competent authority agreement on the automatic exchange of financial account information (the "MCAA"), and based on the MCAA, a number of bilateral AEOI agreements with other countries. Based on such agreements and the implementing laws of Switzerland, depending on the date of effectiveness of the applicable agreement, Switzerland collects and exchanges data in respect of financial assets (including any Subject Securities) held in, and income derived thereon and credited to, accounts or deposits with a paying agent in Switzerland for the benefit of individuals, entities and controlling persons (as applicable) resident in an EU member state or in another treaty state.

------

##### [**Table of Contents**](#toc)
*Swiss Facilitation of the Implementation of U.S. Foreign Account Tax Compliance Act* 

The United States and Switzerland entered into an intergovernmental agreement (the "current U.S.-Switzerland IGA") to facilitate the implementation of the U.S. Foreign Account Tax Compliance Act ("FATCA"). Under the current U.S.-Switzerland IGA, financial institutions acting out of Switzerland generally are directed to become participating foreign financial institutions. The current U.S.-Switzerland IGA ensures that accounts held by U.S. persons with Swiss financial institutions (including any such account in which a Subject Security is held) are disclosed to the U.S. tax authorities either with the consent of the account holder or by means of group requests within the scope of administrative assistance, on the basis of the Convention between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation (the "Double Taxation Treaty"). Since it was amended in 2019, the Double Taxation Treaty includes a mechanism for the exchange of information in tax matters upon request between Switzerland and the United States, which is in line with international standards, and allows the United States to make group requests under FATCA concerning non-consenting non-participating foreign financial institutions for periods from June 30, 2014.

On June 27, 2024, Switzerland and the United States signed a new intergovernmental agreement to facilitate the implementation of FATCA (the "new U.S.-Switzerland IGA") that will change the current direct notification-based regime that is in place under the current U.S.-Switzerland IGA to a regime where the relevant information is sent to the Swiss Federal Tax Administration, which in turn provides the information to the U.S. tax authorities. In Switzerland, the implementation of the new U.S.-Switzerland IGA requires an amendment to national law, which will be decided by the Swiss Federal Assembly. According to communication from the State Secretariat for International Finance SIF, such amendment is currently expected to enter into force in Switzerland on January 1, 2027. However, it is not possible to predict whether and when such amendment will be enacted.

------

##### [**Table of Contents**](#toc)
**BENEFIT PLAN INVESTOR CONSIDERATIONS** 

A fiduciary of a pension, profit-sharing or other employee benefit plan subject to the U.S. Employee Retirement Income Security Act of 1974, as amended ("ERISA") or any entity or account deemed to hold "plan assets" of the foregoing (each, a "Plan"), should consider the fiduciary standards of ERISA in the context of the Plan's particular circumstances before determining whether to accept or reject the Rescission Offer. Among other factors, the fiduciary should consider whether the acceptance or rejection of the Rescission Offer would satisfy the prudence and diversification requirements of ERISA and would be consistent with the documents and instruments governing the Plan, and whether such acceptance or rejection would involve a prohibited transaction under ERISA or the Code.

Section 406 of ERISA and Section 4975 of the Code prohibit Plans, as well as individual retirement accounts, Keogh plans, any other plans that are subject to Section 4975 of the Code and any entities or accounts deemed to hold "plan assets" of the foregoing (also "Plans"), from engaging in certain transactions involving "plan assets" with persons who are "parties in interest" under ERISA or "disqualified persons" under the Code with respect to the Plan. A violation of these prohibited transaction rules may result in excise tax or other liabilities under ERISA or the Code for those persons, unless exemptive relief is available under an applicable statutory, regulatory or administrative exemption. Employee benefit plans that are governmental plans (as defined in Section 3(32) of ERISA), certain church plans (as defined in Section 3(33) of ERISA) and non-U.S. plans (as described in Section 4(b)(4) of ERISA) ("Non-ERISA Arrangements") are not subject to the requirements of Section 406 of ERISA or Section 4975 of the Code but may be subject to similar provisions under applicable federal, state, local, non-U.S. or other laws ("Similar Laws").

UBS Group AG and/or any of its affiliates may be considered a party in interest or disqualified person with respect to a Plan or entity whose underlying assets include "plan assets" by reason of any Plan's investment in the entity (a "Plan Asset Entity"). The continued holding or tender in the Rescission Offer of the Subject Securities by a Plan or a Plan Asset Entity with respect to which UBS Group AG and/or any of its affiliates is or becomes a party in interest or disqualified person may result in a prohibited transaction under ERISA or Section 4975 of the Code, unless the continued holding or tender in the Rescission Offer of the Subject Securities is done pursuant to an applicable exemption.

The U.S. Department of Labor has issued five prohibited transaction class exemptions, or "PTCEs," that may provide exemptive relief if required for direct or indirect prohibited transactions that may arise from the continued holding or tender in the Rescission Offer of the Subject Securities. These exemptions are PTCE 84-14 (for certain transactions determined by independent qualified professional asset managers), PTCE 90-1 (for certain transactions involving insurance company pooled separate accounts), PTCE 91-38 (for certain transactions involving bank collective investment funds), PTCE 95-60 (for transactions involving certain insurance company general accounts), and PTCE 96-23 (for transactions managed by in-house asset managers).

In addition, ERISA Section 408(b)(17) and Section 4975(d)(20) of the Code provide an exemption for the purchase and sale of the Subject Securities, provided that neither UBS Group AG nor any of its affiliates has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Plan involved in the transaction, and provided further that the Plan pays no more and receives no less than "adequate consideration" in connection with the transaction (the "service provider exemption"). There can be no assurance that all of the conditions of any such exemptions will be satisfied.

Any holder of the Subject Securities or any interest therein or investor that accepts or rejects the Rescission Offer will be deemed to have represented by its holding of the Subject Securities or any interest therein or its acceptance or rejection of the Rescission Offer that either (1) it is not a Plan, Plan Asset Entity or Non-ERISA Arrangement and is not accepting or rejecting the Rescission Offer on behalf of, or in respect of the assets of, any Plan, Plan Asset Entity or Non-ERISA Arrangement or (2)(i) the holding of the Subject Securities or acceptance or rejection of the Rescission Offer will not constitute a non-exempt prohibited transaction under ERISA or the

------

##### [**Table of Contents**](#toc)
Code or a similar violation under any applicable Similar Laws and (ii) none of UBS Group AG or any of its affiliates directly or indirectly exercises any discretionary authority or control or renders investment advice or otherwise acts in a fiduciary capacity with respect to the assets of the Plan or Plan Asset Entity within the meaning of ERISA.

Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is important that fiduciaries or other persons considering whether to accept or reject the Rescission Offer on behalf of or with the assets of any Plan, Plan Asset Entity or Non-ERISA Arrangement consult with their counsel regarding the availability of exemptive relief under any of the PTCEs listed above, the service provider exemption or the potential consequences of any holding or tender in the Rescission Offer of the Subject Securities under Similar Laws, as applicable.

Persons holding the Subject Securities have exclusive responsibility for ensuring that their continued holding and disposition (including through the Rescission Offer) of the Subject Securities do not violate the fiduciary or prohibited transaction rules of ERISA or the Code or any similar provisions of Similar Laws. The repurchase of any Subject Security from a Plan, Plan Asset Entity or Non-ERISA Arrangement pursuant to the Rescission Offer is in no respect a representation by UBS Group AG or any of its affiliates or representatives that the rescission meets all relevant legal requirements applicable to any such Plans, Plan Asset Entities or Non-ERISA Arrangements generally or any particular Plan, Plan Asset Entity or Non-ERISA Arrangement, or that the rescission is appropriate for such Plans, Plan Asset Entities or Non-ERISA Arrangements generally or any particular Plan, Plan Asset Entity or Non-ERISA Arrangement.

------

##### [**Table of Contents**](#toc)
**PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)** 

This prospectus may be used by UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG in connection with offers and sales of the Subject Securities in market-making transactions, including following the tender of Subject Securities pursuant to the Rescission Offer. Market-making transactions may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. UBS Securities LLC, UBS Financial Services Inc. or any other affiliate of UBS Group AG may receive compensation in the form of discounts and commissions, including from both counterparties in some cases.

**Conflicts of Interest** 

UBS Securities LLC and UBS Financial Services Inc. are indirect subsidiaries of UBS Group AG. Financial Industry Regulatory Authority ("FINRA") Rule 5121 imposes certain requirements when a member of FINRA, such as UBS Securities LLC and UBS Financial Services Inc., distributes an affiliated company's securities. If UBS Securities LLC, UBS Financial Services Inc. or any of UBS Group AG's other U.S.-registered broker-dealer affiliates participate in the distribution of the Subject Securities, they will conduct the offers and sales of the Subject Securities in accordance with the applicable provisions of FINRA Rule 5121. In any offerings subject to FINRA Rule 5121, no underwriter will confirm initial sales to accounts over which it exercises discretionary authority without the prior written approval of the customer.

------

##### [**Table of Contents**](#toc)
**LEGAL MATTERS** 

Certain legal matters with respect to U.S. law relating to the Subject Securities will be passed upon for UBS Group AG, UBS AG and UBS Americas Inc. by their U.S. counsel, Sullivan & Cromwell LLP, London, England. Certain legal matters with respect to Swiss law relating to the Subject Securities will be passed upon for UBS Group AG and UBS AG by their Swiss counsel, Homburger AG, Zurich, Switzerland.

------

##### [**Table of Contents**](#toc)
**EXPERTS** 

The consolidated financial statements of UBS Group AG appearing in its Annual Report on Form 20-F for the year ended December 31, 2024, and the effectiveness of UBS Group AG's internal control over financial reporting as of December 31, 2024, have been audited by Ernst & Young Ltd, independent registered public accounting firm, as set forth in their reports thereon and included therein and incorporated herein by reference. Such consolidated financial statements and UBS Group AG management's assessments of the effectiveness of internal control over financial reporting as of December 31, 2024 have been so incorporated in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

The consolidated financial statements of UBS AG appearing in its Annual Report on Form 20-F for the year ended December 31, 2024 have been audited by Ernst & Young Ltd, independent registered public accounting firm, as set forth in their reports thereon and included therein and incorporated herein by reference. Such consolidated financial statements have been so incorporated in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

The financial statements of Credit Suisse AG incorporated herein by reference to the report of UBS AG on Form 6-K filed on March 28, 2024, as amended by the additional Form 6-K filed on May 7, 2024, have been so incorporated in reliance on the report of PricewaterhouseCoopers AG, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

------

##### [**Table of Contents**](#toc)
**EXPENSES** 

The following table sets forth the main costs and expenses in connection with this offering, all of which are estimated.

---

| | |
|:---|:---|
|  Securities and Exchange Commission registration fee | $585.0 |
|  Printing expenses | $193.0 |
|  Legal fees and expenses | $8306.0 |
|  Accountants' fees and expenses | $232.0 |
|  Miscellaneous | $27.0 |
|  Total | $9343.0 |

---

------

##### [**Table of Contents**](#toc)
**APPENDIX A** 

**FORMER INVESTOR ACCEPTANCE FORM** 

**Note: This Former Investor Acceptance Form is to be completed only if you are an Eligible Former Investor and you wish to accept the Rescission Offer.** 

**Please confirm the following:** In regard to the Subject Securities in respect of which this Rescission Offer is hereby accepted:

• I am an Eligible Former Investor: **Yes No** 

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE FORMER INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS AMERICAS INC. (THE "ISSUER"), UBS GROUP AG AND UBS AG. ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER AND YOU MEET THE REQUIREMENTS TO BE AN ELIGIBLE FORMER INVESTOR, PLEASE COMPLETE ANDSIGN THIS FORM AND UPLOAD YOUR SUPPORTING EVIDENCE PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Accepting the Rescission Offer**: In order to accept the Rescission Offer, you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Former Investor Acceptance Form and the accompanying acceptance agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Former Investor Acceptance Form on the On-Line Portal; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Complete this Former Investor Acceptance Form, together with the supporting evidence required herein, so that
it is received by UBS on or before 5:00 p.m., Eastern Standard Time, on    , 2026. The Former Investor Acceptance Form must be completed and submitted on the Rescission Offer On-line Portal, which can be found at
https://deals.is.kroll.com/UBSgroupAG.

To access the Rescission Offer On-line Portal, you will need to go to the Rescission Agent's website at https://deals.is.kroll.com/UBSgroupAG.The Rescission Offer On-line Portal will be operated by the Rescission Agent. By completing the registration process for the Rescission Offer On-line Portal, you are authorizing the Rescission Agent to communicate with you on behalf of UBS. If you have technical difficulties, you may contact the Rescission Agent at UBSRescission@is.kroll.com.

This Former Investor Acceptance Form and the supporting evidence that you submit through the Rescission Offer On-line Portal must be legible. If you choose to accept the Rescission Offer, UBS recommends that you complete this Former Investor Acceptance Form and your supporting evidence sufficiently in advance of the Expiration Date to ensure its receipt by UBS by the deadline specified above. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
Supporting evidence must be uploaded into the Rescission Offer On-line Portal in PDF, Doc, Docx, JPEG, JPG or PNG file formats. You may upload up to one file per upload field with a maximum size of 100 MB per file. If you have multiple documents, you will need to upload into one upload field. You may also combine the documents into one before uploading. If you have technical difficulties submitting your Former Investor Acceptance Form or your supporting evidence, you may submit your claim through the Rescission Offer On-line Portal and email any necessary supporting material to UBSRescission@is.kroll.com. within 48 hours of when your claim is submitted for processing but in no event later than the Expiration Date. When you email the supporting evidence for your claim, you must include the confirmation number you receive after submitting the Former Investor Acceptance Form through the Rescission Offer On-line Portal in the subject line of your email. If you do not submit your supporting evidence within 48 hours or do not include the confirmation number you receive after submitting the Former Investor Acceptance Form in the subject line of your email, your claim may be automatically rejected and you will be required to file a new claim if you wish to accept the Rescission Offer.

UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED FORMER INVESTOR ACCEPTANCE FORM AND APPROPRIATE SUPPORTING EVIDENCE ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR FORMER INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE FORMER INVESTOR TO ACCEPT THE RESCISSION OFFER.

You may be subject to information reporting requirements of the Internal Revenue Service (the "IRS") with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or this Former Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion. We reserve the right to, at any time, request any additional information or evidence that we may deem reasonably appropriate to demonstrate that you meet the eligibility requirements to be considered an Eligible Former Investor.

Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date, or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Former Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

If you are an Eligible Former Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms set forth in the Prospectus, we will cause payment of the Rescission Offer

------

##### [**Table of Contents**](#toc)
Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date.

***Questions:*** If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**CLAIM DETAILS** 

*Please complete a separate version of this form for each Applicable Transaction pursuant to which you purchased Subject Securities and the Applicable Disposition pursuant to which you sold such Subject Securities for a loss, in each case, in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. If you sold in an Applicable Disposition part of a lot of Subject Securities that you purchased in an Applicable Transaction and still hold part of that lot and wish to accept the Rescission Offer with respect to the entire lot, please complete the Current Investor Acceptance Form with respect to the part of the lot that you still hold and this Former Investor Acceptance Form with respect to the part of the lot that you sold in an Applicable Disposition.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETED THROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Pursuant to the Prospectus, please note that you may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof.* 

*Further, please note that you must complete one version of this table online through the portal and complete one copy of your signed Former Investor Acceptance Form with respect to each Applicable Transaction pursuant to which you purchased Subject Securities and the Applicable Disposition pursuant to which you sold such Subject Securities for a loss, in each case, in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. Thus, if you bought 1,000 of Subject Security X on two different days, and sold all 2,000 at the same time in an Applicable Disposition, you must file two claims through the portal, one for each Applicable Transaction. If you purchased 2,000 of Subject Security X at the same time in a single Applicable Transaction, and sold 1,000 of Subject Security X for a loss on two different days in two separate Applicable Dispositions, you must file two claims through the portal, one for each Applicable Disposition. For the avoidance of doubt, you must submit one form for each Applicable Transaction and Applicable Disposition. Multiple transactions should not be included in one Acceptance Form Submission.* 

PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL (1) EVIDENCE OF PURCHASE OF THE SUBJECT SECURITIES IN AN APPLICABLE TRANSACTION; (2) EVIDENCE OF THE SALE OF SUCH SUBJECT SECURITIES AT A LOSS IN AN APPLICABLE DISPOSITION; AND (3) IF APPLICABLE, EVIDENCE OF YOUR AUTHORITY TO ACCEPT THIS RESCISSION OFFER ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (E.G., CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.).

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Claimant's Identifying Information<sup>(1)</sup>** | **Claimant's Identifying Information<sup>(1)</sup>** |
| Full Name\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Company (If Filing for an Entity) | *Please provide this information through the Rescission Offer On-line Portal* |
| Phone Number\*<sup>(2)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 1\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| City\* | *Please provide this information through the Rescission Offer On-line Portal* |
| State/Province/Region\* | *Please provide this information through the Rescission Offer On-line Portal* |
| ZIP/Postal Code\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Country\* | *Please provide this information through the Rescission Offer On-line Portal* |
| **Purchase in an Applicable Transaction Information** | **Purchase in an Applicable Transaction Information** |
| CUSIP\*<sup>(3)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Subject Securities\*<sup>(4)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Purchased\*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Trade Date\*<sup>(6)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Settlement Date\*<sup>(7)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Purchase Price\*<sup>(8)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| **Sale in an Applicable Disposition Information** | **Sale in an Applicable Disposition Information** |
| Date of Sale or Redemption\*<sup>(11)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Sale or Redemption Price\*<sup>(12)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Sold or Redeemed\*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Loss on Sale of the Subject Securities\*<sup>(13)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Total Interest, Coupon Payments, Principal, or other Income Received\*<sup>(14)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |

---

**<u>Notes</u>:** 

\* Fields marked with \* are mandatory.

------

##### [**Table of Contents**](#toc)
(1) If you are filing a claim on behalf of yourself, then please provide your details. If you are filing a claim on
behalf of a corporate entity, provide a business address and phone number. If you are filing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are filing.

(3) Provide the CUSIP of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "CUSIP No.; ISIN No." under "*The Rescission Offer—Terms of the Rescission Offer* — *Subject Securities*" in the Prospectus.

(4) Provide the name of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "*Title of Security*" under "*The Rescission Offer—Terms of the Rescission Offer—Subject Securities*" in the Prospectus.

(5) Include the quantity of purchased Subject Securities in respect of which the Rescission Offer is accepted. As
an example, an Eligible Former Investor accepting the Rescission Offer in respect of $10,000,000 in a series of Subject Securities with a minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof, would disclose a quantity
of 10,000.

(6) Provide the date you agreed to purchase the Subject Securities in respect of which the Rescission Offer is
accepted.

(7) Provide the date you received the Subject Securities in respect of which the Rescission Offer is accepted.

(8) Include the price in U.S. dollars at which you purchased the Subject Securities in an Applicable Transaction
for the acquisition of the quantity of Subject Securities described in the third line above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Former Investor accepting the Rescission Offer in respect of 100 Subject
Securities purchased at a price of $1,000 per Subject Security, would disclose a purchase price of $1,000. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(9) Include the reference number or other identification number, if any, assigned to the relevant Applicable
Transaction to help us identify the transaction in the evidence that you submit in support of your claim. If you do not have a Transaction Reference Number, please put "N/A" in this field.

(10) Provide the name of the party with whom you transacted with respect to your relevant purchase and, if
applicable, sale of Subject Securities in respect of which the Rescission Offer is accepted.

(11) Provide the settlement date of the Applicable Disposition of the Subject Securities with respect to which you
are accepting the Rescission Offer and filing a claim.

(12) Include the price in U.S. dollars that you received for the sale of the quantity of Subject Securities
described in the line immediately above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Former Investor accepting the Rescission Offer in respect of 100 Subject Securities sold at a price of $900 per Subject
Security, would disclose a sale price of $900. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(13) Include the amount of loss you are claiming that you incurred as a result of the sale of the Subject Securities
in respect of which the Rescission Offer is accepted. For the avoidance of doubt, the loss should reflect only the sale of the Subject Security on this submission. Holders will need to submit one form for each Applicable Transaction and Applicable
Disposition.

(14) Include the total amount of any interest, coupon payments, principal or other income received by the Eligible
Former Investor on the Applicable Security.

------

##### [**Table of Contents**](#toc)
**RESCISSION OFFER ACCEPTANCE AGREEMENT** 

The undersigned acknowledges receipt of the Prospectus of UBS Americas Inc., UBS Group AG and UBS AG in respect of the Rescission Offer, pursuant to which UBS Americas Inc. offers to rescind the previous purchase of the Subject Securities listed and described under "*The Rescission Offer—Terms of the Rescission Offer—Subject Securities*" in the Prospectus that were acquired by the undersigned in an Applicable Transaction and that were sold by the undersigned in an Applicable Disposition.

**Effective as of the Expiration Date, the undersigned hereby accepts the Rescission Offer for the Subject Securities indicated in this Former Investor Acceptance Form upon the terms and subject to the conditions set forth in the Prospectus, and directs UBS to credit all proceeds to which it is entitled pursuant to the Rescission Offer to the undersigned's bank account, details of which have been provided by the undersigned to UBS.** 

**1. <u>Representations and Warranties, Acknowledgements and Agreements</u>:** By accepting the Rescission Offer, the undersigned hereby represents and warrants, acknowledges to, and agrees with, UBS that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the undersigned has received and reviewed the information contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the undersigned elects to accept the Rescission Offer with respect to the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal), and understands that he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. the undersigned meets the eligibility requirements to be considered an Eligible Former Investor, as set out under "The *Rescission Offer—Terms of the Rescission Offer*—*Eligibility Requirements*" in the Prospectus, including that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned purchased the Subject Securities in respect of which the Rescission Offer is accepted during
the Relevant Period from UBS Group AG or an affiliate of UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. the undersigned no longer held the Subject Securities in respect of which the Rescission Offer is accepted as
at the date of the Prospectus, and such Subject Securities were sold at a loss (provided that the undersigned continuously held such relevant Subject Security until the time of sale);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. the undersigned was the beneficial owner or is the authorized representative of the former beneficial owner of those Subject Securities in respect of which the Rescission Offer is accepted when acquired during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG, and has full power and authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. in evaluating the Rescission Offer and in making the decision whether to participate therein, the undersigned has made his, her or its own independent appraisal of the matters referred to in the Prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to the undersigned by UBS other than those contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. the undersigned is not a Sanctioned Person (as defined below) and none of its Subsidiaries (as defined below) is a Sanctioned Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. the undersigned will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other Person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as defined below), or (y) in any other manner; in each case that would result in a violation of Sanctions (as defined below) or constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. the undersigned acknowledges and agrees that any violation of items (1.f) or (1.g) above constitutes a material change in the commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned acknowledges and agrees that (i) any interest, coupon payments, principal or other income received on the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal) pursuant to their terms received by the undersigned prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to the Prospectus and (ii) the undersigned will repay to UBS Americas Inc. any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. the undersigned understands that UBS and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made herein are at any time prior to the consummation of the Rescission Offer no longer accurate, the undersigned shall promptly notify UBS and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. any documentation provided to us evidencing the foregoing acknowledgements, representations and warranties is true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. the undersigned's participation in the Rescission Offer will not constitute or result in a violation of any provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. the undersigned will execute any further documents and give any further assurances that may be required in connection with any of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

The undersigned acknowledges and agrees that the Company and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and the Company and its affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

For purposes of this document, the term: (i) "**Person**" means any natural person, corporation, limited partnership, general partnership, limited liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign government or agency, instrumentality, or political subdivision, territory, or similar entity or organization; (ii) "**Sanctionable Activity**" means any condition or activity specifically identified under any Sanctions as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described by such condition; (iii) "**Sanctioned Territory**" means any country or territory with which dealings are broadly and comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria); (iv) "**Sanctioned Person**" means any Person with whom dealings are restricted or prohibited under any Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory, or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); (v) "**Sanctions**" means all national and supranational laws, regulations, decrees, orders, or other acts with force of law of the United States, Switzerland, the United Kingdom, or the European Union, or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking of assets of targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any Laws threatening to impose such trade and economic sanctions on any person for engaging in proscribed or targeted behavior; and (vi) "**undersigned**" means you, if filing on behalf of yourself, or the Eligible Former Investor that is the claimant, if filing on behalf of another person or entity.

------

##### [**Table of Contents**](#toc)
**2. <u>Release of Liability</u>**. The undersigned, in consideration of the payment of the Rescission Offer Proceeds under the Rescission Offer in respect of the loss incurred upon the disposition of the Subject Securities specified herein in an Applicable Disposition, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, hereby, acting on his or her own behalf and, if it is not the beneficial owner of the Subject Securities specified in this Former Investor Acceptance Form, on behalf of such beneficial owner, irrevocably releases, discharges and acquits forever UBS Group AG, each of its subsidiaries, including UBS Americas Inc., and other affiliates, and each of its past and present officers, directors, stockholders, employees, agents, attorneys, successors and assigns from any and all claims, demands, rights, causes of action, liabilities and damages whatsoever, whether in law or equity, that the undersigned and the undersigned's successors and assigns ever had, or now has, based in any way upon, related in any way to, or arising in any way from, out of or in connection with, the offer and sale of the Subject Securities during the Relevant Period by UBS Group AG or an affiliate of UBS Group AG, including but not limited to, any violation of federal, state or territorial securities laws or regulations.

------

##### [**Table of Contents**](#toc)
**Bank Account Details to Receive Wire Transfer:** 

---

| | |
|:---|:---|
| **Domestic Wire Transfer** | **Domestic Wire Transfer** |
| Bank Account Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Account Number | *Please provide this information through the Rescission Offer On-line Portal* |
| ABA/Routing Number | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Address | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 3 | *Please provide this information through the Rescission Offer On-line Portal* |

---

---

| | |
|:---|:---|
| **International Wire Transfer** | **International Wire Transfer** |
| Intermediary Bank Name (Bank 1): | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank State: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank SWIFT code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank Name (End Bank): | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank SWIFT Code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| IBAN/Acct #: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2: | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| Signature(s) of Eligible Former Investor(s) or Authorized Representatives | Signature(s) of Eligible Former Investor(s) or Authorized Representatives |
| Dated<u> </u>, 2026 | Dated<u> </u>, 2026 |
| Name(s) of Eligible Former Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Former Investor): |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**<u>INSTRUCTIONS:</u>**

***1. Evidence.***

To accept the Rescission Offer, an Eligible Former Investor must provide evidence to the following effects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. A signed acceptance agreement, a form of which is included in this Appendix A, by which the Eligible Former
Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements set forth in the Prospectus; <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. Satisfactory evidence that the Eligible Former Investor purchased the Subject Security in an Applicable
Transaction (i.e., the Subject Security is an Applicable Security) and that such Applicable Security subsequently was sold in a *bona fide* transaction at a loss. For such purposes, the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG during the Relevant Period, (ii) purchase price information of such Applicable Security and (iii) the subsequent Applicable Disposition (and sale price information, as applicable) of such Applicable Security
before the date of the Prospectus, and demonstrating the continued holding of such Applicable Security until the time of the Applicable Disposition; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) With respect to an Applicable Transaction: receipt, transaction or trade confirmation statement reflecting, for
an Applicable Transaction during the Relevant Period, UBS Group AG or an affiliate of UBS Group AG as a principal seller of such Applicable Security in such Applicable Transaction; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) With respect to an Applicable Disposition: receipt, transaction or trade confirmation statement reflecting such
Applicable Security being sold, including the date, price and other relevant details of the sale; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) With respect to the loss as a result of an Applicable Disposition: tax documents, such as IRS Form 1099 B,
evidencing the losses incurred on the Applicable Disposition of such Applicable Security prior to the date of the Prospectus.

**2. *Signatures.***

*Exact Signatures.* The signature(s) on this Former Investor Acceptance Form must correspond with the name(s) as indicated elsewhere in this Former Investor Acceptance Form.

*Joint Holders*. If any of the Subject Securities that are the subject of this Former Investor Acceptance Form are owned of record by two or more joint owners, all such owners must sign this Former Investor Acceptance Form.

*Signature of Fiduciaries*. If this Former Investor Acceptance Form is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and provide proper evidence satisfactory to UBS of such person's authority so to act.

***3. Backup Withholding and Information Reporting.***

The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service ("IRS"). To avoid the imposition of backup withholding, an Eligible Former Investor should complete the applicable IRS withholding form (W-9 or W-8) which can be obtained at the website of the Internal Revenue Service at www.irs.gov. Certain offerees (including, among others, corporations and certain foreign persons) are exempt from these backup withholding and information reporting requirements, but may be required to establish their entitlement to an exception. If UBS is not provided with the correct TIN or an adequate basis for exemption, an Eligible Former Investor may be subject to a backup withholding tax on the gross proceeds received in the Rescission Offer. If backup withholding results in an overpayment of taxes, a refund or credit may be obtained, provided that the required information is provided to the IRS.

------

##### [**Table of Contents**](#toc)
**APPENDIX B** 

**RESCISSION OFFER WITHDRAWAL FORM** 

**Note: This Rescission Offer Withdrawal Form is to be completed only if you have previously completed and returned a Former Investor Acceptance Form, but no longer wish to participate in the Rescission Offer. If you have previously completed and returned a Current Investor Acceptance Form and tendered the relevant Subject Securities, you should contact your bank or broker where your Subject Securities are held and have them submit a properly transmitted "Requested Message" through ATOP, which must be received by the Rescission Agent through ATOP.** YOU MUST INSTRUCT YOUR ACCOUNT REPRESENTATIVE AT THE BROKER OR BANK WHERE YOU HOLD YOUR SUBJECT SECURITIES IN TIME FOR YOUR TENDER OF SUBJECT SECURITIES TO BE WITHDRAWN ON OR BEFORE THE EXPIRATION DATE (AS DEFINED BELOW).

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS AMERICAS INC., UBS GROUP AG AND UBS AG. ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER AND HAVE NOT COMPLETED AND RETURNED A RESCISSION OFFER ACCEPTANCE FORM, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER UNLESS YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER BY COMPLETING AND RETURNING A RESCISSION OFFER ACCEPTANCE FORM.

IF YOU HAVE PREVIOUSLY COMPLETED AND RETURNED A RESCISSION OFFER ACCEPTANCE FORM, BUT NO LONGER WISH TO ACCEPT THE RESCISSION OFFER, YOU MAY REVOKE YOUR ACCEPTANCE. IN ORDER TO REVOKE YOUR ACCEPTANCE, YOU MUST COMPLETE, SIGN AND RETURN THIS RESCISSION OFFER WITHDRAWAL FORM PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Revoking your previous acceptance of the Rescission Offer*:*** If you have previously completed and returned a Former Investor Acceptance Form but no longer wish to participate in the Rescission Offer, in order to revoke your acceptance you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Rescission Offer Withdrawal Form;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Rescission Offer Withdrawal Form, including the "Details of Claim Being
Withdrawn" below; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Return this Rescission Offer Withdrawal Form by completing it on the Rescission Offer On-line Portal which may be accessed at https://deals.is.kroll.com/UBSgroupAG, so that it is received by UBS on or before the Expiration Date.

This Rescission Offer Withdrawal Form must be legible. If you choose to revoke your previous acceptance of the Rescission Offer, UBS recommends that you complete this Rescission Offer Withdrawal Form sufficiently in

------

##### [**Table of Contents**](#toc)
advance of the Expiration Date to ensure its receipt by UBS by the Expiration Date. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

IF YOU HAVE PREVIOUSLY ACCEPTED THE RESCISSION OFFER AND YOU CHANGE YOUR ELECTION, UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED RESCISSION OFFER WITHDRAWAL FORM ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE ACCEPTED THE RESCISSION OFFER PURSUANT TO YOUR ELECTION ON THE LAST EFFECTIVE FORMER INVESTOR ACCEPTANCE FORM YOU SUBMITTED. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR RESCISSION OFFER WITHDRAWAL FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE ELIGIBLE TO WITHDRAW YOUR ACCEPTANCE OF THE RESCISSION OFFER.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election or tender of Subject Securities or evidence of eligibility), the calculation of the Rescission Offer Proceeds or the withdrawal instructions or this Rescission Offer Withdrawal Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion.

***Questions***: If you have questions or require additional information about the Rescission Offer acceptance or withdrawal procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer Withdrawal Form will be available through the Rescission Offer On-line Portal.

**Effective as of the Expiration Date, the undersigned hereby revokes acceptance of the Rescission Offer for the following Subject Securities described under "Details of Claim Being Withdrawn" below. All of the instructions and covenants set forth in the Former Investor Acceptance Form that were previously completed by the undersigned are hereby revoked.** 

For purposes of this document, the term "undersigned" means you, if filing on behalf of yourself, or the Eligible Former Investor that was the claimant, if filing on behalf of another person or entity.

------

##### [**Table of Contents**](#toc)
**DETAILS OF CLAIM BEING WITHDRAWN** 

*Please complete a separate version of this form for each claim that you previously submitted and now wish to withdraw.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETED THROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Please note that, in order to withdraw your claim, you must provide, on the Rescission Offer On-line Portal (1) the Kroll Confirmation Number that you previously received when submitting your claim* 

IF APPLICABLE, PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL EVIDENCE OF YOUR AUTHORITY TO SUBMIT THIS RESCISSION OFFER WITHDRAWAL FORM ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (e.g. CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.), IF SUCH EVIDENCE HAS NOT ALREADY BEEN SUBMITTED.

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;**Claimant's Identifying Information<sup>(1)</sup>** |
| &nbsp;&nbsp;&nbsp;Full Name\* |
| &nbsp;&nbsp;&nbsp;Company (If Filing for an Entity) |
| &nbsp;&nbsp;&nbsp;Phone Number\*<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;Address Line 1\* |
| &nbsp;&nbsp;&nbsp;Address Line 2 |
| &nbsp;&nbsp;&nbsp;City\* |
| &nbsp;&nbsp;&nbsp;State/Province/Region\* |
| &nbsp;&nbsp;&nbsp;ZIP/Postal Code\* |
| &nbsp;&nbsp;&nbsp;Country\* |
| &nbsp;&nbsp;&nbsp;Kroll Confirmation Number\*<sup>(3)</sup> |

---

<u>Notes:</u> 

\* Fields marked with \* are mandatory.

(1) If you are withdrawing a claim on behalf of yourself, then please provide your details below. If you are
withdrawing a claim on behalf of a corporate entity, provide a business address and phone number. If you are withdrawing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are withdrawing. This phone
number may be different than the phone number provided for receipt of text messages in connection with the account registration process.

(3) Provide the confirmation number provided to you by Kroll, upon submitting your Former Investor Acceptance Form,
corresponding to the rescission offer acceptance you are seeking to withdraw.

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| Signature(s) of Eligible Former Investor(s) or Authorized Representatives | Signature(s) of Eligible Former Investor(s) or Authorized Representatives |
| Dated<u> </u>, 2026 | Dated<u> </u>, 2026 |
| Name(s) of Eligible Former Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Former Investor): |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Former Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**APPENDIX C** 

**CURRENT INVESTOR ACCEPTANCE FORM** 

**Note: This Current Investor Acceptance Form is to be completed only if you are an Eligible Current Investor and you wish to accept the Rescission Offer.** 

**Please confirm the following**: In regard to the Subject Securities in respect of which this Rescission Offer is hereby accepted:

• I am an Eligible Current Investor: **Yes     No** 

IF YOU MEET THE REQUIREMENTS TO BE CONSIDERED AN ELIGIBLE CURRENT INVESTOR, YOU MAY ELECT TO ACCEPT OR REJECT THE RESCISSION OFFER PURSUANT TO THE TERMS AND CONDITIONS OF THE PROSPECTUS DATED , 2026 (THE "PROSPECTUS") OF UBS AMERICAS INC. (THE "ISSUER"). ALL TERMS USED BUT NOT OTHERWISE DEFINED IN THIS FORM HAVE THE MEANING ATTRIBUTED TO THEM IN THE PROSPECTUS.

IF YOU WISH TO REJECT THE RESCISSION OFFER, DO NOT RETURN THIS FORM. YOU DO NOT NEED TO DO ANYTHING TO REJECT THE RESCISSION OFFER.

IF YOU WISH TO ACCEPT THE RESCISSION OFFER AND YOU MEET THE REQUIREMENTS TO BE AN ELIGIBLE CURRENT INVESTOR, PLEASE COMPLETE AND SIGN COMPLETE THIS FORM AND UPLOAD YOUR SUPPORTING EVIDENCE PURSUANT TO THE INSTRUCTIONS BELOW AND ENSURE ITS RECEIPT BY UBS BY 5:00 P.M., EASTERN STANDARD TIME, ON , 2026 (THE "EXPIRATION DATE"), WHICH IS 30 DAYS FROM THE DATE OF THE PROSPECTUS (INCLUDING THE DATE OF THE PROSPECTUS AND THE EXPIRATION DATE).

WE URGE YOU TO REVIEW THE PROSPECTUS CAREFULLY BEFORE DECIDING WHETHER TO ACCEPT OR REJECT THE RESCISSION OFFER. WE ALSO ADVISE YOU TO CONSULT YOUR FINANCIAL, LEGAL, AND TAX ADVISERS, AS YOU DEEM APPROPRIATE, BEFORE MAKING ANY DECISION WITH RESPECT TO THE RESCISSION OFFER.

**Accepting the Rescission Offer**: In order to accept the Rescission Offer, you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Read carefully this Current Investor Acceptance Form and the accompanying acceptance agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Complete, sign and date this Current Investor Acceptance Form on the On-Line Portal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Complete this Current Investor Acceptance Form, together with the supporting evidence required herein, so that
it is received by UBS on or before 5:00 p.m., Eastern Standard Time, on    , 2026. The Current Investor Acceptance Form must be completed and submitted on the Rescission Offer On-line Portal, which can be found at
https://deals.is.kroll.com/UBSgroupAG.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Instruct your broker or bank through which your relevant Applicable Securities are held in time for such
Applicable Securities to be tendered to us through ATOP on or before the Expiration Date

To access the Rescission Offer On-line Portal, you will need to go to the Rescission Agent's website at https://deals.is.kroll.com/UBSgroupAG. The Rescission Offer On-line Portal will be operated by the Rescission Agent. By completing the registration process for the Rescission Offer On-line Portal, you are authorizing the Rescission Agent to communicate with you on behalf of UBS. If you have technical difficulties, you may contact the Rescission Agent at UBSRescission@is.kroll.com.

This Current Investor Acceptance Form and the supporting evidence that you submit through the Rescission Offer On-line Portal must be legible. If you choose to accept the Rescission Offer, UBS recommends that you

------

##### [**Table of Contents**](#toc)
complete this Current Investor Acceptance Form and upload your supporting evidence sufficiently in advance of the Expiration Date to ensure its receipt by UBS by the deadline specified above. Submission will be deemed made only when a confirmation that the upload was successfully completed is displayed in the Rescission Offer On-line Portal.

Supporting evidence must be uploaded into the Rescission Offer On-line Portal in PDF, Doc, Docx, JPEG, JPG or PNG file formats. You may upload up to one file per upload field with a maximum size of 100 MB per file. If you have multiple documents, you will need to upload into one upload field. You may also combine the documents into one before uploading. If you have technical difficulties submitting your Current Investor Acceptance Form or your supporting evidence, you may submit your claim through the Rescission Offer On-line Portal and email any necessary supporting material UBSRescission@is.kroll.com within 48 hours of when your claim is submitted for processing but in no event later than the Expiration Date. When you email the supporting evidence for your claim, you must include the confirmation number you receive after submitting the Current Investor Acceptance Form through the Rescission Offer On-line Portal in the subject line of your email. If you do not submit your supporting evidence within 48 hours or do not include the confirmation number you receive after submitting the Current Investor Acceptance in the subject line of your email, your claim may be automatically rejected and you will be required to file a new claim if you wish to accept the Rescission Offer.

UBS MUST RECEIVE YOUR LEGIBLE AND PROPERLY COMPLETED CURRENT INVESTOR ACCEPTANCE FORM AND APPROPRIATE SUPPORTING EVIDENCE ON OR BEFORE THE EXPIRATION DATE. OTHERWISE, YOU WILL BE DEEMED TO HAVE REJECTED THE RESCISSION OFFER. UBS WILL, IN ITS SOLE DISCRETION, DETERMINE WHETHER YOUR CURRENT INVESTOR ACCEPTANCE FORM HAS BEEN PROPERLY COMPLETED AND TIMELY RECEIVED AND WHETHER YOU ARE AN ELIGIBLE CURRENT INVESTOR TO ACCEPT THE RESCISSION OFFER.

**Your valid acceptance of the Rescission Offer will be conditioned upon the tender of your Subject Security to us. If you are an Eligible Current Investor, in order to accept the Rescission Offer on your behalf, your broker or bank must submit, or cause The Depository Trust Company ("DTC") participant who holds your Subject Security on your behalf to submit, an Agent's Message in accordance with the procedures described in the Prospectus under "The Recission Offer—Acceptance or Rejection of the Rescission Offer—*Eligible Current Investors: Procedures for Brokers and Banks; DTC ATOP Account*". Please note, all positions will be blocked from trading once tendered in accordance with the procedures described in the Prospectus.** 

You may be subject to information reporting requirements of the Internal Revenue Service (the "IRS") with respect to amounts received pursuant to the Rescission Offer. You may also be subject to backup withholding on such payments unless you provide proof of an applicable exemption or a correct taxpayer identification number and otherwise comply with applicable requirements of the backup withholding rules. Before the settlement of the Rescission Offer Proceeds, U.S. holders (which include U.S. citizens and residents) will need to complete and return the IRS Form W-9 and non-U.S. holders will need to complete IRS Form W-8. Please review the section entitled "*United States Tax Considerations*" to determine if you qualify as a U.S. holder or a non-U.S. holder. You may participate in the Rescission Offer even if you do not complete your IRS withholding form (W-9 or W-8). However, if your properly completed IRS withholding form (W-9 or W-8) is not received before the settlement of the Rescission Offer Proceeds, we may be required to withhold additional amounts from the Rescission Offer Proceeds and the IRS may impose certain penalties.

All determinations with respect to the Rescission Offer (including issues relating to the timeliness or effectiveness of any election, withdrawal or evidence of eligibility), the calculation of the Rescission Offer Proceeds or this Current Investor Acceptance Form will be made by us, in our sole discretion, which determinations shall be final and binding, absent manifest error determined by us in our sole discretion. We reserve the right to, at any time, request any additional information or evidence that we may deem reasonably appropriate to demonstrate that you meet the eligibility requirements to be considered an Eligible Current Investor.

------

##### [**Table of Contents**](#toc)
Upon receipt and review of the evidence package submitted with your acceptance of the Rescission Offer, we may, in our sole discretion, but are under no obligation to, inform you of any insufficiency or inconsistency identified in the evidence provided and give you the opportunity to supplement the evidence as required, provided such supplemental evidence is received by us on or before the Expiration Date. For the avoidance of doubt, we are under no obligation to accept any evidence submission after the Expiration Date, or to provide a cure period for insufficient or inconsistent evidence. We expect to make a final determination as to whether you meet the requirements to be considered an Eligible Current Investor no later than the date that is five business days after the Expiration Date, provided that the timing of such determination may vary based on the volume and complexity of the evidence submitted.

If you are an Eligible Current Investor and you validly accept the Rescission Offer on or before the Expiration Date in accordance with the terms set forth in the Prospectus, we will cause payment of the Rescission Offer Proceeds to be made to you as soon as reasonably practicable after the Expiration Date (the date of such payment, the "Settlement Date"). The Settlement Date is expected to occur no later than the tenth business day following the Expiration Date.

***Questions****:* If you have questions or require additional information about the Rescission Offer acceptance procedures, you may contact the broker, bank or other institution through which you purchased your relevant Subject Security. In addition, information regarding how to obtain technical support in relation to the submission of your Rescission Offer acceptance form and supporting evidence of eligibility will be available through the Rescission Offer On-line Portal.

------

##### [**Table of Contents**](#toc)
**CLAIM DETAILS** 

*Please complete a separate version of this form for each Applicable Transaction pursuant to which you purchased Subject Securities in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. If you sold in an Applicable Disposition part of a lot of Subject Securities that you purchased in an Applicable Transaction and still hold part of that lot and wish to accept the Rescission Offer with respect to the entire lot, please complete this Current Investor Acceptance Form with respect to the part of the lot that you still hold and the Former Investor Acceptance Form with respect to the part of the lot that you sold in an Applicable Disposition.* 

NOTE THAT THE RESCISSION OFFER ON-LINE PORTAL WILL INCLUDE AN ON-LINE VERSION OF THE TABLE BELOW THAT SHOULD BE COMPLETED ELECTRONICALLY. YOU SHOULD <u>NOT</u> COMPLETE THE TABLE BELOW IN THE SIGNED PAPER FORM THAT WILL BE COMPLETED THROUGH THE ON-LINE RESCISSION OFFER PORTAL.

*Pursuant to the Prospectus, please note that you may accept the Rescission Offer for any number of Applicable Securities, as long as such acceptance is for Subject Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof.* 

*Further, please note that you must complete one version of this table online through the portal and complete one copy of your signed Current Investor Acceptance Form with respect to each Applicable Transaction pursuant to which you purchased Subject Securities in respect of which the Rescission Offer is to be accepted and you wish to submit a claim for processing. Thus, if you bought 1,000 of Subject Security X on two different days, you must file two claims through the portal, one for each Applicable Transaction. For the avoidance of doubt, you must submit one form for each Applicable Transaction. Multiple transactions should not be included in one Acceptance Form Submission.* 

PLEASE UPLOAD TO THE RESCISSION OFFER ON-LINE PORTAL (1) EVIDENCE OF PURCHASE OF THE SUBJECT SECURITIES IN AN APPLICABLE TRANSACTION AND (2) IF APPLICABLE, EVIDENCE OF YOUR AUTHORITY TO ACCEPT THIS RESCISSION OFFER ON BEHALF OF ANY PARTY FOR WHOM YOU ARE ACTING (E.G., CORPORATE RESOLUTION, TRUST AGREEMENT, POWER OF ATTORNEY, ETC.).

---

| | |
|:---|:---|
| **Claimant's Identifying Information<sup>(1)</sup>** | **Claimant's Identifying Information<sup>(1)</sup>** |
| Full Name\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Company (If Filing for an Entity) | *Please provide this information through the Rescission Offer On-line Portal* |
| Phone Number\*<sup>(2)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 1\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Address Line 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| City\* | *Please provide this information through the Rescission Offer On-line Portal* |
| State/Province/Region\* | *Please provide this information through the Rescission Offer On-line Portal* |
| ZIP/Postal Code\* | *Please provide this information through the Rescission Offer On-line Portal* |
| Country\* | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Purchase in an Applicable Transaction Information** | **Purchase in an Applicable Transaction Information** |
| CUSIP\*<sup>(3)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Subject Securities\*<sup>(4)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Nominal Amount of Bonds Purchased\*<sup>(5)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Trade Date\*<sup>(6)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Settlement Date\*<sup>(7)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Purchase Price\*<sup>(8)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Transaction Reference Number<sup>(9)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Counterparty\*<sup>(10)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| Total Interest, Coupon Payments, Principal, or other Income Received\*<sup>(11)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| **Tender of Securities<sup>(12)</sup>** | **Tender of Securities<sup>(12)</sup>** |
| Quantity Tendered\*<sup>(13)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| VOI (ATOP Confirmation Number) or Euroclear/Clearstream Reference Number\*<sup>(14)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| DTC Participant Number\*<sup>(15)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |
| DTC Participant Name\*<sup>(16)</sup> | *Please provide this information through the Rescission Offer On-line Portal* |

---

**<u>Notes</u>:** 

\* Fields marked with \* are mandatory.

(1) If you are filing a claim on behalf of yourself, then please provide your details. If you are filing a claim on
behalf of a corporate entity, provide a business address and phone number. If you are filing a claim on behalf of a person you are authorized to represent, provide that person's details.

(2) Provide a phone number that we can use to call you regarding the claim that you are filing.

(3) Provide the CUSIP of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "CUSIP No.; ISIN No." under "The Rescission Offer—Terms of the Rescission Offer— *Subject Securities*" in the Prospectus.

(4) Provide the name of the relevant series of Subject Securities in respect of which the Rescission Offer is
accepted as indicated in the column titled "Title of Security" under "The Rescission Offer—Terms of the Rescission Offer— *Subject Securities*" in the Prospectus.

(5) Include the quantity of purchased Subject Securities in respect of which the Rescission Offer is accepted. As
an example, an Eligible Current Investor accepting the Rescission Offer in respect of $10,000,000 in a series of Subject Securities with a minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof, would disclose a quantity
of 10,000.

(6) Provide the date you agreed to purchase the Subject Securities in respect of which the Rescission Offer is
accepted.

(7) Provide the date you received the Subject Securities in respect of which the Rescission Offer is accepted.

(8) Include the price in U.S. dollars at which you purchased the Subject Securities in an Applicable Transaction
for the acquisition of the quantity of Subject Securities described in the third line above and in respect of which the Rescission Offer is accepted. As an example, an Eligible Current Investor accepting the Rescission Offer in respect of 100
Subject Securities purchased at a price of $1,000 per Subject Security,

------

##### [**Table of Contents**](#toc)
would disclose a purchase price of $1,000. This price should exclude any accrued interest, fees, selling concessions or other additional amounts.

(9) Include the reference number or other identification number, if any, assigned to the relevant Applicable
Transaction to help us identify the transaction in the evidence that you submit in support of your claim. If you do not have a Transaction Reference Number, please put "N/A" in this field.

(10) Provide the name of the party with whom you transacted with respect to your relevant purchase of Subject
Securities in respect of which the Rescission Offer is accepted.

(11) Include the total amount of any interest, coupon payments, principal or other income received by the Eligible
Current Investor on the Applicable Security.

(12) You may accept the Rescission Offer for any number of Subject Securities, as long as such acceptance is for
Subject Securities in the minimum denomination of $1,000, and integral multiples of $1,000 in excess thereof. THIS FIELD SHOULD ONLY BE USED TO ACCEPT THE RESCISSION OFFER IN RESPECT OF SUBJECT SECURITIES HELD BY YOU AS AN ELIGIBLE CURRENT INVESTOR.

(13) Provide the quantity of Subject Securities for which you are accepting the Rescission Offer and filing a claim
and have coordinated to have your bank or broker tender into DTC's ATOP platform.

(14) Provide the VOI or ATOP Confirmation Number provided to your bank or broker after they tendered your securities
though DTC's ATOP platform. This is a 14 unique character ID that is generated by DTC once your broker or bank tenders your position. If you hold through Euroclear or Clearstream you will need to provide the unique reference number provided to
them once they tender your position. Please work with your bank or broker to obtain this information.

(15) Provide the DTC participant number associated with your bank or broker. Please work with your bank or broker to
obtain this information.

(16) Provide the DTC participant name associated with your bank or broker. Please work with your bank or broker to
obtain this information.

------

##### [**Table of Contents**](#toc)
**RESCISSION OFFER ACCEPTANCE AGREEMENT** 

The undersigned acknowledges receipt of the Prospectus of UBS Americas Inc., UBS Group AG and UBS AG in respect of the Rescission Offer, pursuant to which UBS Americas Inc. offers to rescind the previous purchase of the Subject Securities listed and described under "The Rescission Offer—Terms of the Rescission Offer—*Subject Securities*" in the Prospectus that were acquired by the undersigned in an Applicable Transaction.

**Effective as of the Expiration Date, the undersigned hereby accepts the Rescission Offer for the Subject Securities indicated in this Current Investor Acceptance Form upon the terms and subject to the conditions set forth in the Prospectus, and directs UBS to credit all proceeds to which it is entitled pursuant to the Rescission Offer to the undersigned's bank or broker through DTC or the undersigned's bank account, details of which have been provided by the undersigned to UBS. If the proceeds are delivered through DTC, they will be sent to the undersigned's bank or broker, and it will be up to the applicable bank or broker to distribute the proceeds to their applicable clients.** 

1. **<u>Representations and Warranties, Acknowledgements and Agreements</u>**: By accepting the Rescission Offer, the undersigned hereby represents and warrants, acknowledges to, and agrees with, UBS that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the undersigned has received and reviewed the information contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. the undersigned elects to accept the Rescission Offer with respect to the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal), and understands that he, she or it will no longer be entitled to any payments on such Subject Securities beyond those received in the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. the undersigned meets the eligibility requirements to be considered an Eligible Current Investor, as set out under "The Rescission Offer—Terms of the Rescission Offer—*Eligibility Requirements*" in the Prospectus, including that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned purchased the Subject Securities in respect of which the Rescission Offer is accepted during the Relevant Period from UBS Group AG or an affiliate of UBS Group AG;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. the undersigned has continued to hold the Subject Securities in respect of which the Rescission Offer is accepted until the date of the Prospectus, and will continue to hold such Subject Securities (unless and until tendered through ATOP pursuant to the Rescission Offer) until the Expiration Date, free and clear of any liens, charges, claims, encumbrances, interests and restrictions of any kind, and UBS Americas Inc. will acquire good, indefeasible and unencumbered title to such Subject Securities, free and clear of all liens, charges, claims, encumbrances, interests and restrictions of any kind, when the tender of the same is accepted by UBS Americas Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. the undersigned is the beneficial owner or is the authorized representative of the beneficial owner of those Subject Securities in respect of which the Rescission Offer is accepted, and has full power and authority to accept the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. the undersigned will not sell, pledge, hypothecate or otherwise encumber or transfer any Subject Securities in respect of which he, she or it is accepting the Rescission Offer, from the date of acceptance of the Rescission Offer, and agrees that any purported sale, pledge, hypothecation or other encumbrance or transfer will be void and of no effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. in evaluating the Rescission Offer and in making the decision whether to participate therein, the undersigned has made his, her or its own independent appraisal of the matters referred to in the Prospectus and in any related communications and is not relying on any statement, representation or warranty, express or implied, made to the undersigned by UBS other than those contained in the Prospectus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. the undersigned is not a Sanctioned Person (as defined below) and none of its Subsidiaries (as defined below) is a Sanctioned Person;

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. the undersigned will not, directly or indirectly, use the Rescission Offer Proceeds, or lend, contribute, or otherwise make available the Rescission Offer Proceeds to any subsidiary, agent, joint venture partner, or other Person: (x) to fund or facilitate any activities or business of, with, in, or relating to any Sanctioned Person or Sanctioned Territory (as defined below), or (y) in any other manner; in each case that would result in a violation of Sanctions (as defined below) or constitute Sanctionable Activity (as defined below) under Sanctions with respect to any person participating in the Rescission Offer, whether as Issuer, Eligible Investor, or otherwise or would result in a violation of any applicable anti-money laundering, anti-terrorism or anti-corruption laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the undersigned acknowledges and agrees that any violation of items (1.g) or (1.h) above constitutes a material change in the commercial risks and benefits of the transactions contemplated hereby;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. the undersigned acknowledges and agrees that (i) any interest, coupon payments, principal or other income due on the Subject Securities specified in the box entitled "Claim Details" above (based on the information provided by the undersigned through the Rescission Offer On-line Portal) pursuant to their terms received by the undersigned prior to or during the Rescission Offer, or following the Expiration Date, will be deducted from the Rescission Offer Proceeds pursuant to the Prospectus and (ii) the undersigned will repay to UBS any such amounts that, for any operational or technical reason or otherwise, were not deducted from the Rescission Offer Proceeds prior to those being paid to the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. the undersigned understands that UBS and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties and agrees that if any of the acknowledgements, representations and warranties made herein are at any time prior to the consummation of the Rescission Offer no longer accurate, the undersigned shall promptly notify UBS and that any such acknowledgement, representation or warranty not being true and accurate when given and/or ceasing so to be true and accurate may invalidate any acceptance of the Rescission Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. if delivering the Subject Securities as a fiduciary or agent for one or more investor accounts, the undersigned has sole investment discretion with respect to each such account and full power to make the foregoing acknowledgements, representations and warranties on behalf of such account;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. any documentation provided to us evidencing the foregoing acknowledgements, representations and warranties is true, correct and complete;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n. the undersigned's participation in the Rescission Offer will not constitute or result in a violation of any provisions of applicable U.S. federal, state, local or foreign law; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o. the undersigned will execute any further documents and give any further assurances that may be required in connection with any of the foregoing, in each case on and subject to the terms and conditions applicable to the Rescission Offer.

The undersigned acknowledges and agrees that the Company and others will rely upon the truth and accuracy of the foregoing acknowledgements, representations and warranties for purposes of the Rescission Offer, and the Company and its affiliates reserve the right to take all actions available at law or in equity to recover any losses incurred as a result of such reliance in case any of the foregoing acknowledgements, representations and warranties proves to be inaccurate, incorrect, false or misleading.

For purposes of this document, the term: (i) "**Person**" means any natural person, corporation, limited partnership, general partnership, limited liability company, limited liability partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust, or other organization, whether or not it is a legal entity, and any sovereign government or agency, instrumentality, or political subdivision, territory, or similar entity or organization; (ii) "**Sanctionable Activity**" means any condition or activity specifically identified under any Sanctions as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described by such condition; (iii) "**Sanctioned Territory**" means any country or territory with which dealings are broadly and comprehensively prohibited by any country-wide or territory-wide Sanctions (as of the

------

##### [**Table of Contents**](#toc)
date hereof, Crimea, Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine, Cuba, Iran, North Korea, and Syria); (iv) "**Sanctioned Person**" means any Person with whom dealings are restricted or prohibited under any Sanctions, including as a result of: (a) being named on any list of Persons subject to Sanctions, (b) being located, organized, or resident in, or directly or indirectly owned or controlled by the government of, any Sanctioned Territory, or (c) any direct or indirect relationship of ownership, control, or agency with, or any direct or indirect commercial dealings with, a Person described in (a) or (b); (v) "**Sanctions**" means all national and supranational laws, regulations, decrees, orders, or other acts with force of law of the United States, Switzerland, the United Kingdom, or the European Union, or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking of assets of targeted Persons; or other restrictions on exports, imports, investment, payments, or other transactions targeted at particular Persons or countries, including any Laws threatening to impose such trade and economic sanctions on any person for engaging in proscribed or targeted behavior; and (vi) "**undersigned**" means you, if filing on behalf of yourself, or the Eligible Current Investor that is the claimant, if filing on behalf of another person or entity.

2. **<u>Release of Liability</u>**. The undersigned, in consideration of the payment of the Rescission Offer Proceeds under the Rescission Offer in respect of the tendered Subject Securities specified herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, hereby, acting on his or her own behalf and, if it is not the beneficial owner of the Subject Securities specified in this Current Investor Acceptance Form, on behalf of such beneficial owner, irrevocably releases, discharges and acquits forever UBS Group AG, each of its subsidiaries, including UBS Americas Inc., and other affiliates, and each of its past and present officers, directors, stockholders, employees, agents, attorneys, successors and assigns from any and all claims, demands, rights, causes of action, liabilities and damages whatsoever, whether in law or equity, that the undersigned and the undersigned's successors and assigns ever had, or now has, based in any way upon, related in any way to, or arising in any way from, out of or in connection with, the offer and sale of the Subject Securities during the Relevant Period by UBS Group AG or an affiliate of UBS Group AG, including but not limited to, any violation of federal, state or territorial securities laws or regulations.

------

##### [**Table of Contents**](#toc)
**Bank Account Details to Receive Wire Transfer:** 

---

| | |
|:---|:---|
| **Domestic Wire Transfer** | **Domestic Wire Transfer** |
| Bank Account Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Account Number | *Please provide this information through the Rescission Offer On-line Portal* |
| ABA/Routing Number | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Name | *Please provide this information through the Rescission Offer On-line Portal* |
| Bank Address | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2 | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 3 | *Please provide this information through the Rescission Offer On-line Portal* |

---

---

| | |
|:---|:---|
| **International Wire Transfer** | **International Wire Transfer** |
| Intermediary Bank Name (Bank 1): | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank State: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Intermediary Bank SWIFT code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank Name (End Bank): | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Address: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) City: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Zip Code/Postal Code: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank (End Bank) Country: | *Please provide this information through the Rescission Offer On-line Portal* |
| Beneficiary Bank SWIFT Code/BIC: | *Please provide this information through the Rescission Offer On-line Portal* |
| IBAN/Acct #: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 1: | *Please provide this information through the Rescission Offer On-line Portal* |
| Wire Reference 2: | *Please provide this information through the Rescission Offer On-line Portal* |

---

------

##### [**Table of Contents**](#toc)
**IMPORTANT** 

**CLAIMANT(S): SIGN HERE** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature(s) of Eligible Current Investor(s) or Authorized Representatives | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature(s) of Eligible Current Investor(s) or Authorized Representatives |
| Dated<u> </u>, 2026 | Dated<u> </u>, 2026 |
| Name(s) of Eligible Current Investor(s) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Company (If Filing for an Entity) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Name of Authorized Representative (If Filing for an Entity or for an individual Eligible Current Investor): |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Print) |
| Capacity<sup>(1)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Please Provide Full Title) |
| Address<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Zip Code) |
| Daytime Telephone No.<sup>(2)</sup>: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Include Area Code) |
| Email Address<sup>(2)</sup>: |  |

---

(1) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Current Investor, you must submit evidence of your authority to complete this agreement (e.g., corporate resolution, trust agreement, power of attorney, etc.) or the claim will be rejected.

(2) If this agreement is being completed by an authorized representative on behalf of an entity or an individual
Eligible Current Investor, the authorized representative completing this claim should provide their contact details here.

------

##### [**Table of Contents**](#toc)
**INSTRUCTIONS:** 

***1. Evidence.***

To accept the Rescission Offer, an Eligible Current Investor must provide evidence to the following effects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. A signed acceptance agreement, a form of which is included in this Appendix C, by which the Eligible Current
Investor provides, at a minimum, the representations and warranties, acknowledgements and agreements set forth in the Prospectus; <u>and</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. Satisfactory evidence that the Eligible Current Investor purchased the Subject Security in an Applicable
Transaction (i.e., the Subject Security is an Applicable Security) and that such Eligible Current Investor continues to hold such Applicable Security as of the date of the Prospectus, and will continue to hold it (unless and until tendered through
ATOP pursuant to the Rescission Offer) until the Expiration Date. For such purposes, the Issuer is prepared to accept the following evidence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Account statement(s) reflecting (i) the purchase of such Applicable Security from UBS Group AG or an
affiliate of UBS Group AG during the Relevant Period and (ii) purchase price information of such Applicable Security, and demonstrating the continued holding of such Applicable Security until at least the date of the Prospectus; <u>and/or</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Receipt, transaction or trade confirmation statement reflecting UBS Group AG or an affiliate of UBS Group AG as
a principal seller of such Applicable Security in such Applicable Transaction.

***2. Signatures.***

*Exact Signatures.* The signature(s) on this Current Investor Acceptance Form must correspond with the name(s) as indicated elsewhere in this Current Investor Acceptance Form.

*Joint Holders*. If any of the Subject Securities that are the subject of this Current Investor Acceptance Form are owned of record by two or more joint owners, all such owners must sign this Current Investor Acceptance Form.

*Signature of Fiduciaries*. If this Current Investor Acceptance Form is signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and provide proper evidence satisfactory to UBS of such person's authority so to act.

***3. Backup Withholding and Information Reporting.***

The disposal of the Subject Securities pursuant to the Rescission Offer may be subject to information reporting requirements of the Internal Revenue Service ("IRS"). To avoid the imposition of backup withholding, an Eligible Current Investor should complete the applicable IRS withholding form (W-9 or W-8) which can be obtained at the website of the Internal Revenue Service at www.irs.gov. Certain offerees (including, among others, corporations and certain foreign persons) are exempt from these backup withholding and information reporting requirements, but may be required to establish their entitlement to an exception. If UBS is not provided with the correct TIN or an adequate basis for exemption, an Eligible Current Investor may be subject to a backup withholding tax on the gross proceeds received in the Rescission Offer. If backup withholding results in an overpayment of taxes, a refund or credit may be obtained, provided that the required information is provided to the IRS.

------

##### [**Table of Contents**](#toc)
**PART II** 

**INFORMATION NOT REQUIRED IN PROSPECTUS** 

**Item 8. Indemnification of Directors and Officers** 

**UBS Group AG and UBS AG** 

Under Swiss law, directors and senior officers acting in violation of their statutory duties, whether dealing with bona fide third parties or performing any other acts on behalf of the company, may become liable to the company, its shareholders and (in bankruptcy) its creditors for damages. The directors' liability is joint and several but only to the extent the damage is attributable to each director based on willful or negligent violation of duty. If the board of directors lawfully delegated the power to carry out day-to-day management to a different corporate body, such as an executive board, the board of directors is not vicariously liable for the acts of the members of the executive board. Instead, the directors can be held liable for their failure to properly select, instruct or supervise the executive board members. If directors and officers enter into a transaction on behalf of the company with bona fide third parties in violation of their statutory duties, the transaction is nevertheless valid as long as it is not excluded by the company's business purpose.

UBS Group AG and UBS AG are Swiss companies and are headquartered in Switzerland and a number of their respective directors and officers are residents of Switzerland and not the United States. As a result, U.S. investors may find it difficult to serve legal process on UBS Group AG, UBS AG or their respective directors and executive officers or have any of them appear in a U.S. court. Furthermore, the United States and Switzerland do not currently have a treaty providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. Consequently, a final judgment rendered against UBS Group AG or UBS AG (or any of their respective directors or executive officers that are residents of Switzerland) by any U.S. federal or state court for payment would not automatically be enforceable in Switzerland and it may be difficult for you to enforce any such judgment in Switzerland against UBS Group AG or UBS AG (or such directors or executive officers). In addition, there is doubt as to the enforceability in Switzerland, in original actions or in actions for enforcement of judgments of U.S. courts, of liabilities predicated solely upon the federal or state securities laws of the United States.

Under Swiss law, a company may indemnify its directors or officers against losses and expenses (unless such losses and expenses result from such director's or officer's gross negligence or willful misconduct), including attorney's fees, judgments, fines and settlement amounts actually and reasonably incurred in a civil or criminal action, suit or proceeding by reason of having been the representative of or serving at the request of the company.

The Articles of Association of UBS Group AG and UBS AG, respectively, as well as Swiss statutory law, contain no provisions regarding the indemnification of directors and officers. According to general principles of Swiss employment law, an employer may, under certain circumstances, be required to indemnify an employee against losses and expenses incurred by such employee in the execution of their duties under the employment agreement, unless the losses and expenses arise from the employee's gross negligence or willful misconduct.

It is UBS Group AG's and UBS AG's policy to indemnify their current or former directors and/or employees against certain losses and expenses in respect of service as a director or employee of UBS Group AG or UBS AG, as the case may be, one of its affiliates or another entity that UBS Group AG has approved, subject to specific conditions or exclusions. UBS Group AG and UBS AG maintain directors' and officers' insurance for their directors and officers.

**UBS Americas Inc.** 

UBS Americas Inc. is a Delaware corporation. Section 102(b)(7) of the Delaware General Corporation Law (the "DGCL") permits a corporation to include in its certificate of incorporation a provision eliminating or

------

##### [**Table of Contents**](#toc)
limiting the personal liability of a director or officer to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, provided that such provision shall not eliminate or limit the liability of (a) a director or officer for any breach of the director's or officer's duty of loyalty to the corporation or its stockholders, (b) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) a director under Section 174 of the DGCL (providing for liability of directors for the unlawful payment of dividends or unlawful stock purchases or redemptions), (d) a director or officer for any transaction from which the director or officer derived an improper personal benefit or (e) an officer in any action by or in the right of the corporation. UBS Americas Inc.'s certificate of incorporation provides that a director of the corporation shall not be liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent that such exemption from liability or limitation thereof is not permitted under the DGCL.

Section 145 of the DGCL provides that a corporation may, subject to the standards set forth therein, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another entity. The bylaws of UBS Americas Inc. provide for such indemnification to the full extent permitted by law.

The DGCL also provides that a corporation may purchase insurance on behalf of any such director, officer, employee or agent. UBS Americas Inc. maintains directors' and officers' insurance for its directors and officers.

------

##### [**Table of Contents**](#toc)
**Item 9. Exhibits** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| &nbsp;&nbsp;&nbsp;&nbsp;4.1 | [Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of September 15, 2015, relating to the 3.800% Senior Notes due 2022 (incorporated by reference to Exhibit 4.4 to Post-Effective Amendment No. 1 to the Registrants' Registration Statement on Form F-3 (No. 333-272452) filed on June 12, 2023)](http://www.sec.gov/Archives/edgar/data/1159510/000104746915008188/a2226315zex-4_4.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.2 | [Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of June 10, 2016, relating to the 3.800% Senior Notes due 2023 (incorporated by reference to Exhibit 4.4 to Registration Statement on Form F-4 (No. 333-213903) of Credit Suisse Group Funding (Guernsey) Limited and Credit Suisse Group AG filed on September 30, 2016)](http://www.sec.gov/Archives/edgar/data/1159510/000104746916015861/a2229860zex-4_4.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.3 | [Supplemental Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of November 3, 2020, relating to the 3.800% Senior Notes due 2023](d17238dex43.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.4 | [Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of March 26, 2015 relating to the 3.750% Senior Notes due 2025 (incorporated by reference to Exhibit 4.2 to Registration Statement on Form F-4 (No. 333-207696) of Credit Suisse Group Funding (Guernsey) Limited and Credit Suisse Group AG filed on October 30, 2015)](http://www.sec.gov/Archives/edgar/data/1159510/000104746915008188/a2226315zex-4_2.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.5 | [Supplemental Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of November 3, 2020, relating to the 3.750% Senior Notes due 2025](d17238dex45.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.6 | [Second Supplemental Indenture, among UBS Group AG, Credit Suisse Group AG and U.S. Bank Trust Company, National Association as successor to U.S. Bank National Association, dated as of June 9, 2023, relating to the 3.750% Senior Notes due 2025](d17238dex46.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.7 | [Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of April 18, 2016, relating to the 4.550% Senior Notes due 2026 (incorporated by reference to Exhibit 4.1 to Registration Statement on Form F-4 (No. 333-213903) of Credit Suisse Group Funding (Guernsey) Limited and Credit Suisse Group AG filed on September 30, 2016)](http://www.sec.gov/Archives/edgar/data/1159510/000104746916015861/a2229860zex-4_1.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.8 | [Supplemental Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of November 3, 2020, relating to the 4.550% Senior Notes due 2026](d17238dex48.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.9 | [Second Supplemental Indenture, among UBS Group AG, Credit Suisse Group AG and U.S. Bank Trust Company, National Association as successor to U.S. Bank National Association, dated as of June 9, 2023, relating to the 4.550% Senior Notes due 2026](d17238dex49.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.10 | [Indenture among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, dated as of May 21, 2015, relating to the 4.875% Senior Notes due 2045 (incorporated by reference to Exhibit 4.3 to Registration Statement on Form F-4 (No. 333-207696) of Credit Suisse Group Funding (Guernsey) Limited and Credit Suisse Group AG filed on October 30, 2015)](http://www.sec.gov/Archives/edgar/data/1159510/000104746915008188/a2226315zex-4_3.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.11 | [Supplemental Indenture among Credit Suisse Group Funding (Guernsey), Credit Suisse Group AG and U.S. Bank National Association, dated as of November 3, 2020, relating to the 4.875% Senior Notes due 2045](d17238dex411.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.12 | [Second Supplemental Indenture, among UBS Group AG, Credit Suisse Group AG and U.S. Bank Trust Company, National Association as successor to U.S. Bank National Association, dated as of June 9, 2023, relating to the 4.875% Senior Notes due 2045](d17238dex412.htm) |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| &nbsp;&nbsp;&nbsp;&nbsp;4.13 | [Form of 4.875% Senior Notes due 2045](d17238dex413.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.14 | [Form of 4.550% Senior Notes due 2026](d17238dex414.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.15 | [Senior Indenture, dated as of June 1, 2001, between Credit Suisse First Boston (USA) Inc. and The Chase Manhattan Bank (incorporated by reference to Exhibit 4.1 to Credit Suisse First Boston (USA), Inc.'s Registration Statement on Form S-3 (No. 333-71850) filed on October 19, 2001)](http://www.sec.gov/Archives/edgar/data/29646/000091205701535969/a2061057zex-4_1.txt) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.16 | [First Supplemental Indenture, dated as of March 26, 2007, among Credit Suisse (USA) Inc. (formerly known as Credit Suisse First Boston (USA), Inc), Credit Suisse Group, Credit Suisse and The Bank of New York (as successor to The Chase Manhattan Bank), to the Senior Indenture (incorporated by reference to Exhibit 4.52 to Post-Effective Amendment No. 1 to the Registrants' Registration Statement on Form F-3 (No. 333-132936) filed on March 29, 2007)](http://www.sec.gov/Archives/edgar/data/29646/000110465907023327/a07-8297_1ex4d52.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.17 | [Second Supplemental Indenture, dated as of June 9, 2023, among Credit Suisse (USA) Inc. (formerly known as Credit Suisse First Boston (USA), Inc), Credit Suisse Group AG, UBS Group AG, Credit Suisse AG and The Bank of New York Mellon (formerly The Bank of New York), to the Senior Indenture (incorporated by reference to Exhibit 4.3 to Post-Effective Amendment No. 1 to the Registrants' Registration Statement on Form F-3 (No. 333-272452) filed on June 12, 2023)](http://www.sec.gov/Archives/edgar/data/29646/000110465923070420/tm2317707d5_ex4-3.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.18 | [Third Supplemental Indenture, dated as of May 30, 2024, among Credit Suisse (USA) LLC, UBS Group AG, Credit Suisse AG, UBS AG and The Bank of New York Mellon](d17238dex418.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.19 | [Fourth Supplemental Indenture, dated as of February 2, 2026, among Credit Suisse (USA) LLC, UBS Americas Inc., UBS Group AG, UBS AG and The Bank of New York Mellon](d17238dex419.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.20 | [Form of 7<sup>1</sup><sub>∕8</sub>% Notes due July 15, 2032](d17238dex420.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;5.1 | [Opinion of Sullivan & Cromwell LLP relating to the 4.875% Senior Notes due 2045 and the 4.550% Senior Notes due 2026](d17238dex51.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;5.2 | [Opinion of Sullivan & Cromwell LLP relating to the 71∕8% Notes due July 15, 2032](d17238dex52.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;5.3 | [Opinion of Homburger AG](d17238dex53.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;8.1 | [Opinion of Sullivan & Cromwell LLP as to United States federal tax matters](d17238dex81.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;8.2 | [Opinion of Homburger AG as to Swiss tax matters](d17238dex82.htm) |
| 23.1 | Consent of Sullivan & Cromwell LLP (included in [Exhibits 5.1](d17238dex51.htm), [5.2](d17238dex52.htm) and [8.1](d17238dex81.htm)) |
| 23.2 | Consent of Homburger AG (included in [Exhibits 5.3](d17238dex53.htm) and [8.2](d17238dex82.htm)) |
| 23.3 | [Consent of Ernst & Young Ltd, relating to UBS Group AG](d17238dex233.htm) |
| 23.4 | [Consent of Ernst & Young Ltd, relating to UBS AG](d17238dex234.htm) |
| 23.5 | [Consent of PricewaterhouseCoopers AG, relating to Credit Suisse AG](d17238dex235.htm) |
| 24.1 | [Power of Attorney for UBS Group AG](d17238dex241.htm) |
| 24.2 | [Power of Attorney for UBS AG](d17238dex242.htm) |
| 24.3 | [Power of Attorney for UBS Americas Inc.](d17238dex243.htm) |
| 25.1 | [Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the Indenture, dated as of April 18, 2016, among Credit Suisse Group Funding (Guernsey) Limited, UBS Group AG as successor to Credit Suisse Group AG and U.S. Bank National Association, as trustee, as supplemented](d17238dex251.htm) |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 25.2 | [Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association, as trustee under the Indenture, dated as of May 21, 2015, among Credit Suisse Group Funding (Guernsey) Limited, UBS Group AG as successor to Credit Suisse Group AG and U.S. Bank National Association, as trustee, as supplemented](d17238dex252.htm) |
| 25.3 | [Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of The Bank of New York Mellon, as trustee under the Senior Indenture, dated June 1, 2001, among UBS Americas Inc. as successor to Credit Suisse First Boston (USA), Inc. and The Bank of New York Mellon as successor to The Chase Manhattan Bank, as trustee, as supplemented](d17238dex253.htm) |
| 107 | [Filing Fee Table](d17238dexfilingfees.htm) |

---

------

##### [**Table of Contents**](#toc)
**Item 10. Undertakings** 

The undersigned registrants (each, a "Registrant" and, together, the "Registrants") hereby undertake:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission (the "Commission") pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

*provided, however*, that the undertakings set forth in paragraphs (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by UBS Group AG or Credit Suisse pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this registration statement or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) In the case of UBS Group AG and UBS AG, to file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act of 1933 need not be furnished, provided, that UBS Group AG or UBS AG, as the case may be, includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act of 1933 or Item 8.A of Form 20-F if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by UBS Group AG or UBS AG, as the case may be, pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Each prospectus filed by a Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

------

##### [**Table of Contents**](#toc)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of the registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) That, for the purpose of determining liability of a Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, each undersigned Registrant undertakes that in a primary offering of securities of such undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, such undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Any preliminary prospectus or prospectus of such undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. Any free writing prospectus relating to the offering prepared by or on behalf of such undersigned Registrant or used or referred to by such undersigned Registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. The portion of any other free writing prospectus relating to the offering containing material information about such undersigned Registrant or its securities provided by or on behalf of such undersigned Registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. Any other communication that is an offer in the offering made by such undersigned Registrant to the purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) That, for purposes of determining any liability under the Securities Act of 1933, each filing of UBS Group AG's or UBS AG's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrants pursuant to the foregoing provisions or otherwise, the Registrants have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrants of expenses incurred or paid by a director, officer or controlling person of the Registrants in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrants will, unless in the opinion of their counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by them is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Trust Indenture Act.

------

##### [**Table of Contents**](#toc)
**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the undersigned registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Zurich, Switzerland, on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| UBS GROUP AG | UBS GROUP AG |
| By: | /s/ David Kelly |
|  | Name: David Kelly |
|  | Title: Managing Director |
| By: | /s/ Ella Copetti-Campi |
|  | Name: Ella Copetti-Campi |
|  | Title: Executive Director |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the following capacities on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| **Name** | **Title** |
| \*<br> Sergio P. Ermotti | Group Chief Executive Officer<br> (principal executive officer) |
| \*<br> Todd Tuckner | Group Chief Financial Officer<br> (principal financial officer) |
| \*<br> Steffen Henrich | Group Controller<br> (company controller) |
| \*<br> Colm Kelleher | Chairman and Member of the Board of Directors |
| \*<br> Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| \*<br> Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| \*<br> William C. Dudley | Member of the Board of Directors |
| \*<br> Patrick Firmenich | Member of the Board of Directors |
| \*<br> Fred Hu | Member of the Board of Directors |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Name** | **Title** |
| \*<br> Mark Hughes | Member of the Board of Directors |
| \*<br> Renata Jungo Brüngger | Member of the Board of Directors |
| \*<br> Gail Kelly | Member of the Board of Directors |
| \*<br> Julie G. Richardson | Member of the Board of Directors |
| \*<br> Lila Tretikov | Member of the Board of Directors |
| \*<br> Jeanette Wong | Member of the Board of Directors |

---

\* Patrick Shilling by signing his name hereto, does hereby sign this registration statement on behalf of the directors and officers of the registrant above in front of whose name asterisks appear, pursuant to powers of attorney duly executed by such directors and officers and filed with the SEC. 

---

| | |
|:---|:---|
|  By: | /s/ Patrick Shilling |
|  | Name: Patrick Shilling |
|  | Title: General Counsel Americas, as Attorney-in-Fact |

---

Pursuant to the requirements of Section 6(a) of the U.S. Securities Act of 1933, the Authorized Representative has duly caused this registration statement to be signed on its behalf by the undersigned, solely in his capacity as the duly authorized representative of UBS Group AG in the United States, on the 12<sup>th</sup> day of February, 2026.

---

| | | |
|:---|:---|:---|
| By: | /s/ Patrick Shilling | Authorized Representative in the United States |
|  | Name: Patrick Shilling |  |
|  | Title: General Counsel Americas |  |

---

------

##### [**Table of Contents**](#toc)
**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the undersigned registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Zurich, Switzerland, on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| UBS AG | UBS AG |
| By: | /s/ David Kelly |
|  | Name: David Kelly |
|  | Title: Managing Director |
| By: | /s/ Ella Copetti-Campi |
|  | Name: Ella Copetti-Campi |
|  | Title: Executive Director |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the following capacities on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| **Name** | **Title** |
| \*<br> Sergio P. Ermotti | Chief Executive Officer<br> (principal executive officer) |
| \*<br> Todd Tuckner | Chief Financial Officer<br> (principal financial officer) |
| \*<br> Steffen Henrich | Controller<br> (company controller) |
| \*<br> Colm Kelleher | Chairman and Member of the Board of Directors |
| \*<br> Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| \*<br> Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| \*<br> William C. Dudley | Member of the Board of Directors |
| \*<br> Patrick Firmenich | Member of the Board of Directors |
| \*<br> Fred Hu | Member of the Board of Directors |

---

------

##### [**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Name** | **Title** |
| \*<br> Mark Hughes | Member of the Board of Directors |
| \*<br> Renata Jungo Brüngger | Member of the Board of Directors |
| \*<br> Gail Kelly | Member of the Board of Directors |
| \*<br> Julie G. Richardson | Member of the Board of Directors |
| \*<br> Lila Tretikov | Member of the Board of Directors |
| \*<br> Jeanette Wong | Member of the Board of Directors |

---

\* Patrick Shilling by signing his name hereto, does hereby sign this registration statement on behalf of the directors and officers of the registrant above in front of whose name asterisks appear, pursuant to powers of attorney duly executed by such directors and officers and filed with the SEC. 

---

| | |
|:---|:---|
| By: | /s/ Patrick Shilling |
|  | Name: Patrick Shilling |
|  | Title: General Counsel Americas, as Attorney-in-Fact |

---

Pursuant to the requirements of Section 6(a) of the U.S. Securities Act of 1933, the Authorized Representative has duly caused this registration statement to be signed on its behalf by the undersigned, solely in his capacity as the duly authorized representative of UBS AG in the United States, on the 12<sup>th</sup> day of February, 2026.

---

| | | |
|:---|:---|:---|
| By: | /s/ Patrick Shilling | Authorized Representative in the United States |
|  | Name: Patrick Shilling |  |
|  | Title: General Counsel Americas |  |

---

------

##### [**Table of Contents**](#toc)
**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the undersigned registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York, New York, on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| UBS AMERICAS INC. | UBS AMERICAS INC. |
| By: | /s/ Patrick Shilling |
|  | Name: Patrick Shilling |
|  | Title: Managing Director |
| By: | /s/ Maria Chiodi |
|  | Name: Maria Chiodi |
|  | Title: Managing Director |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the following capacities on the 12<sup>th</sup> day of February, 2026.

---

| | |
|:---|:---|
| **Name** | **Title** |
| \*<br> David Wildermuth | Director and President<br> (principal executive officer) |
| \*<br> Ben Prata | Chief Financial Officer<br> (principal financial officer) |
| \*<br> Greg Swindle | Legal Entity Controller<br> (company controller) |
| \*<br> Darryll Hendricks | Director |
| \*<br> Robert Karofsky | Chairman and Director |

---

\* Patrick Shilling by signing his name hereto, does hereby sign this registration statement on behalf of the directors and officers of the registrant above in front of whose name asterisks appear, pursuant to powers of attorney duly executed by such directors and officers and filed with the SEC. 

---

| | |
|:---|:---|
| By: | /s/ Patrick Shilling |
|  | Name: Patrick Shilling |
|  | Title: Managing Director, as<br>Attorney-in-Fact |

---

## Exhibit 4.3

**Exhibit 4.3** 

<u>SUPPLEMENTAL INDENTURE</u> 

This SUPPLEMENTAL INDENTURE (this "**Supplemental Indenture**"), dated as of November 3, 2020, among CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED (the "**Company**"), a non-cellular company limited by shares registered under the laws of the Island of Guernsey with registration number 58814 and having its registered office at Helvetia Court, South Esplanade, St Peter Port, Guernsey GY1 3WF, CREDIT SUISSE GROUP AG, a company organized under the laws of Switzerland (the "**Guarantor**") and U.S. BANK NATIONAL ASSOCIATION, as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, the Company and the Guarantor have heretofore executed and delivered to the Trustee an indenture (the "**Indenture**"), dated as of June 10, 2016 providing for the issuance of 3.800% Senior Notes due 2023 (the "**Securities**");

WHEREAS, pursuant to Section 3.08 of the Indenture, the Company and the Guarantor desire to effectuate a Voluntary Issuer Substitution (as defined in the Indenture), pursuant to which the Guarantor shall be substituted as, and assume all of the obligations of the Company as, principal obligor under the Securities on the terms and conditions set forth in the Indenture and herein;

WHEREAS, the Indenture provides that the Guarantor may effectuate a Voluntary Issuer Substitution by delivering to the Trustee a supplemental indenture confirming the foregoing; and

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantor and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS AND UNDERTAKE. Pursuant to and in accordance with Section 3.08(a) of the Indenture, and with effect as of the date of this Supplemental Indenture (the "Voluntary Issuer Substitution Date"), the Company shall be released from its obligations under the Securities and the Guarantor shall succeed to, and be substituted for, and may exercise every right and power of, the Company under the Securities with the same effect as if the Guarantor had been named as issuer under the Indenture and the Securities. The Guarantor hereby (i) assumes all of the Company's obligations as principal obligor under the Securities on the terms and subject to the conditions set forth in this Supplemental Indenture and in the Indenture, (ii) undertakes in favor of each Holder to be bound

------

by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Guarantor had been named as issuer and principal obligor under the Indenture and the Securities and (iii) agrees to indemnify each Holder against any stamp, registration, transfer, documentary or other similar tax, duty, assessment or governmental charge that is imposed on such Holder by (or by any authority in or of) Switzerland and that would not have been so imposed had the Voluntary Issuer Substitution not been made, as well as against any cost or expense incurred by such Holder relating to such substitution, including, but not limited to, legal costs, if any. For the avoidance of doubt, from the Voluntary Issuer Substitution Date, the Guarantee shall cease to exist; provided, however, that any references in the Indenture to the "Guarantor" that remain applicable after the Voluntary Issuer Substitution shall remain references to the Guarantor in its capacity as substituted principal obligor of the Securities. It is understood that the amended Global Notes representing the Securities following the Voluntary Issuer Substitution will not contain provisions of the Securities set forth in Annex I to the Indenture that are no longer applicable following the Voluntary Issuer Substitution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of the Company and the Guarantor agrees that any suit, action or proceeding (each, a "Proceeding") against it arising out of or based upon this Supplemental Indenture may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of the Company and the Guarantor has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "Authorized Agent") upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and each expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of the Company and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time the Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, each of the Company and the Guarantor will immediately appoint an Authorized Agent upon whom such process may be served. Until this Supplemental Indenture is terminated, each of the Company and the Guarantor shall maintain an Authorized Agent in The City of New York, and each of the Company and the Guarantor agrees to take any and all action, including the filing of any and all documents, that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Guarantor or the Company, as applicable.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of the Company and the Guarantor is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to the Company or the Guarantor, as applicable, such an immunity (whether or not claimed), each of the Company and the Guarantor hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding arising out of or based on this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, or in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of the Company or the Guarantor hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Supplemental Indenture without any further act by the Company or the Guarantor before any such court and introduction of a true copy of this Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of the Company or the Guarantor and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Supplemental Indenture.

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company | CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company |
| By: | /s/ Gary Luxton |
|  | Name: Gary Luxton<br> Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: | /s/ Roger Rimann |
|  | Name: Roger Rimann<br> Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| <br> CREDIT SUISSE GROUP AG,<br>as the Guarantor | <br> CREDIT SUISSE GROUP AG,<br>as the Guarantor |
| By: |  |
|  | Name: Gina Orlins<br> Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: |  |
|  | Name: David Wong<br> Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company | CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company |
| By: |  |
|  | Name: Gary Luxton<br> Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: |  |
|  | Name: Roger Rimann<br> Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| <br> CREDIT SUISSE GROUP AG,<br>as the Guarantor | <br> CREDIT SUISSE GROUP AG,<br>as the Guarantor |
| By: | /s/ Gina Orlins |
|  | Name: Gina Orlins<br> Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: | /s/ David Wong |
|  | Name: David Wong<br> Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

---

| | |
|:---|:---|
| U.S. BANK NATIONAL ASSOCIATION,<br>as the Trustee | U.S. BANK NATIONAL ASSOCIATION,<br>as the Trustee |
| By: | /s/ Thomas E. Tabor |
|  | Name: Thomas E. Tabor<br> Title: Vice President |

---

*[Signature Page to Supplemental Indenture]*

## Exhibit 4.5

**Exhibit 4.5** 

<u>SUPPLEMENTAL INDENTURE</u> 

This SUPPLEMENTAL INDENTURE (this "**Supplemental Indenture**"), dated as of November 3, 2020, among CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED (the "**Company**"), a non-cellular company limited by shares registered under the laws of the Island of Guernsey with registration number 58814 and having its registered office at Helvetia Court, South Esplanade, St Peter Port, Guernsey GY1 3WF, CREDIT SUISSE GROUP AG, a company organized under the laws of Switzerland (the "**Guarantor**") and U.S. BANK NATIONAL ASSOCIATION, as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, the Company and the Guarantor have heretofore executed and delivered to the Trustee an indenture (the "**Indenture**"), dated as of March 26, 2015 providing for the issuance of 3.750% Senior Notes due 2025 (the "**Securities**");

WHEREAS, pursuant to Section 3.08 of the Indenture, the Company and the Guarantor desire to effectuate a Voluntary Issuer Substitution (as defined in the Indenture), pursuant to which the Guarantor shall be substituted as, and assume all of the obligations of the Company as, principal obligor under the Securities on the terms and conditions set forth in the Indenture and herein;

WHEREAS, the Indenture provides that the Guarantor may effectuate a Voluntary Issuer Substitution by delivering to the Trustee a supplemental indenture confirming the foregoing; and

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantor and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS AND UNDERTAKE. Pursuant to and in accordance with Section 3.08(a) of the Indenture, and with effect as of the date of this Supplemental Indenture (the "Voluntary Issuer Substitution Date"), the Company shall be released from its obligations under the Securities and the Guarantor shall succeed to, and be substituted for, and may exercise every right and power of, the Company under the Securities with the same effect as if the Guarantor had been named as issuer under the Indenture and the Securities. The Guarantor hereby (i) assumes all of the Company's obligations as principal obligor under the Securities on the terms and subject to the conditions set forth in this Supplemental Indenture and in the Indenture, (ii) undertakes in favor of each Holder to be bound

------

by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Guarantor had been named as issuer and principal obligor under the Indenture and the Securities and (iii) agrees to indemnify each Holder against any stamp, registration, transfer, documentary or other similar tax, duty, assessment or governmental charge that is imposed on such Holder by (or by any authority in or of) Switzerland and that would not have been so imposed had the Voluntary Issuer Substitution not been made, as well as against any cost or expense incurred by such Holder relating to such substitution, including, but not limited to, legal costs, if any. For the avoidance of doubt, from the Voluntary Issuer Substitution Date, the Guarantee shall cease to exist; provided, however, that any references in the Indenture to the "Guarantor" that remain applicable after the Voluntary Issuer Substitution shall remain references to the Guarantor in its capacity as substituted principal obligor of the Securities. It is understood that the amended Global Notes representing the Securities following the Voluntary Issuer Substitution will not contain provisions of the Securities set forth in Annex I to the Indenture that are no longer applicable following the Voluntary Issuer Substitution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of the Company and the Guarantor agrees that any suit, action or proceeding (each, a "Proceeding") against it arising out of or based upon this Supplemental Indenture may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of the Company and the Guarantor has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "Authorized Agent") upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and each expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of the Company and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time the Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, each of the Company and the Guarantor will immediately appoint an Authorized Agent upon whom such process may be served. Until this Supplemental Indenture is terminated, each of the Company and the Guarantor shall maintain an Authorized Agent in The City of New York, and each of the Company and the Guarantor agrees to take any and all action, including the filing of any and all documents, that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Guarantor or the Company, as applicable.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of the Company and the Guarantor is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to the Company or the Guarantor, as applicable, such an immunity (whether or not claimed), each of the Company and the Guarantor hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding arising out of or based on this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, or in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of the Company or the Guarantor hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Supplemental Indenture without any further act by the Company or the Guarantor before any such court and introduction of a true copy of this Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of the Company or the Guarantor and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Supplemental Indenture.

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company | CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company |
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gary Luxton |

---

Name: Gary Luxton <br> Title: Member of the Board of Directors

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Roger Rimann |

---

Name: Roger Rimann <br> Title: Member of the Board of Directors

---

| |
|:---|
| CREDIT SUISSE GROUP AG,<br>as the Guarantor |
| By: |

---

Name: Gina Orlins <br> Title: Authorized Person

 <br> By:   

Name: David Wong <br> Title: Authorized Person

*[Signature Page to Supplemental Indenture}* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| |
|:---|
| CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,<br>as the Company |
| By: |

---

Name: Gary Luxton <br> Title: Member of the Board of Directors

 <br> By:   

Name: Roger Rimann <br> Title: Member of the Board of Directors

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP AG,<br>as the Guarantor | CREDIT SUISSE GROUP AG,<br>as the Guarantor |
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gina Orlins |

---

Name: Gina Orlins <br> Title: Authorized Person

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ David Wong |

---

Name: David Wong <br> Title: Authorized Person

*[Signature Page to Supplemental Indenture}* 

------

---

| | |
|:---|:---|
| U.S. BANK NATIONAL ASSOCIATION,<br>as the Trustee | U.S. BANK NATIONAL ASSOCIATION,<br>as the Trustee |
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Thomas E. Tabor |

---

Name: Thomas E. Tabor <br> Title: Vice President

## Exhibit 4.6

**Exhibit 4.6** 

<u>SECOND SUPPLEMENTAL INDENTURE</u> 

This SECOND SUPPLEMENTAL INDENTURE (this "**Second Supplemental Indenture**"), dated as of June 9, 2023, among UBS GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland (the "**Company**"), CREDIT SUISSE GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**CSG**") and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (as successor in interest to U.S. Bank National Association), as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, Credit Suisse Group Funding Limited (Guernsey), as the initial issuer (the "**Initial Issuer**"), CSG, as guarantor, and the Trustee, entered into an indenture, dated as of March 26, 2015 (the "**Original Indenture**") providing for the issuance of 3.750% Senior Notes due 2025 (the "**Securities**");

WHEREAS, pursuant to a supplemental indenture, dated as of November 3, 2020 (the "**Supplemental Indenture**" and, together with the Original Indenture, the "**Indenture**"), CSG assumed all of the obligations of the Initial Issuer as principal obligor on the Securities and under the Indenture ("the **Voluntary Issuer Substitution**");

WHEREAS, pursuant to the merger agreement between the Company and CSG, dated as of March 19, 2023, as amended on April 6, 2023 and on May 22, 2023, the Company and CSG will merge, with the Company being the absorbing company which shall continue to operate, and CSG being the absorbed company which shall cease to exist (the "**Merger**");

WHEREAS, effective upon registration of the Merger with the Commercial Register of the Canton of Zurich in Switzerland (the date of such registration, the "**Effective Date**"), CSG will be dissolved and its assets, liabilities and contracts (including its obligations under the Indenture and on the Securities) transferred to, and absorbed and taken over by, the Company by operation of Swiss law (*Universalsukzession*);

WHEREAS, pursuant to Section 5.01 of the Indenture, the Company desires to assume all of the obligations of CSG on the Securities and under the Indenture on the terms and conditions set forth in the Indenture and herein with effect as of the Effective Date;

WHEREAS, all conditions and requirements necessary to make this Second Supplemental Indenture a valid and binding instrument in accordance with the terms of the Indenture have been performed and fulfilled and the execution and delivery hereof have been in all respects duly authorized;

WHEREAS, Section 10.01(b) of the Indenture provides that, without the consent of the Holders, CSG and the Trustee may enter into a supplemental indenture to amend or supplement any of the provisions of the Indenture to comply with Sections 5.01, 5.02, 6.01 and 6.02 of the Indenture; and

------

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Second Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, CSG and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS. Pursuant to and in accordance with Section 5.01 of the Indenture and by operation of Swiss law, and with effect as of the Effective Date, the Company shall succeed to, and be substituted for, and may exercise every right and power of, CSG under the Securities with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. As of the Effective Date, the Company hereby (i) assumes all of CSG's obligations as issuer and obligor under the Indenture and on the Securities on the terms and subject to the conditions set forth in this Second Supplemental Indenture and in the Indenture and (ii) undertakes in favor of each Holder to be bound by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. For the avoidance of doubt, from the Effective Date, any references in the Indenture to the "Guarantor" that remained applicable after the Voluntary Issuer Substitution, including those set forth in Section 2.18 and in the definition of "Authorized Person" of the Indenture, shall be to the Company in its capacity as the principal obligor of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of CSG and the Company agrees that any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities may be instituted in any state or federal court in the Borough of Manhattan, The City of New York (each, a "**Proceeding**"), and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. The Company has appointed UBS AG, New York Branch, at 1285 Avenue of the Americas, New York, NY 10019, as its authorized agent (the "**UBS Authorized Agent**") upon whom process may be served in any Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Until the Effective Date, CSG has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "**CS Authorized Agent**" and, together with the UBS Authorized Agent, the "**Authorized Agents**" and each, an "**Authorized Agent**") upon whom process may be served in any

------

Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of CSG and the Company hereby represents and warrants that its respective Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time any Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding, CSG or the Company, as applicable, will immediately appoint an Authorized Agent upon whom such process may be served. Until the Indenture and this Second Supplemental Indenture are terminated, or, with respect to CSG only, until the Effective Date, each of CSG and the Company shall maintain an Authorized Agent in The City of New York, and each of CSG and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon CSG or the Company, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of CSG and the Company is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to CSG or the Company, such an immunity (whether or not claimed), each of CSG and the Company hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding, or any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities which may be instituted in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of CSG or the Company hereunder. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Second Supplemental Indenture without any further act by CSG or the Company before any such court and introduction of a true copy of this Second Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Second Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Second Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Second Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of the Second Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of the Second Supplemental Indenture as to the parties hereto. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words "execution," "signed," "signature," "delivery," and words of like import in or relating to this Second Supplemental Indenture or any document to be signed in connection

------

with this Second Supplemental Indenture shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of CSG and the Company and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. NOTICES. Section 11.02 of the Indenture is hereby amended by replacing the references to addresses and the subparagraph immediately thereafter with the following:

Any notice or communication shall be sufficiently given if written and (a) if delivered in person, when received or (b) if mailed by first class mail, 5 days after mailing, or (c) as among the Company, CSG and the Trustee if sent by facsimile or electronic transmission, when transmission is confirmed, in each case addressed as follows:

If to the Company:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to CSG:

Credit Suisse Group AG

Paradeplatz 8

8001 Zurich, Switzerland

Attention: Legal Counsel

Telephone No.: +41 44 333 1111

If to the Trustee:

U.S. Bank Trust Company, National Association

100 Wall St., Suite 600

New York, New York 10005

Facsimile No.: (212) 361-6153

------

The Company, CSG or the Trustee by written notice to the other may designate additional or different addresses or facsimile numbers for subsequent notices or communications.

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE GROUP AG,

as CSG

---

| | |
|:---|:---|
| By: | /s/ Christopher Chadie |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Christopher Chadie |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |
| By: | /s/ Noah Lee |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Noah Lee |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]*

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

UBS GROUP AG,

as the Company

---

| | |
|:---|:---|
| By: | /s/ Daniel Taylor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel Taylor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |
| By: | /s/ Dean Robson |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Dean Robson |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]*

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,

as the Trustee

---

| | |
|:---|:---|
| By: | /s/ Christopher J. Grell |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Christopher J. Grell |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Vice President |

---

*[Signature Page to Second Supplemental Indenture]*

## Exhibit 4.8

**Exhibit 4.8** 

<u>SUPPLEMENTAL INDENTURE</u> 

This SUPPLEMENTAL INDENTURE (this "**Supplemental Indenture**"), dated as of November 3, 2020, among CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED (the "**Company**"), a non-cellular company limited by shares registered under the laws of the Island of Guernsey with registration number 58814 and having its registered office at Helvetia Court, South Esplanade, St Peter Port, Guernsey GY1 3WF, CREDIT SUISSE GROUP AG, a company organized under the laws of Switzerland (the "**Guarantor**") and U.S. BANK NATIONAL ASSOCIATION, as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, the Company and the Guarantor have heretofore executed and delivered to the Trustee an indenture (the "**Indenture**"), dated as of April 18, 2016 providing for the issuance of 4.550% Senior Notes due 2026 (the "**Securities**");

WHEREAS, pursuant to Section 3.08 of the Indenture, the Company and the Guarantor desire to effectuate a Voluntary Issuer Substitution (as defined in the Indenture), pursuant to which the Guarantor shall be substituted as, and assume all of the obligations of the Company as, principal obligor under the Securities on the terms and conditions set forth in the Indenture and herein;

WHEREAS, the Indenture provides that the Guarantor may effectuate a Voluntary Issuer Substitution by delivering to the Trustee a supplemental indenture confirming the foregoing; and

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantor and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS AND UNDERTAKE. Pursuant to and in accordance with Section 3.08(a) of the Indenture, and with effect as of the date of this Supplemental Indenture (the "Voluntary Issuer Substitution Date"), the Company shall be released from its obligations under the Securities and the Guarantor shall succeed to, and be substituted for, and may exercise every right and power of, the Company under the Securities with the same effect as if the Guarantor had been named as issuer under the Indenture and the Securities. The Guarantor hereby (i) assumes all of the Company's obligations as principal obligor under the Securities on the terms and subject to the conditions set forth in this Supplemental Indenture and in the Indenture, (ii) undertakes in favor of each Holder to be bound

------

by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Guarantor had been named as issuer and principal obligor under the Indenture and the Securities and (iii) agrees to indemnify each Holder against any stamp, registration, transfer, documentary or other similar tax, duty, assessment or governmental charge that is imposed on such Holder by (or by any authority in or of) Switzerland and that would not have been so imposed had the Voluntary Issuer Substitution not been made, as well as against any cost or expense incurred by such Holder relating to such substitution, including, but not limited to, legal costs, if any. For the avoidance of doubt, from the Voluntary Issuer Substitution Date, the Guarantee shall cease to exist; provided, however, that any references in the Indenture to the "Guarantor" that remain applicable after the Voluntary Issuer Substitution shall remain references to the Guarantor in its capacity as substituted principal obligor of the Securities. It is understood that the amended Global Notes representing the Securities following the Voluntary Issuer Substitution will not contain provisions of the Securities set forth in Annex I to the Indenture that are no longer applicable following the Voluntary Issuer Substitution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of the Company and the Guarantor agrees that any suit, action or proceeding (each, a "Proceeding") against it arising out of or based upon this Supplemental Indenture may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of the Company and the Guarantor has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "Authorized Agent") upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and each expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of the Company and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time the Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, each of the Company and the Guarantor will immediately appoint an Authorized Agent upon whom such process may be served. Until this Supplemental Indenture is terminated, each of the Company and the Guarantor shall maintain an Authorized Agent in The City of New York, and each of the Company and the Guarantor agrees to take any and all action, including the filing of any and all documents, that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Guarantor or the Company, as applicable.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of the Company and the Guarantor is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to the Company or the Guarantor, as applicable, such an immunity (whether or not claimed), each of the Company and the Guarantor hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding arising out of or based on this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, or in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of the Company or the Guarantor hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Supplemental Indenture without any further act by the Company or the Guarantor before any such court and introduction of a true copy of this Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of the Company or the Guarantor and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Supplemental Indenture.

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,

as the Company

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

CREDIT SUISSE GROUP AG,

as the Guarantor

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,

as the Company

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

CREDIT SUISSE GROUP AG,

as the Guarantor

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

U.S. BANK NATIONAL ASSOCIATION,

as the Trustee

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Thomas E. Tabor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Thomas E. Tabor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Vice President |

---

*[Signature Page to Supplemental Indenture]*

## Exhibit 4.9

**Exhibit 4.9** 

<u>SECOND SUPPLEMENTAL INDENTURE</u> 

This SECOND SUPPLEMENTAL INDENTURE (this "**Second Supplemental Indenture**"), dated as of June 9, 2023, among UBS GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland (the "**Company**"), CREDIT SUISSE GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**CSG**") and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (as successor in interest to U.S. Bank National Association), as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, Credit Suisse Group Funding Limited (Guernsey), as the initial issuer (the "**Initial Issuer**"), CSG, as guarantor, and the Trustee, entered into an indenture, dated as of April 18, 2016 (the "**Original Indenture**") providing for the issuance of 4.550% Senior Notes due 2026 (the "**Securities**");

WHEREAS, pursuant to a supplemental indenture, dated as of November 3, 2020 (the "**Supplemental Indenture**" and, together with the Original Indenture, the "**Indenture**"), CSG assumed all of the obligations of the Initial Issuer as principal obligor on the Securities and under the Indenture ("the **Voluntary Issuer Substitution**");

WHEREAS, pursuant to the merger agreement between the Company and CSG, dated as of March 19, 2023, as amended on April 6, 2023 and on May 22, 2023, the Company and CSG will merge, with the Company being the absorbing company which shall continue to operate, and CSG being the absorbed company which shall cease to exist (the "**Merger**");

WHEREAS, effective upon registration of the Merger with the Commercial Register of the Canton of Zurich in Switzerland (the date of such registration, the "**Effective Date**"), CSG will be dissolved and its assets, liabilities and contracts (including its obligations under the Indenture and on the Securities) transferred to, and absorbed and taken over by, the Company by operation of Swiss law (*Universalsukzession*);

WHEREAS, pursuant to Section 5.01 of the Indenture, the Company desires to assume all of the obligations of CSG on the Securities and under the Indenture on the terms and conditions set forth in the Indenture and herein with effect as of the Effective Date;

WHEREAS, all conditions and requirements necessary to make this Second Supplemental Indenture a valid and binding instrument in accordance with the terms of the Indenture have been performed and fulfilled and the execution and delivery hereof have been in all respects duly authorized;

WHEREAS, Section 10.01(b) of the Indenture provides that, without the consent of the Holders, CSG and the Trustee may enter into a supplemental indenture to amend or supplement any of the provisions of the Indenture to comply with Sections 5.01, 5.02, 6.01 and 6.02 of the Indenture; and

------

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Second Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, CSG and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS. Pursuant to and in accordance with Section 5.01 of the Indenture and by operation of Swiss law, and with effect as of the Effective Date, the Company shall succeed to, and be substituted for, and may exercise every right and power of, CSG under the Securities with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. As of the Effective Date, the Company hereby (i) assumes all of CSG's obligations as issuer and obligor under the Indenture and on the Securities on the terms and subject to the conditions set forth in this Second Supplemental Indenture and in the Indenture and (ii) undertakes in favor of each Holder to be bound by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. For the avoidance of doubt, from the Effective Date, any references in the Indenture to the "Guarantor" that remained applicable after the Voluntary Issuer Substitution, including those set forth in Section 2.18 and in the definition of "Authorized Person" of the Indenture, shall be to the Company in its capacity as the principal obligor of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of CSG and the Company agrees that any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities may be instituted in any state or federal court in the Borough of Manhattan, The City of New York (each, a "**Proceeding**"), and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. The Company has appointed UBS AG, New York Branch, at 1285 Avenue of the Americas, New York, NY 10019, as its authorized agent (the "**UBS Authorized Agent**") upon whom process may be served in any Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Until the Effective Date, CSG has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "**CS Authorized Agent**" and, together with the UBS Authorized Agent, the "**Authorized Agents**" and each, an "**Authorized Agent**") upon whom process may be served in any

------

Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of CSG and the Company hereby represents and warrants that its respective Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time any Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding, CSG or the Company, as applicable, will immediately appoint an Authorized Agent upon whom such process may be served. Until the Indenture and this Second Supplemental Indenture are terminated, or, with respect to CSG only, until the Effective Date, each of CSG and the Company shall maintain an Authorized Agent in The City of New York, and each of CSG and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon CSG or the Company, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of CSG and the Company is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to CSG or the Company, such an immunity (whether or not claimed), each of CSG and the Company hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding, or any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities which may be instituted in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of CSG or the Company hereunder. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Second Supplemental Indenture without any further act by CSG or the Company before any such court and introduction of a true copy of this Second Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Second Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Second Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Second Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of the Second Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of the Second Supplemental Indenture as to the parties hereto. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words "execution," "signed," "signature," "delivery," and words of like import in or relating to this Second Supplemental Indenture or any document to be signed in connection

------

with this Second Supplemental Indenture shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of CSG and the Company and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. NOTICES. Section 11.02 of the Indenture is hereby amended by replacing the references to addresses and the subparagraph immediately thereafter with the following:

Any notice or communication shall be sufficiently given if written and (a) if delivered in person, when received or (b) if mailed by first class mail, 5 days after mailing, or (c) as among the Company, CSG and the Trustee if sent by facsimile or electronic transmission, when transmission is confirmed, in each case addressed as follows:

If to the Company:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to CSG:

Credit Suisse Group AG

Paradeplatz 8

8001 Zurich, Switzerland

Attention: Legal Counsel

Telephone No.: +41 44 333 1111

If to the Trustee:

U.S. Bank Trust Company, National Association

100 Wall St., Suite 600

New York, New York 10005

Facsimile No.: (212) 361-6153

------

The Company, CSG or the Trustee by written notice to the other may designate additional or different addresses or facsimile numbers for subsequent notices or communications.

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP AG,<br>as CSG | CREDIT SUISSE GROUP AG,<br>as CSG |
| By: | /s/ Christopher Chadie |
|  | Name: Christopher Chadie |
|  | Title: Authorized Person |
| By: | /s/ Noah Lee |
|  | Name: Noah Lee |
|  | Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| UBS GROUP AG, | UBS GROUP AG, |
| as the Company | as the Company |
| By: | /s/ Daniel Taylor |
|  | Name: Daniel Taylor |
|  | Title: Authorized Person |
| By: | /s/ Dean Robson |
|  | Name: Dean Robson |
|  | Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, |
| as the Trustee | as the Trustee |
| By: | /s/ Christopher J. Grell |
|  | Name: Christopher J. Grell |
|  | Title: Vice President |

---

*[Signature Page to Second Supplemental Indenture]*

## Exhibit 4.11

**Exhibit 4.11** 

<u>SUPPLEMENTAL INDENTURE</u> 

This SUPPLEMENTAL INDENTURE (this "**Supplemental Indenture**"), dated as of November 3, 2020, among CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED (the "**Company**"), a non-cellular company limited by shares registered under the laws of the Island of Guernsey with registration number 58814 and having its registered office at Helvetia Court, South Esplanade, St Peter Port, Guernsey GY1 3WF, CREDIT SUISSE GROUP AG, a company organized under the laws of Switzerland (the "**Guarantor**") and U.S. BANK NATIONAL ASSOCIATION, as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, the Company and the Guarantor have heretofore executed and delivered to the Trustee an indenture (the "**Indenture**"), dated as of May 21, 2015 providing for the issuance of 4.875% Senior Notes due 2045 (the "**Securities**");

WHEREAS, pursuant to Section 3.08 of the Indenture, the Company and the Guarantor desire to effectuate a Voluntary Issuer Substitution (as defined in the Indenture), pursuant to which the Guarantor shall be substituted as, and assume all of the obligations of the Company as, principal obligor under the Securities on the terms and conditions set forth in the Indenture and herein;

WHEREAS, the Indenture provides that the Guarantor may effectuate a Voluntary Issuer Substitution by delivering to the Trustee a supplemental indenture confirming the foregoing; and

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantor and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS AND UNDERTAKE. Pursuant to and in accordance with Section 3.08(a) of the Indenture, and with effect as of the date of this Supplemental Indenture (the "Voluntary Issuer Substitution Date"), the Company shall be released from its obligations under the Securities and the Guarantor shall succeed to, and be substituted for, and may exercise every right and power of, the Company under the Securities with the same effect as if the Guarantor had been named as issuer under the Indenture and the Securities. The Guarantor hereby (i) assumes all of the Company's obligations as principal obligor under the Securities on the terms and subject to the conditions set forth in this Supplemental Indenture and in the Indenture, (ii) undertakes in favor of each Holder to be bound

------

by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Guarantor had been named as issuer and principal obligor under the Indenture and the Securities and (iii) agrees to indemnify each Holder against any stamp, registration, transfer, documentary or other similar tax, duty, assessment or governmental charge that is imposed on such Holder by (or by any authority in or of) Switzerland and that would not have been so imposed had the Voluntary Issuer Substitution not been made, as well as against any cost or expense incurred by such Holder relating to such substitution, including, but not limited to, legal costs, if any. For the avoidance of doubt, from the Voluntary Issuer Substitution Date, the Guarantee shall cease to exist; provided, however, that any references in the Indenture to the "Guarantor" that remain applicable after the Voluntary Issuer Substitution shall remain references to the Guarantor in its capacity as substituted principal obligor of the Securities. It is understood that the amended Global Notes representing the Securities following the Voluntary Issuer Substitution will not contain provisions of the Securities set forth in Annex I to the Indenture that are no longer applicable following the Voluntary Issuer Substitution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of the Company and the Guarantor agrees that any suit, action or proceeding (each, a "Proceeding") against it arising out of or based upon this Supplemental Indenture may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of the Company and the Guarantor has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "Authorized Agent") upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, and each expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of the Company and the Guarantor hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time the Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding arising out of or based upon this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, each of the Company and the Guarantor will immediately appoint an Authorized Agent upon whom such process may be served. Until this Supplemental Indenture is terminated, each of the Company and the Guarantor shall maintain an Authorized Agent in The City of New York, and each of the Company and the Guarantor agrees to take any and all action, including the filing of any and all documents, that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Guarantor or the Company, as applicable.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of the Company and the Guarantor is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to the Company or the Guarantor, as applicable, such an immunity (whether or not claimed), each of the Company and the Guarantor hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding arising out of or based on this Supplemental Indenture, which may be instituted in any state or federal court in the Borough of Manhattan, The City of New York, or in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of the Company or the Guarantor hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Supplemental Indenture without any further act by the Company or the Guarantor before any such court and introduction of a true copy of this Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of the Company or the Guarantor and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Supplemental Indenture.

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,

as the Company

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

CREDIT SUISSE GROUP AG,

as the Guarantor

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE GROUP FUNDING (GUERNSEY) LIMITED,

as the Company

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gary Luxton |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

---

| | |
|:---|:---|
| By: |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Roger Rimann |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Member of the Board of Directors |

---

CREDIT SUISSE GROUP AG,

as the Guarantor

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Gina Orlins |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: David Wong |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Supplemental Indenture]* 

------

U.S. BANK NATIONAL ASSOCIATION,

as the Trustee

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Thomas E. Tabor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Thomas E. Tabor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Vice President |

---

*[Signature Page to Supplemental Indenture]*

## Exhibit 4.12

**Exhibit 4.12** 

<u>SECOND SUPPLEMENTAL INDENTURE</u> 

This SECOND SUPPLEMENTAL INDENTURE (this "**Second Supplemental Indenture**"), dated as of June 9, 2023, among UBS GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland (the "**Company**"), CREDIT SUISSE GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**CSG**") and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (as successor in interest to U.S. Bank National Association), as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, Credit Suisse Group Funding Limited (Guernsey), as the initial issuer (the "**Initial Issuer**"), CSG, as guarantor, and the Trustee, entered into an indenture, dated as of May 21, 2015 (the "**Original Indenture**") providing for the issuance of 4.875% Senior Notes due 2045 (the "**Securities**");

WHEREAS, pursuant to a supplemental indenture, dated as of November 3, 2020 (the "**Supplemental Indenture**" and, together with the Original Indenture, the "**Indenture**"), CSG assumed all of the obligations of the Initial Issuer as principal obligor on the Securities and under the Indenture ("the **Voluntary Issuer Substitution**");

WHEREAS, pursuant to the merger agreement between the Company and CSG, dated as of March 19, 2023, as amended on April 6, 2023 and on May 22, 2023, the Company and CSG will merge, with the Company being the absorbing company which shall continue to operate, and CSG being the absorbed company which shall cease to exist (the "**Merger**");

WHEREAS, effective upon registration of the Merger with the Commercial Register of the Canton of Zurich in Switzerland (the date of such registration, the "**Effective Date**"), CSG will be dissolved and its assets, liabilities and contracts (including its obligations under the Indenture and on the Securities) transferred to, and absorbed and taken over by, the Company by operation of Swiss law (*Universalsukzession*);

WHEREAS, pursuant to Section 5.01 of the Indenture, the Company desires to assume all of the obligations of CSG on the Securities and under the Indenture on the terms and conditions set forth in the Indenture and herein with effect as of the Effective Date;

WHEREAS, all conditions and requirements necessary to make this Second Supplemental Indenture a valid and binding instrument in accordance with the terms of the Indenture have been performed and fulfilled and the execution and delivery hereof have been in all respects duly authorized;

WHEREAS, Section 10.01(b) of the Indenture provides that, without the consent of the Holders, CSG and the Trustee may enter into a supplemental indenture to amend or supplement any of the provisions of the Indenture to comply with Sections 5.01, 5.02, 6.01 and 6.02 of the Indenture; and

------

WHEREAS, pursuant to Section 10.05 of the Indenture, the Trustee is authorized to execute and deliver this Second Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, CSG and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. AGREEMENT TO ASSUME OBLIGATIONS. Pursuant to and in accordance with Section 5.01 of the Indenture and by operation of Swiss law, and with effect as of the Effective Date, the Company shall succeed to, and be substituted for, and may exercise every right and power of, CSG under the Securities with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. As of the Effective Date, the Company hereby (i) assumes all of CSG's obligations as issuer and obligor under the Indenture and on the Securities on the terms and subject to the conditions set forth in this Second Supplemental Indenture and in the Indenture and (ii) undertakes in favor of each Holder to be bound by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if the Company had been named as the "Company" under the Indenture and the Securities. For the avoidance of doubt, from the Effective Date, any references in the Indenture to the "Guarantor" that remained applicable after the Voluntary Issuer Substitution, including those set forth in Section 2.18 and in the definition of "Authorized Person" of the Indenture, shall be to the Company in its capacity as the principal obligor of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of CSG and the Company agrees that any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities may be instituted in any state or federal court in the Borough of Manhattan, The City of New York (each, a "**Proceeding**"), and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. The Company has appointed UBS AG, New York Branch, at 1285 Avenue of the Americas, New York, NY 10019, as its authorized agent (the "**UBS Authorized Agent**") upon whom process may be served in any Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Until the Effective Date, CSG has appointed Credit Suisse (USA), Inc., at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "**CS Authorized Agent**" and, together with the UBS Authorized Agent, the "**Authorized Agents**" and each, an "**Authorized Agent**") upon whom process may be served in any

------

Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of CSG and the Company hereby represents and warrants that its respective Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time any Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding, CSG or the Company, as applicable, will immediately appoint an Authorized Agent upon whom such process may be served. Until the Indenture and this Second Supplemental Indenture are terminated, or, with respect to CSG only, until the Effective Date, each of CSG and the Company shall maintain an Authorized Agent in The City of New York, and each of CSG and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon CSG or the Company, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of CSG and the Company is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to CSG or the Company, such an immunity (whether or not claimed), each of CSG and the Company hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding, or any suit, action or proceeding against it arising out of or based upon the Indenture, this Second Supplemental Indenture or the Securities which may be instituted in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of CSG or the Company hereunder. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Second Supplemental Indenture without any further act by CSG or the Company before any such court and introduction of a true copy of this Second Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Second Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Second Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Second Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of the Second Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of the Second Supplemental Indenture as to the parties hereto. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words "execution," "signed," "signature," "delivery," and words of like import in or relating to this Second Supplemental Indenture or any document to be signed in connection

------

with this Second Supplemental Indenture shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of CSG and the Company and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Second Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. NOTICES. Section 11.02 of the Indenture is hereby amended by replacing the references to addresses and the subparagraph immediately thereafter with the following:

Any notice or communication shall be sufficiently given if written and (a) if delivered in person, when received or (b) if mailed by first class mail, 5 days after mailing, or (c) as among the Company, CSG and the Trustee if sent by facsimile or electronic transmission, when transmission is confirmed, in each case addressed as follows:

If to the Company:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to CSG:

Credit Suisse Group AG

Paradeplatz 8

8001 Zurich, Switzerland

Attention: Legal Counsel

Telephone No.: +41 44 333 1111

If to the Trustee:

U.S. Bank Trust Company, National Association

100 Wall St., Suite 600

New York, New York 10005

Facsimile No.: (212) 361-6153

------

The Company, CSG or the Trustee by written notice to the other may designate additional or different addresses or facsimile numbers for subsequent notices or communications.

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE GROUP AG, | CREDIT SUISSE GROUP AG, |
| as CSG | as CSG |
| By: | /s/ Christopher Chadie |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Christopher Chadie |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |
| By: | /s/ Noah Lee |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Noah Lee |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]*

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| UBS GROUP AG, | UBS GROUP AG, |
| as the Company | as the Company |
| By: | /s/ Daniel Taylor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel Taylor |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |
| By: | /s/ Dean Robson |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Dean Robson |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Authorized Person |

---

*[Signature Page to Second Supplemental Indenture]*

------

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed and attested, all as of the date first above written.

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,

as the Trustee

---

| | |
|:---|:---|
| By: | /s/ Christopher J. Grell |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Christopher J. Grell |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Vice President |

---

*[Signature Page to Second Supplemental Indenture]*

## Exhibit 4.13

**Exhibit 4.13** 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION ("<u>DTC</u>" OR THE "<u>DEPOSITARY</u>"), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE REGISTERED FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.

BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OF THE NOTES (INCLUDING EACH BENEFICIAL OWNER) ACKNOWLEDGES, AGREES TO BE BOUND BY, AND CONSENTS TO THE EXERCISE OF, ANY SWISS RESOLUTION POWER (AS DEFINED HEREIN) WITH RESPECT TO THE COMPANY THAT RESULTS IN THE WRITE-DOWN AND CANCELLATION OF THE ENTIRE, OR A PORTION OF THE, PRINCIPAL AMOUNT OF, AND/OR ACCRUED INTEREST ON, THE NOTES AND/OR CONVERSION INTO EQUITY OF THE COMPANY OF THE ENTIRE, OR A PORTION OF THE, PRINCIPAL AMOUNT OF, AND/OR ACCRUED INTEREST ON, THE NOTES, IRRESPECTIVE OF WHETHER SUCH CLAIMS HAVE ALREADY BECOME DUE AND PAYABLE PRIOR TO THE OCCURRENCE OF SUCH ACTION. BY ITS ACQUISITION OF THE NOTES, EACH SUCH HOLDER (INCLUDING EACH BENEFICIAL OWNER) FURTHER ACKNOWLEDGES, AGREES TO BE BOUND BY, AND CONSENTS TO THE ORDERING OF, ANY RESTRUCTURING PROTECTIVE MEASURES (AS DEFINED HEREIN) THAT RESULTS IN THE DEFERMENT OF PAYMENT OF PRINCIPAL AND/OR INTEREST UNDER THE NOTES. BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OF NOTES (INCLUDING EACH BENEFICIAL OWNER)

------

FURTHER ACKNOWLEDGES AND AGREES THAT ITS RIGHTS ARE SUBJECT TO, AND, IF NECESSARY, WILL BE ALTERED WITHOUT SUCH HOLDER'S OR OWNER'S CONSENT, INCLUDING BY MEANS OF AN AMENDMENT OR MODIFICATION TO THE TERMS OF THE INDENTURE OR OF THE NOTES, SO AS TO GIVE EFFECT TO ANY SUCH EXERCISE OF SWISS RESOLUTION POWER OR ANY SUCH ORDERING OF RESTRUCTURING PROTECTIVE MEASURES.

------

[FACE OF NOTE]

**UBS GROUP AG** 

**4.875% Senior Notes due 2045** 

---

| | |
|:---|:---|
| No. __ | Principal Amount: $___________ |
|  | CUSIP: 902613AY4 |
|  | ISIN: US902613AY48<br> Swiss Security Number: 127325867  |

---

UBS Group AG (registration number CHE-395.345.924), a company organized under the laws of Switzerland (together with its successors and assigns, the "Company"), for value received, hereby promises to pay to Cede & Co. or registered assignees, the principal sum of __________________ Dollars (as such sum may be increased or decreased as reflected on the Schedule of Increases and Decreases in Global Note attached hereto) on May 15, 2045.

Interest Payment Dates: May 15 and November 15, beginning November 15, 2015.

Unless the certificate of authentication hereon has been executed by the Trustee, as defined on the reverse hereof, by manual signature, this Note shall not be entitled to any benefit under the Indenture, as defined on the reverse hereof, or be valid or obligatory for any purpose.

------

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed.

---

| | |
|:---|:---|
| UBS GROUP AG | UBS GROUP AG |
| By: |  |
|  | Name: |
|  | Title: Authorized Person |
| By: |  |
|  | Name: |
|  | Title: Authorized Person |

---

------

CERTIFICATE OF AUTHENTICATION

This is one of the Notes referred to in the within-mentioned Indenture.

Dated: ____________

---

| | |
|:---|:---|
|  | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, |
|  | as Trustee |
| By: |  |
|  | Authorized Signatory |

---

------

[REVERSE OF NOTE]

UBS GROUP AG

4.875% Senior Notes due 2045

UBS Group AG (registration number CHE-395.345.924), a company organized under the laws of Switzerland, (together with its successors and assigns, the "Company") for value received, hereby promises to pay to Cede & Co. or registered assignees, $___________ on May 15, 2045 (the "Maturity Date") (except to the extent redeemed prior to the Maturity Date) and to pay interest thereon from May 21, 2015 (the "Original Issue Date") at the rate of 4.875% per annum (the "Interest Rate") until the principal hereof is paid or duly made available for payment (except as provided below). The Company will pay interest semi-annually in arrears on May 15 and November 15 of each year (each, an "Interest Payment Date"), commencing on November 15, 2015, and on the Maturity Date (or any date fixed for any redemption (a "Redemption Date")); <u>provided</u>, <u>however</u>, that if an Interest Payment Date or the Maturity Date (or any Redemption Date) would fall on a day that is not a Business Day, payment of interest, premium, if any, or principal otherwise payable on such date shall not be made on such date, but shall be made on the next succeeding Business Day with the same force and effect as if made on the Interest Payment Date or on the Maturity Date (or any Redemption Date), and no interest shall accrue for the period from and after the Interest Payment Date or the Maturity Date (or any Redemption Date) to such next succeeding Business Day.

This Note is one of a duly authorized issue of senior notes (the "Notes") of the Company. The Notes are issued in exchange and substitution for the senior notes issued on November 3, 2020 by Credit Suisse Group AG ("CSG", and such senior notes, the "CSG Notes"), which were issued in exchange and substitution for the senior notes issued on May 21, 2015 by Credit Suisse Group Funding (Guernsey) Limited, to evidence the assumption by the Company of all of the obligations of CSG in relation to the CSG Notes and under the Indenture (as defined below) in accordance with Section 5.01 of the Indenture and by operation of Swiss law, whereby, effective as of June 12, 2023, the Company assumes all the obligations of CSG as issuer and obligor under the Indenture and the CSG Notes. The Notes are issuable under a senior indenture, dated as of May 21, 2015, between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the "Trustee"), as amended by a supplemental indenture, dated as of November 3, 2020 and a second supplemental indenture, dated as of June 9, 2023 (as amended and supplemented, the "Indenture"), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities of the Company, the Trustee and the Holders and the terms upon which the Notes are to be authenticated and delivered. U.S. Bank Trust Company, National Association at its corporate trust office in The City of New York has been appointed the Registrar and Paying Agent with respect to the Notes. Credit Suisse AG has been appointed the Swiss Paying Agent for the Notes. To the extent not inconsistent herewith, the terms of the Indenture are hereby incorporated by reference herein. This Note will not be subject to any sinking fund and will not be redeemable or subject to repayment at the option of the Holder prior to the Maturity Date. However, subject to the prior approval of FINMA, if then required under Swiss laws and regulations applicable to the Company from time to time, the Company or any subsidiary of the Company may at any time purchase or procure others to purchase beneficially for its account Notes in any manner and at any price. Notes so purchased may, at the Company's discretion, be held, resold or surrendered for cancellation.

------

Interest periods for this Note will begin on and include each Interest Payment Date and end on but exclude the next succeeding Interest Payment Date or the Maturity Date (or earlier Redemption Date), except that the initial interest period will begin on and include the Original Issue Date and end on but exclude the first Interest Payment Date (or earlier Redemption Date). Interest payments for this Note will be computed and paid on the basis of a 360-day year of twelve 30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date, will, subject to certain exceptions described herein, be paid to the person in whose name this Note (or one or more predecessor Notes) is registered in the Security Register at the close of business on the corresponding record date (the "Record Date"), which shall be, for so long as the Notes are in the form of one or more Global Notes, three Business Days prior to the relevant Interest Payment Date and, in the event that any Notes are not represented by one or more Global Notes, the fifteenth day (whether or not a Business Day) prior to the relevant Interest Payment Date; <u>provided</u>, <u>however</u>, that interest payable on the Maturity Date (or any Redemption Date) will be payable to the person to whom the principal hereof shall be payable.

Payment of the principal of this Note, and premium, if any, and the interest due on the Maturity Date (or any Redemption Date) will be made in immediately available funds upon surrender of this Note at the office or agency of such paying agent as the Company may determine and maintained for that purpose in the Borough of Manhattan, The City of New York (a "Paying Agent"), or at the office or agency of such other Paying Agent as the Company may determine.

Payment of the principal of and premium, if any, and interest on this Note will be made in such coin or currency of the United States as at the time of payment is legal tender for payment of public and private debts; <u>provided</u>, <u>however</u>, that payments of interest, other than interest due at the Maturity Date (or any Redemption Date) will be made, at the option of the Company, by U.S. dollar check mailed to the address of the person entitled thereto as such address shall appear in the Security Register or by wire transfer of immediately available funds to an account within the United States maintained by the Holder of this Note if appropriate wire transfer instructions in writing have been received by the Paying Agent not less than 10 days prior to the applicable Interest Payment Date.

This Note constitutes the direct, senior and unsecured obligation of the Company, and ranks *pari passu* with all other unsecured and unsubordinated indebtedness of the Company.

This Note, and any Note or Notes issued upon transfer or exchange hereof, is issuable only in fully registered form, without coupons, and is issuable only in denominations of U.S. $250,000 or any integral multiple of U.S. $1,000 in excess thereof.

In case an Event of Default (as defined in the Indenture) with respect to the Notes shall have occurred and be continuing, the principal hereof and the interest accrued hereon, if any, may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture.

------

The Indenture contains provisions that provide that the Company and the Trustee may amend or supplement the Indenture or the Notes without notice to or the consent of any Holder in order to (i) cure any ambiguity, defect or inconsistency in the Indenture, <u>provided</u> that such amendments or supplements shall not materially and adversely affect the interests of the Holders; (ii) comply with the requirements of the Indenture if the Company consolidates with, merges with or into, or sells, conveys, transfers, leases or otherwise disposes of all or substantially all its property and assets (as an entirety or substantially as an entirety in one transaction or a series of transactions), to any person; (iii) comply with any requirements of the Securities and Exchange Commission in connection with the qualification of the Indenture under the Trust Indenture Act of 1939, as amended; (iv) evidence and provide for the acceptance of appointment under the Indenture with respect to the Notes by a successor Trustee; (v) provide for a further guarantee from a third party on the Notes; (vi) provide for the issuance of any notes issued in exchange for any Notes pursuant to a registration rights agreement; (vii) provide for the issuance of Additional Notes (as defined in the Indenture); (viii) to account for the exercise of any Swiss Resolution Power and/or the ordering of any Protective Measures; or (ix) make any change that does not materially and adversely affect the rights of any Holder.

The Indenture contains provisions that provide that, without prior notice to any Holders, the Company and the Trustee may amend the Indenture and the Notes with the written consent of the Holders of a majority in principal amount of the outstanding Notes, and the Holders of a majority in principal amount of the outstanding Notes by written notice to the Trustee may waive future compliance by the Company with any provision of the Indenture or the Notes; <u>provided</u> that, without the consent of each Holder of the Notes affected thereby, an amendment or waiver, including a waiver of past defaults, may not: (i) impair the right of any Holder to receive payment of the principal of and interest on the Notes on or after the respective due date, (ii) impair the right of any Holder to institute suit for the enforcement of any such payment on or after such respective dates, (iii) extend the stated maturity of the principal of or any installment of interest on, such Holder's Note, or reduce the principal thereof or the rate of interest thereon, or the amount thereof provable in bankruptcy, administration, insolvency or similar proceeding, or change any place of payment where, or the currency in which, any principal or the interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the due date therefor, (iv) reduce the percentage in principal amount of outstanding Notes the consent of whose Holders is required for any such supplemental indenture, or for any waiver of compliance with certain provisions of the Indenture or certain Defaults and their consequences provided for in the Indenture, (v) waive a Default in the payment of principal of or interest on any Note of such Holder by the Company, or (vi) modify any of the provisions of the Indenture governing amendments or waivers with the consent of Holders except to increase any such percentage or to provide that certain other provisions of the Indenture cannot be modified or waived without the consent of the Holder of each outstanding Note affected thereby; <u>provided</u> that any amendment to the Indenture and/or the Notes made as a consequence of or as a result of the exercise of the Swiss Resolution Power and/or the ordering of Restructuring Protective Measures provided for hereunder and under the Indenture shall not be subject to the foregoing.

------

It is also provided in the Indenture that, subject to certain conditions, the Holders of at least a majority in principal amount of the outstanding Notes, by notice to the Trustee, may waive an existing Default or Event of Default with respect to the Notes and its consequences, except a Default in the payment of principal of or interest on any Note or in respect of a covenant or provision of the Indenture which cannot be modified or amended without the consent of the Holder of each outstanding Note affected. Upon any such waiver, such Default shall cease to exist, and any Event of Default with respect to the Notes arising therefrom shall be deemed to have been cured, for every purpose of the Indenture; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereto.

The Indenture also provides that the Company may, without the consent of the Holders hereof, issue Additional Notes, which Notes of different tranches may have different issue dates, public offering prices, initial interest payment dates and initial interest accrual dates but otherwise shall have identical terms. All the Additional Notes issued under the Indenture shall be treated as a single class and consolidated and form a single series with the Notes initially issued for all purposes of the Indenture including waivers, amendments, redemptions and offers to purchase. Such Additional Notes shall be issued for U.S. federal income tax purposes in a "qualified reopening" or with no more than a *de minimis* amount of original issue discount.

So long as this Note shall be outstanding, the Company will cause to be maintained an office or agency for the payment of the principal of and premium, if any, and interest on this Note as herein provided in the Borough of Manhattan, The City of New York, and an office or agency in said Borough of Manhattan for the registration, transfer and exchange as aforesaid of the Notes. The Company may designate other agencies for the payment of said principal, premium, if any, and interest at such place or places (subject to applicable laws and regulations) as the Company may decide. So long as there shall be any such agency, the Company shall keep the Trustee advised of the names and locations of such agencies, if any are so designated.

Except in connection with the exercise of the Swiss Resolution Power and/or the ordering of Restructuring Protective Measures, no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note at the time, place, and rate, and in the coin or currency, herein and in the Indenture prescribed unless otherwise agreed between the Company and the registered Holder of this Note.

Upon due presentment for registration of transfer of this Note, a new Note or Notes of authorized denominations for an equal aggregate principal amount will be issued to the transferee in exchange therefor, subject to the limitations provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith.

The Company or any agent of the Company, the Registrar and the Trustee may treat the Holder in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Registrar, the Trustee nor any such agent shall be affected by notice to the contrary.

------

No recourse shall be had for the payment of the principal of, or premium, if any, or the interest on, this Note, for any claim based hereon, or otherwise in respect hereof, or based on or in respect of the Indenture against any incorporator, shareholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue hereof, expressly waived and released.

*Agreement with Respect to the Exercise of Swiss Resolution Power and the Ordering of Restructuring Protective Measures* 

By its acquisition of the Notes, each Holder of the Notes (including each beneficial owner) acknowledges, agrees to be bound by, and consents to the exercise of, any Swiss Resolution Power with respect to the Company that results in the write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of the, principal amount of, and/or accrued interest on, the Notes, irrespective of whether such amounts have already become due and payable prior to such action. By its acquisition of the Notes, each such Holder (including each beneficial owner) further acknowledges, agrees to be bound by, and consents to the ordering of any Restructuring Protective Measures that results in the deferment of payment of principal and/or interest under the Notes. By its acquisition of the Notes, each Holder of Notes (including each beneficial owner) further acknowledges, agrees and consents that its rights are subject to, and, if necessary, will be altered without such Holder's or owner's consent, including by means of an amendment or modification to the terms of the Indenture or of the Notes so as to give effect to, any such exercise of the Swiss Resolution Power or any such ordering of Restructuring Protective Measures.

By its acquisition of the Notes, each Holder of Notes (including each beneficial owner) will automatically be deemed to have irrevocably waived its right to claim or receive, and will not have any rights against the Company or the Trustee with respect to repayment of the principal amount of the Notes or any accrued and unpaid interest (or any Additional Amounts payable in connection therewith) on any Notes, in each case, that is written-down and/or converted into equity of the Company as a result of the exercise of any Swiss Resolution Power.

By its acquisition of the Notes, each Holder (including each beneficial owner), waives any and all claims, in law and/or in equity, against the Trustee for, agrees not to initiate a suit against the Trustee in respect of, and agrees that the Trustee shall not be liable for, any action that the Trustee takes or abstains from taking, in either case in accordance with (i) a Guarantor Restructuring Event (as defined in the Indenture), (ii) the exercise of any Swiss Resolution Power with respect to the Company that requires or results in any write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of, the principal amount of, and/or accrued interest on, the Notes, (iii) the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of the principal amount and/or interest under the Notes or (iv) any consequences resulting from any of the foregoing.

------

Additionally, by its acquisition of the Notes, each Holder of the Notes (including each beneficial owner) will acknowledge, agree and consent that (a) upon the exercise of any Swiss Resolution Power with respect to the Company or the ordering of any Restructuring Protective Measures, (i) the Trustee will not take any further directions from the Holders under Section 7.05 (*Control by Majority*) of the Indenture, which section authorizes Holders of a majority in aggregate outstanding principal amount of the Notes to direct certain actions relating to the Notes, and that any such direction given prior to the exercise of any Swiss Resolution Power with respect to the Company or the ordering of any Restructuring Protective Measures shall thereafter be deemed null and void, and (ii) the Indenture and the Notes will not impose any duties, liability, cost or expense upon the Trustee whatsoever with respect to the exercise of any such Swiss Resolution Power or the ordering of any Restructuring Protective Measures, and (b) neither a Guarantor Restructuring Event, nor the exercise of any Swiss Resolution Power with respect to the Company that requires or results in any write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of, the principal amount of, and/or accrued interest on, the Notes, nor the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of principal and/or interest under the Notes nor any consequences resulting from any of the foregoing shall give rise to a Default or an Event of Default under the Indenture, including, without limitation, for purposes of Section 315(b) and Section 315(c) under the Trust Indenture Act of 1939, as amended.

By its purchase of the Notes, each Holder and beneficial owner of Notes shall be deemed to have (i) consented to the lack of prior notice by the Swiss Resolution Authority of its decision to exercise any Swiss Resolution Power or order any Restructuring Protective Measure and (ii) authorized, directed and requested DTC and any direct participant in DTC or other intermediary through which it holds such Notes to take any and all necessary action, if required, to implement any such exercise of Swiss Resolution Power or ordering of any Restructuring Protective Measures, without any further action or direction on the part of such Holder or beneficial owner.

No repayment of the principal amount of the Notes or payment of interest on the Notes shall become due and payable after the exercise of any Swiss Resolution Power with respect to the Company that results in the write-down and cancellation and/or conversion into the equity of the Company of the entire, or a portion of, the principal of, and/or accrued but unpaid interest on, the Notes, or the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of principal and/or interest under the Notes, unless, at the time that such repayment or payment, respectively, is scheduled to become due, such repayment or payment would be permitted to be made by the Company under the Swiss laws, regulations and orders applicable to the Company.

Notwithstanding anything herein to the contrary, so long as any Notes remain outstanding (including, for example, if the exercise of the Swiss Resolution Power results in only a partial write-down and/or conversion of the Principal of the Notes), then the Trustee's duties and rights under the Indenture shall remain applicable with respect to the Notes.

BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OR BENEFICIAL OWNER OF NOTES THAT ACQUIRES ITS NOTES IN THE SECONDARY MARKET SHALL BE DEEMED TO ACKNOWLEDGE, AGREE TO BE BOUND BY AND CONSENT TO THE PROVISIONS SPECIFIED IN THE INDENTURE TO THE SAME EXTENT AS THE HOLDERS AND BENEFICIAL OWNERS OF THE NOTES THAT ACQUIRE THE NOTES

------

UPON THEIR INITIAL ISSUANCE, INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO THE ACKNOWLEDGEMENT AND AGREEMENT TO BE BOUND BY AND CONSENT TO THE TERMS OF THE NOTES, INCLUDING THOSE TERMS AND PROVISIONS RELATING TO ANY SWISS RESOLUTION POWER AND ANY RESTRUCTURING PROTECTIVE MEASURES.

*Tax Redemption* 

Subject to the prior approval of FINMA, if then required under Swiss laws and regulations applicable to the Company from time to time, as evidenced by an Officers' Certificate from the Company certifying the same, the Company may at its option redeem the Notes, in whole but not in part, at any time on giving not less than 30 nor more than 60 days' notice to the Holders and the Trustee, at the principal amount of the Notes being redeemed, together with accrued interest to, but excluding the Redemption Date, if it has or will become obligated to pay Additional Amounts in respect of the notes as described below as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of Switzerland or Guernsey, as applicable, or any political subdivision or taxing authority thereof or therein, or any change in the application or official interpretation of such laws, regulations or rulings, which change or amendment becomes effective on or after the date hereof, and such obligation cannot be avoided by the Company taking reasonable measures available to it, <u>provided</u> that no such notice of redemption will be given earlier than 90 days prior to the earliest date on which it would be obliged to pay such Additional Amounts were a payment in respect of the notes then due; <u>provided</u>, <u>however</u>, that if the Company has given such notice and a Restructuring Event occurs thereafter, but prior to the tax redemption date, such tax redemption will be canceled. Prior to the giving of any notice of redemption pursuant to this paragraph, the Company will deliver to the Trustee an Officers' Certificate stating that it is entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to its right to redeem have occurred, and an opinion of independent counsel of recognized standing to the effect that the Company has or will become obligated to pay such Additional Amounts as a result of such change or amendment.

*Payment of Additional Amounts* 

The Company will, subject to the exceptions and limitations set forth below, pay such additional amounts ("Additional Amounts") to the Holders as may be necessary so that every net payment on the Notes, after deduction or withholding for or on account of any present or future tax, assessment or other governmental charge imposed upon or as a result of such payment by Switzerland or Guernsey, as applicable, or any political subdivision or taxing authority thereof or therein, will not be less than the amount provided in the Notes to be then due and payable, subject to the discussion below.

**Switzerland** 

The Company will not be required to make any payments of Additional Amounts described above in respect of any present or future tax, assessment or other governmental charge imposed by Switzerland, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the Holder having some connection with Switzerland other than the mere holding of the Note; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date (as defined below) except to the extent that the Holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including, but not
limited to, the agreement between the European Union and Switzerland of October 26, 2004, or any law or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) where such withholding or deduction is imposed on a payment and is required to be made pursuant to any
agreements between Switzerland and other countries on final withholding taxes (*internationale Quellensteuern*) in respect of persons resident in the other country on income of such person on Notes booked or deposited with a Swiss paying agent,
or any law or the other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) any tax required to be withheld or deducted from a payment pursuant to laws enacted by Switzerland providing
for the taxation of payments according to principles similar to those laid down in the draft legislation proposed by the Swiss Federal Council on December 17, 2014, in particular the principle to have a person other than the Company withhold or
deduct tax; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) where such withholding or deduction is imposed on any payment by reason of FATCA (as defined below); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) any combination of two or more items (i) through (vii) above.

------

**Guernsey** 

The Company will not be required to make any payments of Additional Amounts described above in respect of any present or future tax, assessment or other governmental charge imposed by Guernsey, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the Holder having some connection with Guernsey other than the mere holding of the Note; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to the extent the withholding or deduction is imposed or levied because the Holder (or beneficial owner) of the
Note has not made a declaration of non residence or other claim for exemption, if such holder is able to avoid such deduction or withholding by making such a declaration or claim; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date (as defined below) except to the extent that the Holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including any law
or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) where such withholding or deduction is imposed on any payment by reason of FATCA (as defined below); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) any combination of two or more items (i) through (vi) above.

**U.S. Foreign Account Tax Compliance Act** 

Payments on the Notes will be subject in all cases to any withholding or deduction required pursuant to an agreement described in Section 1471(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), or described in any agreement between any jurisdiction and the United States relating to the foreign account provisions of the U.S. Hiring Incentives to Restore Employment Act of 2010, or otherwise imposed pursuant to Sections 1471 through 1474 of the Code, any regulations or agreements thereunder, official interpretations thereof, or any agreements, law, regulation or other official guidance implementing an intergovernmental agreement or other intergovernmental approach thereto (collectively, "FATCA").

------

Whenever in this Note there is mentioned, in any context, the payment of the principal of or any premium, interest or any other amounts on, or in respect of, this Note, such mention shall be deemed to include mention of the payment of Additional Amounts as provided above to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the terms hereof, and express mention of the payment of Additional Amounts in any provision hereof shall not be construed as excluding the payment of Additional Amounts in those provisions hereof where such express mention in not made.

All terms used in this Note which are defined in the Indenture and not otherwise defined herein shall have the respective meanings assigned to them in the Indenture.

**This Note shall for all purposes be governed by, and construed in accordance with, the laws of the State of New York (without regard to conflicts of law principles thereof).** 

------

ABBREVIATIONS

The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations:

TEN COM – as tenants in common

TEN ENT – as tenants by the entireties

JT TEN – as joint tenants with right of survivorship and not as tenants in common

UNIF GIFT MIN ACT – ______ (Custodian)_______ (Minor)

Under Uniform Gifts to Minors Act ___________ (State)

Additional abbreviations may also be used though not in the above list.

------

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTE

The following increases or decreases of this Global Note have been made:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date of**<br> **Decrease or**<br> **Increase** | **Amount of**<br> **Decrease in**<br> **Principal Amount**<br> **of this Global**<br> **Note** | **Amount of**<br> **Increase in**<br> **Principal Amount**<br> **of this Global**<br> **Note** | **Principal**<br> **Amount**<br> **of this Global**<br> **Note**<br> **Following Such**<br> **Decrease (or**<br> **Increase)** | **Signature of**<br> **Authorized Officer**<br> **of Trustee** |

---

## Exhibit 4.14

**Exhibit 4.14** 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION ("<u>DTC</u>" OR THE "<u>DEPOSITARY</u>"), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE REGISTERED FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.

BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OF THE NOTES (INCLUDING EACH BENEFICIAL OWNER) ACKNOWLEDGES, AGREES TO BE BOUND BY, AND CONSENTS TO THE EXERCISE OF, ANY SWISS RESOLUTION POWER (AS DEFINED HEREIN) WITH RESPECT TO THE COMPANY THAT RESULTS IN THE WRITE-DOWN AND CANCELLATION OF THE ENTIRE, OR A PORTION OF THE, PRINCIPAL AMOUNT OF, AND/OR ACCRUED INTEREST ON, THE NOTES AND/OR CONVERSION INTO EQUITY OF THE COMPANY OF THE ENTIRE, OR A PORTION OF THE, PRINCIPAL AMOUNT OF, AND/OR ACCRUED INTEREST ON, THE NOTES, IRRESPECTIVE OF WHETHER SUCH CLAIMS HAVE ALREADY BECOME DUE AND PAYABLE PRIOR TO THE OCCURRENCE OF SUCH ACTION. BY ITS ACQUISITION OF THE NOTES, EACH SUCH HOLDER (INCLUDING EACH BENEFICIAL OWNER) FURTHER ACKNOWLEDGES, AGREES TO BE BOUND BY, AND CONSENTS TO THE ORDERING OF, ANY RESTRUCTURING PROTECTIVE MEASURES (AS DEFINED HEREIN) THAT RESULTS IN THE DEFERMENT OF PAYMENT OF PRINCIPAL AND/OR INTEREST UNDER THE NOTES. BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OF THE NOTES (INCLUDING EACH BENEFICIAL OWNER)

------

FURTHER ACKNOWLEDGES AND AGREES THAT ITS RIGHTS ARE SUBJECT TO, AND, IF NECESSARY, WILL BE ALTERED WITHOUT SUCH HOLDER'S OR OWNER'S CONSENT, INCLUDING BY MEANS OF AN AMENDMENT OR MODIFICATION TO THE TERMS OF THE INDENTURE OR OF THE NOTES, SO AS TO GIVE EFFECT TO ANY SUCH EXERCISE OF SWISS RESOLUTION POWER OR ANY SUCH ORDERING OF RESTRUCTURING PROTECTIVE MEASURES.

------

[FACE OF NOTE]

**UBS GROUP AG** 

**4.550% Senior Notes due 2026** 

---

| | |
|:---|:---|
| No. __ | Principal Amount: $___________ |
|  | CUSIP: 902613BB3 |
|  | ISIN: US902613BB36<br> Swiss Security Number: 127325868 |

---

UBS Group AG (registration number CHE-395.345.924), a company organized under the laws of Switzerland (together with its successors and assigns, the "Company"), for value received, hereby promises to pay to Cede & Co. or registered assignees, the principal sum of ____________________ Dollars (as such sum may be increased or decreased as reflected on the Schedule of Increases and Decreases in Global Note attached hereto) on April 17, 2026.

Interest Payment Dates: April 18 and October 18, beginning April 18, 2017.

Unless the certificate of authentication hereon has been executed by the Trustee, as defined on the reverse hereof, by manual signature, this Note shall not be entitled to any benefit under the Indenture, as defined on the reverse hereof, or be valid or obligatory for any purpose.

------

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed.

---

| | |
|:---|:---|
| UBS GROUP AG | UBS GROUP AG |
| By: |  |
|  | Name: |
|  | Title: Authorized Person |
| By: |  |
|  | Name: |
|  | Title: Authorized Person |

---

------

CERTIFICATE OF AUTHENTICATION

This is one of the Notes referred to in the within-mentioned Indenture.

Dated: ____________

---

| | |
|:---|:---|
|  | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, |
|  | as Trustee |
| By: |  |
|  | Authorized Signatory |

---

------

[REVERSE OF NOTE]

UBS GROUP AG

4.550% Senior Notes due 2026

UBS Group AG (registration number CHE-395.345.924), a company organized under the laws of Switzerland, (together with its successors and assigns, the "Company") for value received, hereby promises to pay to Cede & Co. or registered assignees, $___________ on April 17, 2026 (the "Maturity Date") (except to the extent redeemed prior to the Maturity Date) and to pay interest thereon from October 18, 2016 (the "Initial Accrual Date") at the rate of 4.550% per annum (the "Interest Rate") until the principal hereof is paid or duly made available for payment (except as provided below). For purposes of this Note, "Principal" means the principal amount of, and, unless the context indicates otherwise, includes any premium payable on, the Note. The Company will pay interest semi-annually in arrears on April 18 and October 18 of each year (each, an "Interest Payment Date"), commencing on April 18, 2017, and on the Maturity Date (or any date fixed for any redemption (a "Redemption Date")); <u>provided</u>, <u>however</u>, that if an Interest Payment Date or the Maturity Date (or any Redemption Date) would fall on a day that is not a Business Day, payment of interest, premium, if any, or Principal otherwise payable on such date shall not be made on such date, but shall be made on the next succeeding Business Day with the same force and effect as if made on the Interest Payment Date or on the Maturity Date (or any Redemption Date), and no interest shall accrue for the period from and after the Interest Payment Date or the Maturity Date (or any Redemption Date) to such next succeeding Business Day.

This Note is one of a duly authorized issue of senior notes (the "Notes") of the Company. The Notes are issued in exchange and substitution for the senior notes issued on November 3, 2020 by Credit Suisse Group AG ("CSG", and such senior notes, the "CSG Notes"), which were issued in exchange and substitution for the senior notes issued on April 18, 2016 by Credit Suisse Group Funding (Guernsey) Limited, to evidence the assumption by the Company of all of the obligations of CSG in relation to the CSG Notes and under the Indenture (as defined below) in accordance with Section 5.01 of the Indenture and by operation of Swiss law, whereby, effective as of June 12, 2023, the Company assumes all the obligations of CSG as issuer and obligor under the Indenture and the CSG Notes. The Notes are issuable under a senior indenture, dated as of April 18, 2016, between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the "Trustee"), as amended by a supplemental indenture, dated as of November 3, 2020 and a second supplemental indenture, dated as of June 9, 2023 (as amended and supplemented, the "Indenture"), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities of the Company, the Trustee and the Holders and the terms upon which the Notes are to be authenticated and delivered. U.S. Bank Trust Company, National Association at its corporate trust office in The City of New York has been appointed the Registrar and Paying Agent with respect to the Notes. Credit Suisse AG has been appointed the Swiss Paying Agent for the Notes. To the extent not inconsistent herewith, the terms of the Indenture are hereby incorporated by reference herein. This Note will not be subject to any sinking fund and will not be redeemable or subject to repayment at the option of the Holder prior to the Maturity Date.

------

However, subject to the prior approval of FINMA, if then required under Swiss laws and regulations applicable to the Company from time to time, the Company or any subsidiary of the Company may at any time purchase or procure others to purchase beneficially for its account Notes in any manner and at any price. Notes so purchased may, at the Company's discretion, be held, resold or surrendered for cancellation.

Interest periods for this Note will begin on and include each Interest Payment Date and end on but exclude the next succeeding Interest Payment Date or the Maturity Date (or earlier Redemption Date), except that the initial interest period will begin on and include the Initial Accrual Date and end on but exclude the first Interest Payment Date (or earlier Redemption Date). Interest payments for this Note will be computed and paid on the basis of a 360-day year of twelve 30-day months. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date, will, subject to certain exceptions described herein, be paid to the person in whose name this Note (or one or more predecessor Notes) is registered in the Security Register at the close of business on the corresponding record date (the "Record Date"), which shall be, for so long as the Notes are in the form of one or more Global Notes, three Business Days prior to the relevant Interest Payment Date and, in the event that any Notes are not represented by one or more Global Notes, the fifteenth day (whether or not a Business Day) prior to the relevant Interest Payment Date; <u>provided</u>, <u>however</u>, that interest payable on the Maturity Date (or any Redemption Date) will be payable to the person to whom the Principal hereof shall be payable.

Payment of the Principal of this Note, and premium, if any, and the interest due on the Maturity Date (or any Redemption Date) will be made in immediately available funds upon surrender of this Note at the office or agency of such paying agent as the Company may determine and maintained for that purpose in the Borough of Manhattan, The City of New York (a "Paying Agent"), or at the office or agency of such other Paying Agent as the Company may determine.

Payment of the Principal of and premium, if any, and interest on this Note will be made in such coin or currency of the United States as at the time of payment is legal tender for payment of public and private debts; <u>provided</u>, <u>however</u>, that payments of interest, other than interest due at the Maturity Date (or any Redemption Date) will be made, at the option of the Company, by U.S. dollar check mailed to the address of the person entitled thereto as such address shall appear in the Security Register or by wire transfer of immediately available funds to an account within the United States maintained by the Holder of this Note as such account shall be provided to the Registrar at least 15 calendar days prior to the applicable Interest Payment Date.

This Note constitutes the direct, senior and unsecured obligation of the Company, and ranks *pari passu* with all other unsecured and unsubordinated indebtedness of the Company.

This Note, and any Note or Notes issued upon transfer or exchange hereof, is issuable only in fully registered form, without coupons, and is issuable only in denominations of U.S. $250,000 or any integral multiple of U.S. $1,000 in excess thereof.

------

In case an Event of Default (as defined in the Indenture) with respect to the Notes shall have occurred and be continuing, the Principal hereof and the interest accrued hereon, if any, may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture.

The Indenture contains provisions that provide that the Company and the Trustee may amend or supplement the Indenture or the Notes without notice to or the consent of any Holder in order to (i) cure any ambiguity, defect or inconsistency in the Indenture, <u>provided</u> that such amendments or supplements shall not materially and adversely affect the interests of the Holders; (ii) comply with the requirements of the Indenture if the Company consolidates with, merges with or into, or sells, conveys, transfers, leases or otherwise disposes of all or substantially all its property and assets (as an entirety or substantially as an entirety in one transaction or a series of transactions), to any person; (iii) comply with any requirements of the Securities and Exchange Commission in connection with the qualification of the Indenture under the Trust Indenture Act of 1939, as amended; (iv) evidence and provide for the acceptance of appointment under the Indenture with respect to the Notes by a successor Trustee; (v) provide for a further guarantee from a third party on the Notes; (vi) provide for the issuance of Exchange Securities (as defined in the Indenture); (vii) provide for the issuance of Additional Securities (as defined in the Indenture); (viii) to account for the exercise of any Swiss Resolution Power and/or the ordering of any Protective Measures; or (ix) make any change that does not materially and adversely affect the rights of any Holder.

The Indenture contains provisions that provide that, without prior notice to any Holders, the Company and the Trustee may amend the Indenture and the Notes with the written consent of the Holders of a majority in Principal of the outstanding Notes, and the Holders of a majority in Principal of the outstanding Notes by written notice to the Trustee may waive future compliance by the Company with any provision of the Indenture or the Notes; <u>provided</u> that, without the consent of each Holder of the Notes affected thereby, an amendment or waiver, including a waiver of past defaults, may not: (i) impair the right of any Holder to receive payment of the Principal of and interest on the Notes on or after the respective due date or impair the right of any Holder to institute suit for the enforcement of any such payment on or after such respective dates, (ii) extend the stated maturity of the Principal of or any installment of interest on, such Holder's Note, or reduce the Principal thereof or the rate of interest thereon, or the amount thereof provable in bankruptcy, administration, insolvency or similar proceeding, or change any place of payment where, or the currency in which, any Principal or the interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the due date therefor, (iii) reduce the percentage in Principal of outstanding Notes the consent of whose Holders is required for any such supplemental indenture, or for any waiver of compliance with certain provisions of the Indenture or certain Defaults and their consequences provided for in the Indenture, (iv) waive a Default in the payment of Principal of or interest on any Note of such Holder by the Company, or (v) modify any of the provisions of the Indenture governing amendments or waivers with the consent of Holders except to increase any such percentage or to provide that certain other provisions of the Indenture cannot be modified or waived without the consent of the Holder of each outstanding Note affected thereby; <u>provided</u> that any amendment to the Indenture and/or the Notes made as a consequence of or as a result of the exercise of the Swiss Resolution Power and/or the ordering of Restructuring Protective Measures provided for hereunder and under the Indenture shall not be subject to the foregoing.

------

It is also provided in the Indenture that, subject to certain conditions, the Holders of at least a majority in Principal of the outstanding Notes, by notice to the Trustee, may waive an existing Default or Event of Default with respect to the Notes and its consequences, except a Default in the payment of Principal of or interest on any Note or in respect of a covenant or provision of the Indenture which cannot be modified or amended without the consent of the Holder of each outstanding Note affected. Upon any such waiver, such Default shall cease to exist, and any Event of Default with respect to the Notes arising therefrom shall be deemed to have been cured, for every purpose of the Indenture; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereto; provided that on or after an Issuer Substitution Date, if Swiss law then so requires, this provision will be subject to the mandatory provisions of Swiss law in relation to meetings of Holders.

The Indenture also provides that the Company may, without the consent of the Holders hereof, issue Additional Securities, which Notes of different tranches may have different issue dates, public offering prices, initial interest payment dates and initial interest accrual dates but otherwise shall have identical terms. All the Additional Securities issued under the Indenture shall be treated as a single class and consolidated and form a single series with the Notes initially issued for all purposes of the Indenture including waivers, amendments, redemptions and offers to purchase. Such Additional Securities that have the same CUSIP, ISIN or other identifying number as the Notes shall be issued for U.S. federal income tax purposes in a "qualified reopening" or with no more than a *de minimis* amount of original issue discount.

So long as this Note shall be outstanding, the Company will cause to be maintained an office or agency for the payment of the Principal of and premium, if any, and interest on this Note as herein provided in the Borough of Manhattan, The City of New York, and an office or agency in said Borough of Manhattan for the registration, transfer and exchange as aforesaid of the Notes. The Company may designate other agencies for the payment of said Principal, premium, if any, and interest at such place or places (subject to applicable laws and regulations) as the Company may decide. So long as there shall be any such agency, the Company shall keep the Trustee advised of the names and locations of such agencies, if any are so designated.

Except in connection with the exercise of the Swiss Resolution Power and/or the ordering of Restructuring Protective Measures, no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the Principal of, premium, if any, and interest on this Note at the time, place, and rate, and in the coin or currency, herein and in the Indenture prescribed unless otherwise agreed between the Company and the registered Holder of this Note.

Upon due presentment for registration of transfer of this Note, a new Note or Notes of authorized denominations for an equal aggregate Principal will be issued to the transferee in exchange therefor, subject to the limitations provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith.

The Company or any agent of the Company, the Registrar and the Trustee may treat the Holder in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Registrar, the Trustee nor any such agent shall be affected by notice to the contrary.

------

No recourse shall be had for the payment of the Principal of, or premium, if any, or the interest on, this Note, for any claim based hereon, or otherwise in respect hereof, or based on or in respect of the Indenture against any incorporator, shareholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue hereof, expressly waived and released.

*Agreement with Respect to the Exercise of Swiss Resolution Power and the Ordering of Restructuring Protective Measures* 

By its acquisition of the Notes, each Holder of the Notes (including each beneficial owner) acknowledges, agrees to be bound by, and consents to the exercise of, any Swiss Resolution Power with respect to the Company that results in the write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of the, Principal of, and/or accrued interest on, the Notes, irrespective of whether such amounts have already become due and payable prior to such action. By its acquisition of the Notes, each such Holder (including each beneficial owner) further acknowledges, agrees to be bound by, and consents to the ordering of any Restructuring Protective Measures that results in the deferment of payment of Principal and/or interest under the Notes. By its acquisition of the Notes, each Holder of Notes (including each beneficial owner) further acknowledges, agrees and consents that its rights are subject to, and, if necessary, will be altered without such Holder's or owner's consent, including by means of an amendment or modification to the terms of the Indenture or of the Notes so as to give effect to, any such exercise of the Swiss Resolution Power or any such ordering of Restructuring Protective Measures. For the avoidance of doubt, this acknowledgement, agreement and consent does not qualify as a waiver of the rights, procedural or otherwise, existing for creditors generally, and the holders of the Notes specifically, under the applicable banking regulation pursuant to which any Swiss Resolution Power is exercised.

By its acquisition of the Notes, each Holder of the Notes (including each beneficial owner) will automatically be deemed to have irrevocably waived its right to claim or receive, and will not have any rights against the Company or the Trustee with respect to repayment of the Principal of the Notes or any accrued and unpaid interest (or any Additional Amounts payable in connection therewith) on any Notes, in each case, that is written-down and/or converted into equity of the Company as a result of the exercise of any Swiss Resolution Power.

By its acquisition of the Notes, each Holder (including each beneficial owner), waives any and all claims, in law and/or in equity, against the Trustee for, agrees not to initiate a suit against the Trustee in respect of, and agrees that the Trustee shall not be liable for, any action that the Trustee takes or abstains from taking, in either case in accordance with (i) a Guarantor Restructuring Event (as defined in the Indenture), (ii) the exercise of any Swiss Resolution Power with respect to the Company that requires or results in any write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of, the Principal of, and/or accrued interest on, the Notes, (iii) the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of the Principal and/or interest under the Notes or (iv) any consequences resulting from any of the foregoing.

------

Additionally, by its acquisition of the Notes, each Holder of the Notes (including each beneficial owner) will acknowledge, agree and consent that (a) upon the exercise of any Swiss Resolution Power with respect to the Company or the ordering of any Restructuring Protective Measures, (i) the Trustee will not take any further directions from the Holders under Section 7.05 (*Control by Majority*) of the Indenture, which section authorizes Holders of a majority in aggregate outstanding Principal of the Notes to direct certain actions relating to the Notes, and that any such direction given prior to the exercise of any Swiss Resolution Power with respect to the Company or the ordering of any Restructuring Protective Measures shall thereafter be deemed null and void, and (ii) the Indenture and the Notes will not impose any duties, liability, cost or expense upon the Trustee whatsoever with respect to the exercise of any such Swiss Resolution Power or the ordering of any Restructuring Protective Measures, and (b) neither a Guarantor Restructuring Event, nor the exercise of any Swiss Resolution Power with respect to the Company that requires or results in any write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of, the Principal of, and/or accrued interest on, the Notes, nor the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of Principal and/or interest under the Notes nor any consequences resulting from any of the foregoing shall give rise to a Default or an Event of Default under the Indenture, including, without limitation, for purposes of Section 315(b) and Section 315(c) under the Trust Indenture Act of 1939, as amended.

By its purchase of the Notes, each Holder and beneficial owner of the Notes shall be deemed to have (i) consented to the exercise of any Swiss Resolution Power with respect to the Company that requires or results in any write-down and cancellation and/or conversion into equity of the Company of the entire, or a portion of, the Principal of, and/or accrued interest on, the Notes and the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of Principal and/or interest under the Notes as such Swiss Resolution Power or Restructuring Protective Measure as it may be imposed without any prior notice by the Swiss Resolution Authority of its decision to exercise such Swiss Resolution Power or order such Restructuring Protective Measure and (ii) authorized, directed and requested DTC and any direct participant in DTC or other intermediary through which it holds such Notes to take any and all necessary action, if required, to implement any such exercise of Swiss Resolution Power or ordering of any Restructuring Protective Measures, without any further action or direction on the part of such Holder or beneficial owner.

No repayment of the Principal of the Notes or payment of interest on the Notes shall become due and payable after the exercise of any Swiss Resolution Power with respect to the Company that results in the write-down and cancellation and/or conversion into the equity of the Company of the entire, or a portion of, the Principal of, and/or accrued but unpaid interest on, the Notes, or the ordering of any Restructuring Protective Measures that require or result in the deferment of payment of Principal and/or interest under the Notes, unless, at the time that such repayment or payment, respectively, is scheduled to become due, such repayment or payment would be permitted to be made by the Company under the Swiss laws, regulations and orders applicable to the Company; provided that the Trustee shall not be liable for any payments it makes until a Responsible Officer of the Trustee has actual knowledge of any such exercise of any Swiss Resolution Power or any such ordering of any Restructuring Protective Measures.

------

Notwithstanding anything herein to the contrary, so long as any Notes remain outstanding (including, for example, if the exercise of the Swiss Resolution Power results in only a partial write-down and/or conversion of the Principal of the Notes), then the Trustee's duties and rights under the Indenture shall remain applicable with respect to the Notes.

BY ITS ACQUISITION OF THE NOTES, EACH HOLDER OR BENEFICIAL OWNER OF THE NOTES THAT ACQUIRES ITS NOTES IN THE SECONDARY MARKET SHALL BE DEEMED TO ACKNOWLEDGE, AGREE TO BE BOUND BY AND CONSENT TO THE PROVISIONS SPECIFIED IN THE INDENTURE TO THE SAME EXTENT AS THE HOLDERS AND BENEFICIAL OWNERS OF THE NOTES THAT ACQUIRE THE NOTES UPON THEIR INITIAL ISSUANCE, INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO THE ACKNOWLEDGEMENT AND AGREEMENT TO BE BOUND BY AND CONSENT TO THE TERMS OF THE NOTES, INCLUDING THOSE TERMS AND PROVISIONS RELATING TO ANY SWISS RESOLUTION POWER AND ANY RESTRUCTURING PROTECTIVE MEASURES.

*Waiver of Set-Off* 

By its acquisition of the Notes, each holder of the Notes (including each beneficial owner) will be deemed to have waived any right of set-off, compensation or retention, or in respect of such other netting arrangement in respect of any amount with respect to the Notes or the applicable Indenture that they might otherwise have against the Company, whether before or during Restructuring Proceedings with respect to or winding up of the Company.

*Tax Redemption* 

Subject to the prior approval of FINMA, if then required under Swiss banking laws applicable to the Company from time to time, as evidenced by an Officers' Certificate from the Company certifying the same, the Company may at its option redeem the Notes, in whole but not in part, at any time on giving not less than 30 nor more than 60 days' notice to the Holders and the Trustee, at the Principal of the Notes being redeemed, together with accrued interest to, but excluding the Redemption Date, if it has or will become obligated to pay Additional Amounts in respect of the Notes as described below as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of Switzerland or Guernsey, as applicable, or any political subdivision or taxing authority thereof or therein, or any change in the application or official interpretation of such laws, regulations or rulings, which change or amendment becomes effective on or after the date hereof, and such obligation cannot be avoided by the Company taking reasonable measures available to it. No such notice of redemption will be given earlier than 90 days prior to the earliest date on which it would be obliged to pay such Additional Amounts were a payment in respect of the Notes then due; <u>provided</u>, <u>however</u>, that if the Company has delivered such notice of redemption, but, prior to the payment of a redemption amount with respect to such redemption, a Restructuring Event occurs, of which a Responsible Officer of the Trustee has actual knowledge, then such redemption notice shall be automatically

------

rescinded and shall be of no force and effect, such redemption will be canceled, payment of the redemption amount in respect of such redemption shall no longer be due and payable and no such redemption of the Notes shall take place. Prior to the giving of any notice of redemption pursuant to this paragraph, the Company will deliver to the Trustee an Officers' Certificate stating that it is entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to its right to redeem have occurred, and an opinion of independent counsel of recognized standing to the effect that the Company has or will become obligated to pay such Additional Amounts as a result of such change or amendment.

*Payment of Additional Amounts* 

The Company will, subject to the exceptions and limitations set forth below, pay such Additional Amounts to the Holders as may be necessary.

**Switzerland** 

The Company will not be required to make any payments of Additional Amounts in respect of any present or future tax, assessment or other governmental charge imposed by Switzerland, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the Holder having some connection with Switzerland other than the mere holding of the Note; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date except to the extent that the Holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including, but not
limited to, the agreement between the European Union and Switzerland of October 26, 2004, or any law or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) where such withholding or deduction is imposed on a payment and is required to be made pursuant to any
agreements between Switzerland and other countries on final withholding taxes (*internationale Quellensteuern*) in respect of persons resident in the other country on income of such person on the Notes booked or deposited with a paying agent in
Switzerland (including, without limitation, the Swiss Paying Agent), or any law or the other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) any such taxes, duties, assessments or other governmental charges imposed on a payment in respect of the Notes
required to be made pursuant to laws enacted by Switzerland providing for the taxation of payments according to principles similar to those laid down in the draft legislation of the Swiss Federal Council of December 17, 2014, or otherwise
changing the Swiss federal withholding tax system from an issuer-based system to a paying-agent-based system pursuant to which a person other than the issuer is required to withhold tax on any interest payments; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) where such withholding or deduction is imposed on any payment by reason of FATCA (as defined below); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) any combination of two or more items (i) through (vii) above.

**Guernsey** 

The Company will not be required to make any payments of Additional Amounts in respect of any present or future tax, assessment or other governmental charge imposed by Guernsey, or any political subdivision or taxing authority thereof or therein, for or on account of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any such taxes, duties, assessments or other governmental charges imposed in respect of such Note by reason of
the Holder having some connection with Guernsey other than the mere holding of the Note; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to the extent the withholding or deduction is imposed or levied because the Holder (or beneficial owner) of the
Note has not made a declaration of non-residence or other claim for exemption, if such holder is able to avoid such deduction or withholding by making such a declaration or claim; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any such taxes, duties, assessments or other governmental charges imposed in respect of any Note presented for
payment more than 30 days after the Relevant Date except to the extent that the Holder would have been entitled to such Additional Amounts on presenting such Note for payment on the last day of such period of 30 days; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any such taxes, duties, assessments or other governmental charges imposed in respect of the relevant Note
presented for payment by or on behalf of a Holder who would have been able to avoid such withholding or deduction by presenting the relevant Note to another paying agent in a member state of the European Union; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) any such taxes, duties, assessments or other governmental charges where such withholding or deduction is
imposed on a payment and is required to be made pursuant to any agreements between the European Community and other countries or territories providing for measures equivalent to those laid down in the Council Directive 2003/48/EC, including any law
or other governmental regulation implementing or complying with, or introduced in order to conform to, such agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) where such withholding or deduction is imposed on any payment by reason of FATCA (as defined below); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) any combination of two or more items (i) through (vi) above.

**U.S. Foreign Account Tax Compliance Act** 

Payments on the Notes will be subject in all cases to any withholding or deduction required pursuant to an agreement described in Section 1471(b) of the U.S. Internal Revenue Code of 1986, as amended (the "Code"), or described in any agreement between any jurisdiction and the United States relating to the foreign account provisions of the U.S. Hiring Incentives to Restore Employment Act of 2010, or otherwise imposed pursuant to Sections 1471 through 1474 of the Code, any regulations or agreements thereunder, official interpretations thereof, or any agreements, law, regulation or other official guidance implementing an intergovernmental agreement or other intergovernmental approach thereto (collectively, "FATCA").

Whenever in this Note there is mentioned, in any context, the payment of the Principal of, interest or any other amounts on, or in respect of, this Note, such mention shall be deemed to include mention of the payment of Additional Amounts as provided above to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the terms hereof, and express mention of the payment of Additional Amounts in any provision hereof shall not be construed as excluding the payment of Additional Amounts in those provisions hereof where such express mention is not made.

All terms used in this Note which are defined in the Indenture and not otherwise defined herein shall have the respective meanings assigned to them in the Indenture.

**This Note shall for all purposes be governed by, and construed in accordance with, the laws of the State of New York (without regard to conflicts of law principles thereof).** 

------

ABBREVIATIONS

The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations:

TEN COM – as tenants in common

TEN ENT – as tenants by the entireties

JT TEN – as joint tenants with right of survivorship and not as tenants in common

UNIF GIFT MIN ACT – ______ (Custodian)_______ (Minor)

Under Uniform Gifts to Minors Act ___________ (State)

Additional abbreviations may also be used though not in the above list.

------

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTE

The following increases or decreases of this Global Note have been made:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date of**<br> **Decrease or**<br> **Increase** | **Amount of**<br> **Decrease in**<br> **Principal Amount**<br> **of this Global**<br> **Note** | **Amount of**<br> **Increase in**<br> **Principal**<br> **Amount**<br> **of this Global**<br> **Note** | **Principal**<br> **Amount**<br> **of this Global**<br> **Note**<br> **Following Such**<br> **Decrease (or**<br> **Increase)** | **Signature of**<br> **Authorized Officer**<br> **of Trustee** |

---

## Exhibit 4.18

**Exhibit 4.18** 

EXECUTION VERSION

<u>THIRD SUPPLEMENTAL INDENTURE</u> 

This THIRD SUPPLEMENTAL INDENTURE (this "**Third Supplemental Indenture**"), dated as of May 30, 2024, among CREDIT SUISSE (USA) LLC (formerly CREDIT SUISSE (USA), INC. and CREDIT SUISSE FIRST BOSTON (USA), INC.), a Delaware limited liability company ("**CS USA**"), UBS GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**UBS Group**"), CREDIT SUISSE AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**CS AG**"), UBS AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**UBS AG**") and THE BANK OF NEW YORK MELLON (formerly THE BANK OF NEW YORK), as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, CS USA has previously issued $742,344,000 aggregate principal amount of 7 1/8% Notes due July 15, 2032 (the "**Securities**") under a senior indenture, dated as of June 1, 2001, between CS USA and the Trustee, as amended by the First Supplemental Indenture, dated as of March 26, 2007, among CS USA, Credit Suisse Group AG ("**CSG**"), CS AG and the Trustee, and the Second Supplemental Indenture, dated as of June 9, 2023, among CS USA, UBS, CSG, CS AG and the Trustee (as heretofore amended and supplemented, the "**Indenture**");

WHEREAS, pursuant to Section 266 of the Delaware General Corporation Law, on May 1, 2024, Credit Suisse (USA), Inc. converted to a limited liability company governed by the Delaware Limited Liability Company Act and changed its name to Credit Suisse (USA) LLC;

WHEREAS, UBS AG and CS AG entered into a merger agreement on December 7, 2023 (as amended or restated from time to time), pursuant to which they agreed to a merger by absorption under Swiss law (*Absorptionsfusion*), whereby Credit Suisse AG will be absorbed by UBS AG (the "**Merger**");

WHEREAS, effective upon registration of the Merger with the commercial registers of the Canton of Zurich and the Canton of Basel-City in Switzerland (such date of registration, the "**Effective Date**"), CS AG will cease to exist and all of its assets, liabilities and contracts (including its obligations under the Bank Guarantee (as defined in the Indenture) and the Indenture) will automatically transfer to, and be absorbed and taken over by, UBS AG by operation of Swiss law (*Universalsukzession*);

WHEREAS, pursuant to Section 5.03 of the Indenture, UBS AG desires to assume all of the obligations of CS AG on the Bank Guarantee by CS AG of the Securities and under the Indenture on the terms and conditions set forth in the Indenture and herein with effect as of the Effective Date;

WHEREAS, all conditions and requirements necessary to make this Third Supplemental Indenture a valid and binding instrument in accordance with the terms of the Indenture have been performed and fulfilled and the execution and delivery hereof have been in all respects duly authorized;

------

WHEREAS, Section 9.01(b) of the Indenture provides that, without the consent of the Holders, CS USA, UBS Group, CS AG and the Trustee may enter into a supplemental indenture to amend or supplement any of the provisions of the Indenture to comply with Article 5 of the Indenture;

WHEREAS, Section 9.01(h) of the Indenture provides that, without the consent of the Holders, CS USA, UBS Group, the Bank Guarantor and the Trustee may enter into a supplemental indenture to amend or supplement any of the provisions of the Indenture to make any change that does not materially and adversely affect the rights of any Holder; and

WHEREAS, pursuant to Section 9.05 of the Indenture, the Trustee is authorized to execute and deliver this Third Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, CS USA, UBS Group, CS AG, UBS AG and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. ASSUMPTION OF OBLIGATIONS.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Credit Suisse (USA) LLC hereby acknowledges that by operation of Delaware law, and with effect as of May 1, 2024, it became the "Company" under the Indenture and the Securities and assumed all of the Company's rights and obligations thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Pursuant to and in accordance with Section 5.03 of the Indenture and by operation of Swiss law, and with effect as of the Effective Date, UBS AG shall succeed to, and be substituted for, and may exercise every right and power of, CS AG under the Bank Guarantee and the Indenture with the same effect as if UBS AG had been named as the "Bank Guarantor" under the Indenture, the Bank Guarantee and the Securities. As of the Effective Date, UBS AG hereby (i) assumes all of CS AG's obligations under the Bank Guarantee and the Indenture on the terms and subject to the conditions set forth in this Third Supplemental Indenture and in the Indenture and (ii) undertakes in favor of each Holder to be bound by the terms and conditions of the Bank Guarantee and the provisions of the Indenture with the same effect as if UBS AG had been named as the "Bank Guarantor" under the Indenture, the Bank Guarantee and the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Third Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of UBS Group, CS AG and UBS AG agrees that any suit, action or proceeding against it arising out of or based upon the Indenture, this Third Supplemental Indenture,

------

the Securities or the Guarantees may be instituted in any state or federal court in the Borough of Manhattan, The City of New York (each, a "**Proceeding**"), and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of UBS Group and UBS AG has appointed UBS AG, New York Branch, at 1285 Avenue of the Americas, New York, NY 10019, as its authorized agent (the "**UBS Authorized Agent**") upon whom process may be served in any Proceeding, and each of UBS Group and UBS AG expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. CS AG has, until the Effective Date, appointed CS USA, at 11 Madison Avenue, New York, New York 10010, as its authorized agent (the "**CS Authorized Agent**" and, together with the UBS Authorized Agent, the "**Authorized Agents**" and each, an "**Authorized Agent**") upon whom process may be served in any Proceeding, and it expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of UBS Group, UBS AG and CS AG hereby represents and warrants that its respective Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time any Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding, each of UBS Group, UBS AG or CS AG, as applicable, will immediately appoint an Authorized Agent upon whom such process may be served. Until the Indenture and this Third Supplemental Indenture are terminated or, with respect to CS AG only, until the Effective Date, each of UBS Group, UBS AG and CS AG shall maintain an Authorized Agent in The City of New York, and each of UBS Group, UBS AG and CS AG agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon UBS Group, UBS AG or CS AG, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that each of CS USA, UBS Group, CS AG and UBS AG is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to CS USA, UBS Group, CS AG, or UBS AG, as applicable, such an immunity (whether or not claimed), each of CS USA, UBS Group, CS AG and UBS AG hereby irrevocably waives and agrees not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding, or any suit, action or proceeding against it arising out of or based upon the Indenture, this Third Supplemental Indenture, the Securities or the Guarantees which may be instituted in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of CS USA, UBS Group, CS AG or UBS AG hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Third Supplemental Indenture without any further act by CS USA, UBS Group, CS AG or UBS AG before any such court and introduction of a true copy of this Third Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Third Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Third Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Third Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of the Third Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of the Third Supplemental Indenture as to the parties hereto. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words "execution," "signed," "signature," and words of like import in this Third Supplemental Indenture or in any other certificate, agreement or document related to this Third Supplemental Indenture shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, "pdf", "tif" or "jpg") and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of CS USA, UBS Group, CS AG and UBS AG and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Third Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. PARTIES. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Third Supplemental Indenture or the Indenture or any provision herein or therein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. SEVERABILITY. In case any provision in this Third Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or unenforceability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. RATIFICATION OF INDENTURE; SUPPLEMENTAL INDENTURE PART OF INDENTURE. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Third Supplemental Indenture shall form a part of the Indenture and every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. NOTICES. With effect as of the Effective Date, Section 10.02 of the Indenture is hereby amended by replacing the first paragraph thereof, the references to addresses and the subparagraph immediately thereafter with the following:

Any notice or communication shall be sufficiently given if written and (a) if delivered in person, when received or (b) if mailed by first class mail, 5 days after mailing, or (c) as among CS USA, UBS Group, UBS AG and the Trustee if sent or electronic transmission, when transmission is confirmed, in each case addressed as follows:

If to CS USA:

Credit Suisse (USA) LLC

Eleven Madison Avenue

New York, New York 10010

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to UBS Group:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to UBS AG:

UBS AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to the Trustee:

The Bank of New York Mellon

240 Greenwich Street, Floor 7E

New York, New York 10286

Attention: Corporate Trust Administration

Telephone: +1 212 815 5723

Email: Janet.Y.Wong@bnymellon.com

CS USA, UBS Group, UBS AG or the Trustee by written notice to the other parties hereto may designate additional or different addresses for subsequent notices or communications.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. ELECTRONIC MEANS. The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions ("**Instructions**"), pursuant to this Third Supplemental Indenture and related documents sent by Electronic Means; *provided*, *however*, that all Parties shall provide to the Trustee an incumbency certificate listing officers or other persons with the authority to provide such Instructions or directions and containing specimen signatures of such authorized officers or persons, which incumbency certificate shall be amended and replaced whenever a person is to be added or deleted from the listing. If the Parties elect to give the Trustee Instructions using Electronic Means and the Trustee in its discretion elects to act upon such Instructions, the Trustee's understanding of such Instructions shall be deemed controlling. All Parties understand and agree that the Trustee cannot determine the identity of the actual sender of such Instructions and that the Trustee shall conclusively presume that directions that purport to have been sent by an authorized officer or person listed on the incumbency certificate provided to the Trustee have been sent by such authorized officer or person. The Parties shall be responsible for ensuring that only authorized officers or persons transmit such Instructions to the Trustee and that the Parties and all respective authorized officers or persons are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or authentication keys upon receipt by the Parties. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from its reliance upon and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written instruction. The Parties agree (i) to assume all risks arising out of its use of Electronic Means to submit Instructions to the Trustee, including the risk of the Trustee acting on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Trustee and that there may be more secure methods of transmitting Instructions than the method(s) selected by the Parties; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances; and (iv) to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures. "**Electronic Means**" shall mean the following communications methods: e-mail, secure electronic transmission containing applicable authorization codes, passwords and/or authentication keys issued by the Trustee, or another method or system specified by the Trustee as available for use in connection with its services hereunder.

------

IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE (USA) LLC,<br>as the Company under the Indenture, | CREDIT SUISSE (USA) LLC,<br>as the Company under the Indenture, |
| By: | /s/ Christopher Chadie |

---

Name: Christopher Chadie <br> Title: Authorized Person

*[Signature Page to Third Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| UBS GROUP AG,<br>as the Group Guarantor under the Indenture, | UBS GROUP AG,<br>as the Group Guarantor under the Indenture, |
| By: | /s/ Kevin Tillotson |

---

Name: Kevin Tillotson <br> Title: Authorized Person

---

| | |
|:---|:---|
| By: | /s/ Antonio Boné |

---

Name: Antonio Boné <br> Title: Authorized Person

*[Signature Page to Third Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| CREDIT SUISSE AG,<br>as the existing Bank Guarantor under the Indenture, | CREDIT SUISSE AG,<br>as the existing Bank Guarantor under the Indenture, |
| By: | /s/ Noah Lee |

---

Name: Noah Lee <br> Title: Authorized Person

---

| | |
|:---|:---|
| By: | /s/ Christopher Chadie |

---

Name: Christopher Chadie <br> Title: Authorized Person

*[Signature Page to Third Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| UBS AG,<br>as the successor Bank Guarantor under the Indenture, | UBS AG,<br>as the successor Bank Guarantor under the Indenture, |
| By: | /s/ Kevin Tillotson |

---

Name: Kevin Tillotson <br> Title: Authorized Person

---

| | |
|:---|:---|
| By: | /s/ Antonio Boné |

---

Name: Antonio Boné <br> Title: Authorized Person

*[Signature Page to Third Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed and attested, all as of the date first above written.

---

| | |
|:---|:---|
| THE BANK OF NEW YORK MELLON,<br>as the Trustee | THE BANK OF NEW YORK MELLON,<br>as the Trustee |
| By: | /s/ Francine Kincaid |

---

Name: Francine Kincaid <br> Title: Vice President

*[Signature Page to Third Supplemental Indenture]*

## Exhibit 4.19

**Exhibit 4.19** 

EXECUTION VERSION

<u>FOURTH SUPPLEMENTAL INDENTURE</u> 

This FOURTH SUPPLEMENTAL INDENTURE (this "**Fourth Supplemental Indenture**"), dated as of February 2, 2026, among CREDIT SUISSE (USA) LLC (formerly CREDIT SUISSE (USA), INC. and CREDIT SUISSE FIRST BOSTON (USA), INC.), a Delaware limited liability company ("**CS USA**"), UBS Americas Inc., a Delaware corporation ("**UBS Americas**"), UBS GROUP AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**UBS Group**"), UBS AG, a corporation (*Aktiengesellschaft*) organized under the laws of Switzerland ("**UBS AG**") and THE BANK OF NEW YORK MELLON (formerly THE BANK OF NEW YORK), as trustee under the Indenture referred to herein (the "**Trustee**").

**RECITALS** 

WHEREAS, $742,344,000 aggregate principal amount of 7 1/8% Notes due July 15, 2032 (the "**Securities**") issued by CS USA are outstanding under a senior indenture, dated as of June 1, 2001, between CS USA and the Trustee, as amended by the First Supplemental Indenture, dated as of March 26, 2007, among CS USA, Credit Suisse Group AG ("**CSG**"), CREDIT SUISSE AG ("**CS AG**") and the Trustee, the Second Supplemental Indenture, dated as of June 9, 2023, among CS USA, UBS Group, CSG, CS AG and the Trustee and the Third Supplemental Indenture, dated as of May 30, 2024, among CS USA, UBS Group, CS AG, UBS AG and the Trustee (as heretofore amended and supplemented, the "**Indenture**");

WHEREAS, CS USA and UBS Americas will enter into a Merger Agreement dated and effective as of February 2, 2026 (the "**Effective Date**"), pursuant to which CS USA will merge with and into UBS Americas. Upon completion of the merger, CS USA will cease to exist as a separate legal entity, and UBS Americas will continue as the surviving entity;

WHEREAS, pursuant to Section 5.01 of the Indenture, UBS Americas desires to assume all of the obligations of CS USA on the Securities and under the Indenture on the terms and conditions set forth in the Indenture and herein with effect as of the Effective Date;

WHEREAS, all conditions and requirements necessary to make this Fourth Supplemental Indenture a valid and binding instrument in accordance with the terms of the Indenture have been performed and fulfilled and the execution and delivery hereof have been in all respects duly authorized; and

WHEREAS, pursuant to Section 9.05 of the Indenture, the Trustee is authorized to execute and deliver this Fourth Supplemental Indenture.

**AGREEMENT** 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, CS USA, UBS Americas, UBS Group, UBS AG and the Trustee mutually covenant and agree for the equal and proportionate benefit of the Holders as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. ASSUMPTION OF OBLIGATIONS. Pursuant to and in accordance with Section 5.01 of the Indenture, and with effect as of the Effective Date, UBS Americas shall succeed to, and be substituted for, and may exercise every right and power of, CS USA under the Securities and the Indenture with the same effect as if UBS Americas had been named as the "Company" under the Indenture and the Securities. As of the Effective Date, UBS Americas hereby (i) assumes all of CS USA's obligations under the Securities and the Indenture on the terms and subject to the conditions set forth in this Fourth Supplemental Indenture and in the Indenture and (ii) undertakes in favor of each Holder to be bound by the terms and conditions of the Securities and the provisions of the Indenture with the same effect as if UBS Americas had been named as the "Company" under the Indenture and the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. GOVERNING LAW; JURISDICTION AND SERVICE OF PROCESS; SOVEREIGN IMMUNITY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Fourth Supplemental Indenture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of UBS Group and UBS AG agrees that any suit, action or proceeding against it arising out of or based upon the Indenture, this Fourth Supplemental Indenture, the Securities or the Guarantees may be instituted in any state or federal court in the Borough of Manhattan, The City of New York (each, a "**Proceeding**"), and waives any objection that it may now or hereafter have to the laying of venue of any such Proceeding and any claim of inconvenient forum, and irrevocably submits to the non-exclusive jurisdiction of such courts in any such Proceeding. Each of UBS Group and UBS AG has appointed UBS AG, New York Branch, at 11 Madison Avenue, New York, New York 10010-3629, United States, Attention: General Counsel, as its authorized agent (the "**Authorized Agent**") upon whom process may be served in any Proceeding, and each of UBS Group and UBS AG expressly accepts the non-exclusive jurisdiction of such courts in respect of any such Proceeding. Each of UBS Group and UBS AG hereby represents and warrants that its respective Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, such appointment to be irrevocable until the appointment of a successor Authorized Agent in The City of New York for such purpose and such successor's acceptance of such appointment shall have occurred. If at any time the Authorized Agent no longer has an office in the Borough of Manhattan, The City of New York, upon whom process may be served in any Proceeding, each of UBS Group and UBS AG, will immediately appoint an Authorized Agent upon whom such process may be served. Until the Indenture and this Fourth Supplemental Indenture are terminated, each of UBS Group and UBS AG shall maintain an Authorized Agent in The City of New York, and each of UBS Group and UBS AG agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon UBS Group and UBS AG, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the extent that any of CS USA, UBS Americas, UBS Group or UBS AG is or may become entitled to claim for itself any immunity from jurisdiction (sovereign or otherwise) and to the extent that in any jurisdiction there may be attributed to CS USA, UBS Americas, UBS Group or UBS AG, as applicable, such an immunity (whether or not claimed), each of CS USA, UBS Americas, UBS Group and UBS AG hereby irrevocably waives and agrees

------

not to claim any immunity from suit, jurisdiction, execution of a judgment, or attachment or set-off in aid of execution of a judgment, to which it or its property might otherwise be entitled in any Proceeding, or any suit, action or proceeding against it arising out of or based upon the Indenture, this Fourth Supplemental Indenture, the Securities or the Guarantees which may be instituted in any competent court in Switzerland, but only to the extent necessary for enforcement of the obligations of CS USA, UBS Americas, UBS Group or UBS AG hereunder, as applicable. The agreements and waiver contained in this Section 3 are intended to be effective upon the execution of this Fourth Supplemental Indenture without any further act by CS USA, UBS Americas, UBS Group or UBS AG before any such court and introduction of a true copy of this Fourth Supplemental Indenture into evidence shall be conclusive and final evidence of such waiver.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Each of the parties hereto hereby waives any right to stay or dismiss any action or proceeding under or in connection with this Fourth Supplemental Indenture brought before the foregoing courts on the basis of *forum non-conveniens*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. TRUST INDENTURE ACT OF 1939. This Fourth Supplemental Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. COUNTERPARTS. The parties may sign any number of copies of this Fourth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of the Fourth Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of the Fourth Supplemental Indenture as to the parties hereto. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. The words "execution," "signed," "signature," and words of like import in this Fourth Supplemental Indenture or in any other certificate, agreement or document related to this Fourth Supplemental Indenture shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, "pdf", "tif" or "jpg") and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. THE TRUSTEE. The recitals contained herein shall be taken as statements of CS USA, UBS Americas, UBS Group, and UBS AG and not of the Trustee and the Trustee assumes no responsibility for the correctness of the same. Neither the Trustee nor any of its agents makes any representation as to the validity, sufficiency or adequacy of this Fourth Supplemental Indenture.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. PARTIES. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Fourth Supplemental Indenture or the Indenture or any provision herein or therein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. SEVERABILITY. In case any provision in this Fourth Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or unenforceability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. RATIFICATION OF INDENTURE; SUPPLEMENTAL INDENTURE PART OF INDENTURE. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Fourth Supplemental Indenture shall form a part of the Indenture and every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. NOTICES. With effect as of the Effective Date, Section 10.02 of the Indenture is hereby amended by replacing the first paragraph thereof, the references to addresses and the subparagraph immediately thereafter with the following:

Any notice or communication shall be sufficiently given if written and (a) if delivered in person, when received or (b) if mailed by first class mail, 5 days after mailing, or (c) as among UBS Americas, UBS Group, UBS AG and the Trustee if sent by electronic transmission, when transmission is confirmed, in each case addressed as follows:

If to UBS Americas:

UBS Americas Inc.

11 Madison Avenue

New York, NY 10010

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to UBS Group:

UBS Group AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

If to UBS AG:

UBS AG

Bahnhofstrasse 45

8001 Zurich, Switzerland

Email: OL-GT-Funding@ubs.com

Attention: Group Treasury

------

If to the Trustee:

The Bank of New York Mellon

240 Greenwich Street, Floor 7E

New York, New York 10286

Attention: Corporate Trust Administration

Telephone: +1 212 815 5723

Email: Janet.Y.Wong@bnymellon.com

UBS Americas, UBS Group, UBS AG or the Trustee by written notice to the other parties hereto may designate additional or different addresses for subsequent notices or communications.

ELECTRONIC MEANS. The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions ("**Instructions**"), pursuant to this Fourth Supplemental Indenture and related documents sent by Electronic Means; *provided*, *however*, that all Parties shall provide to the Trustee an incumbency certificate listing officers or other persons with the authority to provide such Instructions or directions and containing specimen signatures of such authorized officers or persons, which incumbency certificate shall be amended and replaced whenever a person is to be added or deleted from the listing. If the Parties elect to give the Trustee Instructions using Electronic Means and the Trustee in its discretion elects to act upon such Instructions, the Trustee's understanding of such Instructions shall be deemed controlling. All Parties understand and agree that the Trustee cannot determine the identity of the actual sender of such Instructions and that the Trustee shall conclusively presume that directions that purport to have been sent by an authorized officer or person listed on the incumbency certificate provided to the Trustee have been sent by such authorized officer or person. The Parties shall be responsible for ensuring that only authorized officers or persons transmit such Instructions to the Trustee and that the Parties and all respective authorized officers or persons are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or authentication keys upon receipt by the Parties. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from its reliance upon and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written instruction. The Parties agree (i) to assume all risks arising out of its use of Electronic Means to submit Instructions to the Trustee, including the risk of the Trustee acting on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Trustee and that there may be more secure methods of transmitting Instructions than the method(s) selected by the Parties; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances; and (iv) to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures. "**Electronic Means**" shall mean the following communications methods: e-mail, secure electronic transmission containing applicable authorization codes, passwords and/or authentication keys issued by the Trustee, or another method or system specified by the Trustee as available for use in connection with its services hereunder.

------

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed and attested, all as of the date first above written.

CREDIT SUISSE (USA) LLC,

as the existing Company under the Indenture,

---

| | |
|:---|:---|
| By: | /s/ Christopher Chadie |
| Name: | Christopher Chadie |
| Title: | Authorized Person |
| By: | /s/ Elizabeth Lynch |
| Name: | Elizabeth Lynch |
| Title: | Authorized Person |

---

*[Signature Page to Fourth Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed and attested, all as of the date first above written.

UBS Americas Inc.,

as the successor Company under the Indenture,

---

| | | |
|:---|:---|:---|
| By: | /s/ Christopher Chadie | /s/ Christopher Chadie |
|  | Name: | Christopher Chadie |
|  | Title: | Authorized Person |
| By: | /s/ Noah Lee | /s/ Noah Lee |
|  | Name: | Noah Lee |
|  | Title: | Authorized Person |

---

*[Signature Page to Fourth Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed and attested, all as of the date first above written.

UBS GROUP AG,

as the Group Guarantor under the Indenture,

---

| | | |
|:---|:---|:---|
| By: | /s/ Daniel Taylor | /s/ Daniel Taylor |
|  | Name: | Daniel Taylor |
|  | Title: | Authorized Person |
|  |  | Director |
| By: | /s/ Antonio Boné | /s/ Antonio Boné |
|  | Name: | Antonio Boné |
|  | Title: | Authorized Person |
|  |  | Director |

---

*[Signature Page to Fourth Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed and attested, all as of the date first above written.

UBS AG,

as the Bank Guarantor under the Indenture,

---

| | | |
|:---|:---|:---|
| By: | /s/ Daniel Taylor | /s/ Daniel Taylor |
|  | Name: | Daniel Taylor |
|  | Title: | Authorized Person |
|  |  | Director |
| By: | /s/ Antonio Boné | /s/ Antonio Boné |
|  | Name: | Antonio Boné |
|  | Title: | Authorized Person |
|  |  | Director |

---

*[Signature Page to Fourth Supplemental Indenture]* 

------

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed and attested, all as of the date first above written.

THE BANK OF NEW YORK MELLON,

as the Trustee

---

| | | |
|:---|:---|:---|
| By: | /s/ April Bradley | /s/ April Bradley |
|  | Name: | April Bradley |
|  | Title: | Agent |

---

*[Signature Page to Fourth Supplemental Indenture]*

## Exhibit 4.20

**Exhibit 4.20** 

[FACE OF NOTE]

Unless this certificate is presented by an authorized representative of The Depository Trust Company (55 Water Street, New York, New York) (the "Depository") to the issuer or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the name of Cede & Co. or such other name as requested by an authorized representative of the Depository and any payment is made to Cede & Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since the registered owner hereof, Cede & Co., has an interest herein.

CREDIT SUISSE FIRST BOSTON (USA), INC.

7 1/8% Note due July 15, 2032

REGISTERED

CUSIP: 22541L AE 3

ISIN: US22541LAE39

Common Code: 015171740

No. PRINCIPAL AMOUNT: $

CREDIT SUISSE FIRST BOSTON (USA), INC., a Delaware corporation (the '"Company'', which term includes any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, at the office or agency of the Company in New York, New York, the principal sum of $ on July 15, 2032, in the coin or currency of the United States, and to pay interest, semi-annually on January 15 and July 15 of each year, commencing January 15, 2003 on said principal sum at said office or agency, in like coin or currency, at the rate per annum specified in the title of this Note, from January 15 or July 15, as the case may be, next preceding the date of this Note to which interest has been paid or duly provided for, unless the date hereof is a date to which interest has been paid or duly provided for, in which case from the date of this Note or unless no interest has been paid or duly provided for on these Notes, in which case from July 19, 2002, until payment of said principal sum has been made or duly provided for; provided, that payment of interest may be made at the option of the Company by check mailed to the address of the person entitled thereto as such address shall appear on the Security Register or by wire transfer as provided in the Indenture. Notwithstanding the foregoing, if the date hereof is after January 1 or July 1, as the case may be, and before the following January 15 or July 15, this Note shall bear interest from such January 15 or July 15; provided, that if the Company shall default in the payment of interest due on such January 15 or July 15, then this Note shall bear interest from the next preceding July 15 or January 15, to which interest has been paid or duly provided for or, if no interest has been paid or duly provided for on these Notes, from July 19, 2002. The interest so payable on any January 15 or July 15 will, subject to certain exceptions provided in the Indenture referred to on the reverse hereof, be paid to the person in whose name this Note is registered at the close of business on January l or July 1, as the case may be, next preceding such January 15 or July 15, whether or not such day is a Business Day.

------

Reference is made to the further provisions of this Note set forth on the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place.

This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been manually signed by the Trustee under the Indenture referred to on the reverse hereof.

------

IN WITNESS WHEREOF*,* Credit Suisse First Boston (USA), Inc. has caused this Note to be duly executed under its corporate seal.

---

| | |
|:---|:---|
| CREDIT SUISSE FIRST BOSTON (USA), INC. | CREDIT SUISSE FIRST BOSTON (USA), INC. |
| By: |  |
|  | Name:<br> Title: |
| By: |  |
|  | Name:<br> Title: |

---

---

| | |
|:---|:---|
| Attest: | Attest: |
| By: |  |
|  | Name:<br> Title: |

---

CERTIFICATE OF AUTHENTICATION

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture.

Dated:

---

| |
|:---|
| JPMORGAN CHASE BANK,<br> as Trustee |
| By: |
| Authorized Signatory |

---

------

[REVERSE OF NOTE]

CREDIT SUISSE FIRST BOSTON (USA), INC.

7 1/8% Note due July 15, 2032

This Note is one of a duly authorized issue of debentures, notes, bonds or other evidences of indebtedness of the Company (hereinafter called the "Securities") of the series hereinafter specified, all issued or to be issued under and pursuant to a senior indenture dated as of June 1, 2001 (herein called the "Indenture"), duly executed and delivered by the Company to JPMorgan Chase Bank, as trustee (herein called the "Trustee"), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Securities. The Securities may be issued in one or more series, which different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest (if any) at different rates, may be subject to different redemption provisions (if any), may be subject to different sinking, purchase or analogous funds (if any) and may otherwise vary as provided in the Indenture. This Note is one of a series designated as the 7 1/8% Notes due July 15, 2032 of the Company.

Interest will be computed on the basis of a 360-day year of twelve 30-day months. The Company shall pay interest on overdue Principal and, to the extent lawful, on overdue installments of interest at the rate per annum borne by this Note. If a payment date is not a Business Day as defined in the Indenture at a place of payment, payment may be made at that place on the next succeeding day that is a Business Day, and no interest shall accrue for the intervening period.

In case an Event of Default (as defined in the Indenture) with respect to the 7 1/8% Notes due July 15, 2032 shall have occurred and be continuing, the Principal hereof and the interest accrued hereon, if any, may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture.

The Indenture contains provisions which provide that, without prior notice to any Holders, the Company and the Trustee may amend the Indenture and the Securities of any series with the written consent of the Holders of a majority in principal amount of the outstanding Securities of all series affected by such amendment (all such series voting as one class), and the Holders of a majority in principal amount of the outstanding Securities of all series affected thereby (all such series voting as one class) by written notice to the Trustee may waive future compliance by the Company with any provision of the Indenture or the Securities of such series; provided that, without the consent of each Holder of the Securities of each series affected thereby, an amendment or waiver, including a waiver of past defaults, may not: (i) extend the stated maturity of the Principal of, or any sinking fund obligation or any installment of interest on, such Holder's Security, or reduce the principal amount thereof or the rate of interest thereon

------

(including any amount in respect of original issue discount), or any premium payable with respect thereto, or adversely affect the rights of such Holder under any mandatory redemption or repurchase provision or any right of redemption or repurchase at the option of such Holder, or reduce the amount of the Principal of an Original Issue Discount Security that would be due and payable upon an acceleration of the maturity thereof or the amount thereof provable in bankruptcy, or change any place of payment where, or the currency in which, any Security of such series or any premium or the interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the due date therefor; (ii) reduce the percentage in principal amount of outstanding Securities of the relevant series the consent of whose Holders is required for any such supplemental indenture, for any waiver of compliance with certain provisions of the Indenture or certain Defaults and their consequences provided for in the Indenture; (iii) waive a Default in the payment of Principal of or interest on any Security of such Holder; or (iv) modify any of the provisions of the Indenture governing supplemental indentures with the consent of Securityholders except to increase any such percentage or to provide that certain other provisions of the Indenture cannot be modified or waived without the consent of the Holder of each outstanding Security affected thereby.

It is also provided in the Indenture that, subject to certain conditions, the Holders of at least a majority in principal amount (or, if any Securities are Original Issue Discount Securities, such portion of the Principal as is then accelerable) of the outstanding Securities of all series affected (voting as a single class), by notice to the Trustee, may waive an existing Default or Event of Default with respect to the Securities of such series and its consequences, except a Default in the payment of Principal of or interest on any Security or in respect of a covenant or provision of the Indenture which cannot be modified or amended without the consent of the Holder of each outstanding Security affected. Upon any such waiver, such Default shall cease to exist; and any Event of Default with respect to the Securities of such series arising therefrom shall be deemed to have been cured, for every purpose of the Indenture; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereto.

The Indenture provides that a series of Securities may include one or more tranches (each a "tranche") of Securities, including Securities issued in a Periodic Offering. The Securities of different tranches may have one or more different terms, including authentication dates and public offering prices, but all the Securities within each such tranche shall have identical terms, including authentication date and public offering price. Notwithstanding any other provision of the Indenture, subject to certain exceptions, with respect to sections of the Indenture concerning the execution, authentication and terms of the Securities, redemption of the Securities, Events of Default of the Securities, defeasance of the Securities and amendment of the Indenture, if any series of Securities includes more than one tranche, all provisions of such sections applicable to any series of Securities shall be deemed equally applicable to each tranche of any series of Securities in the same manner as though originally designated a series unless otherwise provided with respect to such series or tranche pursuant to a hoard resolution or a supplemental indenture establishing such series or tranche.

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional. to pay the Principal of and any premium and interest on this Note in the manner, at the place, at the respective times, at the rate and in the coin or currency herein prescribed.

------

The Notes are issuable initially only in registered form without coupons in denominations of $1,000 or any integral multiple thereof at the office or agency of the Company in the Borough of Manhattan, The City of New York and in the manner and subject to the limitations provided in the Indenture.

Except as provided below, the Notes may not be redeemed prior to maturity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Company may, at its option, redeem the Notes at any time, in whole or in part, at a redemption price equal to the greater of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) 100% of the Principal of the Notes to be redeemed; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the sum of the present value as of the redemption date of the remaining scheduled payments of Principal and
interest on the Notes to be redeemed (not including any interest accrued to the date of redemption), discounted to the redemption date, on a semi-annual basis, at the "Reinvestment Rate" described below (determined on the third Business
Day preceding the date on which the notice of redemption is given);

plus, in either of the above cases, accrued and unpaid interest on the Notes to be redeemed to but not inducting, the redemption date.

As used in this Note, the term "Reinvestment Rate" means 30 basis points plus the yield, under the heading which represents the average for the immediately preceding week appearing in the most recently published Statistical Release, for the maturity (rounded to the nearest month) corresponding to the remaining life to maturity of the Notes to be redeemed, as of the payment date of the Principal being redeemed. If no maturity exactly corresponds to the maturity, yields for the two published maturities most closely corresponding to the maturity would be calculated and the Reinvestment Rate would be interpolated or extrapolated on a straight-line basis, rounding to the nearest month. The most recent Statistical Release published prior to the date of determination of the redemption price will be used for purposes of calculating the Reinvestment Rate.

As used in this Note, "Statistical Release" means statistical release designated "Statistical Release H.15(519), Selected Interest Rates" or any successor publication which is published by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption "Treasury Constant Maturities."

The redemption price will be calculated by an independent investment banking institution of national standing appointed by the Company.

------

If the Reinvestment Rate is not available as described above, the Reinvestment Rate will be calculated by interpolation or extrapolation of comparable rates selected by the independent investment banking institution.

In the case of any partial redemption of the Notes, selection of the Notes for redemption will be made by the Trustee in compliance with the requirements of the Luxembourg Stock Exchange or, if the Notes are not then listed on the Luxembourg Stock Exchange, by lot or by such other method as the Trustee in its sole discretion deems to be fair and appropriate.

Unless the Company defaults in payment of the redemption price, on or after the redemption date, interest will cease to accrue on the Notes or portions of the Notes called for redemption.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The Company may also redeem the Notes, at its option, at any time, in whole but not in part, at a redemption price equal to 100% of the Principal of the outstanding Notes plus accrued interest thereon to the date of redemption, if the Company has or will become obligated to pay Additional Amounts on the Notes as described below as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of the United States or any political subdivision or taxing authority thereof or therein, or any change in the application or official interpretation of such laws, regulations or rulings, which change or amendment becomes effective on or after July 12, 2002, and such obligation cannot be avoided by the Company's taking reasonable measures available to it, provided that no such notice of redemption will be given earlier than 90 days prior to the earliest date on which the Company would be obliged to pay such additional interest were a payment in respect of the Notes then due. Prior to the publication of any notice of redemption pursuant to this clause (2), the Company will deliver to the Trustee a certificate stating that the Company is entitled to effect such redemption and setting forth a statement of fads showing that the conditions precedent to the Company's right to redeem the Notes have occurred, and an opinion of independent counsel of recognized standing to the effect that the Company has or will become obligated to pay such Additional Amounts as a result of such change or amendment.

Holders shall be given not less than 30 days nor more than 60 days prior notice by the Company of the date fixed for any redemption of the Notes as set forth in clauses (I) or (2) above.

The Company will pay additional amounts ("Additional Amounts") to the beneficial owner of any Note that is a non-United States Holder in order to ensure that every net payment on such Note will not be less, due to payment of U.S. withholding tax, than the amount then due and payable. For this purpose, a "net payment" on a Note means a payment by the Company or a paying agent, including payment of Principal and interest, after deduction for any present or future tax, assessment or other governmental charge of the United States. These Additional Amounts will constitute additional interest on the Note.

The Company will not be required to pay Additional Amounts, however, for or on account of:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) any tax, assessment or other governmental charge that is imposed but for:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the existence of any present or former connection between such Holder and the United States, including, without
limitation, such Holder being or having been a citizen or resident thereof or being or having been engaged in trade or business or present therein or having or having had a permanent establishment therein or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) such Holder's past or present status as a personal holding company, foreign personal holding company or
private foundation or other tax-exempt organization with respect to the United States or as a corporation that accumulates earnings to avoid U.S. federal income tax;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) any estate, inheritance, gift, sales, transfer or personal property tax or any similar tax, assessment or other governmental charge;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) any tax, assessment or other governmental charge that would not have been imposed but for the presentation by the Holder of a Note for payment more than 15 days after the date on which such payment became due and payable or on which payment thereof was duly provided for, whichever occurs later;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) any tax, assessment or other governmental charge that is payable otherwise than by deduction or withholding from a payment on a Note;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) any tax, assessment or other governmental charge required to be deducted or withheld by any paying agent from a payment on a Note, if such payment can be made without such deduction or withholding by any other paying agent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) any tax, assessment or other governmental charge that would not have been imposed but for a failure to comply with any applicable certification, documentation, information or other reporting requirement concerning the nationality, residence, identity or connection with the United States of the Holder or beneficial owner of a Note if, without regard to any tax treaty, such compliance is required by statute or regulation of the United States as a precondition to relief or exemption from such tax, assessment or other governmental charge; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) any tax, assessment or other governmental charge imposed on a Holder of a Note that actually or constructively owns 10 percent or more of the combined voting power of all classes of the Company's stock or that is a controlled foreign corporation related to the Company through stock ownership;

nor will such Additional Amounts be paid with respect to a payment on a Note to a Holder that is a fiduciary or partnership or other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to the additional amounts had such beneficiary, settlor, member or beneficial owner been the Holder of the Note.

------

As used in this Note, "United States Holder" means any individual who is a citizen or resident of the United States, a corporation organized in or under the laws of the United States and any other person who is subject to the U.S. federal income tax on a net income basis in respect of an investment in the Note.

As used in this Note, "non-United States Holder" means a person who is not a United States person for U.S. federal income tax purposes, and "United States" means the United States of America, including the States and the District of Columbia, its territories, its possessions and other areas within its jurisdiction.

Upon due presentment for registration of transfer of this Note at the office or agency of the Company in the Borough of Manhattan, The City of New York, a new Note or Notes of authorized denominations for an equal aggregate principal amount will be issued to the transferee in exchange therefor, subject to the limitations provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith.

The Company, the Trustee and any agent of the Company or the Trustee may deem and treat the registered Holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and notwithstanding any notation of ownership or other writing hereon), for the purpose of receiving payment of, or on account of, the Principal hereof and, subject to the provisions hereof, interest hereon, and for all other purposes, and neither the Company nor the Trustee nor any agent of the Company or the Trustee shall be affected by any notice to the contrary.

No recourse under or upon any obligation, covenant or agreement contained in the Indenture or any indenture supplemental thereto or in any Note, or because of any indebtedness evidenced thereby, shall be had against any incorporator as such, or against any past, present or future stockholder, officer, director or employee, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance hereof and as part of the consideration for the issue hereof.

Terms used herein which are defined in the Indenture shall have the respective meanings assigned thereto in the Indenture.

The laws of the State of New York (without regard to conflicts of laws principles thereof) shall govern this Note.

------

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto

[PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE]

[PLEASE PRINT OR TYPE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE]

the within Note and all rights thereunder, hereby irrevocably constituting and appointing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attorney to transfer such Note on the books of the Issuer, with full power of substitution in the premises.

Signature: <br> Dated: NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any change whatsoever.

## Exhibit 5.1

**Exhibit 5.1** 

---

| | |
|:---|:---|
| ![LOGO](g17238g0211011141552.jpg) <br> **A LIMITED LIABILITY PARTNERSHIP**<br>**TELEPHONE: +44 (0)20-7959-8900**<br> **FACSIMILE: +44 (0)20-7959-8950**<br> WWW.SULLCROM.COM | **One New Fetter Lane**<br> **London EC4A 1AN, England**<br>BRUSSELS • FRANKFURT • PARIS<br>LOS ANGELES • NEW YORK • PALO ALTO • WASHINGTON, D.C.<br>BEIJING • HONG KONG • TOKYO<br>MELBOURNE • SYDNEY |

---

February 12, 2026

UBS Group AG,

Bahnhofstrasse 45,

8001 Zurich, Switzerland.

Ladies and Gentlemen:

In connection with the registration under the Securities Act of 1933 (the "Act") of the previously issued 4.875% Senior Notes due 2045 (the "4.875% Notes") of UBS Group AG and the previously issued 4.550% Senior Notes due 2026 (the "4.550% Notes" and, together with the 4.875% Notes, the "Securities") of the Company, we, as your counsel, have examined such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purposes of this opinion. The 4.550% Notes were issued pursuant to that certain Indenture dated as of April 18, 2016 (the "4.550% Indenture"), between Credit Suisse Group Funding (Guernsey) Limited (the "Original Issuer"), Credit Suisse Group AG ("CSG") and U.S. Bank National Association, as trustee (the "Original Trustee"), as supplemented by (i) the First Supplemental Indenture, dated as of November 3, 2020 (the "First Supplemental 4.550% Indenture"), among the Original Issuer, CSG and the Original Trustee and (ii) the Second Supplemental Indenture dated as of June 9, 2023 (the "Second Supplemental 4.550% Indenture"), among the Company, CSG and U.S. Bank Trust Company, National Association, as successor in interest to the Original Trustee (the "Trustee"). The 4.875% Notes were issued pursuant to that certain Indenture dated as of May 21, 2015 (the "4.875% Indenture" and, together with the 4.550% Indenture, the "Indentures"), between the Original Issuer, CSG and the Original Trustee, as trustee, as supplemented by (i) the First Supplemental Indenture, dated as of November 3, 2020 (the "First Supplemental 4.875% Indenture"), among the Original Issuer, CSG and the Original Trustee and (ii) the Second Supplemental Indenture dated as of June 9, 2023 (the "Second Supplemental 4.875% Indenture" and, together with the First Supplemental 4.550% Indenture, Second Supplemental 4.550% Indenture and First Supplemental 4.875% Indenture, the "Supplemental Indentures"), among the Company, CSG and the Trustee, as successor in interest to the Original Trustee.

Upon the basis of such examination, it is our opinion that the Securities constitute valid and legally binding obligations of the Company, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors' rights and to general equity principles.

Sullivan & Cromwell LLP carries on business in England and Wales through Sullivan & Cromwell MNP LLP, a registered limited liability partnership established under the laws of the State of New York.

The personal liability of our partners is limited to the extent provided in such laws. Additional information is available upon request or at www.sullcrom.com.

Sullivan & Cromwell MNP LLP is authorized and regulated by the Solicitors Regulation Authority (Number 00308712).

A list of the partners' names and professional qualifications is available for inspection at 1 New Fetter Lane, London EC4A 1AN. All partners are either registered foreign lawyers or solicitors.

------

UBS Group AG

In rendering the foregoing opinion, we are not passing upon, and assume no responsibility for, any disclosure in any registration statement or any related prospectus or other offering material regarding the Company, the Securities or their offering or sale.

The foregoing opinion is limited to the Federal laws of the United States and the laws of the State of New York, and we are expressing no opinion as to the effect of the laws of any other jurisdiction. With respect to all matters of Swiss law, we note that you have received an opinion, dated February 12, 2026 of Homburger AG.

We have relied as to certain factual matters on information obtained from public officials, officers of the Company and other sources believed by us to be responsible, and we have assumed that (i) UBS Group AG has been duly incorporated and is validly existing as a corporation (*Aktiengesellschaft*) under the laws of Switzerland, (ii) all corporate action by the Company related to the Securities was duly authorized as a matter of Swiss law, (iii) each of the Second Supplemental 4.550% Indenture and Second Supplemental 4.875% Indenture has been duly authorized, executed and delivered by the Company in so far as the laws of Switzerland are concerned, (iv) the Securities have been duly authorized, executed, authenticated, issued and delivered in so far as the laws of Switzerland are concerned and (v) each of the Indentures and Supplemental Indentures has been duly authorized, executed and delivered by the Trustee, assumptions which we have not independently verified.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the references to us under the heading "Legal Matters" in the Prospectus relating to the Securities. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act.

---

| |
|:---|
| Very truly yours, |
| /s/ Sullivan & Cromwell LLP |

---

## Exhibit 5.2

**Exhibit 5.2** 

---

| | |
|:---|:---|
| ![LOGO](g17238g0211011545941.jpg) <br> **A LIMITED LIABILITY PARTNERSHIP**<br>**TELEPHONE: +44 (0)20-7959-8900**<br> **FACSIMILE: +44 (0)20-7959-8950**<br> WWW.SULLCROM.COM | **One New Fetter Lane**<br> **London EC4A 1AN, England**<br>BRUSSELS • FRANKFURT • PARIS<br>LOS ANGELES • NEW YORK • PALO ALTO • WASHINGTON, D.C.<br>BEIJING • HONG KONG • TOKYO<br>MELBOURNE • SYDNEY |

---

February 12, 2026

UBS Group AG,

Bahnhofstrasse 45,

8001 Zurich, Switzerland.

UBS AG,

Bahnhofstrasse 45,

8001 Zurich, Switzerland.

Aeschenvorstadt 1,

4051 Basel, Switzerland.

UBS Americas Inc.,

11 Madison Avenue,

New York, New York 10010.

Ladies and Gentlemen:

In connection with the registration under the Securities Act of 1933 (the "Act") of the previously issued 7<sup>1</sup>/<sub>8</sub>% Notes due July 15, 2023 (the "Notes") of UBS Americas Inc. ("UBS Americas"), originally issued by Credit Suisse (USA) LLC, formerly known as Credit Suisse (USA), Inc. and Credit Suisse First Boston (USA), Inc., and the guarantees thereof by UBS Group AG (the "UBS Group Guarantee") and UBS AG (the "UBS AG Guarantee" and together with the Notes and the UBS Group Guarantee, the "Securities"), we, as your United States counsel, have examined such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purposes of this opinion. The Securities were issued pursuant to that certain Senior Indenture dated as of June 1, 2001 (the "Senior Indenture"), between Credit Suisse (USA) LLC and The Bank of New York Mellon (formerly known as The Bank of New York, as successor to The Chase Manhattan Bank), as trustee (the "Trustee"), as supplemented by (i) the First Supplemental Indenture, dated as of March 26, 2007 (the "First Supplemental Indenture"), among Credit Suisse Group AG, Credit Suisse (USA) LLC, Credit Suisse AG and the Trustee, (ii) the Second Supplemental Indenture dated as of June 9, 2023 (the "Second Supplemental Indenture"), among UBS Group AG, Credit Suisse Group

Sullivan & Cromwell LLP carries on business in England and Wales through Sullivan & Cromwell MNP LLP, a registered limited liability partnership established under the laws of the State of New York.

The personal liability of our partners is limited to the extent provided in such laws. Additional information is available upon request or at www.sullcrom.com.

Sullivan & Cromwell MNP LLP is authorized and regulated by the Solicitors Regulation Authority (Number 00308712).

A list of the partners' names and professional qualifications is available for inspection at 1 New Fetter Lane, London EC4A 1AN. All partners are either registered foreign lawyers or solicitors.

------

UBS Americas Inc. -2-

AG, Credit Suisse AG, Credit Suisse (USA) LLC and the Trustee, (iii) the Third Supplemental Indenture, dated as of May 30, 2024 (the "Third Supplemental Indenture"), among UBS Group AG, Credit Suisse AG, UBS AG, Credit Suisse (USA) LLC and the Trustee and (iv) the Fourth Supplemental Indenture, dated as of February 2, 2026 (the "Fourth Supplemental Indenture" and, together with the First Supplemental Indenture, the Second Supplemental Indenture and the Third Supplemental Indenture, the "Supplemental Indentures"), among Credit Suisse (USA) LLC, UBS Americas, UBS Group AG, UBS AG and the Trustee.

Upon the basis of such examination, it is our opinion that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. the Notes constitute valid and legally binding obligations of UBS Americas, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors' rights and to general equity principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. assuming the UBS Group Guarantee has been duly authorized, executed and delivered by UBS Group AG insofar as
the laws of Switzerland are concerned, the UBS Group Guarantee constitutes a valid and legally binding obligation of UBS Group AG, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors' rights and to general equity principles; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. assuming the UBS AG Guarantee has been duly authorized, executed and delivered by UBS AG insofar as the laws of
Switzerland are concerned, the UBS AG Guarantee constitutes a valid and legally binding obligation of UBS AG, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or
affecting creditors' rights and to general equity principles.

In rendering the foregoing opinion, we are not passing upon, and assume no responsibility for, any disclosure in any registration statement or any related prospectus or other offering material regarding UBS Americas, UBS Group AG, UBS AG, the Securities or their offering or sale.

The foregoing opinion is limited to the Federal laws of the United States and the laws of the State of New York, and we are expressing no opinion as to the effect of the laws of any other jurisdiction. With respect to all matters of Swiss law, we note that you have received an opinion, dated February 12, 2026 of Homburger AG.

------

UBS Americas Inc. -3-

We have relied as to certain factual matters on information obtained from public officials, officers of UBS Americas, UBS Group AG and UBS AG and other sources believed by us to be responsible, and we have assumed that (i) each of UBS Group AG and UBS AG has been duly incorporated and is validly existing as a corporation (*Aktiengesellschaft*) under the laws of Switzerland, (ii) all corporate action by UBS Group AG or UBS AG related to the Securities was duly authorized as a matter of Swiss law, (iii) each of the Second Supplemental Indenture, Third Supplemental Indenture and Fourth Supplemental Indenture has been duly authorized, executed and delivered by UBS Group AG in so far as the laws of Switzerland are concerned, (iv) each of the Third Supplemental Indenture and Fourth Supplemental Indenture has been duly authorized, executed and delivered by UBS AG in so far as the laws of Switzerland are concerned, (v) the Securities have been duly authorized, executed, authenticated, issued and delivered in so far as the laws of Switzerland are concerned and (vi) each of the Senior Indenture and Supplemental Indentures has been duly authorized, executed and delivered by the Trustee, assumptions which we have not independently verified.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the references to us under the heading "Legal Matters" in the Prospectus relating to the Securities. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act.

---

| |
|:---|
| Very truly yours, |
| /s/ Sullivan & Cromwell LLP |

---

## Exhibit 5.3

**Exhibit 5.3**![LOGO](g17238dsp21.jpg)

---

| | |
|:---|:---|
| UBS Group AG<br> Bahnhofstrasse 45<br> 8001 Zurich<br> Switzerland<br>UBS AG<br> Bahnhofstrasse 45<br> 8001 Zurich<br> Switzerland | **Homburger AG**<br> **Prime Tower**<br> **Hardstrasse 201**<br> **CH–8005 Zurich**<br>homburger.ch<br> T +41 43 222 10 00 |

---

Zurich, February 12, 2026

**UBS Group AG and UBS AG** 

**Registration Statement on Form F-3** 

We, Homburger AG, have acted as special Swiss counsel to UBS Group AG and UBS AG in connection with the registration statement on Form F-3 to be filed by UBS Group AG, UBS AG and UBS Americas Inc. under the United States Securities Act of 1933, as amended (the **Securities Act**), with the U.S. Securities and Exchange Commission (the **SEC**) on or around February 12, 2026 (excluding the documents incorporated by reference therein, the **Registration Statement**), containing (i) a prospectus (x) relating to a rescission offer with respect to the 4.875% Senior Notes due 2045 (ISIN: US902613AY48) issued by UBS Group AG (the **2045 HoldCo Notes**), the 4.550% Senior Notes due 2026 (ISIN: US902613BB36) issued by UBS Group AG (the **2026 HoldCo Notes** and, together with the 2045 Notes, the **Outstanding HoldCo Notes**), and the three other series of notes described therein that are no longer outstanding (such three series of notes, the **Matured HoldCo Notes**), and (y) that may be used in connection with offers and sales of the Outstanding HoldCo Notes in market-making transactions, and (ii) a prospectus (x) relating to a rescission offer with respect to the 7 1/8% Notes due July 15, 2032 (ISIN: US22541LAE39) issued by UBS Americas Inc. (the **UBS Americas Notes**), which are guaranteed by UBS Group AG and UBS AG, and (y) that may be used in connection with offers and sales of the UBS Americas Notes in market-making transactions. As such counsel, we have been requested to give our opinion as to certain matters of Swiss law relating to the Registration Statement.

![LOGO](g17238dsp21a.jpg)

------

![LOGO](g17238dsp21.jpg)

I. Basis of Opinion

This opinion is confined to and given on the basis of the laws of Switzerland in force at the date hereof. Such laws and the interpretation thereof are subject to change. This opinion is also confined to the matters stated herein and the Documents (as defined below), and is not to be read as extending, by implication or otherwise, to any agreement or other document referred to in any of the Documents (including, in the case of the Registration Statement, any document incorporated by reference therein or exhibited thereto) or any other matter.

For purposes of this opinion, we have not conducted any due diligence or similar investigation as to factual circumstances that are or may be referred to in the Documents, and we express no opinion as to the accuracy of representations and warranties of facts set out in the Documents or the factual background assumed therein.

For purposes of this opinion, we have only reviewed the following documents (collectively, the **Documents**):

(i) an electronic copy of the Registration Statement;

(ii) an electronic copy of the executed indenture relating to the 2045 HoldCo Notes (the **2045 HoldCo Note Indenture**), consisting of the Senior Notes Indenture dated as of May 21, 2015, among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, as supplemented by (x) the Supplemental
Indenture dated as of November 3, 2020, among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, and (y) the Second Supplemental Indenture dated as of June 9, 2023 (the **Second 2045 HoldCo Note Supplemental Indenture**), among UBS Group AG, Credit Suisse Group AG and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association);

(iii) an electronic copy of the executed indenture relating to the 2026 HoldCo Notes (the **2026 HoldCo Note Indenture**), consisting of the Senior Notes Indenture dated as of April 18, 2016, among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, as supplemented by (x) the Supplemental
Indenture dated as of November 3, 2020, among Credit Suisse Group Funding (Guernsey) Limited, Credit Suisse Group AG and U.S. Bank National Association, and (y) the Second Supplemental Indenture dated as of June 9, 2023 (the **Second 2026 HoldCo Note Supplemental Indenture**), among UBS Group AG, Credit Suisse Group AG and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association);

(iv) an electronic copy of the executed indenture relating to the UBS Americas Notes (the **UBS Americas Indenture** and, together with the 2045 HoldCo Notes Indenture and the 2026 HoldCo Note Indenture, the **Indentures**) consisting of the Senior Indenture dated as of June 1, 2001, between Credit Suisse First Boston (USA), Inc. and The
Chase Manhattan Bank, as supplemented by (w) the First Supplemental Indenture dated as of March 26, 2007, among Credit Suisse (USA), Inc. (formerly known as Credit Suisse First Boston (USA), Inc.), Credit Suisse Group AG, Credit Suisse and
The Bank of New York (as successor to The Chase Manhattan Bank), (x) the Second Supplemental Indenture dated as of June 9, 2023 (the **Second UBS Americas Supplemental Indenture**), among Credit Suisse (USA), Inc. (formerly known as
Credit Suisse First Boston (USA), Inc.), Credit Suisse Group AG, UBS Group AG, Credit Suisse AG and The Bank of New York Mellon (formerly The Bank of New York), (y) the Third Supplemental Indenture dated as of May 30, 2024 (the **Third UBS** 

2/7

------

![LOGO](g17238dsp21.jpg)

 **Americas Supplemental Indenture), among Credit Suisse (USA) LLC (formerly Credit Suisse (USA), Inc. and Credit Suisse First Boston (USA), Inc.), UBS Group AG, Credit Suisse AG, UBS AG and The Bank of New York Mellon (formerly The Bank of New York), and (z) the Fourth Supplemental Indenture dated as of February 2, 2026 (the Fourth UBS Americas Supplemental Indenture), among Credit Suisse (USA) LLC (formerly Credit Suisse (USA), Inc. and Credit Suisse First Boston (USA), Inc.), UBS Americas Inc., UBS Group AG, UBS AG and The Bank of New York Mellon (formerly The Bank of New York);** 

(v) an electronic copy of the four authenticated global notes representing the 2045 HoldCo Notes and the four
authenticated global notes representing the 2026 HoldCo Notes, in each case, dated June 12, 2023, and executed by UBS Group AG;

(vi) a certified excerpt from the Commercial Register of the Canton of Zurich dated February 6, 2026, relating
to UBS Group AG, and a certified excerpt from the Commercial Register of the Canton of Zurich dated February 11, 2026, relating to UBS AG (collectively, the **Excerpts**);

(vii) an electronic copy of (x) the Articles of Association (*Statuten*) of UBS Group AG in their version
dated as of April 10, 2025, and (y) the Articles of Association (*Statuten*) of UBS AG in their version dated April 23, 2024, each certified by the Commercial Register of the Canton of Zurich (collectively, the **Articles**);

(viii) an electronic copy of (x) the Organization Regulations (*Organisationsreglement*) of UBS Group AG,
valid as of January 1, 2023, including the annexes thereto (the **2023 UBS Group AG Regulations**), (y) the Organization Regulations (*Organisationsreglement*) of UBS Group AG, valid as of March 1, 2024, including the annexes
thereto (the **2024 UBS Group AG Regulations**), and (z) the Organization Regulations (*Organisationsreglement*) of UBS Group AG, valid as of January 5, 2026, including the annexes thereto (the **2026 UBS Group AG Regulations**);

(ix) an electronic copy of (x) the Organization Regulations (*Organisationsreglement*) of UBS AG, valid as
of May 1, 2024, including the annexes thereto (the **2024 UBS AG Regulations**), and (y) the Organization Regulations (*Organisationsreglement*) of UBS AG, valid as of January 5, 2026, including the annexes thereto (the **2026 UBS AG Regulations**);

(x) an electronic copy of (w) the Delegation of Authorities Group Functions 9-C-000010 in its version effective as of November 24, 2020 (the **2020 Group Functions Delegation of Authorities**), (x) the UBS Group Treasury Delegation of Authorities 9-C-002962 in its version effective as of March 31, 2022 (the **2022 Group Treasury Delegation of Authorities**), (y) the UBS Delegation of Authorities
Group Finance (including Group Treasury) 9-C-011610 in its version effective as of October 25, 2023 (the **2023 Delegation of Authorities**), and (z) the
UBS Delegation of Authorities Group Finance (including Group Treasury) 9-C-011610 in its version published on July 9, 2025 (the **2025 Delegation of Authorities**);

(xi) an electronic copy of (x) the Policy on Signing Authority 1-P-000052 in its version effective as of April 19, 2023 (the **April 2023 Signing Authority Policy**), (y) the Policy on Signing Authority 1-P-000052 in its version effective as of December 14, 2023 (the **December 2023 Signing Authority Policy**), and (z) the Policy on Signing Authority 1-P-000052 in its version published on October 31, 2025 (the **2025 Signing Authority Policy**);

3/7

------

![LOGO](g17238dsp21.jpg)

(xii) an electronic copy of the combined (x) approval of the Chief Financial Officer of UBS Group AG and UBS AG
(the **CFO**), approving, among other things, the rescission offers in respect of the Outstanding HoldCo Notes, the Matured HoldCo Notes and the UBS Americas Notes and the Registration Statement, and the Fourth Supplemental Indenture and
(y) authorization of certain persons named therein to take certain actions on behalf of UBS Group AG or UBS AG, as applicable, dated January 20, 2026, and signed by the CFO and the Treasurer of UBS Group AG (the **Registration Statement Approval and Authorization**);

(xiii) an electronic copy of (x) the authorization signed by a managing director and an executive director of UBS
Group AG dated May 17, 2023, delegating authority to negotiate, jointly execute and deliver, on behalf of UBS Group AG, documents in connection with, among other things, the assumption by UBS Group AG of Credit Suisse Group AG's
obligations under the 2045 HoldCo Notes, the 2026 HoldCo Notes and the Group Guarantee (as defined in the UBS Americas Indenture) to any two signatories either registered in the Commercial Register of the Canton of Zurich as signatories for UBS
Group AG or listed in such authorization (the **2023 UBS Group AG Power of Attorney**), and (y) the authorization signed by a managing director and an executive director of UBS Group AG dated May 13, 2024, delegating authority to
negotiate, jointly execute and deliver, on behalf of UBS Group AG, documents in connection with, among other things, the assumption by UBS AG of Credit Suisse AG's obligations under the Bank Guarantee (as defined in the UBS Americas Indenture)
to any two signatories either registered in the Commercial Register of the Canton of Zurich as signatories for UBS Group AG or listed in such authorization (the **2024 UBS Group AG Power of Attorney**);

(xiv) an electronic copy of the authorization signed by a managing director and an executive director of UBS AG dated
May 13, 2024, delegating authority to negotiate, jointly execute and deliver, on behalf of UBS AG, documents in connection with, among other things, the assumption by UBS AG of Credit Suisse AG's obligations under the Bank Guarantee (as
defined in the UBS Americas Indenture) to any two signatories either registered from time to time in the Commercial Registers of the Canton of Zurich or Basel-City in Switzerland as signatories for UBS AG or listed in such authorization (the **2024 UBS AG Power of Attorney**); and

(xv) an electronic copy of (x) the executed amended and restated merger agreement dated March 19, 2023 and
amended on April 6, 2023 and on May 22, 2023, between UBS Group AG and Credit Suisse Group AG, and (y) the executed merger agreement dated December 7, 2023, as amended and restated on April 30, 2024 between UBS AG and Credit
Suisse AG (collectively, the **Merger Agreements**).

No documents have been reviewed by us in connection with this opinion other than the Documents. Accordingly, we shall limit our opinion to the Documents and their legal implications under the laws of Switzerland.

4/7

------

![LOGO](g17238dsp21.jpg)

In this opinion, Swiss legal concepts are expressed in English terms and not in their original language. These concepts may not be identical to the concepts described by the same English terms as they exist under the laws of other jurisdictions. With respect to Documents governed by laws other than the laws of Switzerland, for purposes of this opinion, we have relied on the plain meaning of the words and expressions contained therein without regard to any import they may have under the relevant governing law.

II. Assumptions

In rendering the opinions below, we have assumed the following:

(a) all documents produced to us as originals are authentic and complete, and all documents produced to us as
copies (including, without limitation, fax and electronic copies) conform to the original;

(b) all documents produced to us as originals and the originals of all documents produced to us as copies were duly
executed and certified, as applicable, by the individuals purported to have executed or certified, as the case may be, such documents, and any electronic signature of UBS Group AG or UBS AG on any such document has been affixed thereto by the
individual to whom such electronic signature belongs and such signature has not been removed or otherwise altered in any way;

(c) except as expressly opined upon herein, all information contained in the Documents is, and all material
statements made to us in connection with the Documents are, true and accurate;

(d) the Registration Statement will be executed by the persons required by the Securities Act and the rules and
regulations promulgated thereunder and filed with the SEC in the form reviewed by us;

(e) the Registration Statement will become effective under the Securities Act following SEC review;

(f) none of the Documents furnished to us has been amended, supplemented or terminated;

(g) the Excerpts are correct, complete and up to date, and the Articles, the 2026 UBS Group AG Regulations, the
2026 UBS AG Regulations, the 2025 Delegation of Authorities, the Registration Statement Approval and Authorization, and the 2025 Signing Authority Policy are in full force and effect and have not been amended;

(h) the 2024 UBS Group AG Regulations, the 2024 UBS AG Regulations, the 2023 Delegation of Authorities, the
December 2023 Signing Authority Policy, the 2024 UBS Group AG Power of Attorney and the 2024 UBS AG Power of Attorney were in full force and effect and had not been amended as of the date of the Third UBS Americas Supplemental Indenture;

(i) the 2023 UBS Group AG Regulations, the 2020 Group Functions Delegation of Authorities, the 2022 Group Treasury
Delegation of Authorities, the April 2023 Signing Authority Policy and the 2023 UBS Group AG Power of Attorney were in full force and effect and had not been amended as of the date of the Second 2045 HoldCo Note Supplemental Indenture, the Second
2026 HoldCo Note Supplemental Indenture and the Second UBS Americas Supplemental Indenture; and

5/7

------

![LOGO](g17238dsp21.jpg)

(j) each Merger Agreement is (i) within the capacity and power of, has been duly authorized, executed and
delivered by, and is binding on, all parties thereto, and (ii) in full force and effect and has not been amended or terminated.

III. Opinion

Based on the foregoing and subject to the qualifications set out below, we are of the opinion that:

1. Each of UBS Group AG and UBS AG is a corporation (*Aktiengesellschaft*) duly incorporated and validly
existing under the laws of Switzerland.

2. Each of UBS Group AG and UBS AG has the corporate power and authority to execute, deliver and file the
Registration Statement.

3. Each of UBS Group AG and UBS AG has taken all necessary corporate action to authorize the execution, delivery
and filing of the Registration Statement.

4. UBS Group AG has taken all necessary corporate action to authorize the execution and delivery of, and has
executed and delivered, the Second 2045 HoldCo Note Supplemental Indenture, the Second 2026 HoldCo Note Supplemental Indenture, the Second UBS Americas Supplemental Indenture, the Third UBS Americas Supplemental Indenture and the Fourth UBS Americas
Supplemental Indenture.

5. UBS AG has taken all necessary corporate action to authorize the execution and delivery of, and has executed
and delivered, the Third UBS Americas Supplemental Indenture and the Fourth UBS Americas Supplemental Indenture.

IV. Qualifications

The above opinions are subject to the following qualifications:

(a) The lawyers of our firm are members of the Zurich bar and do not hold themselves out to be experts in any laws
other than the laws of Switzerland. Accordingly, we are opining herein as to Swiss law only, based on our independent professional judgment, and we express no opinion with respect to the applicability or the effect of the laws of any other
jurisdiction to or on the matters covered herein.

(b) We do not render any opinion on or express any views on the legality, validity or enforceability of the
Outstanding HoldCo Notes, the Indentures, the Group Guarantee (as defined in the UBS Americas Indenture), the Bank Guarantee (as defined in the UBS Americas Indenture) or the performance of the obligations assumed by UBS Group AG and UBS AG, as
applicable, thereunder.

(c) We express no opinion (i) as to the accuracy or completeness of the information set out in the
Registration Statement, (ii) on the Merger Agreements, (iii) on the Matured HoldCo Notes, or (iv) on the UBS Americas Notes.

6/7

------

![LOGO](g17238dsp21.jpg)

(d) Further, we express no opinion on any banking, tax, commercial, accounting, calculating, auditing or other non-legal matter.

\* \* \*

We hereby consent to the filing of this opinion with the SEC as an exhibit to the Registration Statement and to the use of our name in each prospectus included in the Registration Statement under the heading "Legal Matters". In giving such consent we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

This opinion is furnished by us, as special Swiss counsel to UBS Group AG and UBS AG, in connection with the filing of the Registration Statement and, except as provided in the immediately preceding paragraph, is not to be used, circulated, quoted or otherwise referred to for any other purpose without our express written permission, or relied upon by any other person.

This opinion is governed by and shall be construed in accordance with the laws of Switzerland. We confirm our understanding that all disputes arising out of or in connection with this opinion shall be subject to the exclusive jurisdiction of the courts of the Canton of Zurich, Switzerland, venue being the City of Zurich.

Sincerely yours,

HOMBURGER AG

7/7

## Exhibit 8.1

**Exhibit 8.1** 

---

| | |
|:---|:---|
| ![LOGO](g17238g0211011940982.jpg) <br>A LIMITED LIABILITY PARTNERSHIP<br>TELEPHONE: +44 (0)20-7959-8900<br>FACSIMILE: +44 (0)20-7959-8950<br> WWW.SULLCROM.COM | <br> **One New Fetter Lane<br>London EC4A 1AN, England**<br>BRUSSELS • FRANKFURT • PARIS<br>LOS ANGELES • NEW YORK • PALO ALTO • WASHINGTON, D.C.<br>BEIJING • HONG KONG • TOKYO<br>MELBOURNE • SYDNEY |

---

February 12, 2026

UBS Group AG,

Bahnhofstrasse 45,

8001 Zurich, Switzerland.

UBS AG,

Bahnhofstrasse 45,

8001 Zurich, Switzerland.

Aeschenvorstadt 1,

4051 Basel, Switzerland.

UBS Americas Inc.,

11 Madison Avenue,

New York, New York 10010.

Ladies and Gentlemen:

As United States counsel to UBS Group AG, UBS AG, and UBS Americas Inc. (together, the "Registrants") in connection with the registration under the Securities Act of 1933 of the (a) (i) 4.875% Senior Notes due 2045 of UBS Group AG, (ii) 4.550% Senior Notes due 2026 of UBS Group AG, (iii) 3.750% Senior Notes due 2025 of UBS Group AG, (iv) 3.800% Senior Notes due 2023 of Credit Suisse Group AG and (v) 3.800% Senior Notes due 2022 of Credit Suisse Group Funding (Guernsey) Limited and the guarantee thereof by Credit Suisse Group AG and (b) 7 1/8% Notes due July 15, 2032 of UBS Americas Inc., and the guarantees thereof by UBS Group AG and UBS AG, as described in each prospectus (the "Prospectuses") that form a part of the Registration Statement on Form F-3, of the Registrants, filed with the Securities and Exchange Commission on February 12, 2026 (the "Registration Statement") to which this opinion is filed as an exhibit, we hereby confirm to you that the discussions of U.S. federal tax law set forth under the headings "United States Tax Considerations" contained in each Prospectus that forms a part of the Registration Statement are a fair and accurate summary of the matters described therein.

Sullivan & Cromwell LLP carries on business in England and Wales through Sullivan & Cromwell MNP LLP, a registered limited liability partnership established under the laws of the State of New York. The personal liability of our partners is limited to the extent provided in such laws. Additional information is available upon request or at www.sullcrom.com.

Sullivan & Cromwell MNP LLP is authorized and regulated by the Solicitors Regulation Authority (Number 00308712). A list of the partners' names and professional qualifications is available for inspection at 1 New Fetter Lane, London EC4A 1AN. All partners are either registered foreign lawyers or solicitors.

------

UBS Group AG UBS AG UBS Americas Inc. -2-

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933.

---

| |
|:---|
| Very truly yours, |
| /s/ Sullivan & Cromwell LLP |

---

## Exhibit 8.2

**Exhibit 8.2**![LOGO](g17238dsp28.jpg)

---

| | |
|:---|:---|
| UBS Group AG<br> Bahnhofstrasse 45<br> 8001 Zurich<br> Switzerland<br>UBS AG<br> Bahnhofstrasse 45<br> 8001 Zurich<br> Switzerland | **Homburger AG**<br> **Prime Tower**<br> **Hardstrasse 201**<br> **CH–8005 Zurich**<br>homburger.ch<br> T +41 43 222 10 00 |

---

Zurich, February 12, 2026

**UBS Group AG and UBS AG** 

**Registration Statement on Form F-3** 

We, Homburger AG, have acted as special Swiss counsel to UBS Group AG and UBS AG in connection with the registration statement on Form F-3 to be filed by UBS Group AG, UBS AG and UBS Americas Inc. under the United States Securities Act of 1933, as amended (the **Securities Act**), with the U.S. Securities and Exchange Commission (the **SEC**) on or around February 12, 2026 (excluding the documents incorporated by reference therein, the **Registration Statement**), for purposes of recission offers with respect to the debt securities described therein (the **Debt Securities**) and market-making transactions that have occurred or that may occur on a delayed or continuous basis in outstanding Debt Securities.

As such counsel, we have been requested to render a tax opinion in relation to the Registration Statement as to the correctness of certain tax considerations in each prospectus included in the Registration Statement under the caption "Swiss Tax Considerations".

I. Basis of Opinion

This opinion is confined to and given on the basis of the taxation laws of Switzerland in force at the date hereof. Such laws and the interpretation thereof are subject to change. This opinion is also confined to the matters stated herein and the Documents (as defined below), and is not to be read as extending, by implication or otherwise, to any agreement or other document referred to in any of the Documents or any other matter.

For purposes of this opinion, we have not conducted any due diligence or similar investigation as to factual circumstances that are or may be referred to in the Documents, and we express no opinion as to the accuracy of representations and warranties of facts set out in the Documents or the factual background assumed therein.

![LOGO](g17238dsp21a.jpg)

------

![LOGO](g17238dsp28.jpg)

For purposes of this opinion, we have only examined the following documents (collectively the **Documents**):

(i) an electronic copy of the Registration Statement; and

(ii) an electronic copy of the approval of the Swiss Financial Market Supervisory Authority FINMA dated
February 28, 2020, relating to, among other things, the outstanding Debt Securities (the **FINMA Approval**).

No documents have been reviewed by us in connection with this opinion other than the Documents. Accordingly, we shall limit our opinion to the Documents and their legal implications under Swiss law.

In this opinion, Swiss legal concepts are expressed in English terms and not in their original language. These concepts may not be identical to the concepts described by the same English terms as they exist under the laws of other jurisdictions. With respect to Documents governed by laws other than the laws of Switzerland, for purposes of this opinion we have relied on the plain meaning of the words and expressions contained therein without regard to any import they may have under the relevant governing law.

II. Assumptions

In rendering the opinion below, we have assumed the following:

(a) all documents produced to us as originals are authentic and complete, and all documents produced to us as
copies (including, without limitation, fax and electronic copies) conform to the original;

(b) all factual information contained in is, and all material statements made to us in connection with, the
Documents are, true and accurate;

(c) the Registration Statement will be executed and filed with the SEC in the form reviewed by us, and will become
effective under the Securities Act (the date of such effectiveness, the **Registration Statement Effective Date**);

(d) the FINMA Approval is in full force and effect and has not been amended; and

(e) all parties entered and will enter into the transactions contemplated under the Registration Statement for *bona fide* commercial reasons and at arm's length terms.

III. Opinion

Based on the foregoing and subject to the qualifications set out below, we are of the opinion that as of the date hereof the statements set forth in each prospectus included in the Registration Statement under the caption "Swiss Tax Considerations", insofar as such statements purport to summarize certain tax laws, regulations and regulatory practices of Switzerland are a correct summary of such laws, regulations and regulatory practices and do not omit to state any tax laws, regulations and regulatory practices necessary in order to make such summary not misleading in any material respect.

2/3

------

![LOGO](g17238dsp28.jpg)

IV. Qualifications

The above opinion is subject to the following qualifications:

(a) The lawyers of our firm are members of the Zurich bar and do not hold themselves out to be experts in any laws
other than the laws of Switzerland. Accordingly, we are opining herein as to Swiss law only, based on our independent professional judgment, and we express no opinion with respect to the applicability or the effect of the laws of any other
jurisdiction to or on the matters covered herein.

(b) We express no opinion as to the accuracy or completeness of the information set out in the Registration
Statement.

\* \* \*

We have issued this opinion as of the date hereof and we assume no obligation to advise you of any changes in fact or in law that are made or brought to our attention hereafter.

We hereby consent to the filing of this opinion with the SEC as an exhibit to the Registration Statement and to the use of our name in each prospectus included in the Registration Statement under the heading "Legal Matters". In giving such consent we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

This opinion is furnished by us, as special Swiss counsel to UBS Group AG and UBS AG, in connection with the filing of the Registration Statement and, except as provided in the immediately preceding paragraph, is not to be used, circulated, quoted or otherwise referred to for any other purpose without our express written permission, or relied upon by any other person.

This opinion is governed by and shall be construed in accordance with the laws of Switzerland. We confirm our understanding that all disputes arising out of or in connection with this opinion shall be subject to the exclusive jurisdiction of the courts of the Canton of Zurich, Switzerland, venue being the City of Zurich.

Sincerely yours,

HOMBURGER AG

3/3

## Exhibit 23.3

**Exhibit 23.3** 

**Zurich, 12 February 2026** 

**Consent of Independent Registered Public Accounting Firm** 

We consent to the reference to our firm under the caption "Experts" in the Registration Statement on Form F-3 and related prospectuses of UBS Group AG and UBS Americas Inc. in connection with the recission offer relating to the specified notes and to the incorporation by reference therein of our reports dated 14 March 2025, with respect to the consolidated financial statements of UBS Group AG, and the effectiveness of internal control over financial reporting of UBS Group AG, included in its Annual Report (Form 20-F) for the year ended 31 December 2024, filed with the Securities and Exchange Commission.

/s/ Ernst & Young Ltd

## Exhibit 23.4

**Exhibit 23.4** 

**Zurich, 12 February 2026** 

**Consent of Independent Registered Public Accounting Firm** 

We consent to the reference to our firm under the caption "Experts" in the Registration Statement on Form F-3 and related prospectus of UBS Americas Inc. in connection with the recission offer related to the specified notes and to the incorporation by reference therein of our report dated 14 March 2025, with respect to the consolidated financial statements of UBS AG, included in its Annual Report (Form 20-F) for the year ended 31 December 2024, filed with the Securities and Exchange Commission.

/s/ Ernst & Young Ltd

## Exhibit 23.5

**Exhibit 23.5**![LOGO](g17238g05l13.jpg)

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM** 

We hereby consent to the incorporation by reference in this Registration Statement on Form F-3 of UBS AG of our report dated March 28, 2024, relating to the financial statements of Credit Suisse AG and its subsidiaries, which appears in UBS AG's Report on Form 6-K dated May 7, 2024. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ PricewaterhouseCoopers AG

Zurich, Switzerland

February 12, 2026

PricewaterhouseCoopers AG, Birchstrasse 160, Postfach, CH-8050 Zurich, Switzerland

T: +41 58 792 44 00, www.pwc.ch

PricewaterhouseCoopers AG is a member of the global PricewaterhouseCoopers network of firms, each of which is a separate and independent legal entity.

## Exhibit 24.1

**Exhibit 24.1** 

**POWER OF ATTORNEY** 

KNOW ALL MEN BY THESE PRESENTS, that each undersigned does hereby make, constitute and appoint David Kelly, Ella Campi, Patrick Shilling, Michael Loftus, Kelsang Tsuen, and each of them, each with full power to act without the others, as his or her true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, in his or her name, place and stead, in any and all capacities, to sign the registration statement on Form F-3 relating to securities of, or guaranteed by, UBS Group AG, including a rescission offer for such securities, and any and all amendments thereto (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing whatsoever necessary or appropriate to be done in and about the premises as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that his or her said attorneys-in-fact and agent or their substitutes may lawfully do or cause to be done by virtue hereof.

---

| | |
|:---|:---|
| Name | Title |
| /s/ Sergio P. Ermotti | Group Chief Executive Officer<br> (principal executive officer) |
| Sergio P. Ermotti | Group Chief Executive Officer<br> (principal executive officer) |
| /s/ Todd Tuckner | Group Chief Financial Officer<br> (principal financial officer) |
| Todd Tuckner | Group Chief Financial Officer<br> (principal financial officer) |
| /s/ Steffen Henrich | Group Controller<br> (company controller) |
| Steffen Henrich | Group Controller<br> (company controller) |
| /s/ Colm Kelleher | Chairman and Member of the Board of Directors |
| Colm Kelleher | Chairman and Member of the Board of Directors |
| /s/ Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| /s/ Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| /s/ William C. Dudley | Member of the Board of Directors |
| William C. Dudley | Member of the Board of Directors |
| /s/ Patrick Firmenich | Member of the Board of Directors |
| Patrick Firmenich | Member of the Board of Directors |
| /s/ Fred Hu | Member of the Board of Directors |
| Fred Hu | Member of the Board of Directors |
| /s/ Mark Hughes | Member of the Board of Directors |
| Mark Hughes | Member of the Board of Directors |
| /s/ Renata Jungo Brüngger | Member of the Board of Directors |
| Renata Jungo Brüngger | Member of the Board of Directors |
| /s/ Gail Kelly | Member of the Board of Directors |
| Gail Kelly | Member of the Board of Directors |

---

------

---

| | |
|:---|:---|
| /s/ Julie G. Richardson | Member of the Board of Directors |
| Julie G. Richardson | Member of the Board of Directors |
| /s/ Lila Tretikov | Member of the Board of Directors |
| Lila Tretikov | Member of the Board of Directors |
| /s/ Jeanette Wong | Member of the Board of Directors |
| Jeanette Wong | Member of the Board of Directors |

---

## Exhibit 24.2

**Exhibit 24.2** 

**POWER OF ATTORNEY** 

KNOW ALL MEN BY THESE PRESENTS, that each undersigned does hereby make, constitute and appoint David Kelly, Ella Campi, Patrick Shilling, Michael Loftus, Kelsang Tsuen, and each of them, each with full power to act without the others, as his or her true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, in his or her name, place and stead, in any and all capacities, to sign the registration statement on Form F-3 relating to securities guaranteed by UBS AG, including a rescission offer with respect to such securities, and any and all amendments thereto (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing whatsoever necessary or appropriate to be done in and about the premises as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that his or her said attorneys-in-fact and agent or their substitutes may lawfully do or cause to be done by virtue hereof.

---

| | |
|:---|:---|
| Name | Title |
| /s/ Sergio P. Ermotti | Group Chief Executive Officer<br> (principal executive officer) |
| Sergio P. Ermotti | Group Chief Executive Officer<br> (principal executive officer) |
| /s/ Todd Tuckner | Group Chief Financial Officer<br> (principal financial officer) |
| Todd Tuckner | Group Chief Financial Officer<br> (principal financial officer) |
| /s/ Steffen Henrich | Group Controller<br> (company controller) |
| Steffen Henrich | Group Controller<br> (company controller) |
| /s/ Colm Kelleher | Chairman and Member of the Board of Directors |
| Colm Kelleher | Chairman and Member of the Board of Directors |
| /s/ Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| Lukas Gähwiler | Vice Chairman and Member of the Board of Directors |
| /s/ Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| Jeremy Anderson | Senior Independent Director and Member of the Board of Directors |
| /s/ William C. Dudley | Member of the Board of Directors |
| William C. Dudley | Member of the Board of Directors |
| /s/ Patrick Firmenich | Member of the Board of Directors |
| Patrick Firmenich | Member of the Board of Directors |
| /s/ Fred Hu | Member of the Board of Directors |
| Fred Hu | Member of the Board of Directors |
| /s/ Mark Hughes | Member of the Board of Directors |
| Mark Hughes | Member of the Board of Directors |
| /s/ Renata Jungo Brüngger | Member of the Board of Directors |
| Renata Jungo Brüngger | Member of the Board of Directors |
| /s/ Gail Kelly | Member of the Board of Directors |
| Gail Kelly | Member of the Board of Directors |

---

------

---

| | |
|:---|:---|
| /s/ Julie G. Richardson | Member of the Board of Directors |
| Julie G. Richardson | Member of the Board of Directors |
| /s/ Lila Tretikov | Member of the Board of Directors |
| Lila Tretikov | Member of the Board of Directors |
| /s/ Jeanette Wong | Member of the Board of Directors |
| Jeanette Wong | Member of the Board of Directors |

---

## Exhibit 24.3

**Exhibit 24.3** 

**POWER OF ATTORNEY** 

KNOW ALL MEN BY THESE PRESENTS, that each undersigned does hereby make, constitute and appoint David Kelly, Ella Campi, Patrick Shilling, Kelsang Tsuen, Maria Chiodi, Michael Loftus, Jacqueline Granados, and each of them, each with full power to act without the others, as his or her true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution in his or her name, place and stead, in any and all capacities, to sign the registration statement on Form F-3 relating to, among other things, securities of UBS Americas Inc., including a rescission offer for such securities, and any and all amendments thereto (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing whatsoever necessary or appropriate to be done in and about the premises as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that his or her said attorneys-in-fact and agent or their substitutes may lawfully do or cause to be done by virtue hereof.

---

| | |
|:---|:---|
| Name | Title |
| /s/ David Wildermuth | Director and President<br> (principal executive officer) |
| David Wildermuth | Director and President<br> (principal executive officer) |
| /s/ Ben Prata | Chief Financial Officer<br> (principal financial officer) |
| Ben Prata | Chief Financial Officer<br> (principal financial officer) |
| /s/ Greg Swindle | Legal Entity Controller<br> (company controller) |
| Greg Swindle | Legal Entity Controller<br> (company controller) |
| /s/ Darryll Hendricks | Director |
| Darryll Hendricks | Director |
| /s/ Robert Karofsky | Chairman and Director |
| Robert Karofsky | Chairman and Director |

---

## Exhibit 25.1

**Exhibit 25.1** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM T-1** 

**STATEMENT OF ELIGIBILITY** 

**UNDER THE TRUST INDENTURE ACT OF 1939** 

**OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE** 

☐ **Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2)** 

## U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
**(Exact name of Trustee as specified in its charter)** 

**91-1821036** 

**I.R.S. Employer Identification No.** 

---

| | |
|:---|:---|
| **800 Nicollet Mall**<br> **Minneapolis, Minnesota** | **55402** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Gregory M. Jackson** 

**U.S. Bank Trust Company, National Association** 

**2 Concourse Pkwy Suite 800** 

**Atlanta, GA 30308** 

**(404) 898-8837** 

**(Name, address and telephone number of agent for service)** 

**UBS GROUP AG** 

**(Issuer with respect to the Securities)** 

---

| | |
|:---|:---|
| **Switzerland** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |
| **Bahnhofstrasse 45,**<br> **8001 Zurich, Switzerland** | **Not Applicable** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**4.550% Senior Notes due 2026** 

**(Title of the Indenture Securities)** 

------

**<u>FORM T-1</u>**

**Item 1.** **GENERAL INFORMATION*.*** Furnish the following information as to the Trustee. <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) *Name and address of each examining or supervising authority to which it is subject.* 

Comptroller of the Currency

Washington, D.C.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) *Whether it is authorized to exercise corporate trust powers.* 

Yes

**Item 2.** **AFFILIATIONS WITH THE OBLIGOR.** *If the obligor is an affiliate of the Trustee, describe each such affiliation.* <br>

None

---

| | |
|:---|:---|
| **Items 3-15** | *Items 3-15 are not applicable because to the best of the Trustee's knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.*  |

---

**Item 16.** **LIST OF EXHIBITS:** *List below all exhibits filed as a part of this statement of eligibility and qualification.* <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. A copy of the Articles of Association of the Trustee, attached as Exhibit 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. A copy of the certificate of authority of the Trustee to commence business, attached as Exhibit 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. A copy of the authorization of the Trustee to exercise corporate trust powers, included as Exhibit 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. A copy of the existing bylaws of the Trustee, attached as Exhibit 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. A copy of each Indenture referred to in Item 4. Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as
Exhibit 6.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Report of Condition of the Trustee as of September 30, 2025, published pursuant to law or the requirements
of its supervising or examining authority, attached as Exhibit 7.

------

**SIGNATURE** 

Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Atlanta, State of Georgia on the of February, 2026.

---

| | |
|:---|:---|
| By: | /s/ Gregory M. Jackson |
|  | Gregory M. Jackson |
|  | Vice President |

---

------

**<u>Exhibit 1</u>**

**ARTICLES OF ASSOCIATION** 

**OF** 

**U. S. BANK TRUST COMPANY, NATIONAL ASSOCIATION** 

For the purpose of organizing an association (the "Association") to perform any lawful activities of national banks, the undersigned enter into the following Articles of Association:

**FIRST.** The title of this Association shall be U. S. Bank Trust Company, National Association.

**SECOND.** The main office of the Association shall be in the city of Portland, county of Multnomah, state of Oregon. The business of the Association will be limited to fiduciary powers and the support of activities incidental to the exercise of those powers. The Association may not expand or alter its business beyond that stated in this article without the prior approval of the Comptroller of the Currency.

**THIRD.** The board of directors of the Association shall consist of not less than five nor more than twenty-five persons, the exact number to be fixed and determined from time to time by resolution of a majority of the full board of directors or by resolution of a majority of the shareholders at any annual or special meeting thereof. Each director shall own common or preferred stock of the Association or of a holding company owning the Association, with an aggregate par, fair market, or equity value of not less than $1,000, as of either (i) the date of purchase, (ii) the date the person became a director, or (iii) the date of that person's most recent election to the board of directors, whichever is more recent. Any combination of common or preferred stock of the Association or holding company may be used.

Any vacancy in the board of directors may be filled by action of a majority of the remaining directors between meetings of shareholders. The board of directors may increase the number of directors up to the maximum permitted by law. Terms of directors, including directors selected to fill vacancies, shall expire at the next regular meeting of shareholders at which directors are elected, unless the directors resign or are removed from office. Despite the expiration of a director's term, the director shall continue to serve until his or her successor is elected and qualified or until there is a decrease in the number of directors and his or her position is eliminated.

Honorary or advisory members of the board of directors, without voting power or power of final decision in matters concerning the business of the Association, may be appointed by resolution of a majority of the full board of directors, or by resolution of shareholders at any annual or special meeting. Honorary or advisory directors shall not be counted to determined the number of directors of the Association or the presence of a quorum in connection with any board action, and shall not be required to own qualifying shares.

**FOURTH.** There shall be an annual meeting of the shareholders to elect directors and transact whatever other business may be brought before the meeting. It shall be held at the main office or any other convenient place the board of directors may designate, on the day of each year specified therefor in the Bylaws, or if that day falls on a legal holiday in the state in which the

------

Association is located, on the next following banking day. If no election is held on the day fixed or in the event of a legal holiday on the following banking day, an election may be held on any subsequent day within 60 days of the day fixed, to be designated by the board of directors, or, if the directors fail to fix the day, by shareholders representing two-thirds of the shares issued and outstanding. In all cases, at least 10 days' advance notice of the meeting shall be given to the shareholders by first-class mail.

In all elections of directors, the number of votes each common shareholder may cast will be determined by multiplying the number of shares he or she owns by the number of directors to be elected. Those votes may be cumulated and cast for a single candidate or may be distributed among two or more candidates in the manner selected by the shareholder. On all other questions, each common shareholder shall be entitled to one vote for each share of stock held by him or her.

A director may resign at any time by delivering written notice to the board of directors, its chairperson, or to the Association, which resignation shall be effective when the notice is delivered unless the notice specifies a later effective date.

A director may be removed by the shareholders at a meeting called to remove him or her, when notice of the meeting stating that the purpose or one of the purposes is to remove him or her is provided, if there is a failure to fulfill one of the affirmative requirements for qualification, or for cause; provided, however, that a director may not be removed if the number of votes sufficient to elect him or her under cumulative voting is voted against his or her removal.

**FIFTH.** The authorized amount of capital stock of the Association shall be 1,000,000 shares of common stock of the par value of ten dollars ($10) each; but said capital stock may be increased or decreased from time to time, according to the provisions of the laws of the United States. The Association shall have only one class of capital stock.

No holder of shares of the capital stock of any class of the Association shall have any preemptive or preferential right of subscription to any shares of any class of stock of the Association, whether now or hereafter authorized, or to any obligations convertible into stock of the Association, issued, or sold, nor any right of subscription to any thereof other than such, if any, as the board of directors, in its discretion, may from time to time determine and at such price as the board of directors may from time to time fix.

Transfers of the Association's stock are subject to the prior written approval of a federal depository institution regulatory agency. If no other agency approval is required, the approval of the Comptroller of the Currency must be obtained prior to any such transfers.

Unless otherwise specified in the Articles of Association or required by law, (1) all matters requiring shareholder action, including amendments to the Articles of Association must be approved by shareholders owning a majority voting interest in the outstanding voting stock, and (2) each shareholder shall be entitled to one vote per share.

------

Unless otherwise specified in the Articles of Association or required by law, all shares of voting stock shall be voted together as a class, on any matters requiring shareholder approval.

Unless otherwise provided in the Bylaws, the record date for determining shareholders entitled to notice of and to vote at any meeting is the close of business on the day before the first notice is mailed or otherwise sent to the shareholders, provided that in no event may a record date be more than 70 days before the meeting.

The Association, at any time and from time to time, may authorize and issue debt obligations, whether subordinated, without the approval of the shareholders. Obligations classified as debt, whether subordinated, which may be issued by the Association without the approval of shareholders, do not carry voting rights on any issue, including an increase or decrease in the aggregate number of the securities, or the exchange or reclassification of all or part of securities into securities of another class or series.

**SIXTH.** The board of directors shall appoint one of its members president of this Association and one of its members chairperson of the board and shall have the power to appoint one or more vice presidents, a secretary who shall keep minutes of the directors' and shareholders' meetings and be responsible for authenticating the records of the Association, and such other officers and employees as may be required to transact the business of this Association. A duly appointed officer may appoint one or more officers or assistant officers if authorized by the board of directors in accordance with the Bylaws.

The board of directors shall have the power to:

(1) Define the duties of the officers, employees, and agents of the Association.

(2) Delegate the performance of its duties, but not the responsibility for its duties, to the officers, employees,
and agents of the Association.

(3) Fix the compensation and enter employment contracts with its officers and employees upon reasonable terms and
conditions consistent with applicable law.

(4) Dismiss officers and employees.

(5) Require bonds from officers and employees and to fix the penalty thereof.

(6) Ratify written policies authorized by the Association's management or committees of the board.

(7) Regulate the manner any increase or decrease of the capital of the Association shall be made; provided that
nothing herein shall restrict the power of shareholders to increase or decrease the capital of the Association in accordance with law, and nothing shall raise or lower from two-thirds the percentage required
for shareholder approval to increase or reduce the capital.

------

(8) Manage and administer the business and affairs of the Association.

(9) Adopt initial Bylaws, not inconsistent with law or the Articles of Association, for managing the business and
regulating the affairs of the Association.

(10) Amend or repeal Bylaws, except to the extent that the Articles of Association reserve this power in whole or in
part to the shareholders.

(11) Make contracts.

(12) Generally perform all acts that are legal for a board of directors to perform.

**SEVENTH.** The board of directors shall have the power to change the location of the main office to any authorized branch within the limits of the city of Portland, Oregon, without the approval of the shareholders, or with a vote of shareholders owning two-thirds of the stock of the Association for a location outside such limits and upon receipt of a certificate of approval from the Comptroller of the Currency, to any other location within or outside the limits of the city of Portland, Oregon, but not more than thirty miles beyond such limits. The board of directors shall have the power to establish or change the location of any office or offices of the Association to any other location permitted under applicable law, without approval of shareholders, subject to approval by the Comptroller of the Currency.

**EIGHTH.** The corporate existence of this Association shall continue until termination according to the laws of the United States.

**NINTH.** The board of directors of the Association, or any shareholder owning, in the aggregate, not less than 25 percent of the stock of the Association, may call a special meeting of shareholders at any time. Unless otherwise provided by the Bylaws or the laws of the United States, or waived by shareholders, a notice of the time, place, and purpose of every annual and special meeting of the shareholders shall be given by first-class mail, postage prepaid, mailed at least 10, and no more than 60, days prior to the date of the meeting to each shareholder of record at his/her address as shown upon the books of the Association. Unless otherwise provided by the Bylaws, any action requiring approval of shareholders must be effected at a duly called annual or special meeting.

**TENTH.** These Articles of Association may be amended at any regular or special meeting of the shareholders by the affirmative vote of the holders of a majority of the stock of the Association, unless the vote of the holders of a greater amount of stock is required by law, and in that case by the vote of the holders of such greater amount; provided, that the scope of the Association's activities and services may not be expanded without the prior written approval of the Comptroller of the Currency. The Association's board of directors may propose one or more amendments to the Articles of Association for submission to the shareholders.

------

In witness whereof, we have hereunto set our hands this 11<sup>th</sup> of June, 1997.

---

| |
|:---|
| /s/ Jeffrey T. Grubb |
| Jeffrey T. Grubb |
| /s/ Robert D. Sznewajs |
| Robert D. Sznewajs |
| /s/ Dwight V. Board |
| Dwight V. Board |
| /s/ P. K. Chatterjee |
| P. K. Chatterjee |
| /s/ Robert Lane |
| Robert Lane |

---

------

**<u>Exhibit 2</u>**

![LOGO](g17238g0209181954756.jpg)

------

**<u>Exhibit 4</u>**

**U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION** 

**<u>AMENDED AND RESTATED BYLAWS</u>**

<u>ARTICLE I</u> 

<u>Meetings of Shareholders</u> 

Section 1.1. <u>Annual Meeting</u>. The annual meeting of the shareholders, for the election of directors and the transaction of any other proper business, shall be held at a time and place as the Chairman or President may designate. Notice of such meeting shall be given not less than ten (10) days or more than sixty (60) days prior to the date thereof, to each shareholder of the Association, unless the Office of the Comptroller of the Currency (the "OCC") determines that an emergency circumstance exists. In accordance with applicable law, the sole shareholder of the Association is permitted to waive notice of the meeting. If, for any reason, an election of directors is not made on the designated day, the election shall be held on some subsequent day, as soon thereafter as practicable, with prior notice thereof. Failure to hold an annual meeting as required by these Bylaws shall not affect the validity of any corporate action or work a forfeiture or dissolution of the Association.

Section 1.2. <u>Special Meetings</u>. Except as otherwise specially provided by law, special meetings of the shareholders may be called for any purpose, at any time by a majority of the board of directors (the "Board"), or by any shareholder or group of shareholders owning at least ten percent of the outstanding stock.

Every such special meeting, unless otherwise provided by law, shall be called upon not less than ten (10) days nor more than sixty (60) days prior notice stating the purpose of the meeting.

Section 1.3. <u>Nominations for Directors</u>. Nominations for election to the Board may be made by the Board or by any shareholder.

Section 1.4. <u>Proxies</u>. Shareholders may vote at any meeting of the shareholders by proxies duly authorized in writing. Proxies shall be valid only for one meeting and any adjournments of such meeting and shall be filed with the records of the meeting.

Section 1.5. <u>Record Date</u>. The record date for determining shareholders entitled to notice and to vote at any meeting will be thirty days before the date of such meeting, unless otherwise determined by the Board.

------

Section 1.6. <u>Quorum and Voting</u>. A majority of the outstanding capital stock, represented in person or by proxy, shall constitute a quorum at any meeting of shareholders, unless otherwise provided by law, but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice. A majority of the votes cast shall decide every question or matter submitted to the shareholders at any meeting, unless otherwise provided by law or by the Articles of Association.

Section 1.7. <u>Inspectors</u>. The Board may, and in the event of its failure so to do, the Chairman of the Board may appoint Inspectors of Election who shall determine the presence of quorum, the validity of proxies, and the results of all elections and all other matters voted upon by shareholders at all annual and special meetings of shareholders.

Section 1.8. <u>Waiver and Consent</u>. The shareholders may act without notice or a meeting by a unanimous written consent by all shareholders.

Section 1.9. <u>Remote Meetings</u>. The Board shall have the right to determine that a shareholder meeting not be held at a place, but instead be held solely by means of remote communication in the manner and to the extent permitted by the General Corporation Law of the State of Delaware.

<u>ARTICLE II</u> 

<u>Directors</u> 

Section 2.1. <u>Board of Directors</u>. The Board shall have the power to manage and administer the business and affairs of the Association. Except as expressly limited by law, all corporate powers of the Association shall be vested in and may be exercised by the Board.

Section 2.2. <u>Term of Office</u>. The directors of this Association shall hold office for one year and until their successors are duly elected and qualified, or until their earlier resignation or removal.

Section 2.3. <u>Powers</u>. In addition to the foregoing, the Board shall have and may exercise all of the powers granted to or conferred upon it by the Articles of Association, the Bylaws and by law.

Section 2.4. <u>Number</u>. As provided in the Articles of Association, the Board of this Association shall consist of no less than five nor more than twenty-five members, unless the OCC has exempted the Association from the twenty-five- member limit. The Board shall consist of a number of members to be fixed and determined from time to time by resolution of the Board or the shareholders at any meeting thereof, in accordance with the Articles of Association. Between meetings of the shareholders held for the purpose of electing directors, the Board

------

by a majority vote of the full Board may increase the size of the Board but not to more than a total of twenty-five directors, and fill any vacancy so created in the Board; provided that the Board may increase the number of directors only by up to two directors, when the number of directors last elected by shareholders was fifteen or fewer, and by up to four directors, when the number of directors last elected by shareholders was sixteen or more. Each director shall own a qualifying equity interest in the Association or a company that has control of the Association in each case as required by applicable law. Each director shall own such qualifying equity interest in his or her own right and meet any minimum threshold ownership required by applicable law.

Section 2.5. <u>Organization Meeting</u>. The newly elected Board shall meet for the purpose of organizing the new Board and electing and appointing such officers of the Association as may be appropriate. Such meeting shall be held on the day of the election or as soon thereafter as practicable, and, in any event, within thirty days thereafter, at such time and place as the Chairman or President may designate. If, at the time fixed for such meeting, there shall not be a quorum present, the directors present may adjourn the meeting until a quorum is obtained.

Section 2.6. <u>Regular Meetings</u>. The regular meetings of the Board shall be held, without notice, as the Chairman or President may designate and deem suitable.

Section 2.7. <u>Special Meetings</u>. Special meetings of the Board may be called at any time, at any place and for any purpose by the Chairman of the Board or the President of the Association, or upon the request of a majority of the entire Board. Notice of every special meeting of the Board shall be given to the directors at their usual places of business, or at such other addresses as shall have been furnished by them for the purpose. Such notice shall be given at least twelve hours (three hours if meeting is to be conducted by conference telephone) before the meeting by telephone or by being personally delivered, mailed, or electronically delivered. Such notice need not include a statement of the business to be transacted at, or the purpose of, any such meeting.

Section 2.8. <u>Quorum and Necessary Vote</u>. A majority of the directors shall constitute a quorum at any meeting of the Board, except when otherwise provided by law; but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice. Unless otherwise provided by law or the Articles or Bylaws of this Association, once a quorum is established, any act by a majority of those directors present and voting shall be the act of the Board.

------

Section 2.9. <u>Written Consent</u>. Except as otherwise required by applicable laws and regulations, the Board may act without a meeting by a unanimous written consent by all directors, to be filed with the Secretary of the Association as part of the corporate records.

Section 2.10. <u>Remote Meetings</u>. Members of the Board, or of any committee thereof, may participate in a meeting of such Board or committee by means of conference telephone, video or similar communications equipment by means of which all persons participating in the meeting can hear each other and such participation shall constitute presence in person at such meeting.

Section 2.11. <u>Vacancies</u>. When any vacancy occurs among the directors, the remaining members of the Board may appoint a director to fill such vacancy at any regular meeting of the Board, or at a special meeting called for that purpose.

<u>ARTICLE III</u> 

<u>Committees</u> 

Section 3.1. <u>Advisory Board of Directors</u>. The Board may appoint persons, who need not be directors, to serve as advisory directors on an advisory board of directors established with respect to the business affairs of either this Association alone or the business affairs of a group of affiliated organizations of which this Association is one. Advisory directors shall have such powers and duties as may be determined by the Board, provided, that the Board's responsibility for the business and affairs of this Association shall in no respect be delegated or diminished.

Section 3.2. <u>Trust Audit Committee</u>. At least once during each calendar year, the Association shall arrange for a suitable audit (by internal or external auditors) of all significant fiduciary activities under the direction of its trust audit committee, a function that will be fulfilled by the Audit Committee of the financial holding company that is the ultimate parent of this Association. The Association shall note the results of the audit (including significant actions taken as a result of the audit) in the minutes of the Board. In lieu of annual audits, the Association may adopt a continuous audit system in accordance with 12 C.F.R. § 9.9(b).

------

The Audit Committee of the financial holding company that is the ultimate parent of this Association, fulfilling the function of the trust audit committee:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Must not include any officers of the Association or an affiliate who participate significantly in the administration of the Association's fiduciary activities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Must consist of a majority of members who are not also members of any committee to which the Board has delegated power to manage and control the fiduciary activities of the Association.

Section 3.3. <u>Executive Committee</u>. The Board may appoint an Executive Committee which shall consist of at least three directors and which shall have, and may exercise, to the extent permitted by applicable law, all the powers of the Board between meetings of the Board or otherwise when the Board is not meeting.

Section 3.4. <u>Trust Management Committee</u>. The Board of this Association shall appoint a Trust Management Committee to provide oversight of the fiduciary activities of the Association. The Trust Management Committee shall determine policies governing fiduciary activities. The Trust Management Committee or such sub-committees, officers or others as may be duly designated by the Trust Management Committee shall oversee the processes related to fiduciary activities to assure conformity with fiduciary policies it establishes, including ratifying the acceptance and the closing out or relinquishment of all trusts. The Trust Management Committee will provide regular reports of its activities to the Board.

Section 3.5. <u>Other Committees</u>. The Board may appoint, from time to time, committees of one or more persons who need not be directors, for such purposes and with such powers as the Board may determine; however, the Board will not delegate to any committee any powers or responsibilities that it is prohibited from delegating under any law or regulation. In addition, either the Chairman or the President may appoint, from time to time, committees of one or more officers, employees, agents or other persons, for such purposes and with such powers as either the Chairman or the President deems appropriate and proper. Whether appointed by the Board, the Chairman, or the President, any such committee shall at all times be subject to the direction and control of the Board.

Section 3.6. <u>Meetings, Minutes and Rules</u>. An advisory board of directors and/or committee shall meet as necessary in consideration of the purpose of the advisory board of directors or committee, and shall maintain minutes in sufficient detail to indicate actions taken or recommendations made; unless required by the members, discussions, votes or other specific details need not be reported. An advisory board of directors or a committee may, in consideration of its purpose, adopt its own rules for the exercise of any of its functions or authority.

------

<u>ARTICLE IV</u> 

<u>Officers</u> 

Section 4.1. <u>Chairman of the Board</u>. The Board may appoint one of its members to be Chairman of the Board to serve at the pleasure of the Board. The Chairman shall supervise the carrying out of the policies adopted or approved by the Board; shall have general executive powers, as well as the specific powers conferred by these Bylaws; and shall also have and may exercise such powers and duties as from time to time may be conferred upon or assigned by the Board.

Section 4.2. <u>President</u>. The Board may appoint one of its members to be President of the Association. In the absence of the Chairman, the President shall preside at any meeting of the Board. The President shall have general executive powers, and shall have and may exercise any and all other powers and duties pertaining by law, regulation or practice, to the office of President, or imposed by these Bylaws. The President shall also have and may exercise such powers and duties as from time to time may be conferred or assigned by the Board.

Section 4.3. <u>Vice President</u>. The Board may appoint one or more Vice Presidents who shall have such powers and duties as may be assigned by the Board and to perform the duties of the President on those occasions when the President is absent, including presiding at any meeting of the Board in the absence of both the Chairman and President.

Section 4.4. <u>Secretary</u>. The Board shall appoint a Secretary, or other designated officer who shall be Secretary of the Board and of the Association, and shall keep accurate minutes of all meetings. The Secretary shall attend to the giving of all notices required by these Bylaws to be given; shall be custodian of the corporate seal, records, documents and papers of the Association; shall provide for the keeping of proper records of all transactions of the Association; shall, upon request, authenticate any records of the Association; shall have and may exercise any and all other powers and duties pertaining by law, regulation or practice, to the Secretary, or imposed by these Bylaws; and shall also perform such other duties as may be assigned from time to time by the Board. The Board may appoint one or more Assistant Secretaries with such powers and duties as the Board, the President or the Secretary shall from time to time determine.

Section 4.5. <u>Other Officers</u>. The Board may appoint, and may authorize the Chairman, the President or any other officer to appoint, any officer as from time to time may appear to the Board, the Chairman, the President or such other

------

officer to be required or desirable to transact the business of the Association. Such officers shall exercise such powers and perform such duties as pertain to their several offices, or as may be conferred upon or assigned to them by these Bylaws, the Board, the Chairman, the President or such other authorized officer. Any person may hold two offices.

Section 4.6. <u>Tenure of Office</u>. The Chairman or the President and all other officers shall hold office until their respective successors are elected and qualified or until their earlier death, resignation, retirement, disqualification or removal from office, subject to the right of the Board or authorized officer to discharge any officer at any time.

<u>ARTICLE V</u> 

<u>Stock</u> 

Section 5.1. The Board may authorize the issuance of stock either in certificated or in uncertificated form. Certificates for shares of stock shall be in such form as the Board may from time to time prescribe. If the Board issues certificated stock, the certificate shall be signed by the President, Secretary or any other such officer as the Board so determines. Shares of stock shall be transferable on the books of the Association, and a transfer book shall be kept in which all transfers of stock shall be recorded. Every person becoming a shareholder by such transfer shall, in proportion to such person's shares, succeed to all rights of the prior holder of such shares. Each certificate of stock shall recite on its face that the stock represented thereby is transferable only upon the books of the Association properly endorsed. The Board may impose conditions upon the transfer of the stock reasonably calculated to simplify the work of the Association for stock transfers, voting at shareholder meetings, and related matters, and to protect it against fraudulent transfers.

<u>ARTICLE VI</u> 

<u>Corporate Seal</u> 

Section 6.1. The Association shall have no corporate seal; provided, however, that if the use of a seal is required by, or is otherwise convenient or advisable pursuant to, the laws or regulations of any jurisdiction, the following seal may be used, and the Chairman, the President, the Secretary and any Assistant Secretary shall have the authority to affix such seal:

------

<u>ARTICLE VII</u> 

<u>Miscellaneous Provisions</u> 

Section 7.1. <u>Execution of Instruments</u>. All agreements, checks, drafts, orders, indentures, notes, mortgages, deeds, conveyances, transfers, endorsements, assignments, certificates, declarations, receipts, discharges, releases, satisfactions, settlements, petitions, schedules, accounts, affidavits, bonds, undertakings, guarantees, proxies and other instruments or documents may be signed, countersigned, executed, acknowledged, endorsed, verified, delivered or accepted on behalf of the Association, whether in a fiduciary capacity or otherwise, by any officer of the Association, or such employee or agent as may be designated from time to time by the Board by resolution, or by the Chairman or the President by written instrument, which resolution or instrument shall be certified as in effect by the Secretary or an Assistant Secretary of the Association. The provisions of this section are supplementary to any other provision of the Articles of Association or Bylaws.

Section 7.2. <u>Records</u>. The Articles of Association, the Bylaws as revised or amended from time to time and the proceedings of all meetings of the shareholders, the Board, and standing committees of the Board, shall be recorded in appropriate minute books provided for the purpose. The minutes of each meeting shall be signed by the Secretary, or other officer appointed to act as Secretary of the meeting.

Section 7.3. <u>Trust Files</u>. There shall be maintained in the Association files all fiduciary records necessary to assure that its fiduciary responsibilities have been properly undertaken and discharged.

Section 7.4. <u>Trust Investments</u>. Funds held in a fiduciary capacity shall be invested according to the instrument establishing the fiduciary relationship and according to law. Where such instrument does not specify the character and class of investments to be made and does not vest in the Association a discretion in the matter, funds held pursuant to such instrument shall be invested in investments in which corporate fiduciaries may invest under law.

Section 7.5. <u>Notice</u>. Whenever notice is required by the Articles of Association, the Bylaws or law, such notice shall be by mail, postage prepaid, e- mail, in person, or by any other means by which such notice can reasonably be expected to be received, using the address of the person to receive such notice, or such other personal data, as may appear on the records of the Association.

Except where specified otherwise in these Bylaws, prior notice shall be proper if given not more than 30 days nor less than 10 days prior to the event for which notice is given.

------

<u>ARTICLE VIII</u> 

<u>Indemnification</u> 

Section 8.1. The Association shall indemnify such persons for such liabilities in such manner under such circumstances and to such extent as permitted by Section 145 of the Delaware General Corporation Law, as now enacted or hereafter amended. The Board may authorize the purchase and maintenance of insurance and/or the execution of individual agreements for the purpose of such indemnification, and the Association shall advance all reasonable costs and expenses (including attorneys' fees) incurred in defending any action, suit or proceeding to all persons entitled to indemnification under this Section 8.1. Such insurance shall be consistent with the requirements of 12 C.F.R. § 7.2014 and shall exclude coverage of liability for a formal order assessing civil money penalties against an institution-affiliated party, as defined at 12 U.S.C. § 1813(u).

Section 8.2. Notwithstanding Section 8.1, however, (a) any indemnification payments to an institution-affiliated party, as defined at 12 U.S.C. § 1813(u), for an administrative proceeding or civil action initiated by a federal banking agency, shall be reasonable and consistent with the requirements of 12 U.S.C. § 1828(k) and the implementing regulations thereunder; and (b) any indemnification payments and advancement of costs and expenses to an institution-affiliated party, as defined at 12 U.S.C. § 1813(u), in cases involving an administrative proceeding or civil action not initiated by a federal banking agency, shall be in accordance with Delaware General Corporation Law and consistent with safe and sound banking practices.

<u>ARTICLE IX</u> 

<u>Bylaws: Interpretation and Amendment</u> 

Section 9.1. These Bylaws shall be interpreted in accordance with and subject to appropriate provisions of law, and may be added to, altered, amended, or repealed, at any regular or special meeting of the Board.

Section 9.2. A copy of the Bylaws and all amendments shall at all times be kept in a convenient place at the principal office of the Association, and shall be open for inspection to all shareholders during Association hours.

------

<u>ARTICLE X</u> 

<u>Miscellaneous Provisions</u> 

Section 10.1. <u>Fiscal Year</u>. The fiscal year of the Association shall begin on the first day of January in each year and shall end on the thirty-first day of December following.

Section 10.2. <u>Governing Law</u>. This Association designates the Delaware General Corporation Law, as amended from time to time, as the governing law for its corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations or bank safety and soundness.

\*\*\*

(February 8, 2021)

------

**<u>Exhibit 6</u>**

**CONSENT** 

In accordance with Section 321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION hereby consents that reports of examination of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.

Dated: February , 2026

---

| | |
|:---|:---|
| By: | /s/ Gregory M. Jackson |
|  | Gregory M. Jackson |
|  | Vice President |

---

------

**<u>Exhibit 7</u>**

**U.S. Bank Trust Company, National Association** 

**Statement of Financial Condition** 

**as of 9/30/2025** 

**($000's)** 

---

| | |
|:---|:---|
|  | **9/30/2025** |
|  **Assets** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash and Balances Due From Depository Institutions | $1949886 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities | 4656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal Funds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans & Lease Financing Receivables | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fixed Assets | 713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intangible Assets | 574611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Assets | 162279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Assets** | $**2692145** |
|  **Liabilities** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deposits | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fed Funds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury Demand Notes | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trading Liabilities | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Borrowed Money | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acceptances | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subordinated Notes and Debentures | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Liabilities | 222254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Liabilities** | $**222254** |
|  **Equity** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common and Preferred Stock | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surplus | 1171635 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undivided Profits | 1298056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Minority Interest in Subsidiaries | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Equity Capital** | $**2469891** |
|  **Total Liabilities and Equity Capital** | $**2692145** |

---

## Exhibit 25.2

**Exhibit 25.2** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM T-1** 

**STATEMENT OF ELIGIBILITY** 

**UNDER THE TRUST INDENTURE ACT OF 1939** 

**OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE** 

☐ **Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2)** 

## U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
**(Exact name of Trustee as specified in its charter)** 

**91-1821036** 

**I.R.S. Employer Identification No.** 

---

| | |
|:---|:---|
| **800 Nicollet Mall**<br> **Minneapolis, Minnesota** | **55402** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Gregory M. Jackson** 

**U.S. Bank Trust Company, National Association** 

**2 Concourse Pkwy Suite 800** 

**Atlanta, GA 30308** 

**(404) 898-8837** 

**(Name, address and telephone number of agent for service)** 

**UBS GROUP AG** 

**(Issuer with respect to the Securities)** 

---

| | |
|:---|:---|
| **Switzerland** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |
| **Bahnhofstrasse 45,**<br> **8001 Zurich, Switzerland** | **Not Applicable** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**4.875% Senior Notes due 2045** 

**(Title of the Indenture Securities)** 

------

**<u>FORM T-1</u>**

**Item 1.** **GENERAL INFORMATION*.*** Furnish the following information as to the Trustee. <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) *Name and address of each examining or supervising authority to which it is subject.* 

Comptroller of the Currency

Washington, D.C.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) *Whether it is authorized to exercise corporate trust powers.* 

Yes

**Item 2.** **AFFILIATIONS WITH THE OBLIGOR.** *If the obligor is an affiliate of the Trustee, describe each such affiliation.* <br>

None

---

| | |
|:---|:---|
| **Items 3-15** | *Items 3-15 are not applicable because to the best of the Trustee's knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.*  |

---

**Item 16.** **LIST OF EXHIBITS:** *List below all exhibits filed as a part of this statement of eligibility and qualification.* <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. A copy of the Articles of Association of the Trustee, attached as Exhibit 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. A copy of the certificate of authority of the Trustee to commence business, attached as Exhibit 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. A copy of the authorization of the Trustee to exercise corporate trust powers, included as Exhibit 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. A copy of the existing bylaws of the Trustee, attached as Exhibit 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. A copy of each Indenture referred to in Item 4. Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as
Exhibit 6.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Report of Condition of the Trustee as of September 30, 2025, published pursuant to law or the requirements
of its supervising or examining authority, attached as Exhibit 7.

------

**SIGNATURE** 

Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Atlanta, State of Georgia on the of February, 2026.

---

| | |
|:---|:---|
| By: | /s/ Gregory M. Jackson |
|  | Gregory M. Jackson |
|  | Vice President |

---

------

**<u>Exhibit 1</u>**

**ARTICLES OF ASSOCIATION** 

**OF** 

**U. S. BANK TRUST COMPANY, NATIONAL ASSOCIATION** 

For the purpose of organizing an association (the "Association") to perform any lawful activities of national banks, the undersigned enter into the following Articles of Association:

**FIRST.** The title of this Association shall be U. S. Bank Trust Company, National Association.

**SECOND.** The main office of the Association shall be in the city of Portland, county of Multnomah, state of Oregon. The business of the Association will be limited to fiduciary powers and the support of activities incidental to the exercise of those powers. The Association may not expand or alter its business beyond that stated in this article without the prior approval of the Comptroller of the Currency.

**THIRD.** The board of directors of the Association shall consist of not less than five nor more than twenty-five persons, the exact number to be fixed and determined from time to time by resolution of a majority of the full board of directors or by resolution of a majority of the shareholders at any annual or special meeting thereof. Each director shall own common or preferred stock of the Association or of a holding company owning the Association, with an aggregate par, fair market, or equity value of not less than $1,000, as of either (i) the date of purchase, (ii) the date the person became a director, or (iii) the date of that person's most recent election to the board of directors, whichever is more recent. Any combination of common or preferred stock of the Association or holding company may be used.

Any vacancy in the board of directors may be filled by action of a majority of the remaining directors between meetings of shareholders. The board of directors may increase the number of directors up to the maximum permitted by law. Terms of directors, including directors selected to fill vacancies, shall expire at the next regular meeting of shareholders at which directors are elected, unless the directors resign or are removed from office. Despite the expiration of a director's term, the director shall continue to serve until his or her successor is elected and qualified or until there is a decrease in the number of directors and his or her position is eliminated.

Honorary or advisory members of the board of directors, without voting power or power of final decision in matters concerning the business of the Association, may be appointed by resolution of a majority of the full board of directors, or by resolution of shareholders at any annual or special meeting. Honorary or advisory directors shall not be counted to determined the number of directors of the Association or the presence of a quorum in connection with any board action, and shall not be required to own qualifying shares.

**FOURTH.** There shall be an annual meeting of the shareholders to elect directors and transact whatever other business may be brought before the meeting. It shall be held at the main office or any other convenient place the board of directors may designate, on the day of each year specified therefor in the Bylaws, or if that day falls on a legal holiday in the state in which the

------

Association is located, on the next following banking day. If no election is held on the day fixed or in the event of a legal holiday on the following banking day, an election may be held on any subsequent day within 60 days of the day fixed, to be designated by the board of directors, or, if the directors fail to fix the day, by shareholders representing two-thirds of the shares issued and outstanding. In all cases, at least 10 days' advance notice of the meeting shall be given to the shareholders by first-class mail.

In all elections of directors, the number of votes each common shareholder may cast will be determined by multiplying the number of shares he or she owns by the number of directors to be elected. Those votes may be cumulated and cast for a single candidate or may be distributed among two or more candidates in the manner selected by the shareholder. On all other questions, each common shareholder shall be entitled to one vote for each share of stock held by him or her.

A director may resign at any time by delivering written notice to the board of directors, its chairperson, or to the Association, which resignation shall be effective when the notice is delivered unless the notice specifies a later effective date.

A director may be removed by the shareholders at a meeting called to remove him or her, when notice of the meeting stating that the purpose or one of the purposes is to remove him or her is provided, if there is a failure to fulfill one of the affirmative requirements for qualification, or for cause; provided, however, that a director may not be removed if the number of votes sufficient to elect him or her under cumulative voting is voted against his or her removal.

**FIFTH.** The authorized amount of capital stock of the Association shall be 1,000,000 shares of common stock of the par value of ten dollars ($10) each; but said capital stock may be increased or decreased from time to time, according to the provisions of the laws of the United States. The Association shall have only one class of capital stock.

No holder of shares of the capital stock of any class of the Association shall have any preemptive or preferential right of subscription to any shares of any class of stock of the Association, whether now or hereafter authorized, or to any obligations convertible into stock of the Association, issued, or sold, nor any right of subscription to any thereof other than such, if any, as the board of directors, in its discretion, may from time to time determine and at such price as the board of directors may from time to time fix.

Transfers of the Association's stock are subject to the prior written approval of a federal depository institution regulatory agency. If no other agency approval is required, the approval of the Comptroller of the Currency must be obtained prior to any such transfers.

Unless otherwise specified in the Articles of Association or required by law, (1) all matters requiring shareholder action, including amendments to the Articles of Association must be approved by shareholders owning a majority voting interest in the outstanding voting stock, and (2) each shareholder shall be entitled to one vote per share.

------

Unless otherwise specified in the Articles of Association or required by law, all shares of voting stock shall be voted together as a class, on any matters requiring shareholder approval.

Unless otherwise provided in the Bylaws, the record date for determining shareholders entitled to notice of and to vote at any meeting is the close of business on the day before the first notice is mailed or otherwise sent to the shareholders, provided that in no event may a record date be more than 70 days before the meeting.

The Association, at any time and from time to time, may authorize and issue debt obligations, whether subordinated, without the approval of the shareholders. Obligations classified as debt, whether subordinated, which may be issued by the Association without the approval of shareholders, do not carry voting rights on any issue, including an increase or decrease in the aggregate number of the securities, or the exchange or reclassification of all or part of securities into securities of another class or series.

**SIXTH.** The board of directors shall appoint one of its members president of this Association and one of its members chairperson of the board and shall have the power to appoint one or more vice presidents, a secretary who shall keep minutes of the directors' and shareholders' meetings and be responsible for authenticating the records of the Association, and such other officers and employees as may be required to transact the business of this Association. A duly appointed officer may appoint one or more officers or assistant officers if authorized by the board of directors in accordance with the Bylaws.

The board of directors shall have the power to:

(1) Define the duties of the officers, employees, and agents of the Association.

(2) Delegate the performance of its duties, but not the responsibility for its duties, to the officers, employees,
and agents of the Association.

(3) Fix the compensation and enter employment contracts with its officers and employees upon reasonable terms and
conditions consistent with applicable law.

(4) Dismiss officers and employees.

(5) Require bonds from officers and employees and to fix the penalty thereof.

(6) Ratify written policies authorized by the Association's management or committees of the board.

(7) Regulate the manner any increase or decrease of the capital of the Association shall be made; provided that
nothing herein shall restrict the power of shareholders to increase or decrease the capital of the Association in accordance with law, and nothing shall raise or lower from two-thirds the percentage required
for shareholder approval to increase or reduce the capital.

------

(8) Manage and administer the business and affairs of the Association.

(9) Adopt initial Bylaws, not inconsistent with law or the Articles of Association, for managing the business and
regulating the affairs of the Association.

(10) Amend or repeal Bylaws, except to the extent that the Articles of Association reserve this power in whole or in
part to the shareholders.

(11) Make contracts.

(12) Generally perform all acts that are legal for a board of directors to perform.

**SEVENTH.** The board of directors shall have the power to change the location of the main office to any authorized branch within the limits of the city of Portland, Oregon, without the approval of the shareholders, or with a vote of shareholders owning two-thirds of the stock of the Association for a location outside such limits and upon receipt of a certificate of approval from the Comptroller of the Currency, to any other location within or outside the limits of the city of Portland, Oregon, but not more than thirty miles beyond such limits. The board of directors shall have the power to establish or change the location of any office or offices of the Association to any other location permitted under applicable law, without approval of shareholders, subject to approval by the Comptroller of the Currency.

**EIGHTH.** The corporate existence of this Association shall continue until termination according to the laws of the United States.

**NINTH.** The board of directors of the Association, or any shareholder owning, in the aggregate, not less than 25 percent of the stock of the Association, may call a special meeting of shareholders at any time. Unless otherwise provided by the Bylaws or the laws of the United States, or waived by shareholders, a notice of the time, place, and purpose of every annual and special meeting of the shareholders shall be given by first-class mail, postage prepaid, mailed at least 10, and no more than 60, days prior to the date of the meeting to each shareholder of record at his/her address as shown upon the books of the Association. Unless otherwise provided by the Bylaws, any action requiring approval of shareholders must be effected at a duly called annual or special meeting.

**TENTH.** These Articles of Association may be amended at any regular or special meeting of the shareholders by the affirmative vote of the holders of a majority of the stock of the Association, unless the vote of the holders of a greater amount of stock is required by law, and in that case by the vote of the holders of such greater amount; provided, that the scope of the Association's activities and services may not be expanded without the prior written approval of the Comptroller of the Currency. The Association's board of directors may propose one or more amendments to the Articles of Association for submission to the shareholders.

------

In witness whereof, we have hereunto set our hands this 11<sup>th</sup> of June, 1997.

---

| |
|:---|
| /s/ Jeffrey T. Grubb |
| Jeffrey T. Grubb |
| /s/ Robert D. Sznewajs |
| Robert D. Sznewajs |
| /s/ Dwight V. Board |
| Dwight V. Board |
| /s/ P. K. Chatterjee |
| P. K. Chatterjee |
| /s/ Robert Lane |
| Robert Lane |

---

------

**<u>Exhibit 2</u>**

![LOGO](g17238g0209181954756.jpg)

------

**<u>Exhibit 4</u>**

**U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION** 

**<u>AMENDED AND RESTATED BYLAWS</u>**

<u>ARTICLE I</u> 

<u>Meetings of Shareholders</u> 

Section 1.1. <u>Annual Meeting</u>. The annual meeting of the shareholders, for the election of directors and the transaction of any other proper business, shall be held at a time and place as the Chairman or President may designate. Notice of such meeting shall be given not less than ten (10) days or more than sixty (60) days prior to the date thereof, to each shareholder of the Association, unless the Office of the Comptroller of the Currency (the "OCC") determines that an emergency circumstance exists. In accordance with applicable law, the sole shareholder of the Association is permitted to waive notice of the meeting. If, for any reason, an election of directors is not made on the designated day, the election shall be held on some subsequent day, as soon thereafter as practicable, with prior notice thereof. Failure to hold an annual meeting as required by these Bylaws shall not affect the validity of any corporate action or work a forfeiture or dissolution of the Association.

Section 1.2. <u>Special Meetings</u>. Except as otherwise specially provided by law, special meetings of the shareholders may be called for any purpose, at any time by a majority of the board of directors (the "Board"), or by any shareholder or group of shareholders owning at least ten percent of the outstanding stock.

Every such special meeting, unless otherwise provided by law, shall be called upon not less than ten (10) days nor more than sixty (60) days prior notice stating the purpose of the meeting.

Section 1.3. <u>Nominations for Directors</u>. Nominations for election to the Board may be made by the Board or by any shareholder.

Section 1.4. <u>Proxies</u>. Shareholders may vote at any meeting of the shareholders by proxies duly authorized in writing. Proxies shall be valid only for one meeting and any adjournments of such meeting and shall be filed with the records of the meeting.

Section 1.5. <u>Record Date</u>. The record date for determining shareholders entitled to notice and to vote at any meeting will be thirty days before the date of such meeting, unless otherwise determined by the Board.

------

Section 1.6. <u>Quorum and Voting</u>. A majority of the outstanding capital stock, represented in person or by proxy, shall constitute a quorum at any meeting of shareholders, unless otherwise provided by law, but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice. A majority of the votes cast shall decide every question or matter submitted to the shareholders at any meeting, unless otherwise provided by law or by the Articles of Association.

Section 1.7. <u>Inspectors</u>. The Board may, and in the event of its failure so to do, the Chairman of the Board may appoint Inspectors of Election who shall determine the presence of quorum, the validity of proxies, and the results of all elections and all other matters voted upon by shareholders at all annual and special meetings of shareholders.

Section 1.8. <u>Waiver and Consent</u>. The shareholders may act without notice or a meeting by a unanimous written consent by all shareholders.

Section 1.9. <u>Remote Meetings</u>. The Board shall have the right to determine that a shareholder meeting not be held at a place, but instead be held solely by means of remote communication in the manner and to the extent permitted by the General Corporation Law of the State of Delaware.

<u>ARTICLE II</u> 

<u>Directors</u> 

Section 2.1. <u>Board of Directors</u>. The Board shall have the power to manage and administer the business and affairs of the Association. Except as expressly limited by law, all corporate powers of the Association shall be vested in and may be exercised by the Board.

Section 2.2. <u>Term of Office</u>. The directors of this Association shall hold office for one year and until their successors are duly elected and qualified, or until their earlier resignation or removal.

Section 2.3. <u>Powers</u>. In addition to the foregoing, the Board shall have and may exercise all of the powers granted to or conferred upon it by the Articles of Association, the Bylaws and by law.

Section 2.4. <u>Number</u>. As provided in the Articles of Association, the Board of this Association shall consist of no less than five nor more than twenty-five members, unless the OCC has exempted the Association from the twenty-five- member limit. The Board shall consist of a number of members to be fixed and determined from time to time by resolution of the Board or the shareholders at any meeting thereof, in accordance with the Articles of Association. Between meetings of the shareholders held for the purpose of electing directors, the Board

------

by a majority vote of the full Board may increase the size of the Board but not to more than a total of twenty-five directors, and fill any vacancy so created in the Board; provided that the Board may increase the number of directors only by up to two directors, when the number of directors last elected by shareholders was fifteen or fewer, and by up to four directors, when the number of directors last elected by shareholders was sixteen or more. Each director shall own a qualifying equity interest in the Association or a company that has control of the Association in each case as required by applicable law. Each director shall own such qualifying equity interest in his or her own right and meet any minimum threshold ownership required by applicable law.

Section 2.5. <u>Organization Meeting</u>. The newly elected Board shall meet for the purpose of organizing the new Board and electing and appointing such officers of the Association as may be appropriate. Such meeting shall be held on the day of the election or as soon thereafter as practicable, and, in any event, within thirty days thereafter, at such time and place as the Chairman or President may designate. If, at the time fixed for such meeting, there shall not be a quorum present, the directors present may adjourn the meeting until a quorum is obtained.

Section 2.6. <u>Regular Meetings</u>. The regular meetings of the Board shall be held, without notice, as the Chairman or President may designate and deem suitable.

Section 2.7. <u>Special Meetings</u>. Special meetings of the Board may be called at any time, at any place and for any purpose by the Chairman of the Board or the President of the Association, or upon the request of a majority of the entire Board. Notice of every special meeting of the Board shall be given to the directors at their usual places of business, or at such other addresses as shall have been furnished by them for the purpose. Such notice shall be given at least twelve hours (three hours if meeting is to be conducted by conference telephone) before the meeting by telephone or by being personally delivered, mailed, or electronically delivered. Such notice need not include a statement of the business to be transacted at, or the purpose of, any such meeting.

Section 2.8. <u>Quorum and Necessary Vote</u>. A majority of the directors shall constitute a quorum at any meeting of the Board, except when otherwise provided by law; but less than a quorum may adjourn any meeting, from time to time, and the meeting may be held as adjourned without further notice. Unless otherwise provided by law or the Articles or Bylaws of this Association, once a quorum is established, any act by a majority of those directors present and voting shall be the act of the Board.

------

Section 2.9. <u>Written Consent</u>. Except as otherwise required by applicable laws and regulations, the Board may act without a meeting by a unanimous written consent by all directors, to be filed with the Secretary of the Association as part of the corporate records.

Section 2.10. <u>Remote Meetings</u>. Members of the Board, or of any committee thereof, may participate in a meeting of such Board or committee by means of conference telephone, video or similar communications equipment by means of which all persons participating in the meeting can hear each other and such participation shall constitute presence in person at such meeting.

Section 2.11. <u>Vacancies</u>. When any vacancy occurs among the directors, the remaining members of the Board may appoint a director to fill such vacancy at any regular meeting of the Board, or at a special meeting called for that purpose.

<u>ARTICLE III</u> 

<u>Committees</u> 

Section 3.1. <u>Advisory Board of Directors</u>. The Board may appoint persons, who need not be directors, to serve as advisory directors on an advisory board of directors established with respect to the business affairs of either this Association alone or the business affairs of a group of affiliated organizations of which this Association is one. Advisory directors shall have such powers and duties as may be determined by the Board, provided, that the Board's responsibility for the business and affairs of this Association shall in no respect be delegated or diminished.

Section 3.2. <u>Trust Audit Committee</u>. At least once during each calendar year, the Association shall arrange for a suitable audit (by internal or external auditors) of all significant fiduciary activities under the direction of its trust audit committee, a function that will be fulfilled by the Audit Committee of the financial holding company that is the ultimate parent of this Association. The Association shall note the results of the audit (including significant actions taken as a result of the audit) in the minutes of the Board. In lieu of annual audits, the Association may adopt a continuous audit system in accordance with 12 C.F.R. § 9.9(b).

------

The Audit Committee of the financial holding company that is the ultimate parent of this Association, fulfilling the function of the trust audit committee:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Must not include any officers of the Association or an affiliate who participate significantly in the administration of the Association's fiduciary activities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Must consist of a majority of members who are not also members of any committee to which the Board has delegated power to manage and control the fiduciary activities of the Association.

Section 3.3. <u>Executive Committee</u>. The Board may appoint an Executive Committee which shall consist of at least three directors and which shall have, and may exercise, to the extent permitted by applicable law, all the powers of the Board between meetings of the Board or otherwise when the Board is not meeting.

Section 3.4. <u>Trust Management Committee</u>. The Board of this Association shall appoint a Trust Management Committee to provide oversight of the fiduciary activities of the Association. The Trust Management Committee shall determine policies governing fiduciary activities. The Trust Management Committee or such sub-committees, officers or others as may be duly designated by the Trust Management Committee shall oversee the processes related to fiduciary activities to assure conformity with fiduciary policies it establishes, including ratifying the acceptance and the closing out or relinquishment of all trusts. The Trust Management Committee will provide regular reports of its activities to the Board.

Section 3.5. <u>Other Committees</u>. The Board may appoint, from time to time, committees of one or more persons who need not be directors, for such purposes and with such powers as the Board may determine; however, the Board will not delegate to any committee any powers or responsibilities that it is prohibited from delegating under any law or regulation. In addition, either the Chairman or the President may appoint, from time to time, committees of one or more officers, employees, agents or other persons, for such purposes and with such powers as either the Chairman or the President deems appropriate and proper. Whether appointed by the Board, the Chairman, or the President, any such committee shall at all times be subject to the direction and control of the Board.

Section 3.6. <u>Meetings, Minutes and Rules</u>. An advisory board of directors and/or committee shall meet as necessary in consideration of the purpose of the advisory board of directors or committee, and shall maintain minutes in sufficient detail to indicate actions taken or recommendations made; unless required by the members, discussions, votes or other specific details need not be reported. An advisory board of directors or a committee may, in consideration of its purpose, adopt its own rules for the exercise of any of its functions or authority.

------

<u>ARTICLE IV</u> 

<u>Officers</u> 

Section 4.1. <u>Chairman of the Board</u>. The Board may appoint one of its members to be Chairman of the Board to serve at the pleasure of the Board. The Chairman shall supervise the carrying out of the policies adopted or approved by the Board; shall have general executive powers, as well as the specific powers conferred by these Bylaws; and shall also have and may exercise such powers and duties as from time to time may be conferred upon or assigned by the Board.

Section 4.2. <u>President</u>. The Board may appoint one of its members to be President of the Association. In the absence of the Chairman, the President shall preside at any meeting of the Board. The President shall have general executive powers, and shall have and may exercise any and all other powers and duties pertaining by law, regulation or practice, to the office of President, or imposed by these Bylaws. The President shall also have and may exercise such powers and duties as from time to time may be conferred or assigned by the Board.

Section 4.3. <u>Vice President</u>. The Board may appoint one or more Vice Presidents who shall have such powers and duties as may be assigned by the Board and to perform the duties of the President on those occasions when the President is absent, including presiding at any meeting of the Board in the absence of both the Chairman and President.

Section 4.4. <u>Secretary</u>. The Board shall appoint a Secretary, or other designated officer who shall be Secretary of the Board and of the Association, and shall keep accurate minutes of all meetings. The Secretary shall attend to the giving of all notices required by these Bylaws to be given; shall be custodian of the corporate seal, records, documents and papers of the Association; shall provide for the keeping of proper records of all transactions of the Association; shall, upon request, authenticate any records of the Association; shall have and may exercise any and all other powers and duties pertaining by law, regulation or practice, to the Secretary, or imposed by these Bylaws; and shall also perform such other duties as may be assigned from time to time by the Board. The Board may appoint one or more Assistant Secretaries with such powers and duties as the Board, the President or the Secretary shall from time to time determine.

Section 4.5. <u>Other Officers</u>. The Board may appoint, and may authorize the Chairman, the President or any other officer to appoint, any officer as from time to time may appear to the Board, the Chairman, the President or such other

------

officer to be required or desirable to transact the business of the Association. Such officers shall exercise such powers and perform such duties as pertain to their several offices, or as may be conferred upon or assigned to them by these Bylaws, the Board, the Chairman, the President or such other authorized officer. Any person may hold two offices.

Section 4.6. <u>Tenure of Office</u>. The Chairman or the President and all other officers shall hold office until their respective successors are elected and qualified or until their earlier death, resignation, retirement, disqualification or removal from office, subject to the right of the Board or authorized officer to discharge any officer at any time.

<u>ARTICLE V</u> 

<u>Stock</u> 

Section 5.1. The Board may authorize the issuance of stock either in certificated or in uncertificated form. Certificates for shares of stock shall be in such form as the Board may from time to time prescribe. If the Board issues certificated stock, the certificate shall be signed by the President, Secretary or any other such officer as the Board so determines. Shares of stock shall be transferable on the books of the Association, and a transfer book shall be kept in which all transfers of stock shall be recorded. Every person becoming a shareholder by such transfer shall, in proportion to such person's shares, succeed to all rights of the prior holder of such shares. Each certificate of stock shall recite on its face that the stock represented thereby is transferable only upon the books of the Association properly endorsed. The Board may impose conditions upon the transfer of the stock reasonably calculated to simplify the work of the Association for stock transfers, voting at shareholder meetings, and related matters, and to protect it against fraudulent transfers.

<u>ARTICLE VI</u> 

<u>Corporate Seal</u> 

Section 6.1. The Association shall have no corporate seal; provided, however, that if the use of a seal is required by, or is otherwise convenient or advisable pursuant to, the laws or regulations of any jurisdiction, the following seal may be used, and the Chairman, the President, the Secretary and any Assistant Secretary shall have the authority to affix such seal:

------

<u>ARTICLE VII</u> 

<u>Miscellaneous Provisions</u> 

Section 7.1. <u>Execution of Instruments</u>. All agreements, checks, drafts, orders, indentures, notes, mortgages, deeds, conveyances, transfers, endorsements, assignments, certificates, declarations, receipts, discharges, releases, satisfactions, settlements, petitions, schedules, accounts, affidavits, bonds, undertakings, guarantees, proxies and other instruments or documents may be signed, countersigned, executed, acknowledged, endorsed, verified, delivered or accepted on behalf of the Association, whether in a fiduciary capacity or otherwise, by any officer of the Association, or such employee or agent as may be designated from time to time by the Board by resolution, or by the Chairman or the President by written instrument, which resolution or instrument shall be certified as in effect by the Secretary or an Assistant Secretary of the Association. The provisions of this section are supplementary to any other provision of the Articles of Association or Bylaws.

Section 7.2. <u>Records</u>. The Articles of Association, the Bylaws as revised or amended from time to time and the proceedings of all meetings of the shareholders, the Board, and standing committees of the Board, shall be recorded in appropriate minute books provided for the purpose. The minutes of each meeting shall be signed by the Secretary, or other officer appointed to act as Secretary of the meeting.

Section 7.3. <u>Trust Files</u>. There shall be maintained in the Association files all fiduciary records necessary to assure that its fiduciary responsibilities have been properly undertaken and discharged.

Section 7.4. <u>Trust Investments</u>. Funds held in a fiduciary capacity shall be invested according to the instrument establishing the fiduciary relationship and according to law. Where such instrument does not specify the character and class of investments to be made and does not vest in the Association a discretion in the matter, funds held pursuant to such instrument shall be invested in investments in which corporate fiduciaries may invest under law.

Section 7.5. <u>Notice</u>. Whenever notice is required by the Articles of Association, the Bylaws or law, such notice shall be by mail, postage prepaid, e- mail, in person, or by any other means by which such notice can reasonably be expected to be received, using the address of the person to receive such notice, or such other personal data, as may appear on the records of the Association.

Except where specified otherwise in these Bylaws, prior notice shall be proper if given not more than 30 days nor less than 10 days prior to the event for which notice is given.

------

<u>ARTICLE VIII</u> 

<u>Indemnification</u> 

Section 8.1. The Association shall indemnify such persons for such liabilities in such manner under such circumstances and to such extent as permitted by Section 145 of the Delaware General Corporation Law, as now enacted or hereafter amended. The Board may authorize the purchase and maintenance of insurance and/or the execution of individual agreements for the purpose of such indemnification, and the Association shall advance all reasonable costs and expenses (including attorneys' fees) incurred in defending any action, suit or proceeding to all persons entitled to indemnification under this Section 8.1. Such insurance shall be consistent with the requirements of 12 C.F.R. § 7.2014 and shall exclude coverage of liability for a formal order assessing civil money penalties against an institution-affiliated party, as defined at 12 U.S.C. § 1813(u).

Section 8.2. Notwithstanding Section 8.1, however, (a) any indemnification payments to an institution-affiliated party, as defined at 12 U.S.C. § 1813(u), for an administrative proceeding or civil action initiated by a federal banking agency, shall be reasonable and consistent with the requirements of 12 U.S.C. § 1828(k) and the implementing regulations thereunder; and (b) any indemnification payments and advancement of costs and expenses to an institution-affiliated party, as defined at 12 U.S.C. § 1813(u), in cases involving an administrative proceeding or civil action not initiated by a federal banking agency, shall be in accordance with Delaware General Corporation Law and consistent with safe and sound banking practices.

<u>ARTICLE IX</u> 

<u>Bylaws: Interpretation and Amendment</u> 

Section 9.1. These Bylaws shall be interpreted in accordance with and subject to appropriate provisions of law, and may be added to, altered, amended, or repealed, at any regular or special meeting of the Board.

Section 9.2. A copy of the Bylaws and all amendments shall at all times be kept in a convenient place at the principal office of the Association, and shall be open for inspection to all shareholders during Association hours.

------

<u>ARTICLE X</u> 

<u>Miscellaneous Provisions</u> 

Section 10.1. <u>Fiscal Year</u>. The fiscal year of the Association shall begin on the first day of January in each year and shall end on the thirty-first day of December following.

Section 10.2. <u>Governing Law</u>. This Association designates the Delaware General Corporation Law, as amended from time to time, as the governing law for its corporate governance procedures, to the extent not inconsistent with Federal banking statutes and regulations or bank safety and soundness.

\*\*\*

(February 8, 2021)

------

**<u>Exhibit 6</u>**

**CONSENT** 

In accordance with Section 321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION hereby consents that reports of examination of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.

Dated: February , 2026

---

| | |
|:---|:---|
| By: | /s/ Gregory M. Jackson |
|  | Gregory M. Jackson |
|  | Vice President |

---

------

**<u>Exhibit 7</u>**

**U.S. Bank Trust Company, National Association** 

**Statement of Financial Condition** 

**as of 9/30/2025** 

**($000's)** 

---

| | |
|:---|:---|
|  | **9/30/2025** |
|  **Assets** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash and Balances Due From Depository Institutions | $1949886 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities | 4656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal Funds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans & Lease Financing Receivables | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fixed Assets | 713 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intangible Assets | 574611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Assets | 162279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Assets** | $**2692145** |
|  **Liabilities** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deposits | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fed Funds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury Demand Notes | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trading Liabilities | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Borrowed Money | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acceptances | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subordinated Notes and Debentures | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Liabilities | 222254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Liabilities** | $**222254** |
|  **Equity** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common and Preferred Stock | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Surplus | 1171635 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undivided Profits | 1298056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Minority Interest in Subsidiaries | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total Equity Capital** | $**2469891** |
|  **Total Liabilities and Equity Capital** | $**2692145** |

---

## Exhibit 25.3

**Exhibit 25.3** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM T-1** 

**STATEMENT OF ELIGIBILITY** 

**UNDER THE TRUST INDENTURE ACT OF 1939** 

**OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE** 

☐ **CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2)** 

## THE BANK OF NEW YORK MELLON
**(Exact name of trustee as specified in its charter)** 

---

| | |
|:---|:---|
| **New York** | **13-5160382** |
| **(Jurisdiction of incorporation**<br> **if not a U.S. national bank)** | **(I.R.S. employer**<br> **identification no.)** |
| **240 Greenwich Street, New York, N.Y.** | **10286** |
| **(Address of principal executive offices)** | **(Zip code)** |

---

**UBS AMERICAS INC.** 

**(Exact name of obligor as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **06-1595848** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. employer**<br> **identification no.)** |
| **11 Madison Avenue**<br> **New York, New York** | **10010** |
| **(Address of principal executive offices)** | **(Zip code)** |

---

**UBS Group AG** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Canton of Zurich, Switzerland** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. employer**<br> **identification no.)** |
| **Bahnhofstrasse 45,**<br> **8001 Zurich, Switzerland** |  |
| **(Address of principal executive offices)** | **(Zip code)** |

---

**UBS AG** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Canton of Zurich, Switzerland** | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. employer**<br> **identification no.)** |
| **Bahnhofstrasse 45,**<br> **8001 Zurich, Switzerland**<br> **and**<br> **Aeschenvorstadt 1,**<br> **4051 Basel, Switzerland** |  |
| **(Address of principal executive offices)** | **(Zip code)** |

---

**7<sup>1</sup>⁄<sub>8</sub>% Notes due July 15, 2032** 

**and Guarantees of 7<sup>1</sup>⁄<sub>8</sub>% Notes due July 15, 2032** 

**(Title of the indenture securities)** 

------

**1.** **General information. Furnish the following information as to the Trustee:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Name and address of each examining or supervising authority to which it is subject.** 

---

| | |
|:---|:---|
| Name | Address |
|  Superintendent of the Department of Financial Services of the State of New York | One State Street, New York, N.Y.<br> 10004-1417, and Albany,<br> N.Y. 12223 |
|  Federal Reserve Bank of New York | 33 Liberty Street, New York, N.Y. 10045 |
|  Federal Deposit Insurance Corporation | 550 17<sup>th</sup> Street, NW<br> Washington, D.C. 20429 |
|  The Clearing House Association L.L.C. | 100 Broad Street<br> New York, N.Y. 10004 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Whether it is authorized to exercise corporate trust powers.** 

Yes.

**2.** **Affiliations with Obligor.** 

**If the obligor is an affiliate of the trustee, describe each such affiliation.** 

None.

**16.** **List of Exhibits.** 

**Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the "Act").** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York,
itself formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with Registration Statement No. 33-29637, Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-261533).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its
supervising or examining authority.

------

SIGNATURE

Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Houston, and State of Texas, on the 2nd day of February, 2026.

---

| | |
|:---|:---|
|  THE BANK OF NEW YORK MELLON | THE BANK OF NEW YORK MELLON |
| By: | /s/ April Bradley |
| Name: | April Bradley |
| Title: | Agent |

---

------

**<u>EXHIBIT 7</u>** 

Consolidated Report of Condition of

THE BANK OF NEW YORK MELLON

of 240 Greenwich Street, New York, N.Y. 10286

And Foreign and Domestic Subsidiaries,

a member of the Federal Reserve System, at the close of business September 30, 2025, published in accordance with a call made by the Federal Reserve Bank of this District pursuant to the provisions of the Federal Reserve Act.

---

| | |
|:---|:---|
|  | Dollar amounts<br>in thousands |
|  **ASSETS** |  |
|  Cash and balances due from depository institutions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noninterest-bearing balances and currency and coin | 3883000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest-bearing balances | 113411000 |
|  Securities: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Held-to-maturity securities | 49539000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Available-for-sale debt securities | 99736000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity securities with readily determinable fair values not held for trading | 0 |
|  Federal funds sold and securities purchased under agreements to resell: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal funds sold in domestic offices | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities purchased under agreements to resell | 23061000 |
|  Loans and lease financing receivables: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans and leases held for sale | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans and leases held for investment | 37648000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LESS: Allowance for credit losses on loans and leases | 248000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loans and leases held for investment, net of allowance | 37400000 |
|  Trading assets | 6956000 |
|  Premises and fixed assets (including right-of-use assets) | 3208000 |
|  Other real estate owned | 0 |
|  Investments in unconsolidated subsidiaries and associated companies | 2259000 |
|  Direct and indirect investments in real estate ventures | 0 |
|  Intangible assets | 7375000 |
|  Other assets | 19674000 |
|  Total assets | 366502000 |

---

------

---

| | |
|:---|:---|
|  **LIABILITIES** <br>|  |
|  Deposits: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In domestic offices | 206711000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noninterest-bearing | 61784000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest-bearing | 144927000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In foreign offices, Edge and Agreement subsidiaries, and IBFs | 111433000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Noninterest-bearing | 6525000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest-bearing | 104908000 |
|  Federal funds purchased and securities sold under agreements to repurchase: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal funds purchased in domestic offices | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities sold under agreements to repurchase | 2313000 |
|  Trading liabilities | 971000 |
|  Other borrowed money: <br>(includes mortgage indebtedness) | 5159000 |
|  Not applicable |  |
|  Not applicable |  |
|  Subordinated notes and debentures | 0 |
|  Other liabilities | 10656000 |
|  Total liabilities | 337243000 |
|  **EQUITY CAPITAL** |  |
|  Perpetual preferred stock and related surplus | 0 |
|  Common stock | 1135000 |
|  Surplus (exclude all surplus related to preferred stock) | 12854000 |
|  Retained earnings | 17216000 |
|  Accumulated other comprehensive income | -1946000 |
|  Other equity capital components | 0 |
|  Total bank equity capital | 29259000 |
|  Noncontrolling (minority) interests in consolidated subsidiaries | 0 |
|  Total equity capital | 29259000 |
|  Total liabilities and equity capital | 366502000 |

---

------

I, Dermot McDonogh, Chief Financial Officer of the above-named bank do hereby declare that this Report of Condition is true and correct to the best of my knowledge and belief.

Dermot McDonogh

Chief Financial Officer

We, the undersigned directors, attest to the correctness of this statement of resources and liabilities. We declare that it has been examined by us, and to the best of our knowledge and belief has been prepared in conformance with the instructions and is true and correct.

Robin A. Vince <br>Jeffrey A. Goldstein <br>Joseph J. Echevarria Directors <br>

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**F-3**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**UBS Group AG**  |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Security Type**  | **Security Class Title**  | **Fee Calculation or Carry Forward Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| Fees to be Paid | 1 | Debt | 4.875% Senior Notes due 2045 of UBS Group AG | Other | 104502677.88 | $1.00 | $104502677.88 | 0.0001381 | $14431.82 |
| Fees to be Paid | 2 | Debt | 4.550% Senior Notes due 2026 of UBS Group AG | Other | 395800850.32 | $1.00 | $395800850.32 | 0.0001381 | $54660.10 |
| Fees to be Paid | 3 | Debt | 3.750% Senior Notes due 2025 of UBS Group AG | Other | 400623852.57 | $1.00 | $400623852.57 | 0.0001381 | $55326.15 |
| Fees to be Paid | 4 | Debt | 3.800% Senior Notes due 2023 of UBS Group AG | Other | 175079315.5 | $1.00 | $175079315.50 | 0.0001381 | $24178.45 |
| Fees to be Paid | 5 | Debt | 3.800% Senior Notes due 2022 of Credit Suisse Group Funding (Guernsey) Limited | Other | 13856732.28 | $1.00 | $13856732.28 | 0.0001381 | $1913.61 |
| Fees to be Paid | 6 | Debt | 7 1/8% Notes due July 15, 2032 | Other | 4232000 | $1.00 | $4232000.00 | 0.0001381 | $584.44 |
| Fees to be Paid | 7 | Other | Guarantees of UBS AG in connection with the 7 1/8% Notes due July 15, 2032 of Credit Suisse (USA) LLC | Other |  |  |  | 0.0001381 | $0.00 |
| Fees to be Paid | 8 | Other | Subordinated Guarantees of UBS Group AG in connection with the 7 1/8% Notes due July 15, 2032 of Credit Suisse (USA) LLC | Other |  |  |  | 0.0001381 | $0.00 |
| Fees Previously Paid |  |  |  |  |  |  |  |  |  |
| **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** |
| Carry Forward Securities |  |  |  |  |  |  |  |  |  |
|  |  |  | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $1094095428.55  |  | $151094.57  |
|  |  |  | Total Fees Previously Paid:  | Total Fees Previously Paid:  | Total Fees Previously Paid:  |  |  |  | $0.00  |
|  |  |  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
|  |  |  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $151094.57  |

---

 **Offering Note** <br>

<sup>1</sup> (1) These securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act of 1933, as amended (the "Securities Act"), the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. In addition to the rescission offer, the issuer of these securities or its affiliates may reoffer or resell these securities on an ongoing basis in market-making transactions. Pursuant to Rule 457(q) under the Securities Act, no separate registration fee is payable with respect to any such market-making transactions. The aggregate principal amount of the 4.875% Senior Notes due 2045 of UBS Group AG currently outstanding is $1,924,666,000.

<sup>2</sup> (2) These securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act, the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. In addition to the rescission offer, the issuer of these securities or its affiliates may reoffer or resell these securities on an ongoing basis in market-making transactions. Pursuant to Rule 457(q) under the Securities Act, no separate registration fee is payable with respect to any such market-making transactions. The aggregate principal amount of the 4.550% Senior Notes due 2026 of UBS Group AG currently outstanding is $1,982,535,000.

<sup>3</sup> (3) These securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act, the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. These securities have matured and are no longer outstanding.

<sup>4</sup> (3) These securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act, the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. These securities have matured and are no longer outstanding.

<sup>5</sup> (3) These securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act, the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. These securities have matured and are no longer outstanding. (4) The 3.800% Senior Notes due 2022 of Credit Suisse Group Funding (Guernsey) Limited were guaranteed by Credit Suisse Group AG. As these securities have matured and are no longer outstanding, such guarantees are note being registered under this Registration Statement.

<sup>6</sup> (5) Certain of these securities were sold prior to the registration of such sales and are subsequently registered for the purpose of making an offer of rescission of such sales. In accordance with Rule 475(j) under the Securities Act, the registration fee is to be calculated on the basis of the amount at which such securities were sold. To determine such price, the issuer has excluded any accrued interest, fees, selling concessions or other additional amounts. In addition to the rescission offer, the issuer of these securities or its affiliates may reoffer or resell these securities on an ongoing basis in market-making transactions. Pursuant to Rule 457(q) under the Securities Act, no separate registration fee is payable with respect to any such market-making transactions. The aggregate principal amount of the 7 1/8% Notes due July 15, 2032 of Credit Suisse (USA) LLC currently outstanding is $742,344,000.

<sup>7</sup> (6) No separate consideration will be received for the subordinated guarantees of UBS Group AG and the guarantees of UBS AG in connection with the 7 1/8% Notes due July 15, 2032 of Credit Suisse (USA) LLC. Pursuant to Rule 475(n) under the Securities Act, no registration fee is payable with respect to the subordinated guarantees of UBS Group AG and guarantees of UBS AG being registered.

<sup>8</sup> (6) No separate consideration will be received for the subordinated guarantees of UBS Group AG and the guarantees of UBS AG in connection with the 7 1/8% Notes due July 15, 2032 of Credit Suisse (USA) LLC. Pursuant to Rule 475(n) under the Securities Act, no registration fee is payable with respect to the subordinated guarantees of UBS Group AG and guarantees of UBS AG being registered.

---

| | |
|:---|:---|
| | |
| **Rules 457(b) and 0-11(a)(2)** | **Rules 457(b) and 0-11(a)(2)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Security Type**  | **Security Class Title**  | **Amount of Securities Previously Registered**  | **Maximum Aggregate Offering Price of Securities Previously Registered**  | **Form Type**  | **File Number**  | **Initial Effective Date**  |
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---